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A B S T R A C T
Background
This is an updated version of the original Cochrane Review published in 2010, Issue 9, and last updated in 2014, Issue 4. Non-invasive
brain stimulation techniques aim to induce an electrical stimulation of the brain in an attempt to reduce chronic pain by directly
altering brain activity. They include repetitive transcranial magnetic stimulation (rTMS), cranial electrotherapy stimulation (CES),
transcranial direct current stimulation (tDCS), transcranial random noise stimulation (tRNS) and reduced impedance non-invasive
cortical electrostimulation (RINCE).
Objectives
To evaluate the efficacy of non-invasive cortical stimulation techniques in the treatment of chronic pain.
Search methods
For this update we searched CENTRAL, MEDLINE, Embase, CINAHL, PsycINFO, LILACS and clinical trials registers from July
2013 to October 2017.
Selection criteria
Randomised and quasi-randomised studies of rTMS, CES, tDCS, RINCE and tRNS if they employed a sham stimulation control
group, recruited patients over the age of 18 years with pain of three months’ duration or more, and measured pain as an outcome.
Outcomes of interest were pain intensity measured using visual analogue scales or numerical rating scales, disability, quality of life and
adverse events.
Data collection and analysis
Two review authors independently extracted and verified data. Where possible we entered data into meta-analyses, excluding studies
judged as high risk of bias. We used the GRADE system to assess the quality of evidence for core comparisons, and created three
’Summary of findings’ tables.
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Main results
We included an additional 38 trials (involving 1225 randomised participants) in this update, making a total of 94 trials in the review
(involving 2983 randomised participants). This update included a total of 42 rTMS studies, 11 CES, 36 tDCS, two RINCE and two
tRNS. One study evaluated both rTMS and tDCS. We judged only four studies as low risk of bias across all key criteria. Using the
GRADE criteria we judged the quality of evidence for each outcome, and for all comparisons as low or very low; in large part this was
due to issues of blinding and of precision.
rTMS
Meta-analysis of rTMS studies versus sham for pain intensity at short-term follow-up (0 to < 1 week postintervention), (27 studies,
involving 655participants), demonstrated a small effectwith heterogeneity (standardisedmean difference (SMD) -0.22, 95%confidence
interval (CI) -0.29 to -0.16, low-quality evidence). This equates to a 7% (95%CI 5% to 9%) reduction in pain, or a 0.40 (95% CI 0.53
to 0.32) point reduction on a 0 to 10 pain intensity scale, which does not meet the minimum clinically important difference threshold
of 15% or greater. Pre-specified subgroup analyses did not find a difference between low-frequency stimulation (low-quality evidence)
and rTMS applied to the prefrontal cortex compared to sham for reducing pain intensity at short-term follow-up (very low-quality
evidence). High-frequency stimulation of the motor cortex in single-dose studies was associated with a small short-term reduction in
pain intensity at short-term follow-up (low-quality evidence, pooled n = 249, SMD -0.38 95% CI -0.49 to -0.27). This equates to a
12% (95% CI 9% to 16%) reduction in pain, or a 0.77 (95% CI 0.55 to 0.99) point change on a 0 to 10 pain intensity scale, which
does not achieve the minimum clinically important difference threshold of 15% or greater. The results from multiple-dose studies
were heterogeneous and there was no evidence of an effect in this subgroup (very low-quality evidence). We did not find evidence
that rTMS improved disability. Meta-analysis of studies of rTMS versus sham for quality of life (measured using the Fibromyalgia
Impact Questionnaire (FIQ) at short-term follow-up demonstrated a positive effect (MD -10.80 95% CI -15.04 to -6.55, low-quality
evidence).
CES
For CES (five studies, 270 participants) we found no evidence of a difference between active stimulation and sham (SMD -0.24, 95%
CI -0.48 to 0.01, low-quality evidence) for pain intensity. We found no evidence relating to the effectiveness of CES on disability.
One study (36 participants) of CES versus sham for quality of life (measured using the FIQ) at short-term follow-up demonstrated a
positive effect (MD -25.05 95% CI -37.82 to -12.28, very low-quality evidence).
tDCS
Analysis of tDCS studies (27 studies, 747 participants) showed heterogeneity and a difference between active and sham stimulation
(SMD -0.43 95% CI -0.63 to -0.22, very low-quality evidence) for pain intensity. This equates to a reduction of 0.82 (95% CI 0.42
to 1.2) points, or a percentage change of 17% (95% CI 9% to 25%) of the control group outcome. This point estimate meets our
threshold for a minimum clinically important difference, though the lower confidence interval is substantially below that threshold.
We found evidence of small study bias in the tDCS analyses. We did not find evidence that tDCS improved disability. Meta-analysis
of studies of tDCS versus sham for quality of life (measured using different scales across studies) at short-term follow-up demonstrated
a positive effect (SMD 0.66 95% CI 0.21 to 1.11, low-quality evidence).
Adverse events
All forms of non-invasive brain stimulation and sham stimulation appear to be frequently associated with minor or transient side effects
and there were two reported incidences of seizure, both related to the active rTMS intervention in the included studies. However many
studies did not adequately report adverse events.
Authors’ conclusions
There is very low-quality evidence that single doses of high-frequency rTMS of the motor cortex and tDCS may have short-term
effects on chronic pain and quality of life but multiple sources of bias exist that may have influenced the observed effects. We did not
find evidence that low-frequency rTMS, rTMS applied to the dorsolateral prefrontal cortex and CES are effective for reducing pain
intensity in chronic pain. The broad conclusions of this review have not changed substantially for this update. There remains a need for
substantially larger, rigorously designed studies, particularly of longer courses of stimulation. Future evidence may substantially impact
upon the presented results.
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P L A I N L A N G U A G E S U M M A R Y
Stimulating the brain without surgery in the management of chronic pain in adults
Bottom line
There is a lack of high-quality evidence to support or refute the effectiveness of non-invasive brain stimulation techniques for chronic
pain.
Background
Electrical stimulationof the brain has beenused to address a variety of painful conditions. Various devices are available that can electrically
stimulate the brain without the need for surgery or any invasive treatment. There are five main treatment types: repetitive transcranial
magnetic stimulation (rTMS) in which the brain is stimulated by a coil applied to the scalp, cranial electrotherapy stimulation (CES)
in which electrodes are clipped to the ears or applied to the scalp, transcranial direct current stimulation (tDCS), reduced impedance
non-invasive cortical electrostimulation (RINCE) and transcranial random noise stimulation (tRNS) in which electrodes are applied
to the scalp. These have been used to try to reduce pain by aiming to alter the activity of the brain. How effective they are is uncertain.
Study characteristics
This review update included 94 randomised controlled studies: 42 of rTMS, 11 of CES, 36 of tDCS two of RINCE, two of tRNS and
one study which evaluated both tDCS and rTMS.
Key findings
rTMS applied to the motor cortex may lead to small, short-term reductions in pain but these effects are not likely to be clinically
important. tDCS may reduce pain when compared with sham but for rTMS and tDCS our estimates of benefit are likely to be
exaggerated by the small number of participants in each of the studies and limitations in the way the studies were conducted. Low- or
very low-quality evidence suggests that low-frequency rTMS and rTMS that is applied to prefrontal areas of the brain are not effective.
Low-quality evidence does not suggest that CES is an effective treatment for chronic pain. For all forms of stimulation the evidence is
not conclusive and there is substantial uncertainty about the possible benefits and harms of the treatment. Of the studies that clearly
reported side effects, short-lived and minor side effects such as headache, nausea and skin irritation were usually reported both with real
and sham stimulation. Two cases of seizure were reported following real rTMS. Our conclusions for rTMS, CES, tDCS, and RINCE
have not changed substantially in this update.
Quality of the evidence
We rated the quality of the evidence from studies using four levels: very low, low, moderate, or high. Very low-quality evidence means
that we are very uncertain about the results. High-quality evidence means that we are very confident in the results. We considered all
of the evidence to be of low or very low quality, mainly because of bias in the studies that can lead to unreliable results and the small
size of the studies, which makes them imprecise.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
rTMS compared with sham for chronic pain
Patient or population: adults with chronic pain
Settings: laboratory/ clinic
Intervention: act ive rTMS
Comparison: sham rTMS
Outcomes Effect size Relative and absolute effect
(average % improvement (reduc-
tion) in pain (95% CIs) in rela-
tion to post- treatment score from
sham group)*
*Where 95%CIs do not cross the
line of no effect.
No of participants
(studies)
Quality of the evidence
(GRADE)
Pain intensity (0 to < 1 week
post intervent ion)
measured using visual analogue
scales or numerical rat ing scales
SMD -0.22 (-0.29 to -0.16) This equates to a 7% (95% CI 5%
to 9%) reduct ion in pain intensity,
or a 0.40 (95% CI 0.53 to 0.32)
point reduct ion on a 0 to 10 pain
intensity scale
655 (27) ⊕⊕©© low1
Disability (0 to < 1 week post in-
tervent ion)
measured using self -reported dis-
ability/ pain interference scales
SMD -0.29, 95%CI -0.87 to 0.29 - 119 (5) ⊕©©©
very low2
Quality of life (0 to < 1 week
post intervent ion)
measured using Fibromyalgia Im-
pact Quest ionnaire
MD -10.80, 95%CI -15.04 to -6.55 - 105 (4) ⊕⊕©© low3
CI: conf idence interval; MD: mean dif ference; rTMS: repet it ive transcranial magnetic st imulat ion; SMD: standardised mean dif ference
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GRADE Working Group grades of evidence
High quality: we are very conf ident that the true ef fect lies close to that of the est imate of the ef fect;
Moderate quality: we are moderately conf ident in the ef fect est imate; the true ef fect is likely to be close to the est imate of ef fect, but there is a possibility that it is substant ially
dif f erent;
Low quality: our conf idence in the ef fect est imate is lim ited; the true ef fect may be substant ially dif f erent f rom the est imate of the ef fect;
Very low quality: we have very lit t le conf idence in the ef fect est imate; the true ef fect is likely to be substant ially dif f erent f rom the est imate of ef fect
1Downgraded once for study lim itat ions due to high or unclear risk of bias and once for inconsistency due to heterogeneity.
2Downgraded once for study lim itat ions due to high or unclear risk of bias, once for inconsistency due to heterogeneity and
once for imprecision due to low part icipant numbers.
3Downgraded once for study lim itat ions due to high or unclear risk of bias and once for imprecision due to low part icipant
numbers.
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
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B A C K G R O U N D
This is an updated version of the original Cochrane Review pub-
lished in 2010, Issue 9, on non-invasive brain stimulation tech-
niques for chronic pain (O’Connell 2010) and updated in 2014
(O’Connell 2014).
Description of the condition
Chronic pain is a common problem. When defined as pain of
greater than three months’ duration, prevalence studies indicate
that up to half the adult population suffer from chronic pain, and
10% to 20% experience clinically significant chronic pain (Smith
2008; Van Hecke 2013). In Europe, 19% of adults experience
chronic pain of moderate to severe intensity with serious negative
implications for their social and working lives and many of these
receive inadequate pain management (Breivik 2006; Van Hecke
2013). Chronic pain is a heterogeneous phenomenon that results
from a wide variety of pathologies including chronic somatic tis-
sue degeneration such as in arthritis, peripheral nerve injury and
central nervous system injury, as well as a range of chronic pain
syndromes such as fibromyalgia and complex regional pain syn-
drome. It is likely that different mechanisms of pain production
underpin these different types of chronic pain (Ossipov 2006).
Description of the intervention
Electrical brain stimulation techniques have been used to address
a variety of pathological pain conditions including fibromyal-
gia, chronic poststroke pain and complex regional pain syndrome
(Cruccu 2017; Fregni 2007; Gilula 2007), and clinical studies of
both invasive and non-invasive techniques have produced prelim-
inary data showing reductions in pain (Fregni 2007; Lefaucheur
2008b). Various types of brain stimulation, both invasive and non-
invasive, are currently in clinical use for the treatment of chronic
pain (Cruccu 2017). Non-invasive stimulation techniques require
no surgical procedure and are therefore easier and safer to apply
than invasive procedures.
Repetitive transcranial magnetic stimulation (rTMS) involves
stimulation of the cerebral cortex (the outer layer of the brain)
by a stimulating coil applied to the scalp. Electric currents are in-
duced in the neurons (brain cells) directly using rapidly changing
magnetic fields (Fregni 2007). Trains of these stimuli are applied
to the target region of the cortex to induce alterations in brain
activity both locally and in remote brain regions (Leo 2007). A
recent meta-analysis suggested that rTMS may be more effective
in the treatment of neuropathic pain conditions (pain arising as a
result of a lesion or a disease of the somatosensory nervous system,
as in diabetes, traumatic nerve injury, stroke, multiple sclerosis,
epilepsy, spinal cord injury and cancer) with a central compared
to a peripheral nervous system origin (Leung 2009).
Transcranial direct current stimulation (tDCS), transcranial ran-
dom noise stimulation (tRNS) and cranial electrotherapy stim-
ulation (CES) involve the safe and painless application of low-
intensity (commonly ≤ 2 mA) electrical current to the cerebral
cortex of the brain (Fregni 2007; Gilula 2007; Hargrove 2012a).
tDCS has been developed as a clinical tool for the modulation of
brain activity in recent years and uses relatively large electrodes
that are applied to the scalp over the targeted brain area to de-
liver a weak constant current (Lefaucheur 2008a). Clinical studies
have concluded that tDCS was more effective than sham stimu-
lation at reducing pain in both fibromyalgia and spinal cord in-
jury-related pain (Fregni 2006a; Fregni 2006b). tRNS is similar
to tDCS but the stimulating current is varied randomly. It has
been found to increase cortical excitability (Paulus 2011). CES
was initially developed in the USSR as a treatment for anxiety and
depression in the 1950s and its use later spread to Europe and the
USA, where it began to be considered and used as a treatment for
pain (Kirsch 2000). The electrical current in CES is commonly
pulsed and is applied via clip electrodes that are attached to the
patient’s earlobes. A Cochrane Review of non-invasive treatments
for headaches identified limited evidence that CES is superior to
placebo in reducingpain intensity after six to 10weeks of treatment
(Bronfort 2004). Reduced impedance non-invasive cortical elec-
trostimulation (RINCE) similarly applies an electrical current via
scalp electrodes but utilises specific stimulation frequencies, which
are hypothesised to reduce electrical impedance from the tissues of
the skin and skull, allowing deeper cortical penetration and mod-
ulation of lower-frequency cortical activity (Hargrove 2012a).
How the intervention might work
Brain stimulation techniques primarily seek to modulate activity
in brain regions by directly altering the level of brain activity. The
aim of brain stimulation in the management of pain is to reduce
pain by altering activity in the areas of the brain that are involved
in pain processing.
Both tDCS and rTMS have been shown to modulate brain ac-
tivity specific to the site of application and the stimulation pa-
rameters. As a general rule, low-frequency rTMS (≤ 1 Hz) results
in lowered cortical excitability at the site of stimulation, whereas
high-frequency stimulation (≥ 5 Hz) results in raised cortical ex-
citability (Lefaucheur 2008a; Pascual-Leone 1999). Similarly, an-
odal tDCS, wherein the anode electrode is placed over the cortical
target, results in a raised level of excitability at the target, whereas
cathodal stimulation decreases local cortical excitability (Nitsche
2008). It is suggested that the observed alterations in cortical ex-
citability (readiness for activity) following rTMS and tDCS that
last beyond the time of stimulation are the result of long-term
synaptic changes (Lefaucheur 2008a). Both RINCE and tRNS are
applied in a similar way to tDCS, though the current is delivered
differently to enhance, in theory, signal transmission to neural net-
works. Modulation of activity in brain networks is also proposed
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as themechanism of action of CES therapy and it is suggested that
the therapeutic effects are primarily achieved by direct action upon
the hypothalamus, limbic system and/or the reticular activating
system (Gilula 2007).
Imaging studies in humans suggest that motor cortex stimulation
may reduce pain by modulating activity in networks of brain areas
involved in pain processing, such as the thalamus, and by facilitat-
ing descending pain inhibitory mechanisms (Garcia-Larrea 1997;
Garcia-Larrea 1999; Peyron 2007).
Sham credibility issues for non-invasive brain
stimulation studies
An issue regarding the credibility of sham conditions specifically
for rTMS studies is whether the sham condition that is employed
controls for the auditory (clicking sounds of various frequen-
cies) and sensory stimulation that occurs during active stimula-
tion (Lisanby 2001; Loo 2000). Various types of sham have been
proposed including angling the coil away from the scalp (thus pre-
serving the auditory cues but not the sensation of stimulation),
using coils that mimic the auditory cues combined with gentle
scalp electrical stimulation to mask the sensation and simple inert
coils that reproduce neither the sound nor the sensation of active
stimulation. Failure to control for such cuesmay impact negatively
on participant blinding, particularly in cross-over design studies.
Lisanby 2001 and Loo 2000 suggest that an ideal sham condition
for rTMS should:
• not stimulate the cortex;
• be the same as active stimulation in visual terms and in
terms of its position on the scalp; and
• not differ from active stimulation in terms of the acoustic
and afferent sensory sensations that it elicits.
Strategies have been developed to try to meet these criteria
(Borckardt 2008; Rossi 2007; Sommer 2006). There is evidence
that simply angling the coil away from the scalp at an angle of
less than 90° may still result in brain stimulation and not be truly
inert (Lisanby 2001). This strategy is also easily detected by the
recipient of stimulation. In these ways this type of sham might
obscure or exaggerate a real clinical effect of active stimulation.
In studies of tDCS the sham condition commonly involves the
delivery of a short initial period (30 seconds to one minute) of
identical stimulation to the active condition, at which point the
stimulation is ceased without the participant’s knowledge. There
is evidence that this achieves effective blinding of tDCS at stim-
ulation intensities of 1 mA in naive participants (Ambrus 2012;
Gandiga 2006), but at a stimulation intensity of 2 mA tDCS both
participant and assessor blinding has been shown to be inadequate,
since participants can distinguish the active condition more than
would be expected by chance and a proportion of those receiving
active stimulation develop a temporary but visible redness over
the electrode sites (O’Connell 2012). At 1.5 mA there are de-
tectable differences in the experience of tDCS that might com-
promise blinding (Kessler 2013), though a formal investigation of
the adequacy of blinding at this intensity has not been published
to date.
Why it is important to do this review
This approach to pain treatment is relatively novel. It is important
to assess the existing literature robustly to ascertain the current
level of supporting evidence and to inform future research and
potential clinical use. Published reviews have addressed this area
and concluded that non-invasive brain stimulation can exert a
significant effect on chronic pain, but they have restricted their
findings to specific cortical regions, types of painful condition or
types of stimulation and did not carry out a thorough assessment
of study quality or risk of bias (Lefaucheur 2008b; Leung 2009;
Lima 2008).
O B J E C T I V E S
To evaluate the efficacy of non-invasive cortical stimulation tech-
niques in the treatment of chronic pain.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We included randomised controlled trials (RCTs) and quasi-ran-
domised trials (e.g. by order of entry or date of birth) that utilised
a sham control group. We included parallel and cross-over study
designs. We included studies regardless of language.
Types of participants
We included studies involving male or female participants over the
age of 18 years with any chronic pain syndrome (with a duration
of more than threemonths). It was not anticipated that any studies
were likely to exist in a younger population. Migraine and other
headache studies were not included due to the episodic nature of
these conditions.
Types of interventions
We included studies investigating the therapeutic use of non-in-
vasive forms of brain stimulation (tDCS, rTMS, CES, RINCE
or tRNS). We did not include studies of electroconvulsive ther-
apy (ECT), as its mechanism of action (the artificial induction
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of an epileptic seizure (Stevens 1996)) differs substantially from
the other forms of brain stimulation. We also excluded invasive
forms of brain stimulation involving the use of electrodes im-
planted within the brain, and indirect forms of stimulation, such
as caloric vestibular stimulation and occipital nerve stimulation.
In order to meet our second objective of considering the influence
of varying stimulation parameters, we included studies regardless
of the number of stimulation sessions delivered, including single-
dose studies.
Types of outcome measures
Primary outcomes
The primary outcome measure was change in pain intensity using
validated measures of pain intensity such as visual analogue scales
(VAS), verbal rating scales (VRS) or numerical rating scales (NRS).
Secondary outcomes
Secondary outcomes that we extracted when available were self-
reported disability data, quality-of-lifemeasures and the incidence/
nature of adverse events.
Search methods for identification of studies
Electronic searches
For the OVID MEDLINE search, we ran the subject search with
the Cochrane Highly Sensitive Search Strategy for identifying
randomised trials in MEDLINE: sensitivity maximising version
(2008 revision) as referenced in Chapter 6 and detailed in box
6.4c of the Cochrane Handbook for Systematic Reviews of Interven-
tions Version 5.0.1 (Lefebvre 2011). We have slightly adapted this
filter to include the term ’sham’ in the title or abstract. The search
strategies for this update are presented in Appendix 1 and in-
cluded a combination of controlled vocabulary (MeSH) and free-
text terms. We based all database searches on this strategy but ap-
propriately revised them to suit each database.
Electronic databases
Previous updates searched all databases from their inception to July
2013. To identify studies for inclusion in this update we searched
the following electronic databases from July 2013 to September
2016 to identify additional published articles and performed a
further search update in October 2017:
• the Cochrane Central Register of Controlled Trials
(CENTRAL; 2017, Issue 10);
• MEDLINE & MEDLINE in Process via OVID to 11
October 2017;
• Embase via OVID to 11 October 2017;
• PsycINFO via OVID to 11 October 2017;
• CINAHL via EBSCO to 11 October 2017;
• LILACS via Birme to 11 October 2017;
For full details of the search parameters including for this update
see Appendix 1 and Appendix 2.
Searching other resources
Reference lists
We searched reference lists of all eligible trials, key textbooks and
previous systematic reviews to identify additional relevant articles.
Unpublished data
For this update we searched ClinialTrials.gov (clinicaltrials.gov)
and the World Health Organization International Clinical Trials
Registry Platform ( www.who.int/ictrp/en/) to October 2017 to
identify research in progress and unpublished research.
Language
The search attempted to identify all relevant studies irrespective
of language. We assessed non-English papers and, if necessary,
translated them with the assistance of a native speaker.
We sent a final list of included articles to two experts in the field
of therapeutic brain stimulation with a request that they review
the list for possible omissions.
Data collection and analysis
Selection of studies
Two review authors (NOC and BW) independently checked the
search results and the reference lists of included eligible studies.
Initially two review authors (NOC and BW) read the titles or
abstracts (or both) of identified studies. Where it was clear from
the study title or abstract that the study was not relevant or did
not meet the selection criteria we excluded it. If it was unclear
then we assessed the full paper, as well as all studies that appeared
to meet the selection criteria. Disagreement was resolved through
discussion between the two review authors. Where resolution was
not achieved a third review author (LDS) considered the paper(s)
in question.
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Data extraction and management
Two review authors (NOC and BW) extracted data independently
using a standardised form that was piloted by both authors inde-
pendently on three randomised controlled trials of transcutaneous
electrical nerve stimulation prior to the searches. We resolved dis-
crepancies by consensus. The form included the following.
• ’Risk of bias’ assessment results
• Country of origin
• Study design
• Study population - condition; pain type; duration of
symptoms; age range; gender split; prior management
• Sample size - active and control groups
• Intervention - stimulation site, parameters and dosage
(including number and duration of trains of stimuli and number
of pulses for rTMS studies)
• Type of sham
• Credibility of sham (for rTMS studies - see below)
• Outcomes - mean postintervention pain scores for the
active and sham treatment groups at all follow-up points
• Results - short, intermediate and long-term follow-up
• Adverse effects
• Conflict of interest disclosure
Assessment of risk of bias in included studies
We assessed risk of bias using the Cochrane ’Risk of bias’ assess-
ment tool outlined in Chapter 8 of the Cochrane Handbook for
Systematic Reviews of Interventions Version 5.0.1 (Higgins 2011a).
The criteria assessed for parallel study designs (using low/high/un-
clear judgements) were: adequate sequence generation; adequate
allocation concealment; adequate blinding of assessors; adequate
blinding of participants; adequate assessment of incomplete out-
come data; whether free of suggestion of selective outcome report-
ing; and whether free of other bias.
The criteria assessed for cross-over study designs (using low/high/
unclear judgements) were: adequate sequence generation; whether
data were clearly free from carry-over effects; adequate blinding
of assessors; adequate blinding of participants; whether free of the
suggestion of selective outcome reporting; and whether free of
other bias.
Aswith the previous update, in compliancewith newauthor guide-
lines from Cochrane Pain, Palliative and Supportive Care and the
recommendations of Moore 2010 we added two criteria, ’study
size’ and ’study duration’, to our ’Risk of bias’ assessment using
the thresholds for judgement suggested by Moore 2010:
• size (we rated studies with fewer than 50 participants per
arm as being at high risk of bias, those with between 50 and 199
participants per arm at unclear risk of bias, and 200 or more
participants per arm at low risk of bias);
• duration (we rated studies with follow-up of less than two
weeks as being at high risk of bias, two to seven weeks at unclear
risk of bias and eight weeks or longer at low risk of bias).
Two review authors (NOCandBW) independently checked risk of
bias. Disagreement between review authors was resolved through
discussion between the two review authors. Where resolution was
not achieved a third review author (LDS) considered the paper(s)
in question.
Assessment of sham credibility
We rated the type of sham used in studies of rTMS for credibility:
as optimal (the sham controls for the auditory and sensory charac-
teristics of stimulation and is visually indistinguishable from real
stimulation (Lisanby 2001; Loo 2000)) and suboptimal (fails to
account for either the auditory and sensory characteristics of stim-
ulation, or is visually distinguishable from the active stimulation,
or fails on more than one of these criteria). We made a judgement
of ’unclear’ where studies did not adequately describe the sham
condition.
In light of empirical evidence that tDCS may be inadequately
blinded at intensities of 2mA (O’Connell 2012), and of detectable
differences in the experience of tDCS at 1.5mA (Kessler 2013), for
this update we assessed studies that used these stimulation intensi-
ties to be at unclear risk of bias for participant and assessor blind-
ing. We chose ’unclear’ instead of ’high’ risk of bias as the avail-
able evidence demonstrates the potential for inadequate blinding
rather than providing clear evidence that individual studies were
effectively unblinded. We applied this rule to all newly identified
studies and retrospectively to studies identified in the first version
of this review.
Two independent review authors (NOC and BW) performed rat-
ing of sham credibility. We resolved disagreement between review
authors through consensus. Where resolution was not achieved a
third review author (LDS) considered the paper(s) in question.
Where sham credibility was assessed as unclear or suboptimal we
made a judgement of ’unclear’ for the criterion ’adequate blinding
of participants’ in the ’Risk of bias’ assessment.
Measures of treatment effect
We used standardised mean difference (SMD) to express the size
of treatment effect on pain intensity measured with a VAS orNRS.
In order to aid interpretation of the pooled effect size we back-
transformed the SMD to a 0 to 10 pain intensity rating scale on
the basis of the mean standard deviation from trials using a 0 to
10 point VAS. We considered the likely clinical importance of the
pooled effect size using the criteria proposed in the IMMPACT
consensus statement (Dworkin 2008). Specifically, we judged a
decrease in pain of less than 15% as no important change, of 15%
or more as a minimally important change, of 30% or more as a
moderately important change and of 50% or more as a substan-
tially important change.
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Unit of analysis issues
We entered cross-over trials into a meta-analysis where it was clear
that these data were free of carry-over effects. We combined the
results of cross-over studies with parallel studies using the generic
inverse-variance method as suggested in the Cochrane Handbook
for Systematic Reviews of Interventions, section 16.4.6.2 (Higgins
2011b). We imputed the post-treatment between-condition cor-
relation coefficient from an included cross-over study that pre-
sented individual participant data and used this to calculate the
standard error of the standardised mean difference (SE (SMD)).
Where data from the same cross-over trials were enteredmore than
once into the same meta-analysis we corrected the number of par-
ticipants by dividing by the number of times data from that trial
were entered in the meta-analysis. We calculated the SMD (SE)
for parallel studies in Review Manager 5 (RevMan 5) (RevMan
2014). For each study we entered the SMD (SE) into the meta-
analysis using the generic inverse-variance method.
Dealing with missing data
Where insufficient data were presented in the study report to enter
a study into the meta-analysis, we contacted the study authors to
request access to the missing data.
Assessment of heterogeneity
We conducted separate meta-analysis for each type of brain stim-
ulation. We assessed heterogeneity using the Chi2 test to investi-
gate its statistical significance and the I2 statistic (Higgins 2003)
to estimate the amount. We planned to investigate the influ-
ence of altered chronic pain condition or stimulation parameters
through pre-planned subgroup analyses (see Subgroup analysis and
investigation of heterogeneity).
Assessment of reporting biases
Weplanned to consider the possible influence of publication/small
study biases on review findings. The influence of small study biases
were, in part, addressed by the risk of bias criterion ’study size’.
We planned to use funnel plots to visually explore the likelihood
of reporting biases when at least 10 studies were included in a
meta-analysis and included studies differed in size. For continuous
outcomes, we planned to use Egger’s test to detect possible small
study bias and, for dichotomised outcomes, we planned to test
for the possible influence of publication bias on each outcome by
estimating the number of participants in studies with zero effect
required to change the number needed to treat for an additional
beneficial outcome (NNTB) to anunacceptably high level (defined
as a NNTB of 10).
Data synthesis
We performed pooling of results where adequate data supported
this using RevMan 5 software (RevMan 2014), with a random-
effects model. Where an analysis included parallel and cross-over
trials we used the generic inverse variance method (see Unit of
analysis issues). We conducted separate meta-analyses for different
forms of stimulation intervention (i.e. rTMS, tDCS,CES,RINCE
and tRNS) and for short-term (0 to < 1 week postintervention),
mid-term (≥ 1 to 6 weeks postintervention) and long-term (≥
6 weeks postintervention) outcomes where adequate data were
identified.
Where more than one data point was available for short-term
outcomes, we used the first poststimulation measure, and where
multiple treatmentswere givenwe took the first outcome at the end
of the treatment period. For medium-term outcomes where more
than one data point was available, we used the measure that fell
closest to the mid-point of this time period. We excluded studies
from the meta-analysis that we rated at high risk of bias on any
criteria, excluding the criteria ’study size’ and ’study duration’.
Two review authors (NOC, BW) independently rated the quality
of the outcomes. We used the GRADE system to rank the qual-
ity of the evidence, and the guidelines provided in Chapter 12.2
of the Cochrane Handbook for Systematic Reviews of Interventions
(Schünemann 2011). The GRADE approach uses five consider-
ations (study limitations, consistency of effect, imprecision, indi-
rectness and publication bias) to assess the quality of the body of
evidence for each outcome. The GRADE system uses the follow-
ing criteria for assigning grade of evidence.
• High: we are very confident that the true effect lies close to
that of the estimate of the effect.
• Moderate: we are moderately confident in the effect
estimate; the true effect is likely to be close to the estimate of
effect, but there is a possibility that it is substantially different.
• Low: our confidence in the effect estimate is limited; the
true effect may be substantially different from the estimate of the
effect.
• Very low: we have very little confidence in the effect
estimate; the true effect is likely to be substantially different from
the estimate of effect.
The GRADE system uses the following criteria for assigning a
quality level to a body of evidence (Chapter 12, Schünemann
2011).
• High: randomised trials; or double-upgraded observational
studies
• Moderate: downgraded randomised trials; or upgraded
observational studies
• Low: double-downgraded randomised trials; or
observational studies
• Very low: triple-downgraded randomised trials; or
downgraded observational studies; or case series/case reports
Factors that may decrease the quality level of a body of evidence
are:
• limitations in the design and implementation of available
studies suggesting high likelihood of bias;
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• indirectness of evidence (indirect population, intervention,
control, outcomes);
• unexplained heterogeneity or inconsistency of results
(including problems with subgroup analyses);
• imprecision of results (wide confidence intervals);
• high probability of publication bias.
To ensure consistency of GRADE judgements we applied the fol-
lowing criteria to each domain equally for all key comparisons of
the primary outcome.
• Limitations of studies: downgrade once if less than 75% of
included studies are at low risk of bias across all key ’Risk of bias’
criteria.
• Inconsistency: downgrade once if heterogeneity is
significant (p<0.05) and the I2 value is more than 40%.
• Indirectness: downgrade once if more than 50% of the
participants were outside the target group.
• Imprecision: downgrade once if there were fewer than 400
participants for continuous data and fewer than 300 events for
dichotomous data (Guyatt 2011).
• Publication bias: downgrade where there is direct evidence
of publication bias.
We considered single studies to be both inconsistent and imprecise,
unless more than 400 participants were randomised.
’Summary of findings’ table
We included three ’Summary of findings’ tables to present themain
findings in a transparent and simple tabular format for the three
main forms of non-invasive brain stimulation techniques (rTMS,
tDCS, CES) compared to sham. In particular, we included key
information concerning the quality of evidence, the magnitude of
effect of the interventions examined and the sum of available data
on the outcomes pain, disability and quality of life at short-term
follow-up (see Summary of findings for the main comparison;
Summary of findings 3; Summary of findings 2).
Subgroup analysis and investigation of heterogeneity
Where heterogeneity (P < 0.1) was present we explored subgroup
analyses. Pre-planned comparisons included site of stimulation,
frequency of rTMS stimulation (low≤ 1 Hz, high ≥ 5 Hz), mul-
tiple-dose versus single-dose studies and the type of painful con-
dition (central neuropathic versus peripheral neuropathic versus
non-neuropathic pain versus facial pain) for each stimulation type.
Central neuropathic pain included pain due to identifiable pathol-
ogy of the central nervous system (e.g. stroke, spinal cord injury),
peripheral neuropathic pain included injury to the nerve root or
peripheral nerves, facial pain included trigeminal neuralgia and
other idiopathic chronic facial pains, and non-neuropathic pain
included all chronic pain conditions without a clear neuropathic
cause (e.g. chronic low back pain, fibromyalgia, complex regional
pain syndrome type I).
Sensitivity analysis
When sufficient datawere available, we conducted sensitivity anal-
yses on the following study factors: risk of bias, sham credibility
(for rTMS studies) and cross-over versus parallel-group designs.
R E S U L T S
Description of studies
See:Characteristics of included studies; Characteristics of excluded
studies.
Results of the search
For a full description of our screening process, see the study flow
diagram (Figure 1). For a summary of the search results for this
update see Appendix 2 andAppendix 3. See Appendix 4; Appendix
5; Appendix 6; Appendix 7 and Appendix 8 for full details of the
search results and strategies from earlier versions of this review.
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Figure 1. Study flow diagram
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This 2017 update is based on a September 2016 search and a fur-
ther search update in October 2017. For this update, the searches
of the databases (see Electronic searches) retrieved 1256 records.
Handsearching reference lists of included articles identified one
additional RCT thatmet the inclusion criteria. Our searches of the
trials registers identified 305 records. We therefore had a total of
1561 records. Once duplicates had been removed from the main
searches and nonrelevant records were removed from the trials reg-
istry search results we had a total of 884 records. We excluded 759
records based on titles and abstracts leaving 76 full-text papers,
14 conference reports and 35 trials register records. We obtained
the full text of the remaining 76 records. We excluded 12 studies
from 15 records, see Characteristics of excluded studies). Fourteen
records were conference abstract reports relating to 12 RCTs. Of
these we added nine records to Studies awaiting classification and
classified three as Ongoing studies. Of the remaining 52 records
(47 RCTs), nine RCTs had been included in previous versions of
this update.
We included 38 new studies in this review. Of these, 12 stud-
ies (355 participants) investigated only rTMS (Boyer 2014;
Dall’Agnol 2014; de Oliveira 2014; Jetté 2013; Malavera 2013;
Medeiros 2016; Nardone 2017; Nurmikko 2016; Tekin 2014;
Umezaki 2016; Yagci 2014; Yilmaz 2014), 22 studies (772 par-
ticipants) investigated tDCS (Ahn 2017; Ayache 2016; Bae 2014;
Brietzke 2016; Chang 2017; Donnell 2015; Fagerlund 2015;
Hagenacker 2014; Harvey 2017; Hazime 2017; Jales Junior 2015;
Khedr 2017; Kim2013; Lagueux 2017; Luedtke 2015;Mendonca
2016;Ngernyam2015;Oliveira 2015; Sakrajai 2014; Souto 2014;
Thibaut 2017; Volz 2016) one study (36 participants) investigated
tDCS and rTMS (Attal 2016), two studies (16 participants) in-
vestigated tRNS (Curatolo 2017; Palm 2016) and one study in-
vestigated RINCE (Deering 2017, 46 participants). Overall this
updated review included 94 studies (2983 participants), with 42
trials of rTMS (1101 participants), 36 trials of tDCS (1073 par-
ticipants), 11 studies of CES (572 participants), one study (36
participants) of both rTMS and tDCS, two studies of RINCE
(137 participants) and two studies of tRNS (36 participants).
We identified 13 conference abstract reports of 11 studies that
were not related to full published studies (Ansari 2013; Fricová
2013;Deering 2017;Hwang 2015;Mattoo 2017;Moreno-Duarte
2013a; Muniswamy 2016; Mylius 2013; Parhizgar 2011; Tanwar
2016;Williams 2014).We contacted the authors of these abstracts
to try to ascertain whether they were unique studies or duplicates
and to acquire full study reports. Of these, two authors confirmed
that the studies were ongoing or had been submitted for publica-
tion (Ansari 2013;Muniswamy 2016) and they were subsequently
included inOngoing studies. The authors of one abstract (Deering
2017) shared a full unpublished study report and the study was
included in this review. Where we were unable to obtain this infor-
mation we placed these records in Studies awaiting classification.
One report previously placed in Studies awaiting classification was
identified as a full paper and included in this review (Yagci 2014).
We identified 35 new ongoing studies in total (see Characteristics
of ongoing studies). We contacted the authors by email for
any relevant data but no data were available for inclusion.
Three studies, classified as ongoing after previous searches, had
been published and were included in the review (Boyer 2014
NCT00697398; Luedtke 2015 ISRCTN89874874, Thibaut
2017 NCT01599767), one was terminated without results
(NCT01608321). The remaining studies identified as ongoing
in the last update of this review remain unpublished to our
knowledge (NCT00815932; NCT00947622; NCT01112774;
NCT01220323; NCT01402960; NCT01404052;
NCT01575002; NCT01746355; NCT01747070).
Included studies
See Characteristics of included studies.
Country of origin and language of publication
All but one of the studies (Irlbacher 2006,written inGerman)were
written in English. Studies were undertaken in Brazil, Canada,
Colombia, Egypt, Europe (Austria, France, Germany, Italy, Spain,
Norway, Russia and theUK), Israel, Japan, SouthKorea, Thailand,
Australia and the USA. Most studies were based in a laboratory or
outpatient pain clinic setting.
Type of stimulation, application and use
In total 43 studies investigated rTMS (Ahmed 2011; André-
Obadia 2006; André-Obadia 2008; André-Obadia 2011; Avery
2013; Borckardt 2009; Boyer 2014, Carretero 2009; Dall’Agnol
2014; Defrin 2007; de Oliveira 2014; Fregni 2005; Fregni 2011;
Hirayama 2006; Hosomi 2013; Irlbacher 2006; Jetté 2013, Kang
2009; Khedr 2005; Lee 2012; Lefaucheur 2001a; Lefaucheur
2001b; Lefaucheur 2004; Lefaucheur 2006; Lefaucheur 2008;
Malavera 2013; Medeiros 2016; Mhalla 2011; Nardone 2017;
Nurmikko 2016; Onesti 2013; Passard 2007; Picarelli 2010;
Pleger 2004; Rollnik 2002; Saitoh 2007; Short 2011; Tekin
2014; Tzabazis 2013; Umezaki 2016; Yagci 2014; Yilmaz 2014).
Eleven studies investigated CES (Capel 2003; Cork 2004; Gabis
2003; Gabis 2009; Katsnelson 2004; Lichtbroun 2001; Rintala
2010; Tan 2000; Tan 2006; Tan 2011; Taylor 2013), 36 stud-
ies investigated tDCS (Ahn 2017; Antal 2010; Ayache 2016;
Bae 2014; Boggio 2009; Brietzke 2016; Chang 2017; Donnell
2015; Fagerlund 2015; Fenton 2009; Fregni 2006a; Fregni 2006b;
Hagenacker 2014; Harvey 2017; Hazime 2017; Jales Junior 2015;
Jensen 2013; Khedr 2017; Kim 2013; Lagueux 2017; Luedtke
2015; Mendonca 2011; Mendonca 2016; Mori 2010; Ngernyam
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2015; Oliveira 2015; Portilla 2013; Riberto 2011; Sakrajai 2014;
Soler 2010; Souto 2014; Thibaut 2017; Valle 2009; Villamar
2013; Volz 2016;Wrigley 2014), two studies investigated RINCE
(Deering 2017; Hargrove 2012a) two studies investigated tRNS
(Curatolo 2017; Palm 2016) and one both rTMS and tDCS (Attal
2016).
Study designs
There was a mixture of parallel and cross-over study designs.
For rTMS there were 22 parallel studies (Ahmed 2011; Avery
2013; Boyer 2014; Carretero 2009; Dall’Agnol 2014; Defrin
2007; de Oliveira 2014; Fregni 2011; Khedr 2005; Lee 2012;
Malavera 2013; Medeiros 2016; Mhalla 2011; Nardone 2017
Passard 2007; Picarelli 2010; Short 2011; Tekin 2014; Tzabazis
2013; Umezaki 2016; Yagci 2014; Yilmaz 2014), and 20 cross-
over studies (André-Obadia 2006; André-Obadia 2008; André-
Obadia 2011; Borckardt 2009; Fregni 2005; Hirayama 2006;
Hosomi 2013; Irlbacher 2006; Jetté 2013; Kang 2009; Lefaucheur
2001a; Lefaucheur 2001b; Lefaucheur 2004; Lefaucheur 2006;
Lefaucheur 2008; Nurmikko 2016; Onesti 2013; Pleger 2004;
Rollnik 2002; Saitoh 2007). For CES there were eight parallel
studies (Gabis 2003; Gabis 2009; Katsnelson 2004; Lichtbroun
2001; Rintala 2010; Tan 2006; Tan 2011; Taylor 2013), and
three cross-over studies (Capel 2003; Cork 2004; Tan 2000), of
which we considered two as parallel studies, with only the open-
ing phase of the study considered in this review because subse-
quent phases were unblinded (Capel 2003; Cork 2004). For tDCS
there were 26 parallel studies (Ahn 2017; Bae 2014; Brietzke
2016; Chang 2017;Donnell 2015; Fagerlund 2015; Fregni 2006a;
Fregni 2006b; Harvey 2017; Hazime 2017; Jales Junior 2015;
Khedr 2017; Lagueux 2017; Kim2013; Luedtke 2015;Mendonca
2011; Mendonca 2016; Mori 2010; Oliveira 2015; Riberto 2011;
Sakrajai 2014; Soler 2010; Souto 2014; Thibaut 2017; Valle
2009; Volz 2016), and 10 cross-over studies (Antal 2010; Ayache
2016; Boggio 2009; Fenton 2009;Hagenacker 2014; Jensen2013;
Ngernyam 2015; Portilla 2013; Villamar 2013; Wrigley 2014), of
which we considered one as a parallel study with only the opening
phase of the study considered in this review due to excessive attri-
tion after the first phase (Antal 2010). One study of tRNS (Palm
2016) used a cross-over design and one a parallel design (Curatolo
2017) and both RINCE studies used a parallel design (Deering
2017; Hargrove 2012a). The one study of both rTMS and tDCS
employed a parallel design (Attal 2016).
Study participants
The included studies were published between 2000 and 2017. In
rTMS studies sample sizes at the study outset ranged from four
to 70 participants. In CES studies sample size ranged from 19 to
105 participants, in tDCS studies sample size ranged from three
to 135 participants, the two RINCE studies recruited 91 and 46
participants and the two studies of tRNS included 16 and 20
participants.
Studies included a variety of chronic pain conditions. Ten rTMS
studies included participants with neuropathic pain of mixed ori-
gin; of these, seven included a mix of participants with central, pe-
ripheral and facial neuropathic pain (André-Obadia 2006; André-
Obadia 2008; André-Obadia 2011; Hirayama 2006; Hosomi
2013, Lefaucheur 2004; Lefaucheur 2008), three included a
mix of participants with central and peripheral neuropathic pain
(Lefaucheur 2006; Nurmikko 2016; Saitoh 2007), of which two
studies included one or more participants with phantom limb
pain (Nurmikko 2016; Saitoh 2007). One study included a mix
of participants with central neuropathic pain and phantom limb
pain (Irlbacher 2006). One study included a mix of participants
with central and facial neuropathic pain (Lefaucheur 2001a), six
rTMS studies included only participants with central neuropathic
pain (Defrin 2007; de Oliveira 2014; Jetté 2013; Kang 2009;
Nardone 2017, Yilmaz 2014 ), one included only participants
with peripheral neuropathic pain (Borckardt 2009), and one study
included participants with burning mouth syndrome (Umezaki
2016). Sixteen studies included non-neuropathic chronic pain in-
cluding fibromyalgia (Boyer 2014; Carretero 2009; Lee 2012;
Mhalla 2011; Passard 2007; Short 2011; Tekin 2014; Tzabazis
2013; Yagci 2014), chronic widespread pain (Avery 2013), chronic
pancreatitis pain (Fregni 2005; Fregni 2011), chronic myofas-
cial pain (Dall’Agnol 2014; Medeiros 2016) and complex re-
gional pain syndrome type I (CRPSI) (Picarelli 2010; Pleger
2004). Two studies included only phantom limb pain (Ahmed
2011; Malavera 2013). Finally one study included a mix of pe-
ripheral neuropathic and non-neuropathic chronic pain (Rollnik
2002), including one participant with phantom limb pain and one
with osteomyelitis. The majority (21) of rTMS studies specified
chronic pain that was refractory to current medical management
(André-Obadia 2006; André-Obadia 2008, André-Obadia 2011;
Defrin 2007; Hirayama 2006; Hosomi 2013; Kang 2009; Khedr
2005; Lefaucheur 2001a; Lefaucheur 2001b; Lefaucheur 2004;
Lefaucheur 2006; Lefaucheur 2008; Nardone 2017; Nurmikko
2016; Onesti 2013; Picarelli 2010; Rollnik 2002; Saitoh 2007;
Yagci 2014; Yilmaz 2014). This inclusion criterion was varyingly
described as intractable, resistant to medical intervention or resis-
tant to drug management.
Of the studies investigating CES, one study included participants
with pain related to osteoarthritis of the hip and knee (Katsnelson
2004), and two studied chronic back and neck pain (Gabis 2003;
Gabis 2009). Of these, the later study also included participants
with chronic headache but these data were not considered in
this review. Three studies included participants with fibromyalgia
(Cork 2004; Lichtbroun 2001; Taylor 2013), and three studies
included participants with chronic pain following spinal cord in-
jury (Capel 2003; Tan 2006; Tan 2011), although only one of
these reports specified that the pain was neuropathic (Tan 2011).
One study included participants with amixture of “neuromuscular
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pain” excluding fibromyalgia, of which back pain was reportedly
themost prevalent complaint (Tan 2000), although further details
were not reported. One study included participants with chronic
pain related to Parkinson’s disease (Rintala 2010).
Of the studies of tDCS one study included participants with a
mixture of central, peripheral and facial neuropathic pain (Boggio
2009), two studies included participants with neuropathic pain
secondary to multiple sclerosis (Ayache 2016; Mori 2010), five
included participants with central neuropathic pain following
spinal cord injury (Fregni 2006a; Ngernyam 2015; Soler 2010;
Thibaut 2017; Wrigley 2014), one with central poststroke pain
(Bae 2014), onewith neuropathic or non-neuropathic pain follow-
ing spinal cord injury (Jensen 2013), one with trigeminal neuralgia
(Hagenacker 2014) and one with painful diabetic polyneuropa-
thy (Kim 2013). Twenty studies included non-neuropathic pain,
specifically chronic pelvic pain (Fenton 2009), osteoarthritis (OA)
of the knee (Ahn 2017; Chang 2017), fibromyalgia (Fagerlund
2015; Fregni 2006b; Jales Junior 2015; Khedr 2017; Mendonca
2011; Mendonca 2016; Riberto 2011; Villamar 2013), temporo-
mandibular joint pain (Donnell 2015; Oliveira 2015), hepatitis
C-related chronic pain (Brietzke 2016), human T-lymphotropic
virus 1 (HTLV-1) and viral hepatitis-related chronic back or leg
pain (Souto 2014), chronic nonspecific low back pain (Hazime
2017; Luedtke 2015), inflammatory bowel disease-related pain
(Volz 2016) or a mixed pain group (Antal 2010; Harvey 2017).
One study included participants with neuropathic pain following
burn injury (Portilla 2013) and one included participants with
CRPS1 (Lagueux 2017). Four studies of tDCS specified recruit-
ing participants with pain that was refractory to medical manage-
ment (Antal 2010; Boggio 2009; Fenton 2009; Fregni 2006a). The
studies relating to RINCE included participants with fibromyalgia
(Deering 2017; Hargrove 2012a). The studies of tRNS included
participantswithmultiple sclerosis-related neuropathic pain (Palm
2016) and fibromyalgia (Curatolo 2017). The study of both tDCS
and rTMS included participants with lumbar radicular pain (Attal
2016).
Most studies included both male and female participants except
Fenton 2009 (chronic pelvic pain), Dall’Agnol 2014, Medeiros
2016 (chronicmyofascial pain),Donnell 2015 (temporomandibu-
lar disorder), Curatolo 2017; Fregni 2006b; Jales Junior 2015; Lee
2012; Mhalla 2011; Riberto 2011; Valle 2009; Yagci 2014 (fi-
bromyalgia) which recruited women only and Yilmaz 2014 (post-
spinal cord injury pain), which recruited only men. Three studies
did not present data on gender distribution (Capel 2003; Fregni
2005; Katsnelson 2004).
Outcomes
Primary outcomes
All included studies assessed pain using self-reported pain visual
analogue scales (VAS) or numerical rating scales (NRS). There was
variation in the precise measure of pain (for example, current pain
intensity, average pain intensity over 24 hours) and in the anchors
used particularly for the upper limit of the scale (e.g. “worst pain
imaginable”, “unbearable pain”, “most intense pain sensation”).
Several studies did not specify the anchors used.
All studies assessed pain at the short-term (< 1 week post-treat-
ment) follow-up stage. Thirty-seven studies reported medium-
term outcome data (1 to 6 weeks post-treatment) (Ahmed
2011; Ahn 2017 André-Obadia 2008; Antal 2010; Ayache 2016;
Bae 2014; Borckardt 2009; Carretero 2009; Defrin 2007; de
Oliveira 2014; Fagerlund 2015; Fenton 2009; Fregni 2006a;
Fregni 2006b; Fregni 2011; Gabis 2009; Kang 2009; Khedr 2005;
Khedr 2017; Kim 2013; Lee 2012; Lefaucheur 2001a; Luedtke
2015; Mendonca 2016; Mori 2010; Nardone 2017; Nurmikko
2016; Passard 2007; Picarelli 2010; Short 2011; Soler 2010;
Thibaut 2017; Tzabazis 2013; Valle 2009; Volz 2016; Wrigley
2014; Yagci 2014). Eight studies collected outcome data at long-
term (> 6 weeks post-treatment) follow-up (Avery 2013; Hazime
2017; Kang 2009; Luedtke 2015; Mendonca 2016; Passard 2007;
Thibaut 2017; Yagci 2014).
Secondary outcomes
We considered secondary outcomes that distinctly measured self-
reported disability (that capture the extent of disability or func-
tional limitation experienced, usually in relation to the pain) or
quality of life (amultidimensional construct that includes domains
related to physical, emotional and social functioning).
Sixteen studies used measures of disability (Ahn 2017; Attal 2016;
Avery 2013; Chang 2017; Cork 2004; Hazime 2017; Kang 2009;
Lagueux 2017; Luedtke 2015; Mhalla 2011; Passard 2007; Short
2011; Soler 2010; Tan 2000; Tan 2006; Umezaki 2016), and 27
studies collected measures of quality of life (Avery 2013; Boyer
2014; Curatolo 2017; deOliveira 2014; Fregni 2006b; Jales Junior
2015; Lagueux 2017; Lee 2012; Lichtbroun 2001; Mendonca
2016; Mhalla 2011; Mori 2010; Oliveira 2015; Passard 2007;
Picarelli 2010;Riberto 2011;Sakrajai 2014; Short 2011;Tan 2011;
Taylor 2013; Tekin 2014; Thibaut 2017; Tzabazis 2013; Valle
2009; Villamar 2013; Volz 2016; Yagci 2014).
Twenty-four studies did not report any information regarding
adverse events (Ahmed 2011; André-Obadia 2011; Bae 2014;
Borckardt 2009; Brietzke 2016; Cork 2004; Curatolo 2017;
Defrin 2007; Gabis 2009; Harvey 2017; Jales Junior 2015; Jensen
2013; Kang 2009; Katsnelson 2004; Khedr 2005; Lefaucheur
2006; Lefaucheur 2008; Lichtbroun 2001; Pleger 2004; Riberto
2011; Tan 2000; Tan 2006; Tekin 2014; Yilmaz 2014). Reporting
of adverse events in the remaining studies varied substantially in
terms of detail.
Studies of rTMS
See Table 1 for a summary of stimulation characteristics utilised
in rTMS studies.
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Stimulation location
The parameters for rTMS application varied significantly between
studies, including by site of stimulation, stimulation parameters
and the number of stimulation sessions. The majority of rTMS
studies targeted the primary motor cortex (M1) (Ahmed 2011;
André-Obadia 2006; André-Obadia 2008; André-Obadia 2011;
Attal 2016; Boyer 2014;Dall’Agnol 2014;Defrin 2007;Hirayama
2006; Hosomi 2013; Irlbacher 2006; Jetté 2013; Kang 2009;
Khedr 2005; Lee 2012, Lefaucheur 2001a; Lefaucheur 2001b;
Lefaucheur 2004; Lefaucheur 2006; Lefaucheur 2008; Malavera
2013; Medeiros 2016; Mhalla 2011; Nurmikko 2016; Onesti
2013; Passard 2007; Picarelli 2010; Pleger 2004; Rollnik 2002;
Saitoh 2007; Tekin 2014;). Of these, one study specified stimula-
tion of the right hemisphere (Kang 2009), five studies specified the
left hemisphere (Boyer 2014; Dall’Agnol 2014; Medeiros 2016;
Mhalla 2011; Yagci 2014), and four studies specified stimulation
over the midline (Defrin 2007; Pleger 2004; Tekin 2014; Yilmaz
2014). One study used a novel H-coil to stimulate the motor cor-
tex of the leg representation situated deep in the central sulcus
(Onesti 2013), and the remainder stimulated over the contralat-
eral cortex to the side of dominant pain. One of these studies also
investigated stimulation of the supplementary motor area (SMA),
pre-motor area (PMA) and primary somatosensory cortex (S1)
(Hirayama 2006). Seven studies stimulated the dorsolateral pre-
frontal cortex (DLPFC) or prefrontal cortex (PFC), with five stud-
ies stimulating the left hemisphere (Borckardt 2009; de Oliveira
2014; Nardone 2017; Short 2011; Umezaki 2016), and two stud-
ies the right (Carretero 2009; Lee 2012). One study investigated
stimulation of the left and right secondary somatosensory cortex
(SII) as separate treatment conditions (Fregni 2005), and another
investigated stimulation to the right SII area (Fregni 2011). One
study used a four-coil configuration to target the anterior cingu-
late cortex (Tzabazis 2013).
Stimulation parameters
Frequency
Twelve studies investigated low-frequency (< 5Hz) rTMS (André-
Obadia 2006;Carretero 2009; Fregni 2005; Fregni 2011; Irlbacher
2006; Lee 2012; Lefaucheur 2001b; Lefaucheur 2006; Lefaucheur
2008; Saitoh 2007; Tzabazis 2013; Yagci 2014). Of these, one
study used a frequency of 0.5 Hz in one treatment condition
(Lefaucheur 2001b), and the rest used a frequency of 1Hz. Thirty-
nine studies investigated high-frequency (≥ 5 Hz) rTMS (Ahmed
2011; André-Obadia 2006; André-Obadia 2008; André-Obadia
2011; Attal 2016; Avery 2013; Borckardt 2009; Boyer 2014;
Dall’Agnol 2014; Defrin 2007; de Oliveira 2014; Fregni 2005;
Hirayama 2006; Hosomi 2013; Irlbacher 2006; Jetté 2013; Kang
2009; Khedr 2005; Lee 2012; Lefaucheur 2001a; Lefaucheur
2001b; Lefaucheur 2004; Lefaucheur 2006; Lefaucheur 2008;
Malavera 2013; Medeiros 2016; Mhalla 2011; Nardone 2017;
Nurmikko 2016; Onesti 2013; Passard 2007; Picarelli 2010;
Pleger 2004; Rollnik 2002; Saitoh 2007; Short 2011; Tekin 2014;
Umezaki 2016; Yilmaz 2014). While the study by Tzabazis 2013
did apply high-frequency stimulation to some participants, the al-
location of the high-frequency groups was not randomised in that
study (confirmed through correspondence with authors) and so
those data will not be considered further in this review as they do
not meet our inclusion criteria.
Other parameters
We observed wide variation between studies for various stimula-
tion parameters. The overall number of rTMS pulses delivered
varied from 120 to 4000. Defrin 2007 reported a total num-
ber of pulses of 500 although the reported stimulation parame-
ters of 500 trains, delivered at a frequency of 5 Hz for 10 sec-
onds would imply 25,000 pulses. Thirteen studies specified a
posteroanterior or parasagittal orientation of the stimulating coil
(André-Obadia 2006; Attal 2016; Boyer 2014; Lefaucheur 2001b;
Lefaucheur 2004; Lefaucheur 2006; Lefaucheur 2008; Nardone
2017; Nurmikko 2016; Passard 2007; Picarelli 2010; Short 2011;
Yilmaz 2014), seven studies specified a coil orientation 45º to the
midline (Ahmed 2011; Dall’Agnol 2014; Jetté 2013; Kang 2009;
Malavera 2013;Medeiros 2016; Tekin 2014), one study compared
a posteroanterior coil orientation with a medial-lateral coil orien-
tation (André-Obadia 2008), one used an H-coil (Onesti 2013),
one used a four-coil configuration (Tzabazis 2013), and the re-
maining studies did not specify the orientation of the coil. Within
studies that reported the information, the duration and number
of trains and the inter-train intervals varied. Two studies did not
report this information (Fregni 2005; Fregni 2011).
Type of sham
rTMS studies employed a variety of sham controls. In 13 stud-
ies the stimulating coil was angled away from the scalp to pre-
vent significant cortical stimulation (Ahmed 2011; André-Obadia
2006; André-Obadia 2008; Carretero 2009; Hirayama 2006;
Kang 2009; Khedr 2005; Lee 2012; Pleger 2004; Rollnik 2002;
Saitoh 2007; Yagci 2014; Yilmaz 2014), of which two studies
also simultaneously electrically stimulated the skin of the scalp
in both the active and sham stimulation conditions in order to
mask the sensations elicited by active rTMS and thus preserve
participants’ blinding (Hirayama 2006; Saitoh 2007). One study
(Nurmikko 2016) applied active stimulation at the same param-
eters as for the active stimulation condition, but applied to the
occipital fissure, which is a site at which stimulation is not hypoth-
esised to induce analgesia. The remaining studies utilised sham
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coils. Of these, 13 studies specified that the sham coil made simi-
lar or identical sounds to those elicited during active stimulation
(André-Obadia 2011; Borckardt 2009; Boyer 2014; Defrin 2007;
de Oliveira 2014; Irlbacher 2006; Malavera 2013; Mhalla 2011;
Nardone 2017; Passard 2007; Picarelli 2010; Tekin 2014; Tzabazis
2013), and eight specified that the sham coil made similar sounds,
looked the same and elicited similar scalp sensations as the real
coil (Attal 2016; Avery 2013; Fregni 2011; Hosomi 2013; Jetté
2013; Onesti 2013; Short 2011; Umezaki 2016). Eight studies
did not specify whether the sham coil controlled for the audi-
tory characteristics of active stimulation (Dall’Agnol 2014; Fregni
2005; Lefaucheur 2001a; Lefaucheur 2001b; Lefaucheur 2004;
Lefaucheur 2006; Lefaucheur 2008; Medeiros 2016).
Studies of CES
See Table 2 for a summary of stimulation characteristics utilised
in CES studies.
Stimulation device, parameters and electrode location
Seven studies of CES used the ’Alpha-stim’ CES device (Elec-
tromedical Products International, Inc, Mineral Wells, Texas,
USA). This device uses two ear clip electrodes that attach to each
of the participant’s ears (Cork 2004; Lichtbroun 2001; Rintala
2010; Tan 2000; Tan 2006; Tan 2011; Taylor 2013), and these
studies utilised stimulation intensities of 100 µA with a frequency
of 0.5Hz. One study (Capel 2003) used a device manufactured by
Carex (Hemel Hempstead, UK) that also used earpiece electrodes
and delivered a stimulus intensity of 12 µA.
Two studies used the ’Pulsatilla 1000’ device (Pulse Mazor In-
struments, Rehavol, Israel) (Gabis 2003; Gabis 2009). The elec-
trode array for this device involved an electrode attached to each
of the participant’s mastoid processes and one attached to the fore-
head; current is passed to the mastoid electrodes. One study used
the ’Nexalin’ device (Kalaco Scientific Inc, Scottsdale, AZ, USA)
(Katsnelson 2004). With this device current is applied to a fore-
head electrode and returned via electrodes placed behind the par-
ticipant’s ears. These three studies utilised significantly higher cur-
rent intensities than those using ear clip electrodes with intensities
of 4 mA (Gabis 2003; Gabis 2009), and 11 to 15 mA (Katsnelson
2004).
All CES studies gavemultiple treatment sessions for each treatment
group with variation between the number of treatments delivered.
Type of sham
Eight studies utilised inert sham units (Capel 2003; Cork 2004;
Lichtbroun 2001; Rintala 2010; Tan 2000; Tan 2006; Tan 2011;
Taylor 2013). These units were visually indistinguishable from the
active devices. Stimulation at the intensities used is subsensation
and as such it should not have been possible for participants to
distinguish between the active and sham conditions.
Two studies utilised an “active placebo” treatment unit (Gabis
2003; Gabis 2009). This sham device was visually indistinguish-
able and delivered a current of much lower intensity (≤ 0.75 mA)
than the active stimulator to evoke a similar sensation to ensure
participant blinding. Similarly, Katsnelson 2004 utilised a visually
indistinguishable sham device that delivered brief pulses of cur-
rent of less than 1 mA. The placebo conditions used in these three
studies delivered current at much greater intensities than those
used in the active stimulation conditions of the other CES studies.
Studies of tDCS
See Table 3 for a summary of stimulation characteristics utilised
in tDCS studies.
Stimulation parameters and electrode location
Four studies of tDCS stimulated the dorsolateral prefrontal cor-
tex in one treatment group (Ayache 2016; Fregni 2006b; Kim
2013; Valle 2009). Thirty-four studies stimulated the motor cor-
tex (Ahn 2017; Antal 2010; Bae 2014; Boggio 2009; Brietzke
2016; Chang 2017; Donnell 2015; Fagerlund 2015; Fenton 2009;
Fregni 2006a; Fregni 2006b; Hagenacker 2014; Harvey 2017;
Hazime 2017; Jales Junior 2015; Jensen 2013; Khedr 2017; Kim
2013; Lagueux 2017; Luedtke 2015;Mendonca 2016;Mori 2010;
Ngernyam 2015; Oliveira 2015; Portilla 2013; Riberto 2011;
Sakrajai 2014; Soler 2010; Souto 2014; Thibaut 2017; Valle 2009;
Villamar 2013; Volz 2016; Wrigley 2014). Of these, 23 stim-
ulated the cortex contralateral to the side of worst pain (Ahn
2017; Bae 2014; Boggio 2009; Chang 2017;Donnell 2015; Fregni
2006a; Fregni 2006b; Hagenacker 2014; Harvey 2017; Hazime
2017; Khedr 2017; Lagueux 2017; Mori 2010; Ngernyam 2015;
Oliveira 2015; Portilla 2013; Riberto 2011; Sakrajai 2014; Soler
2010; Thibaut 2017; Villamar 2013; Volz 2016; Wrigley 2014),
of which six studies stimulated the opposite hemisphere to the
dominant hand where pain did not have a unilateral dominance
(Fregni 2006a; Fregni 2006b; Jensen 2013; Riberto 2011; Soler
2010;Wrigley 2014). Seven studies stimulated the left hemisphere
for all participants (Antal 2010; Brietzke 2016; Jales Junior 2015;
Mendonca 2016; Souto 2014; Valle 2009; Villamar 2013). One
study of chronic pelvic pain stimulated the opposite hemisphere to
the dominant hand in all participants (Fenton 2009). One study
specifically investigated the use of tDCS in conjunction with tran-
scutaneous electrical nerve stimulation (TENS) therapy (Boggio
2009).We extracted data comparing active tDCS and shamTENS
with sham tDCS and sham TENS for the purposes of this review.
One study applied anodal or cathodal stimulation to the left mo-
tor cortex or to the right supraorbital area (Mendonca 2011).
Eighteen studies delivered a current intensity of 2 mA for 20 min-
utes once a day for five days (Ahn 2017; Antal 2010; Brietzke 2016;
Donnell 2015; Fagerlund 2015; Fregni 2006a; Fregni 2006b;
Harvey 2017; Kim 2013; Luedtke 2015; Mendonca 2016; Mori
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2010; Sakrajai 2014; Souto 2014; Thibaut 2017; Valle 2009; Volz
2016; Wrigley 2014). Across the remaining studies, dose, in terms
of the number and frequency of stimulation sessions, varied con-
siderably, from a single 20-minute session to up to 10 weeks of
stimulation with either one or multiple sessions of stimulation in
a week. In one study (Hagenacker 2014) tDCS was self-adminis-
tered by participants, daily for 14 days. Six studies (Antal 2010;
Chang 2017; Fenton 2009; Hagenacker 2014; Jales Junior 2015;
Sakrajai 2014) delivered stimulation at a current intensity of 1
mA.
All studies of tDCS utilised a sham condition whereby active
stimulation was ceased after 30 seconds without the participants’
knowledge.
Excluded studies
See Characteristics of excluded studies.
In previous versions of this review we excluded 20 studies after
consideration of the full study report. Of these, two were not stud-
ies of brain stimulation (Carraro 2010; Frentzel 1989), two did
not assess self-reported pain as an outcome (Belci 2004; Johnson
2006), seven were not restricted to participants with chronic pain
or clearly in a chronic pain population (Avery 2007; Choi 2012a;
Choi 2012b; Evtiukhin 1998; Katz 1991; Longobardi 1989; Pujol
1998), two were single case studies (Silva 2007; Zaghi 2009), one
study presented duplicate data from a study already accepted for
inclusion (Roizenblatt 2007, duplicate data from Fregni 2006b),
one did not employ a sham control (Evtiukhin 1998), one was
not a randomised controlled trial (O’Connell 2013), one reported
uncontrolled long-term follow-up data from an included study
(Hargrove 2012b), one employed an intervention that was not de-
signed to alter cortical activity directly through electrical stimula-
tion (Nelson 2010), and one included some participants who did
not meet our criterion of chronic pain (Bolognini 2013). A final
study was screened by a Russian translator and excluded on the
basis that it did not employ a sham control for tDCS (Sichinava
2012).
In this update we excluded a further 14 reports of 12 studies.
Three of these studies did not randomly allocate participants to
groups (Cummiford 2016; Lindholm 2015; Yoon 2014). Six were
not clearly in a chronic population (Bolognini 2015; Choi 2014;
Khedr 2005; Ma 2015; Morin 2017; Schabrun 2014), two were
not studies of electrical brain stimulation (Maestu 2013; Smania
2005), one did not employ a sham control (Seada 2013).
Studies awaiting classification
In this update we have 18 studies registered as awaiting classifica-
tion. Of these 16 have been published as conference abstracts but
we have not been able to obtain a full study report. We were un-
able to source the original study report for the remaining two. For
further details see Characteristics of studies awaiting classification.
Ongoing studies
In this update we have identified 48 ongoing studies. These studies
all investigate the effect of either tDCS or rTMS for chronic pain.
For further details see Characteristics of ongoing studies.
Risk of bias in included studies
Risk of bias varied across studies for all of the assessment criteria.
For summaries of ’Risk of bias’ assessment across studies see Figure
2 and Figure 3.
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Figure 2. Methodological quality summary: review authors’ judgements about each methodological quality
item for each included study
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Figure 3. Risk of bias graph: review authors’ judgements about each risk of bias item presented as
percentages across all included studies
Sequence generation
For the criterion ’adequate sequence generation’ we awarded cross-
over trials a judgement of ’low risk of bias’ where the study report
mentioned that the order of treatment conditionswas randomised.
Since this criterion has a greater potential to introduce bias in
parallel designs we only awarded a judgement of ’low risk of bias’
where the method of randomisation was specified and adequate.
We judged 28 trials as having an unclear risk of bias (Antal 2010;
Bae 2014; Carretero 2009; Chang 2017; Cork 2004; Curatolo
2017; Deering 2017; Defrin 2007; Hagenacker 2014; Hargrove
2012a; Jales Junior 2015; Jetté 2013; Katsnelson 2004; Lagueux
2017; Lee 2012; Mendonca 2011; Mendonca 2016; Nardone
2017; Palm 2016; Picarelli 2010; Riberto 2011; Rintala 2010;
Sakrajai 2014; Tan 2006; Taylor 2013; Thibaut 2017; Tzabazis
2013; Yagci 2014), as they did not specify themethod of randomi-
sation used or the description was not clear.We judged two studies
as having a high risk of bias for this criterion (Ahmed 2011; Khedr
2005), as the reports suggested that participants were allocated
depending on the day of the week on which they were recruited,
which we did not judge as being genuinely random.We judged the
remaining 64 studies as having a low risk of bias for this domain.
Allocation concealment
We only considered allocation concealment for parallel designs
or cross-over trials from which only data from the first cross-
over phase of the study was included (i.e. we considered them
as parallel-group studies). Thirty-four studies did not clearly re-
port concealment of allocation and we judged them as unclear
(Antal 2010; Avery 2013; Bae 2014; Carretero 2009; Cork 2004;
Curatolo 2017; de Oliveira 2014; Deering 2017; Defrin 2007;
Donnell 2015; Fagerlund 2015; Fregni 2011; Hargrove 2012a;
Harvey 2017; Jales Junior 2015; Katsnelson 2004; Kim 2013; Lee
2012; Mendonca 2011; Nardone 2017; Passard 2007; Picarelli
2010; Riberto 2011; Rintala 2010; Sakrajai 2014; Soler 2010; Tan
2006; Taylor 2013; Tekin 2014; Thibaut 2017; Tzabazis 2013;
Umezaki 2016; Volz 2016; Yilmaz 2014), andwe judged two stud-
ies as having a high risk of bias for this criterion since the method
of randomisation employed would not have supported conceal-
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ment of allocation (Ahmed 2011; Khedr 2005). We judged 28
studies as having a low risk of bias for this domain.
Blinding
Blinding of participants
All studies attempted to blind participants. However, due to the
difficulties involved in producing a robust sham control in rTMS
studies (see Assessment of risk of bias in included studies) wemade
an assessment of sham credibility. Where the coil was angled or
angled and elevated away from the scalp, this is potentially dis-
tinguishable both visually and by the sensory effects of stimula-
tion. Two studies simultaneously electrically stimulated the scalp
during rTMS stimulation to mask the differences in sensation be-
tween conditions (Hirayama 2006; Saitoh 2007). However, by an-
gling the coil away from the scalp, participants may have been able
to visually distinguish between the conditions. Where sham coils
were utilised they usually did not control for the sensory aspects of
stimulation. We assessed most rTMS studies as having suboptimal
sham control conditions and we therefore assessed them as having
an ’unclear’ risk of bias.
One studywith a shamof this type presented a formal assessment of
blinding that demonstrated blinding success (Malavera 2013) and
was rated at low risk. Seven rTMS studies included in this update
utilised sham coils that are visually indistinguishable, emit the
same noise during stimulation and elicit similar scalp sensations
(Avery 2013; Dall’Agnol 2014; Fregni 2011; Jetté 2013; Onesti
2013; Short 2011; Umezaki 2016). One study (Nurmikko 2016)
applied active stimulation to a site of the brain not hypothesised
to elicit analgesia as its sham condition. While there may be a risk
of this stimulation having an effect we considered that this sham
could be expected to be indistinguishable from real stimulation.
These studies met the criteria for an optimal sham condition and
as such we judged them at low risk of bias for participant blinding.
Similarly with tDCS studies, due to evidence that blinding of
participants to the stimulation condition may be compromised
at intensities of 1.5 mA and above, we judged the majority of
tDCS studies at unclear risk of bias on this criterion (Ahn 2017;
Attal 2016; Ayache 2016; Bae 2014; Boggio 2009; Brietzke 2016;
Donnell 2015; Fagerlund 2015; Fregni 2006a; Fregni 2006b;
Harvey 2017; Hazime 2017; Jensen 2013; Khedr 2017; Kim
2013; Mendonca 2011; Mendonca 2016; Mori 2010; Ngernyam
2015; Oliveira 2015; Portilla 2013; Riberto 2011; Soler 2010;
Souto 2014; Thibaut 2017; Valle 2009; Villamar 2013; Volz
2016;Wrigley 2014) unless there was evidence of blinding success
(Lagueux 2017; Luedtke 2015).We judged one studyHagenacker
2014 at unclear risk of bias as the method of blinding was not
described.
We assessed all studies of CES and RINCE and the single study
of tRNS as having a low risk of bias for this criterion.
Overall, we judged 27 studies at low risk of bias, and 57 studies
at unclear risk of bias.
Blinding of assessors
While many studies used self-reported pain outcomes we consid-
ered that the complex nature of the intervention, and the level
of interaction this entails between participants and assessors, sug-
gested that a lack of blinding of the researchers engaged in the
collection of outcomes might potentially introduce bias. This is
particularly the case when a VAS is used to measure pain intensity
as this requires the assessor to measure the distance from the zero
anchor point to the mark made by the participant. As such, where
blinding of assessors was not clearly stated wemade a judgement of
’unclear’ for this criterion. We rated studies of tDCS that applied
stimulation intensity of 2 mA and where no formal assessment
of blinding success was presented as at unclear risk of bias, since
there is evidence that assessor blinding may be compromised at
the stimulation intensities used (O’Connell 2012).
We judged 48 studies to be at unclear risk of bias (Ahn
2017; André-Obadia 2011; Attal 2016; Ayache 2016; Bae
2014; Boggio 2009; Borckardt 2009; Brietzke 2016; Curatolo
2017; Deering 2017; Fregni 2006a; Fregni 2006b; Hagenacker
2014; Harvey 2017; Hazime 2017; Hirayama 2006; Irlbacher
2006; Jensen 2013; Khedr 2017; Kim 2013; Lagueux 2017;Lee
2012; Lefaucheur 2001a; Lefaucheur 2001b; Lefaucheur 2004;
Lefaucheur 2006; Mendonca 2011; Mendonca 2016; Mori 2010;
Ngernyam 2015; Oliveira 2015; Onesti 2013; Picarelli 2010;
Pleger 2004; Portilla 2013; Riberto 2011; Rollnik 2002; Saitoh
2007; Sakrajai 2014; Soler 2010; Souto 2014; Tan 2000; Thibaut
2017; Tzabazis 2013; Valle 2009; Villamar 2013; Volz 2016;
Wrigley 2014), two studies (Donnell 2015;Umezaki 2016) at high
risk of bias, as they clearly reported that assessors were not blinded,
and we rated the remaining studies at low risk of bias.
Incomplete outcome data
We assessed 19 studies as having an unclear risk of bias for this cri-
terion (Ahmed 2011; André-Obadia 2006; André-Obadia 2011;
Bae 2014; Brietzke 2016; Boggio 2009; Chang 2017; Cork 2004;
Fagerlund 2015; Fregni 2011; Hargrove 2012a; Jales Junior 2015;
Katsnelson 2004; Lefaucheur 2006; Lichtbroun 2001; Mendonca
2016; Tzabazis 2013; Volz 2016; Yagci 2014). Of these, Ahmed
2011; Bae 2014; Cork 2004; Fregni 2011; Jales Junior 2015;
Katsnelson 2004; Lefaucheur 2006; Lichtbroun 2001; Tzabazis
2013 and Volz 2016 did not report the level of dropout from their
studies. Tzabazis 2013 reported recruiting 16 participants in the
full study report (Tzabazis 2013), but an earlier abstract report
of the same study reported the recruitment of 45 participants.
In the study of André-Obadia 2006, two participants (17% of
the study cohort) did not complete the study and this was not
clearly accounted for in the data analysis. This was also the case for
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Boggio 2009, where two participants (25% of the cohort) failed to
complete the study. Brietzke 2016 and Mendonca 2016 reported
dropout of more than10% and used the last observation carried
forward (LOCF) approach for imputation. Chang 2017 and Yagci
2014 reported dropout of more than 10% and conducted an avail-
able case analysis. Fagerlund 2015 had a high noncompletion rate
for some outcomes and did not clearly report how many partici-
pants were analysed for each outcome.
We assessed fifteen studies as having a high risk of bias for this cri-
terion (Antal 2010; Boyer 2014;Deering 2017;Hagenacker 2014;
Harvey 2017; Irlbacher 2006; Kim 2013; Lee 2012; Nurmikko
2016; Palm 2016; Rintala 2010; Souto 2014; Tan 2000; Thibaut
2017; Umezaki 2016). In the Antal 2010 study, of 23 participants
recruited only 12 completed the full cross over. Boyer 2014 re-
ported dropout of more than 20% and, while an intention-to-
treat approach was reported the details of this and any imputation
of missing data were not reported. Deering 2017 excluded eight
out of 15 participants randomised to the sham condition on the
basis that “an unexpected signal source was discovered in EEG
traces”. Harvey 2017 reported a 25% dropout rate in the active
stimulation arm only and those participants appear to have been
excluded from the analysis. In the study by Irlbacher 2006, only 13
of the initial 27 participants completed all of the treatment condi-
tions. Kim 2013 reported a 15% dropout rate and excluded those
participants from the analysis. Nurmikko 2016 reported a 33%
dropout rate with a per-protocol analysis. Palm 2016 reported
13% dropout and excluded those participants from the analysis.
Souto 2014 reported 20% dropout and used the LOCF method
to impute missing data. In the studies of Hagenacker 2014; Lee
2012 and Rintala 2010, attrition exceeded 30% of the randomised
cohort. In the study by Tan 2000, 17 participants did not com-
plete the study (61% of the cohort) and this was not clearly ac-
counted for in the analysis. Thibaut 2017 reported a 57% dropout
rate. Umezaki 2016 reported dropout of more than 20% and con-
ducted a per-protocol analysis.
Selective reporting
We assessed studies as having a high risk of bias for this crite-
rion where the study report did not produce adequate data to as-
sess the effect size for all groups/conditions at all follow-up time
points, and these data were not made available upon request. We
assessed 18 studies as having a high risk of bias for this criterion
(Attal 2016; Capel 2003; Cork 2004; Curatolo 2017; Dall’Agnol
2014; Deering 2017; Donnell 2015; Fregni 2005; Fregni 2011;
Katsnelson 2004; Kim 2013; Lichtbroun 2001; Mendonca 2011;
Onesti 2013; Portilla 2013; Tzabazis 2013; Umezaki 2016; Valle
2009). We judged three studies as being at unclear risk of bias
(Fregni 2006a; Fregni 2006b; Medeiros 2016). In the reports of
Fregni 2006a and Fregni 2006b data were not presented in a for-
mat that could be easily interpreted.On request datawere available
from these two studies for the primary outcome at baseline and
short-term follow-up but not for other follow-up points. Medeiros
2016 reported pain VAS scores but not the results of pain diaries
that were described in the methods. We assessed the remaining
73 studies as having a low risk of bias for this criterion. For this
update, we first made requests for data (by email where possible).
If any data are made available in time for future updates then we
will revise judgements on this criterion accordingly.
Carry-over effects in cross-over trials
We judged seven studies (Attal 2016; Ayache 2016; Fenton 2009;
Hagenacker 2014; Jetté 2013; Palm 2016; Portilla 2013) as un-
clear on this criterion as no formal investigation of carry-over ef-
fects was discussed in the study report. In one cross-over study
baseline differences between the sham and the 10 Hz stimulation
condition were notable (Saitoh 2007). A paired t-test did not show
a difference (P > 0.1) and we judged this study as having a low
risk of bias for carry-over effects. We rated 25 cross-over studies
at low risk of bias and the remaining 52 studies were not assessed
due to their parallel design.
A number of studies were judged at unclear risk of bias as infor-
mation regarding between group baseline comparability was not
presented.
Study size
We rated four studies at unclear risk of bias (Hosomi 2013;
Lefaucheur 2004; Luedtke 2015; Tan 2011), with all remaining
studies rated at high risk of bias on this criterion.
Study duration
We rated 14 studies at low risk of bias on this criterion (Ahmed
2011; Avery 2013; Dall’Agnol 2014; Gabis 2009; Hazime 2017;
Luedtke 2015; Mendonca 2016; Mhalla 2011; Passard 2007;
Picarelli 2010; Thibaut 2017; Valle 2009; Yagci 2014; Yilmaz
2014), 34 studies at unclear risk of bias (Ahn 2017; André-Obadia
2008; André-Obadia 2011; Antal 2010; Bae 2014; Borckardt
2009; Carretero 2009; Deering 2017; Defrin 2007; de Oliveira
2014; Donnell 2015; Fagerlund 2015; Fenton 2009; Fregni
2006a; Fregni 2006b; Fregni 2011; Hosomi 2013; Kang 2009;
Khedr 2005; Khedr 2017; Kim 2013; Lagueux 2017; Lee 2012;
Malavera 2013; Mori 2010; Nardone 2017; Nurmikko 2016;
Oliveira 2015; Onesti 2013; Sakrajai 2014; Soler 2010; Tzabazis
2013; Umezaki 2016;Wrigley 2014), and the remaining studies at
high risk of bias (André-Obadia 2006; Attal 2016; Ayache 2016;
Boggio 2009; Boyer 2014; Brietzke 2016; Capel 2003; Chang
2017; Cork 2004; Curatolo 2017; Fregni 2005; Gabis 2003;
Hagenacker 2014; Hargrove 2012a; Harvey 2017; Hirayama
2006; Irlbacher 2006; Jales Junior 2015; Jensen 2013; Jetté
2013; Katsnelson 2004; Lefaucheur 2001a; Lefaucheur 2001b;
Lefaucheur 2004; Lefaucheur 2006; Lefaucheur 2008; Lichtbroun
2001; Medeiros 2016; Mendonca 2011; Ngernyam 2015; Palm
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2016; Pleger 2004; Portilla 2013; Riberto 2011; Rintala 2010;
Rollnik 2002; Saitoh 2007; Short 2011; Souto 2014; Tan 2000;
Tan 2006; Tan 2011; Taylor 2013; Tekin 2014; Villamar 2013;
Volz 2016).
Other potential sources of bias
Overall, we judged 13 studies at unclear risk of bias and one study
at high risk of bias on this criterion. Five studies (Deering 2017;
Fregni 2011; Jales Junior 2015; Katsnelson 2004; Tzabazis 2013)
were judged at unclear risk of bias as they did not adequately
report baseline values for the groups to allow assessment of baseline
comparability. One of those studies (Deering 2017) was rated as
unclear on the criteria as no formal baseline comparisons were
presented and around half of those randomised to the sham group
were excluded from the baseline score. We judged four studies
(Ahn 2017; Defrin 2007; Riberto 2011; Tan 2011) at unclear
risk of bias as baseline differences were apparent for pain-related
measures. We rated Harvey 2017 at high risk of bias on the basis
of a greater than 3-point difference between the active and sham
groups in baseline pain levels on a 0 to 10 scale.
One study of CES also applied electrical stimulation to the painful
body area as part of the treatment, which may have affected the
final outcomes (Tan 2000). Two studies of CES used an “active
placebo condition” that delivered a level of cortical stimulation that
was greater than that used in the active arm of other CES studies
(Gabis 2003; Gabis 2009). It is possible that delivering cortical
stimulation in the sham groupmightmask differences between the
sham and active condition. Also such a large difference in current
intensity compared with other studies of CES might be a source
of heterogeneity.We judged these three studies as ’unclear’ on this
criterion. We rated one study (Lefaucheur 2001b) at unclear risk
of bias as the outcome of a planned statistical analysis was not
reported.We judged 80 studies at low risk of bias for this criterion.
Effects of interventions
See: Summary of findings for the main comparison Repetitive
transcranial magnetic stimulation (rTMS) compared with sham
for chronic pain; Summary of findings 2 Cranial electrotherapy
stimulation (CES) compared with sham for chronic pain;
Summary of findings 3 Transcranial direct current stimulation
(tDCS) compared with sham for chronic pain
For a summary of all core findings, see Summary of findings for the
main comparison; Summary of findings 2; Summary of findings
3.
Primary outcome: pain intensity
Repetitive transcranial magnetic stimulation (rTMS): short-
term (0 to < 1 week postintervention)
The primary meta-analysis (Analysis 1.1) pooled data from all
rTMS studies with low or unclear risk of bias (excluding the
risk of bias criteria ’study size’ and ’study duration’) where
data were available (27 studies, n = 655), including cross-over
and parallel designs, using the generic inverse variance method
(André-Obadia 2006; André-Obadia 2008; André-Obadia 2011;
Avery 2013; Borckardt 2009; Carretero 2009; Defrin 2007; de
Oliveira 2014; Hirayama 2006; Hosomi 2013; Jetté 2013; Kang
2009; Lefaucheur 2001a; Lefaucheur 2001b; Lefaucheur 2004;
Lefaucheur 2006; Lefaucheur 2008;Medeiros 2016;Mhalla 2011;
Nardone 2017; Passard 2007; Pleger 2004; Rollnik 2002; Saitoh
2007; Short 2011;Tekin 2014; Yagci 2014).We excluded the stud-
ies by Ahmed 2011; Boyer 2014; Dall’Agnol 2014; Khedr 2005;
Irlbacher 2006; Lee 2012; Nurmikko 2016 and Umezaki 2016
as we classified them as having a high risk of bias on at least one
criterion. We were unable to include data from six studies (Fregni
2005; Fregni 2011; Onesti 2013; Picarelli 2010; Tzabazis 2013;
Umezaki 2016, combined n = 107) as the necessary data were not
available in the study report or upon request by the submission
date of this update. We could not include the data from Yilmaz
2014 as outcomes were only reported as a median (interquartile
range). We imputed the correlation coefficient used to calculate
the standard error (SE) (standardised mean difference (SMD)) for
cross-over studies (0.764) from data extracted fromAndré-Obadia
2008 (as outlined in Unit of analysis issues) and we entered the
SMD (SE) for each study into a generic inverse variance meta-
analysis. We divided the number of participants in each cross-over
study by the number of comparisons made by that study included
in themeta-analysis. For parallel studies we calculated the standard
error of the mean (SEM) from the 95% confidence intervals (CIs)
of the standardised mean difference (SMD) and entered both the
SMD and the SEM into the meta-analysis. We then entered this
into the meta-analysis with the SMD using the generic inverse
variance method.
The pooled SMD for this comparison was -0.22 (95%CI -0.29 to
-0.16, P < 0.001). We back-transformed the SMD to a mean dif-
ference using the mean standard deviation of the post-treatment
sham group scores of the studies included in this analysis (1.86).
We then used this to estimate the real percentage change on a 0
to 10 pain intensity scale of active stimulation compared with the
mean poststimulation score from the sham groups of the included
studies (5.94). This equates to a 7% (95% CI 5% to 9%) reduc-
tion in pain, or a 0.40 (95% CI 0.53 to 0.32) point reduction on
a 0 to 10 pain intensity scale, which does not meet the minimum
clinically important difference threshold of 15% or more. Using
GRADE we rated the quality of evidence for this comparison as
low, downgraded once on the basis of study limitations due to risk
of bias and once on the basis of inconsistency due to heterogeneity
(see Summary of findings for the main comparison). We observed
substantial heterogeneity (I2 = 70%, P < 0.001) and investigated
this using pre-planned subgroup analyses. Categorising studies by
high (≥ 5 Hz) or low (< 5 Hz) frequency, rTMS demonstrated
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a difference between subgroups (P < 0.001) and reduced hetero-
geneity in the low-frequency group (n = 106, I2 = 0%). In this
group there was no evidence of an effect of low-frequency rTMS
for pain intensity (SMD 0.13, 95% CI -0.03 to 0.28, P = 0.11).
While high-frequency stimulation demonstrated an effect (n =
560, SMD -0.30, 95% CI -0.37 to -0.23, P < 0.001), we observed
substantial heterogeneity in this analysis (P < 0.001, I2 = 68%).
Separating studies that delivered a single treatment per condition
from those that delivered multiple treatment sessions did not re-
duce heterogeneity substantially inmultiple-dose studies (n = 357,
I2 = 80%, P < 0.001) or single-dose studies (n = 319, I2 = 57%, P
< 0.001) (Analysis 1.2).
There were insufficient data to support the subgroup analysis by
the type of painful condition as planned. However, when the anal-
ysis was restricted to studies including only well-defined neuro-
pathic pain populations (Analysis 1.3), there was little impact on
heterogeneity (I2 = 69%, P < 0.001). In the subgroup of non-
neuropathic pain studies overall heterogeneity remained high (I2
= 77%, P < 0.001) (Analysis 1.4). Responder data were available
from one study not judged at high risk of bias (Malavera 2013 n =
54, Analysis 1.14; Analysis 1.25). This demonstrated an effect in
favour of active stimulation for 30% reduction in pain (risk ratio
(RR) 2.11, 95% CI 1.17 to 3.80, P = 0.01).
rTMS motor cortex
Restricting the analysis to studies of high-frequency stimulation
of the motor cortex (Analysis 1.5) (21 studies, n = 505) the pooled
SMD was -0.37 (-0.51 to 0.22, P < 0.001) though heterogeneity
was high (I2 = 67%, P < 0.001). Using GRADE we rated the
quality of evidence for this comparison as low, downgraded once
on the basis of study limitations due to risk of bias and once on
the basis of inconsistency due to heterogeneity (see Summary of
findings for the main comparison).
Further restricting the analysis to single-dose studies of high-fre-
quency stimulation of the motor cortex (n = 249) reduced hetero-
geneity (I2 = 23%, P = 0.19) (Analysis 1.5). The pooled SMDwas
-0.38 (95% CI -0.49 to -0.27, P < 0.001). We back-transformed
the SMD to a mean difference using the mean standard deviation
of the post-treatment sham group scores of the studies included in
this analysis (2.04). We then used this to estimate the real percent-
age change on a 0 to 10 pain intensity scale of active stimulation
compared with the mean poststimulation score from the sham
groups of the included studies (6.2). This equated to a reduction
of 0.77 (95% CI 0.55 to 0.99) points, or a percentage change of
12% (95% CI 9% to 16%) of the control group outcome. This
estimate does not reach the pre-established criteria for a minimal
clinically important difference (≥ 15%). Of the included studies
in this subgroup, nine did not clearly report blinding of assessors
and we awarded them a judgement of ’unclear’ risk of bias for
this criterion (André-Obadia 2011; Hirayama 2006; Lefaucheur
2001a; Lefaucheur 2001b; Lefaucheur 2004; Lefaucheur 2006;
Pleger 2004; Rollnik 2002; Saitoh 2007). A sensitivity analysis
removing these studies reduced heterogeneity to I2 = 0% although
only three studies were preserved in the analysis (André-Obadia
2006; André-Obadia 2008; Lefaucheur 2008). There remained
a difference between sham and active stimulation although the
SMD reduced to -0.29 (95% CI -0.49 to -0.13). This equates to
a percentage change of 9% (95% CI 4% to 14%) in compari-
son with sham stimulation. For multiple-dose studies of high-fre-
quency motor cortex stimulation heterogeneity was high (n = 256,
I2 = 82%, P < 0.001), and the pooled effect was not significant
(SMD -0.34, 95% CI -0.73 to 0.05, P = 0.09).
When the analysis was restricted to studies of single-dose, high-
frequency motor cortex stimulation in well-defined neuropathic
pain populations (excluding data from Pleger 2004 and Rollnik
2002), there was little effect on the pooled estimate (SMD -0.41,
95% CI -0.52 to -0.29) or heterogeneity (I2 = 23%, P = 0.20).
When we applied the same process to multiple-dose studies of
high-frequency motor cortex stimulation (excluding data from
Medeiros 2016;Mhalla 2011; Passard 2007; Tekin 2014 and Yagci
2014 we found no pooled effect (SMD 0.12, 95% CI -0.16 to
0.40) and heterogeneity remained high.
Sensitivity analysis
To assess whether the imputation of standard errors for cross-over
studies was robust we repeated the analysis with the correlation
coefficient reduced to 0.66 and increased to 0.86. This had no
marked effect on the overall analysis (Analysis 1.6; Analysis 1.7).
We applied the same process to the subgroup analysis of single-
dose studies of high-frequency motor cortex stimulation (Analysis
1.8; Analysis 1.9). This had a negligible impact on the effect size
or the statistical significance for this subgroup.
To assess the impact of excluding the studies at high risk of bias
we performed the analysis with data from these studies included (
Analysis 1.10).While this produced amodest increase in the SMD
it increased heterogeneity from 68% to 72%. Inclusion of high
risk of bias studies to the multiple-dose studies of high-frequency
motor cortex stimulation subgroup increased heterogeneity (I2
= 85%, P < 0.001), though the analysis demonstrated an effect
(SMD -0.53, 95% CI -0.91 to -0.15, P = 0.006) (Analysis 1.11).
Inclusion of the Irlbacher 2006 study in the single-dose studies of
high-frequency motor cortex stimulation subgroup caused a slight
decrease in the pooled effect size (SMD -0.35, 95% CI -0.46 to -
0.24) with no impact on heterogeneity.
Small study effects
We investigated small study effects using Egger’s test. The results
are not suggestive of a significant influence of small study effects.
rTMS prefrontal cortex
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Restricting the analysis to studies that stimulated the prefrontal
cortex (PFC) included six studies (n =103) (Avery 2013; Borckardt
2009; Carretero 2009; de Oliveira 2014; Nardone 2017; Short
2011) (Analysis 1.12). We excluded the study by Lee 2012 due to
its high risk of bias. Therewas no clear pooled effect (P = 0.11) with
substantial heterogeneity (I2 = 79%, P < 0.001). Restricting the
analysis to high-frequency studies (Avery 2013; Borckardt 2009;
Nardone 2017; Short 2011), the results were unchanged (P = 0.12,
I2 = 83%, P < 0.001).
Sensitivity analysis
To assess the impact of excluding the study of Lee 2012, we per-
formed the analysis with data from this study included (Analysis
1.13). The overall effect remained non-significant (P = 0.08) with
high heterogeneity (I2 = 75%, P < 0.001).
rTMS: medium-term (≥ 1 to < 6 weeks postintervention)
Eleven studies provided data on medium-term pain outcomes (
Avery 2013; Carretero 2009; de Oliveira 2014; Hosomi 2013;
Lefaucheur 2001a; Kang 2009; Malavera 2013; Nardone 2017;
Passard 2007; Short 2011; Yagci 2014).We excluded the studies by
Ahmed 2011; Khedr 2005; Lee 2012 and Nurmikko 2016 as we
classified them as having a high risk of bias. The analysis included
293 participants (Analysis 1.16). Overall heterogeneity was high
(I2 = 77%, P < 0.001) and no clear evidence of effect was observed
(SMD -0.28, 95% CI -0.61 to 0.05, P = 0.09). Using GRADE
we rated the quality of evidence for this comparison as very low,
downgraded once on the basis of study limitations due to risk of
bias, once on the basis of inconsistency due to heterogeneity and
once for imprecision due to low participant numbers. Restricting
the analysis to studies of prefrontal cortex stimulation (Avery 2013;
Carretero 2009; de Oliveira 2014; Nardone 2017; Short 2011)
demonstrated no clear effect (SMD -1.08, 95% CI -2.49 to 0.32,
P = 0.13, I2 = 88%, P < 0.001, Analysis 1.19 ). Studies of motor
cortex stimulation also demonstrated no effect (SMD -0.22, 95%
CI -0.46 to 0.02, P = 0.08) although heterogeneity was high (I2
= 59%, P < 0.02) and remained high when only high-frequency
stimulation studies were included (SMD -0.23 (-0.49 to 0.03,
P = 0.08, I2 = 66%, P = 0.01) (Analysis 1.18). We performed
sensitivity analysis to assess the impact of excluding the studies by
Ahmed 2011; Khedr 2005; Lee 2012 and Nurmikko 2016 on the
basis of risk of bias (Analysis 1.17). Including these studies did not
substantially alter heterogeneity (I2 = 80%, P < 0.01) though the
effect reached significance overall (SMD -0.50, 95% CI -0.80 to
-0.20, P = 0.001).
rTMS: long-term (≥ 6 weeks postintervention)
Four studies provided data for long-term pain relief (Avery 2013;
Kang 2009; Passard 2007; Yilmaz 2014) (Analysis 1.20). The anal-
ysis included 75 participants. There was no heterogeneity (I2 =
0%, P = 0.99). The analysis demonstrated no effect (SMD -0.14,
95% CI -0.44 to 0.17, P = 0.39). Using GRADE we rated the
quality of evidence for this comparison as low, downgraded once
on the basis of study limitations due to risk of bias and once for
imprecision due to low participant numbers. Sensitivity analysis
to assess the impact of excluding the study of Ahmed 2011 due
to its high risk of bias continued to demonstrate no evidence of
effect, though heterogeneity was introduced (Analysis 1.21, I2 =
57%, P = 0.05).
Cranial electrotherapy stimulation (CES): short-term (0 to <
1 week postintervention)
Six studies provideddata for this analysis (Gabis 2003;Gabis 2009;
Tan 2006; Tan 2011; Taylor 2013) (Analysis 2.1, n = 270). We
excluded the study by Rintala 2010 due to high risk of attrition
bias. All studies utilised a parallel-group design and so we used a
standard inverse variance meta-analysis using SMD. Four studies
did not provide the necessary data to enter into the analysis (Capel
2003; Cork 2004; Katsnelson 2004; Lichtbroun 2001, combined
n = 228) and we classified two studies as being at high risk of
bias on criteria other than ’free of selective outcome reporting’
(Katsnelson 2004; Tan 2000). The studies by Gabis 2003 and
Gabis 2009 differed substantially from the other included stud-
ies on the location of electrodes and the intensity of the current
provided. Despite this, there was no heterogeneity (I2 = 0%). No
individual study in this analysis demonstrated superiority of active
stimulation over sham and the results of the meta-analysis do not
demonstrate a clear effect (SMD -0.24, 95% CI -0.48 to 0.01,
P = 0.06). Using GRADE we rated the quality of evidence for
this comparison as low, downgraded once on the basis of study
limitations due to risk of bias and once for imprecision due to
low participant numbers (see Summary of findings 2). Sensitivity
analysis, including the study by Rintala 2010, did not meaning-
fully affect the results (SMD -0.21, 95% CI -0.45 to 0.02, P =
0.07).
CES: medium-term (≥ 1 to 6 weeks postintervention) and
long-term (≥ 6 weeks postintervention)
There were insufficient data to perform a meta-analysis for
medium- or long-term pain outcomes for CES.
Transcranial direct current stimulation (tDCS): short-term
(0 to < 1 week postintervention)
Adequate data were available from 27 studies (Ahn 2017; Antal
2010; Ayache 2016; Bae 2014; Boggio 2009; Brietzke 2016;
Chang 2017; Fagerlund 2015; Fenton 2009; Fregni 2006a; Fregni
2006b; Hazime 2017; Jales Junior 2015; Jensen 2013; Khedr
2017; Lagueux 2017; Luedtke 2015;Mendonca 2016;Mori 2010;
Ngernyam 2015; Oliveira 2015; Riberto 2011; Sakrajai 2014;
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Soler 2010; Villamar 2013; Volz 2016;Wrigley 2014) for this anal-
ysis (n = 747).We were unable to include data fromDonnell 2015;
Mendonca 2011; and Valle 2009 (combined n = 95) as the neces-
sary data were not reported in the study report or available upon
request to the study authors. We analysed data using the generic
inverse variance method. We imputed the correlation coefficient
(0.635) used to calculate the SE (SMD) for cross-over studies from
data extracted from Boggio 2009 (see Unit of analysis issues). One
study compared two distinct active stimulation conditions to one
sham condition (Fregni 2006b). We considered that combining
the treatment conditions would be inappropriate, as each involved
stimulation of different locations and combination would hinder
subgroup analysis. Instead we included both comparisons sepa-
rately with the number of participants in the sham control group
divided by the number of comparisons. We excluded data from
Harvey 2017 as there was a baseline imbalance greater than 3 out
of 10 in pain scores. We only included first-stage data from the
study of Antal 2010 (n = 12) due to the unsustainable level of
attrition following this stage.
The overall meta-analysis demonstrated an effect of active stimu-
lation (SMD -0.43, 95% CI -0.63 to -0.22, P < 0.001) (Analysis
3.1), but heterogeneity was high (I2 = 60%, P < 0.001). We back-
transformed the SMD to a mean difference using the mean stan-
dard deviation of the post-treatment sham group scores of the
studies included in this analysis (1.91). We then used this to esti-
mate the real percentage change on a 0 to 10 pain intensity scale
of active stimulation compared with the mean post-stimulation
score from the sham groups of the included studies (4.77). This
equates to a reduction of 0.82 (95% CI 0.42 to 1.2) points, or a
percentage change of 17% (95% CI 9% to 25%) of the control
group outcome, which meets our threshold for a clinically impor-
tant difference, though the lower confidence interval is substan-
tially below that threshold. Using GRADE we rated the quality of
evidence for this comparison as very low, downgraded once on the
basis of study limitations due to risk of bias, once for inconsistency
due to heterogeneity and once for evidence of possible publication
bias (see Summary of findings 3).
Subgrouping studies by multiple or single dose decreased hetero-
geneity in the single-dose subgroup (I2 = 0%, P = 0.70) but did not
reduce heterogeneity in the multiple-dose subgroup (I2 = 64%, P
< 0.001). Inclusion of studies at high risk of bias (Analysis 3.4;
Antal 2010; Hagenacker 2014; Kim 2013; Souto 2014; Thibaut
2017) slightly increased the effect size (SMD -0.48, 95%CI -0.67
to -0.29, P < 0.001, I2 = 60%, P < 0.001). Analysis restricted to
comparisons of active motor cortex stimulation (single- and mul-
tiple-dose studies) (n = 655, Analysis 3.5) did not reduce hetero-
geneity substantially (I2 = 58%, P < 0.001) and demonstrated an
effect (SMD -0.47, 95% CI -0.67 to -0.28, P < 0.001).
There were insufficient data to support the planned subgroup anal-
ysis by the type of painful condition as planned. However, a mod-
ified subgroup analysis by neuropathic or non-neuropathic pain
conditions (Analysis 3.8) demonstrated no subgroup difference (P
= 0.41) though heterogeneity was reduced in the neuropathic pain
group (I2 = 40%, P = 0.10).
Responder datawere only available froma small number of studies,
all that were considered at high risk of bias. As such we did not
conduct a formalmeta-analysis but the data can be seen inAnalysis
3.9; Analysis 3.10; Analysis 3.12 and Analysis 3.13.
To assess whether the imputation of standard errors for cross-
over studies was robust we repeated the analyses with the imputed
correlation coefficient reduced and increased by a value of 0.1
(Analysis 3.2; Analysis 3.3; Analysis 3.6; Analysis 3.7). This had
no meaningful impact upon the results.
Small study effects
We investigated small study effects using Egger’s test. Funnel plot
asymmetry was apparent and Egger’s test indicated small study ef-
fects for the overall comparisons (Figure 4, P = 0.019) and the sub-
groups of motor cortex stimulation studies (Figure 5, P = 0.002).
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Figure 4. Funnel plot of comparison 3. Transcranial direct current stimulation (tDCS), outcome 3.1. Pain:
short-term follow-up
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Figure 5. Funnel plot of comparison 3. Transcranial direct current stimulation (tDCS), outcome 3.5. Pain:
short-term follow-up, subgroup analysis: motor cortex studies only
tDCS: medium-term (1 to < 6 weeks post-treatment)
Fourteen studies provided adequate data for this analysis (Ahn
2017; Ayache 2016 ; Bae 2014; Fagerlund 2015; Fenton 2009;
Khedr 2017; Lagueux 2017; Luedtke 2015; Mendonca 2016;
Mori 2010; Sakrajai 2014; Soler 2010, Volz 2016; Wrigley 2014,
pooled n = 443) (Analysis 3.11). There was heterogeneity (I2 =
60%, P = 0.003) and the pooled results demonstrated an effect
of tDCS (SMD -0.43, 95% CI -0.72 to -0.13, P = 0.004). Using
GRADE we rated the quality of evidence for this comparison as
very low, downgraded once on the basis of study limitations due
to risk of bias, once for inconsistency and once for evidence of
publication bias.
Small study effects
We investigated small study effects using Egger’s test. Funnel plot
asymmetry was apparent and Egger’s test indicated small study
effects (P = 0.013).
tDCS: long-term (> 6 weeks post-treatment)
Three studies provide data for this analysis (Hazime 2017; Luedtke
2015; Mendonca 2016, pooled n = 137). There was no hetero-
geneity (I2 = 36%, P = 0.21) and no effect of tDCS was observed
(SMD -0.01, 95% CI -0.43 to 0.41, P = 0.97) (Analysis 3.15).
Using GRADE we rated the quality of evidence for this compar-
ison as low, downgraded once on the basis of study limitations
due to risk of bias and once for imprecision due to low participant
numbers.
Reduced impedance non-invasive cortical electrostimulation
(RINCE): short-term (0 to < 1 week postintervention)
The one study not at high risk of bias that investigated RINCE
demonstrated a positive effect on pain intensity (n = 77, mean
difference (0 to 10 pain scale) -1.41, 95% CI -2.48 to -0.34, P
< 0.01) (Analysis 4.1; Hargrove 2012a). Using GRADE we rated
the quality of evidence as very low, downgraded once on the basis
of study limitations due to risk of bias, once for inconsistency
(single study) and once for imprecision due to low participant
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numbers. Sensitivity analysis including the study at high risk of
bias (Deering 2017) did not increase heterogeneity (pooled n =
115, SMD -0.59, 95% CI -0.99 to -0.18, P = 0.004).
Transcranial random noise stimulation (tRNS): short-term
(0 to < 1 week postintervention)
One study at high risk of bias Palm 2016 offered data for tRNS.
This study did not report a difference between active and sham
stimulation (Analysis 5.1). Using GRADE we rated the quality of
evidence as very low, downgraded once on the basis of study limi-
tations due to risk of bias, once for inconsistency (single study) and
once for imprecision due to low participant numbers. Curatolo
2017 did not report outcome data in a numeric format at any
postintervention time point but the authors reported a statistically
significant difference in favour of tRNS. It was not possible to
extract an estimate of effect size from this high-risk-of-bias study.
tRNS: medium-term (≥1 to 6 weeks postintervention) and
long-term (≥ 6 weeks postintervention)
No data were available for medium- or long-term pain outcomes
for tRNS.
Secondary outcome: disability
rTMS: short-term (0 to < 1 week postintervention) disability
Five studies provided data on disability at short-term follow-
up (Avery 2013; Kang 2009; Mhalla 2011; Passard 2007; Short
2011). Pooling of these studies (Analysis 1.22; n = 119) demon-
stratedno effect (SMD-0.29, 95%CI -0.87 to 0.29, P =0.33)with
substantial heterogeneity (I2 = 71%, P = 0.007). All of these stud-
ies delivered multiple doses of high-frequency stimulation. Using
GRADE we rated the quality of evidence for this comparison as
very low, downgraded once on the basis of study limitations due
to risk of bias, once on the basis of inconsistency due to hetero-
geneity and once for imprecision due to low participant numbers
(see Summary of findings for the main comparison). Two stud-
ies stimulated the DLPFC (Avery 2013; Short 2011) and three
stimulated the motor cortex (Kang 2009; Mhalla 2011; Passard
2007). Subgrouping studies by stimulation site had no impact on
heterogeneity. Sensitivity analysis including studies at high risk of
bias (Umezaki 2016, n = 20) increased heterogeneity but did not
substantially change the outcome (pooled n = 139, SMD -0.36,
95% CI -0.72 to 0.12, P = 0.16, I2 = 59%, P = 0.02).
rTMS:medium-term (1 to < 6 weeks postintervention)
disability
Four studies provided data on disability at medium-term follow-
up (Avery 2013; Kang 2009;Mhalla 2011; Passard 2007). Pooling
of these studies (Analysis 1.24; n = 99) demonstrated no effect
(SMD -0.37, 95% CI -1.07 to 0.33, P = 0.3) with heterogeneity
(I2 = 78%, P = 0.004). Using GRADE we rated the quality of
evidence for this comparison as very low, downgraded once on the
basis of study limitations due to risk of bias, once on the basis of
inconsistency due to heterogeneity and once for imprecision due
to low participant numbers (see Summary of findings for themain
comparison).
All studies delivered multiple sessions of high-frequency stimula-
tion. Of these, one study stimulated theDLPFC (Avery 2013) and
the remaining studies stimulated the motor cortex (Kang 2009;
Mhalla 2011; Passard 2007). Removing the study of Avery 2013
did not decrease heterogeneity (I2 = 85%, P = 0.001). Sensitivity
analysis including studies at high risk of bias (Umezaki 2016, n =
20) increased heterogeneity but did not substantially change the
outcome (pooled n = 119, SMD -0.42, 95% CI -1.01 to 0.17, P
= 0.17, I2 = 72%, P < 0.001).
rTMS: long-term (≥ 6 weeks postintervention) disability
Three studies provided data on disability at long-term follow-up
(Avery 2013; Kang 2009; Passard 2007). Pooling of these studies
demonstrated no effect (pooled n = 63, SMD -0.23, 95% CI -
0.62 to 0.16, P = 0.24) without heterogeneity (I2 = 15%, P = 0.31)
(Analysis 1.26). Using GRADE we rated the quality of evidence
for this comparison as low, downgraded once on the basis of study
limitations due to risk of bias and once for imprecision due to low
participant numbers. Sensitivity analysis including studies at high
risk of bias (Umezaki 2016, n = 20) did not substantially change
the outcome (pooled n = 83, SMD -0.41, 95% CI -0.87 to 0.05,
P = 0.08, I2 = 39%, P = 0.18).
tDCS: short-term (0 to < 1 week postintervention) disability
Four studies (Ahn 2017; Chang 2017; Luedtke 2015; Soler 2010)
provided data on disability in the short term. While Ayache 2016
reported disability, this was a cross-over study and we were unable
to source a representative correlation coefficient for this outcome in
order to calculate the standard error (SMD) for cross-over studies.
No effect was seen (pooled n = 212, SMD -0.01, 95% -0.28 to
0.26, P = 0.84) and there was no heterogeneity (I2 = 0%, P = 0.59,
Analysis 3.16). Using GRADE we rated the quality of evidence
for this comparison as low, downgraded once on the basis of study
limitations due to risk of bias and once for imprecision due to low
participant numbers (see Summary of findings 3).
tDCS: medium-term (1 to < 6 weeks post-treatment)
disability
One study (Luedtke 2015) provided data on disability in the
medium term. This study demonstrated no effect of tDCS
(RMDQ mean difference 0.00 (95% CI -0.38 to 0.38).
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Secondary outcome: quality of life
rTMS: short-term (0 to < 1 week postintervention) quality
of life
Four studies provided data on quality of life at short-term follow-
up (Mhalla 2011; Passard 2007; Short 2011; Yagci 2014). We
were unable to include data from Tzabazis 2013, as the size of the
treatment groups was not clear from the study report. All studies
used the Fibromyalgia Impact Questionnaire (FIQ) so we were
able to use the mean difference as the measure of effect. Pooling
data from these studies (Analysis 1.28; n = 105) demonstrated
an effect in favour of active stimulation (mean difference (MD) -
10.80, 95% CI -15.04 to -6.55, P < 0.001) with no heterogeneity
(I2 = 0%, P = 0.96). Using GRADE we rated the quality of evi-
dence for this comparison as low, downgraded once on the basis
of study limitations due to risk of bias and once for imprecision
due to low participant numbers (see Summary of findings for the
main comparison). Tekin 2014 measured quality of life using the
World Health Organization Quality of Life (WH-QoL) scale but
only reported data from individual subdomains. They reported a
statistically significant difference in favour of active stimulation
for the physical subdomain but not the psychological, social, en-
vironmental or national domains.
rTMS: medium-term (1 to < 6 weeks postintervention)
quality of life
The same four studies provided data on quality of life at medium-
term follow-up (Mhalla 2011; Passard 2007; Short 2011; Yagci
2014). All studies used the FIQ so we were able to use the mean
difference as the measure of effect. Pooling data from these studies
(Analysis 1.29; n = 105) demonstrated an effect (MD -11.49, 95%
CI -16.73 to -6.25, P < 0.001) with no heterogeneity (I2 = 0%,
P = 0.82). Using GRADE we rated the quality of evidence for
this comparison as low, downgraded once on the basis of study
limitations due to risk of bias and once for imprecision due to
low participant numbers. Sensitivity analysis including studies at
high risk of bias (Boyer 2014) did not meaningfully alter the result
(pooled n = 143, MD -8.93, 95% CI -13.49 to -4.37, P < 0.001,
I2 = 15%, P = 0.32).
rTMS: long-term (≥ 6 weeks postintervention) quality of life
Data were available from two studies (Passard 2007, Yagci 2014,
pooled n = 51) for quality of life at long-term follow-up. The
analysis demonstrated an effect in favour of active stimulation
(FIQ total score: MD -6.78, 95% CI -13.43 to -0.14, I2 = 0%,
P = 0.56) (Analysis 1.31). Using GRADE we rated the quality of
evidence for this comparison as low, downgraded once on the basis
of study limitations due to risk of bias and once for imprecision due
to low participant numbers. Sensitivity analysis including studies
at high risk of bias (Boyer 2014) did not meaningfully alter the
result (pooled n = 89, MD -8.58, 95% CI -13.84 to -3.33, P <
0.001, I2 = 0%, P = 0.58).
CES: short-term (0 to < 1 week postintervention) quality of
life
Two studies provided quality of life data for this analysis (Tan
2011; Taylor 2013). One study used the physical component score
of the SF-12 and the other used the FIQ. However, one study
demonstrated a baseline imbalance of the SF-12 that exceeded
in size any pre-poststimulation change (Tan 2011), therefore we
considered it inappropriate to enter this into a meta-analysis. The
study byTaylor 2013 (n=36) demonstrated a positive effect on this
outcome (MD-25.05,95%CI -37.82, -12.28, Analysis 2.2).Using
GRADE we rated the quality of evidence for this comparison as
very low, downgraded once on the basis of study limitations due
to risk of bias, once for inconsistency (single study) and once
for imprecision due to low participant numbers (see Summary of
findings 2).
tDCS: short-term (0 to < 1 week postintervention) quality of
life
Four studies provided adequate data for this analysis (Jales Junior
2015; Mori 2010; Riberto 2011; Volz 2016; pooled n = 82). Of
these, Jales Junior 2015 used the FIQ, Mori 2010 used the Multi-
ple Sclerosis Quality of Life 54 scale (MS-QoL-54), Riberto 2011
used the SF-36 (total score) and Volz 2016 used the Inflammatory
Bowel Disease Questionnaire Quality of Life scale. The pooled
effect was in favour of active stimulation (SMD 0.66, 95% CI
0.21 to 1.11, P = 0.004) with no heterogeneity (I2 = 0%, P =
0.62) (Analysis 3.18). Using GRADE we rated the quality of evi-
dence for this comparison as low, downgraded once on the basis of
study limitations due to risk of bias and once for imprecision due
to low participant numbers. Lagueux 2017, Mendonca 2016 and
Oliveira 2015 reported quality of life using the or SF-36 andWH-
QoL scales but did not report composite scores that we could enter
into the meta-analysis. All three studies reported no statistically
significant differences across the different quality-of-life domains.
We excluded Thibaut 2017 from the analysis due to high risk of
bias. They measured quality of life using the Patient Health Ques-
tionnaire (PHQ-9) but reported no significant difference between
groups.
tDCS: medium-term (1 to < 6 weeks post-treatment)
quality of life
At medium-term follow-up Fagerlund 2015; Mori 2010 and Volz
2016 (pooled n = 87) provided data and demonstrated no clear
effect of tDCS on quality of life (SMD 0.34, 95% CI -0.09 to
0.76, P = 0.12, I2 = 0%, P = 0.54, Analysis 3.19). Using GRADE
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we rated the quality of evidence for this comparison as low, down-
graded once on the basis of study limitations due to risk of bias
and once for imprecision due to low participant numbers.
RINCE: short-term (0 to < 1 week postintervention) quality
of life
One study of RINCE therapy (Hargrove 2012a, n = 77) demon-
strated no effect on quality of life (FIQ, MD -6.50, 95% CI -
15.21 to 2.21, Analysis 4.3). Using GRADE we rated the quality
of evidence as very low, downgraded once on the basis of study
limitations due to risk of bias, once for inconsistency (single study)
and once for imprecision due to low participant numbers. Sen-
sitivity analysis including studies at risk of bias (the addition of
Deering 2017, n = 38) did not alter the outcome (SMD -0.45,
95% CI -0.91 to 0.02, P = 0.06, I2 = 10%, P = 0.33).
Secondary outcome: adverse events
rTMS
Minor
Thirty-one of 42 studies of rTMS reported on adverse events.
Of these, 10 studies reported none (André-Obadia 2006;
André-Obadia 2008; Boyer 2014; Fregni 2005; Hirayama 2006;
Lefaucheur 2001a; Lefaucheur 2001b; Lefaucheur 2004; Onesti
2013; Saitoh 2007). Attal 2016 reported similar proportions of
side effects between stimulation conditions with no serious events.
Avery 2013 reported a range of reported sensations including
headache, pain at the stimulation site, muscle aches/fatigue, dizzi-
ness and insomnia, though there were no clear differences in the
frequency of these events between the two groups. Carretero 2009
reported neck pain or headache symptoms in six out of 14 par-
ticipants in the active stimulation group compared with two out
of 12 in the sham group. One participant in the active stimula-
tion group reported worsening depression and four participants
in the sham group reported symptoms of nausea and tiredness.
Dall’Agnol 2014 reported that they did not observe moderate or
severe adverse effects but did not report any details on the inci-
dence of mild effects. de Oliveira 2014 reported mild headaches
in three participants (27.3%) receiving active rTMS and in one
participant receiving sham rTMS. In the study by Fregni 2011,
the incidence of headache and neck pain was higher in the active
stimulation group than in the sham group. Forty-one participants
reported headache after active stimulation compared to 19 after
sham and 18 participants reported neck pain after active stimula-
tion compared with three after sham. Hosomi 2013 reported no
difference between real and sham rTMS for minor adverse events.
Jetté 2013 reported that seven participants receiving rTMS re-
ported mild discomfort related to scalp pressure and facial twitch-
ing. Malavera 2013 reported no serious adverse effects but reports
of headache, neck pain and sleepiness without differences between
groups, while Medeiros 2016 simply reported that they did not
observe serious or moderate side effects from the treatment, with
no further detail.Mhalla 2011 reported that nine participants (five
following active stimulation and four following sham stimulation)
reported transient headache, and one participant reported tran-
sient dizziness after active stimulation. Nardone 2017 reported
that two participants undergoing active rTMS reported uncom-
fortable twitching of facial muscles during stimulation but that
rTMS was tolerated well. Nurmikko 2016 reported that rTMS
was well tolerated. Minor adverse effects observed during active
stimulation included headache (25%), sleepiness (38%), transient
increase in pain (31%) and dizziness (15%). Passard 2007 reported
incidence of headaches (four out of 15 participants in the active
group versus five out of 15 in the sham group), feelings of nausea
(one participant in the active group), tinnitus (two participants
in the sham group) and dizziness (one participant in the sham
group). Picarelli 2010 found six reports of headache following ac-
tive stimulation and four following sham stimulation, and two
reports of neck pain following active stimulation with four re-
ports following sham stimulation. Rollnik 2002 reported that one
participant experienced headache, but it is unclear in the report
whether this was following active or sham stimulation. Short 2011
reported that therewere few side effects.Following four-coil rTMS,
Tzabazis 2013 reported no serious adverse events. The incidence
of scalp pain, headache, lightheadedness, back pain, otalgia, hot
flashes and pruritis was more commonly reported following sham
stimulation than active stimulation. Neck pain (14% of partici-
pants following active stimulation versus no participants following
sham) and nausea (19% of participants following active stimula-
tion versus 11% following sham) were more common with active
stimulation. Umezaki 2016 reported headaches in seven (58%)
participants in the active stimulation and five (62%) in the sham
stimulation group that were mild and resolved in one to two days.
Yagci 2014 reported that three (23%) participants in the active
group and one (8%) in the sham group reported adverse events.
They only described those in the active group, which were two
cases of transient headache and one of “daily tinnitus”.
Major
Both Lee 2012 and Picarelli 2010 reported one incidence of seizure
followinghigh-frequency active stimulation.The seizures occurred
after the 6th and 7th session of active stimulation respectively.
Nurmikko 2016 reported that one participant experienced a per-
manent reduction of hearing during an active stimulation phase.
Investigations ruled out cochlear damage leading the study authors
to conclude that an association with rTMS was unlikely.
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CES
Four out of 11 studies of CES reported the incidence of adverse
events (Capel 2003; Gabis 2003; Rintala 2010; Tan 2011). In
these studies no serious adverse events were reported. Rintala
2010 reported that in the active stimulation group participants
reported incidences of pulsing, tingling and tickling in the ears
(three participants), tender ears (one participant) and a pins and
needles feeling near the bladder (one participant). In the sham
group they reported drowsiness (one participant), warm ears (one
participant) and headache after one session (one participant). Tan
2011 reported only mild adverse events with a total of 41 reports
in the active stimulation group and 56 in the sham group. Of
note, sensations of ear pulse/sting/itch/electric sensations or ear
clip tightness seemedmore common in active group than the sham
group (12 versus six incidents). Through correspondence with the
authors of Taylor 2013, we confirmed that there were no adverse
events reported.
tDCS
Thirty out of 36 studies of tDCS reported the incidence of adverse
events with varying degrees of detail. Of these, five studies reported
none (Fregni 2006a; Hagenacker 2014; Mendonca 2011; Mori
2010; Portilla 2013). Attal 2016 reported similar proportions of
side effects between stimulation conditions with no serious events.
Most studies reported similar rates of mild and transient effects.
Ahn 2017 reported six incidents of pain at the stimulation site; two
in the sham group and four in the active group. One participant
in the active group reported change in visual perception. Thirteen
participants reported tingling, itching or burning sensations at the
stimulation site. The severity of these symptoms was rated as low.
Tinglingwasmore commonduring active stimulation. Antal 2010
recorded reports of tingling, moderate fatigue, tiredness, headache
and sleep disturbances, though there were no large differences in
the frequency of these between the active and sham stimulation
groups. Ayache 2016 reported that headache occurred in three
participants after active stimulation and one after sham but that
otherwise rates were similar between active and sham stimulation
and there was no difference in discomfort rates. Boggio 2009 re-
ported that one participant experienced headache with active stim-
ulation. Chang 2017 reported two adverse reactions to tDCS, one
participant reported a headache after active stimulation and one
participant reported a single incident of painful sensation under
the electrode that resolved on cessation of stimulation. Donnell
2015 reported only mild adverse events with higher rates of skin
redness in the active group (16.6% in active group versus 3.3% in
the sham group) but similar rates for all others. Fagerlund 2015
found no difference in adverse events between active and sham
stimulation except for acutemood change, whichwas higher in the
sham group. However trouble concentrating was higher after ac-
tive stimulation (18% of total sessions after active stimulation ver-
sus 5% of sessions after sham), as was scalp pain (18% of sessions
versus 9%) and headache (18% of sessions versus 12%).The study
by Fenton 2009 reported three cases of headache, two of neck ache,
one of scalp pain and five of a burning sensation over the scalp
in the active stimulation group versus one case of headache in the
sham stimulation group. Fregni 2006b reported one case of sleepi-
ness and one of headache in response to active stimulation of the
DLPFC, three cases of sleepiness and three of headache with active
stimulation of M1 and one case of sleepiness and two of headache
in response to sham stimulation. Hazime 2017 reported the inci-
dence of a variety of adverse effects but did not separate them into
active and sham stimulation groups. These included headache,
neck pain, scalp pain, back pain, tingling, itching, redness, burn-
ing sensations, sleepiness, trouble concentrating and largely re-
ported as mild or moderate in severity. Khedr 2017 reported that
all participants tolerated stimulation well with three cases of itch-
ing and redness seen in the active stimulation group. Kim 2013
reported that all participants tolerated tDCS well without “signifi-
cant adverse events”. Headache was reported in three participants,
all in an active stimulation group, and skin itching was reported by
three participants, one in each active stimulation group and one in
the sham group. Lagueux 2017 reported that three participants in
the active stimulation group and two in the sham group reported
minor transient headaches. One participant reported skin redness
and itching after active stimulation. Two participants in the active
group and one in the sham group reported feelings of tiredness.
Four participants in the active stimulation group are reported to
have declared “being indisposed” by a stinging/ burning sensa-
tion under the electrodes. Luedtke 2015 briefly reported that the
stimulation was tolerated well with minimal transitory side effects
but gave no further detail. Mendonca 2016 reported just that all
adverse events were mild and did not differ between groups, with
no further detail. Ngernyam 2015 reported that all participants
tolerated stimulation well, seven (of 20) in the active group ex-
perienced erythematous skin rash at the cathode placement site.
Oliveira 2015 also did not formally report all events but reported
that one of the participants suffered burns due to an electrode be-
ing placed on a skin site with acne, the skin healed but left a small
scar. Similarly Sakrajai 2014 reported no adverse events in either
group except transient skin redness in 13% of the active group.
Soler 2010 recorded three reports of headache, all following active
stimulation. Souto 2014 recorded adverse events in nine out of
10 participants in the sham group and all 10 participants in the
active group. Thibaut 2017 reported that all participants tolerated
stimulation well and that the majority reported mild to moderate
itching and tingling during both active and sham stimulations.
These were all mild and transient. Villamar 2013 reported that the
vast majority of participants reported a mild to moderate tingling
or itching sensation during both active and sham stimulation that
faded over a few minutes but no other adverse effects. Valle 2009
reported “minor and uncommon” side effects, such as skin redness
and tingling, which were equally distributed between active and
sham stimulation. Volz 2016 reported no differences in side effects
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between stimulation groups except that skin redness was more
common in the active group. Wrigley 2014 reported only “mild
to moderate” side effects with no difference between active and
sham over the 24-hour poststimulation period. These included
sleepiness (70% of participants following active, 60% following
sham), fatigue, inertia (60% of participants following active, 30%
following sham), lightheadedness (20% of participants during ac-
tive and sham treatment) and headache (10% of participants dur-
ing active and sham treatment).
Four studies monitored for possible effects on cognitive function
using the Mini Mental State Examination questionnaire (Boggio
2009; Fregni 2006a; Fregni 2006b; Valle 2009) and three of these
also used a battery of cognitive tests including the digit-span mem-
ory test and the Stroop word-colour test (Boggio 2009; Fregni
2006a; Fregni 2006b) and simple reaction time tasks (Fregni
2006a). No studies demonstrated any negative influence of stim-
ulation on these outcomes. No studies of tDCS reported severe or
lasting side effects. Bae 2014; Brietzke 2016; Harvey 2017; Jales
Junior 2015; Jensen 2013 and Riberto 2011 did not consider ad-
verse events in their study reports.
tRNS
Curatolo 2017 did not report on adverse events. Palm 2016 re-
ported similar rates of adverse events between the active and sham
groupswith no suggestionof higher rates of any in the active group.
Phosphenes were reported by one participant after sham treatment
but none after active treatment. Six participants reported insom-
nia after sham treatment compared to five after tRNS, nausea oc-
curred in four participants after sham treatment and in two after
tRNS. Severe headache was reported by one participant after sham
treatment but no participants reported severe headache after active
stimulation.
RINCE
Hargrove 2012a reported a low incidence of side effects from
RINCE including short-lived headache (two participants in the
active group, one in the sham group), eye movement/flutter dur-
ing stimulation (one active, one sham), restlessness (one active
and none sham) and nausea (one active and none sham). Deering
2017 reported an average of two adverse events per participant,
of which 47% were reported to be mild and 50% moderate in
severity. Thirty-seven per cent of adverse events were reported to
be related to study treatments. The authors reported that com-
pared to sham, RINCE may be associated with small increases in
the risk of mild to moderate headaches, nausea, dizziness/vertigo,
and localised skin reactions, possibly due to the electrode gel. All
events were short lived and resolved without further intervention.
The study by Attal 2016 delivered both rTMS and tDCS. They
reported that the proportion of participants displaying side effects
was low and similar between active rTMS or tDCS and sham
stimulations. Three (out of 35) participants withdrew from the
study because of side effects, after the second day of stimulation
in the second treatment block.
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A D D I T I O N A L S U M M A R Y O F F I N D I N G S [Explanation]
CES compared with sham for chronic pain
Patient or population: adults with chronic pain
Settings: laboratory/ clinic
Intervention: act ive CES
Comparison: sham CES
Outcomes Effect size Relative effect
(average % improvement (reduc-
tion) in pain (95%CIs) in relation to
post- treatment score from sham
group)*
*Where 95%CIs do not cross the
line of no effect.
No of participants
(studies)
Quality of the evidence
(GRADE)
Pain intensity (0 to < 1 week
post intervent ion)
measured using visual analogue
scales or numerical rat ing scales
SMD -0.24 (-0.48 to 0.01) - 270 (5) ⊕⊕©© low1
Disability (0 to < 1 week post in-
tervent ion)
measured using self -reported dis-
ability/ pain interference scales
No data available No data available No data available No data available
Quality of life (0 to < 1 week
post intervent ion)
measured using Fibromyalgia Im-
pact Quest ionnaire
MD -25.05 (-37.82 to -12.28) - 36 (1) ⊕©©© very low2
CI: conf idence interval; CES: cranial electrotherapy st imulat ion; MD: mean dif ference; SMD: standardised mean dif ference
3
4
N
o
n
-in
v
a
siv
e
b
ra
in
stim
u
la
tio
n
te
c
h
n
iq
u
e
s
fo
r
c
h
ro
n
ic
p
a
in
(R
e
v
ie
w
)
C
o
p
y
rig
h
t
©
2
0
1
8
T
h
e
A
u
th
o
rs.
C
o
c
h
ra
n
e
D
a
ta
b
a
se
o
f
S
y
ste
m
a
tic
R
e
v
ie
w
s
p
u
b
lish
e
d
b
y
Jo
h
n
W
ile
y
&
S
o
n
s,
L
td
.
o
n
b
e
h
a
lf
o
f
T
h
e
C
o
c
h
ra
n
e
C
o
lla
b
o
ra
tio
n
.
GRADE Working Group grades of evidence
High quality: we are very conf ident that the true ef fect lies close to that of the est imate of the ef fect;
Moderate quality: we are moderately conf ident in the ef fect est imate; the true ef fect is likely to be close to the est imate of ef fect, but there is a possibility that it is substant ially
dif f erent;
Low quality: our conf idence in the ef fect est imate is lim ited; the true ef fect may be substant ially dif f erent f rom the est imate of the ef fect;
Very low quality: we have very lit t le conf idence in the ef fect est imate; the true ef fect is likely to be substant ially dif f erent f rom the est imate of ef fect
1Downgraded once for study lim itat ions due to high or unclear risk of bias and once for imprecision due to low part icipant
numbers.
2Downgraded once for study lim itat ions due to high or unclear risk of bias, once for inconsistency (single study) and once for
imprecision due to low part icipant numbers.
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tDCS compared with sham for chronic pain
Patient or population: adults with chronic pain
Settings: laboratory/ clinic
Intervention: act ive tDCS
Comparison: sham tDCS
Outcomes Effect size Relative effect
(average % improvement (reduc-
tion) in pain (95% CIs) in rela-
tion to post- treatment score from
sham group)*
*Where 95%CIs do not cross the
line of no effect.
No of participants
(studies)
Quality of the evidence
(GRADE)
Pain intensity (0 to < 1 week
post intervent ion)
measured using visual analogue
scales or numerical rat ing scales
SMD -0.43 (-0.63 to -0.22) This equates to a 17% (95%CI 9%
to 25%) reduct ion in pain intensity
or a 0.82 (95% CI 0.42 to 1.2)
point reduct ion on a 0 to 10 pain
intensity scale
747 (27) ⊕©©© very low1
Disability (0 to < 1 week post in-
tervent ion)
measured using self -reported dis-
ability/ pain interference scales
SMD -0.01, (95%CI -0.28 to 0.26) - 212 (4) ⊕⊕©© low2
Quality of life (0 to < 1 week
post intervent ion)
measured using dif ferent scales
across studies
SMD 0.66, 95% CI 0.21 to 1.11 - 82 (4) ⊕⊕©© low2
CI: conf idence interval; MD: mean dif ference; SMD: standardised mean dif ference; tDCS: t ranscranial direct current st imulat ion
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GRADE Working Group grades of evidence
High quality: we are very conf ident that the true ef fect lies close to that of the est imate of the ef fect;
Moderate quality: we are moderately conf ident in the ef fect est imate; the true ef fect is likely to be close to the est imate of ef fect, but there is a possibility that it is substant ially
dif f erent;
Low quality: our conf idence in the ef fect est imate is lim ited; the true ef fect may be substant ially dif f erent f rom the est imate of the ef fect;
Very low quality: we have very lit t le conf idence in the ef fect est imate; the true ef fect is likely to be substant ially dif f erent f rom the est imate of ef fect
1Downgraded once for study lim itat ions due to high or unclear risk of bias, once for inconsistency due to heterogeneity and
once for evidence of possible publicat ion bias.
2Downgraded once for study lim itat ions due to high or unclear risk of bias and once for imprecision due to low part icipant
numbers.
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D I S C U S S I O N
Summary of main results
This update has included a substantial number of new studies.
Despite this our findings have not altered substantially from the
previous version of this review.
Repetitive transcranial magnetic stimulation (rTMS)
for chronic pain
Meta-analysis of all rTMS studies in chronic pain demonstrated
substantial heterogeneity. Predetermined subgroup analysis sug-
gests a short-term effect of single-dose, high-frequency rTMS ap-
plied to the motor cortex on chronic pain. This effect is small
and does not conclusively exceed the threshold of minimal clinical
importance. The evidence from multiple-dose studies of rTMS
demonstrates conflicting results with substantial heterogeneity
both overall and when the analysis is confined to high-frequency
motor cortex studies. Low-frequency rTMS does not appear to be
effective. rTMS applied to the prefrontal cortex does not appear
to be effective. That the majority of studies in this analysis are at
unclear risk of bias, particularly for participant blinding, suggests
that the observed effect sizes might be exaggerated. While there is
substantial unexplained heterogeneity the available evidence does
not strongly suggest an effect of rTMS in the medium term. The
limited evidence at long-term follow-up consistently suggests no
effect of rTMS. The evidence for all comparisons or rTMS is con-
sidered to be of low to very low quality.
Cranial electrotherapy stimulation (CES) for chronic
pain
The evidence from trials where it is possible to extract data is not
clearly suggestive of a beneficial effect of CES on chronic pain.
While there are substantial differences within the trials in terms
of the populations studied and the stimulation parameters used,
there is no measurable heterogeneity and no trial shows a clear
benefit of active CES over sham stimulation. The evidence for all
comparisons or CES is considered to be of low to very low quality.
Transcranial direct current stimulation (tDCS) for
chronic pain
Meta-analysis of all tDCS studies in chronic pain demonstrated
heterogeneity but did demonstrate an effect versus sham inter-
ventions. Predetermined subgroup analyses did not reduce het-
erogeneity. This effect may be exaggerated by study biases and
small study effects. The evidence available at the medium term
also demonstrates an effect but with substantial heterogeneity. Ev-
idence from long follow-up does not suggest an effect of tDCS.
We consider the evidence for all comparisons for tDCS to be of
low to very low quality.
Reduced impedance non-invasive cortical
electrostimulation (RINCE) stimulation for chronic
pain
We analysed one small trial suggesting a positive effect of RINCE
over sham for chronic pain. This trial is at unclear risk of bias due
to possible attrition bias. As such, further high-quality research is
needed to confirm this exploratory finding.
Transcranial random noise stimulation (tRNS) for
chronic pain
We identified two small studies of tRNS, both at high risk of bias.
We are unable to draw any conclusions about the effectiveness or
lack of effectiveness of tRNS for chronic pain.
Secondary outcome measures
The available evidence does not suggest an effect of rTMS or tDCS
on disability levels at any follow-up point. There is insufficient
evidence from which to draw conclusions regarding CES for dis-
ability.
Limited, low-quality to very low-quality evidence suggests that
rTMS and tDCSmay have positive effects on quality of life. Given
the limited amount of data available to inform these analyses, the
risks of bias in the evidence base and the small effects observed
in pain for both rTMS and tDCS we would recommend that
this finding should be interpreted with caution. Limited evidence
suggest that RINCE has no effect on quality of life.
rTMS, CES, tDCS, RINCE, tRNS and sham stimulation are as-
sociated with transient adverse effects such as headache, scalp ir-
ritation and dizziness, but reporting of adverse effects was incon-
sistent and did not allow for a detailed analysis. There were two
incidences of seizure following active rTMS, which occurred in
separate studies. For all forms of stimulation, adverse events re-
porting is inconsistent across studies.
Overall completeness and applicability of
evidence
For rTMS we were unable to include pain intensity data from six
full published studies (Fregni 2005; Fregni 2011, Onesti 2013;
Picarelli 2010; Tzabazis 2013; Umezaki 2016, combined n = 107).
In addition, we identified 11 studies of rTMS published in ab-
stract format for which we have not been able to acquire full study
reports. A conservative estimate of the combined number of par-
ticipants that those studies might add is 438, assuming that some
reports refer to the same study.
We were unable to extract the relevant data from four studies
of CES (Capel 2003; Cork 2004; Katsnelson 2004; Lichtbroun
2001). This may have impacted upon the results of our meta-
analysis although one of those studies would have been excluded
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from the meta-analysis as we judged it as being at risk of bias on
criteria other than selective outcome reporting (Katsnelson 2004).
We were also unable to extract the relevant data from three studies
of tDCS (Donnell 2015; Mendonca 2011; Valle 2009), and these
data were not made available upon request to the study authors.
These data would have contributed a further 95 participants to
our analysis and may have altered our conclusions. In addition, we
identified five studies of tDCS (Acler 2012; Albu 2011; Knotkova
2011; Moreno-Duarte 2013a; Mylius 2013) published in abstract
format that appear clearly relevant for which we have not been
able to acquire full study reports.
For both rTMS and tDCS there are a number of ongoing studies
identified through the trials registry searches. Of note, eight trials
were registered prior to 2012, seven of which are of tDCS and
have not yet been published to our knowledge. Given our finding
of small study effects in tDCS studies this gives cause for concern
regarding the risk of potential publication bias and this is reflected
in our GRADE judgements. We hope that future updates of this
review will include the aforementioned data.
Quality of the evidence
Using the GRADE criteria we judged the quality of evidence for
all comparisons as low or very low, meaning that our confidence
in the effect estimate is limited or we have very little confidence in
the effect estimate and the true effect is likely to be substantially
different from the estimated effect. In large part this is due to is-
sues of blinding and of precision. The majority of studies of rTMS
were at unclear risk of bias. The predominant reason for this was
the use of suboptimal sham controls that were unable to control
for all possible sensory cues associated with active stimulation. A
number of studies did not clearly report blinding of assessors and
sensitivity analysis excluding those studies reduced both hetero-
geneity and the pooled effect size. It could be reasonably argued
that the presence of a subgroup of single-dose studies of high-fre-
quency stimulation specific to the motor cortex that does demon-
strate superiority over sham with acceptable levels of heterogene-
ity is evidence for a specific clinical effect of rTMS. It should be
considered, however, that high-frequency rTMS is associated with
more intense sensory and auditory cues that might plausibly elicit
a larger placebo response, and many of the included studies were
unable to control conclusively for these factors. Furthermore, the
pooled effect size for the high-frequency studies of motor cortex
rTMS does not meet our predetermined threshold for clinical sig-
nificance. This estimate is based solely on studies that delivered
a single dose of rTMS. It is feasible that a single dose may be
insufficient to induce clinically meaningful improvement. These
single-dose studies included in the analysis are best characterised
as proof of principle studies, which sought to test whether rTMS
could modulate pain, rather than full-scale clinical studies with
the aim of demonstrating clinical utility. The combined evidence
from studies of high-frequency rTMS to the motor cortex that
delivered multiple doses, so better reflecting the likely clinical de-
livery of rTMS (excluding studies judged as being at high risk of
bias), demonstrate no effect, but with substantial heterogeneity.
There are multiple sources of potential heterogeneity within the
rTMS literature, relating to stimulation parameters, dose and pop-
ulation. We have explored, through pre-planned subgroup anal-
yses the influence of cortical target, stimulation frequency and
dose at the crude level of single versus multiple dose. However we
did not plan to formally explore the influence of all of the po-
tential sources of variation in terms of stimulation parameters. As
an example it is possible that some studies delivered suboptimal
stimulation in terms of the numbers of pulses delivered, which
ranged in our review from 120 to more than 2000 per treatment
session. In addition, for studies of motor cortex stimulation there
was variation in the somatotopic target of stimulation and this
may be an important factor. While some studies used imaging-
based neuro-navigation techniques to more precisely locate tar-
geted brain regions most did not. There were not adequate data
to meaningfully explore the influence of using neuro-navigation
on outcomes. There is evidence that approaches to identifying
prefrontal targets that do not use neuronavigation are inaccurate
(Ahdab 2010; Herwig 2001). Should neuro-navigation be found
to be crucial to effectiveness it would have implications for the
costs and availability of this intervention.
Similarly, we judged no study of tDCS as having a low risk of bias
on all criteria. While there is evidence that the sham control used
in tDCS does achieve effective blinding of participants at stimu-
lation intensities of 1 mA (Gandiga 2006), evidence has emerged
since the first version of this review that indicates that at 1.5 mA
the sensory profile of stimulation differs between active and sham
stimulation (Kessler 2013), and at 2 mA participant and assessor
blinding may be compromised (Ezquerro 2014; Horvath 2014;
O’Connell 2012; Wallace 2016). Meta-epidemiological evidence
demonstrates that incomplete blinding in controlled trials that
measure subjective outcomes may exaggerate the observed effect
sizes (Savovic 2012; Wood 2008). It is therefore reasonable to ex-
pect that incomplete blindingmay have exaggerated the effect sizes
seen in the current analyses of rTMS and tDCS. It is noteworthy
that the largest study of tDCS (Luedtke 2015), also judged at low
risk of bias for all criteria except study size, demonstrated no effect
of tDCS versus sham.
No study of CES could be judged as having a low risk of bias
across all criteria. Despite this, no study from which data were
available demonstrated a clear advantage of active over sham stim-
ulation. There was substantial variation in the stimulation param-
eters used between studies. Notably three studies utilised an ’active
placebo’ control, in which stimulating current was delivered but
at much lower intensities (Gabis 2003; Gabis 2009; Katsnelson
2004). These intensities well exceed those employed in the active
stimulation condition of other studies of CES devices and as such
it could be hypothesised that they might induce a therapeutic ef-
fect themselves. This could possibly disadvantage the active stim-
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ulation group in these studies. However, the data available in the
meta-analysis do not suggest such a trend and statistical hetero-
geneity between studies entered into the analysis was low.
All of the included studies may be considered to be small in terms
of sample size and we reflected this in our ’Risk of bias’ assessment.
The prevalence of small studies increases the risk of small study
bias and the related issue of publication bias, wherein there is a
propensity for small negative studies to not reach full publication.
There is evidence that this might lead to an overly positive pic-
ture for some interventions (Dechartres 2013; Nüesch 2010). In
a review of meta-analyses, Dechartres 2013 demonstrated that tri-
als with fewer than 50 participants, which reflects the majority of
studies included in this review, returned effect estimates that were
on average 48% larger than the largest trials and 23% larger than
estimates from studieswith sample sizes ofmore than 50. Similarly,
in Cochrane Reviews of amitriptyline for neuropathic pain and
fibromyalgia (Moore 2015a; Moore 2015b), smaller studies were
associated with substantially lower numbers needed to treat for an
additional beneficial outcome (NNTBs) for treatment response
than larger studies. In their recommendations for establishing best
practice in chronic pain systematic reviews, the authors of Moore
2010 suggest that study size should be considered an important
source of bias. It is therefore reasonable to consider that the evi-
dence base for all non-invasive brain stimulation techniques is at
risk of bias on the basis of sample size. In this update we found ev-
idence of small study effects affecting the tDCS evidence, but not
for rTMS or CES.However, it is accepted that existing approaches
to detecting publication bias are unsatisfactory and lack sensitiv-
ity. It should therefore be noted that even where a pooled estimate
includes a large number of participants, if it is dominated by small
studies, as are all comparisons in this review, then it is prone to
small study effects. Funnel plot asymmetry may be explained by
reasons other than publication bias, such as methodological qual-
ity, or simple chance (Sterne 2011), but for tDCS there is an as-
sociation between study size and effect size, with smaller studies
demonstrating larger effects.
Potential biases in the review process
There is substantial variation between the included studies of
rTMS and tDCS. Studies varied in terms of the clinical popula-
tions included, the stimulation parameters and location, the num-
ber of treatment sessions delivered and in the length of follow-
up employed. This heterogeneity is reflected in the I2 statistic for
the overall rTMS and tDCS meta-analyses. However, pre-planned
subgroup investigation reduced this heterogeneity in some in-
stances.
Many of the rTMS and tDCS studies specifically recruited par-
ticipants whose symptoms were resistant to current clinical man-
agement andmost rTMS studies specifically recruited participants
with neuropathic pain. As such it is important to recognise that
this analysis in large part reflects the efficacy of rTMS and tDCS
for refractory chronic pain conditions and may not accurately re-
flect their efficacy across all chronic pain conditions.
One study included in the analysis of rTMS studies demonstrated
a difference in pain levels between the two groups at baseline that
exceeded the size of the difference observed at follow-up (Defrin
2007). Specifically, the group that received sham stimulation re-
ported less pain at baseline than those in the active stimulation
group. The use in the current analysis of a between-groups rather
than a change-from-baseline comparison is likely to have affected
the results although the study contributes only 1.5% weight to the
overall meta-analysis and the study itself reported no difference in
the degree of pain reduction between the active and sham stimu-
lation groups.
Themethod used to back-transform the pooled standardisedmean
difference (SMD) to a 0-10 pain intensity scale and subsequent
calculation of the effect as a percentage improvement rests upon
the assumption that the standard deviation and the pain levels used
are representative of the wider body of evidence and should be
considered an estimate at best. Representing average change scores
on continuous scales is problematic in chronic pain studies since
response to pharmacological treatments has been found to display
a bimodal distribution (Moore 2013). More plainly, some partici-
pants demonstrate a substantial improvement with pain therapies
while many demonstrate little or no change, with few individual
participants demonstrating a change similar to the average. As a
consequence the meaning of the average effect sizes seen in this
review is difficult to interpret. This had led to the recommen-
dation that chronic pain trials employ responder analyses based
on predetermined cut-offs for a clinically important response (≥
30% reduction in pain for a moderate benefit, ≥ 50% reduction
for a substantial benefit) (Dworkin 2008; Moore 2010). Very few
studies identified in this review presented the results of responder
analyses and so this type of meta-analysis was not possible. How-
ever, where effects were observed in this review they were small,
which would indicate that if there is a subgroup of ’responders’
to active stimulation who demonstrate moderate or substantial
benefits it is likely to include only a small number of participants.
We are not aware of any direct evidence that participant outcomes
are commonly bimodally distributed following these interventions
and a recent analysis of data from trials of various non-surgical
interventions for spinal pain did not find evidence for bimodal
distribution of outcomes (O’Connell 2017). It is also worth not-
ing that when the effect estimates were back-transformed to a 0 to
10 pain intensity scale they were also below theminimal clinically
important difference threshold for the between-group difference
of 1 point recently recommended by the OMERACT-12 group
(Busse 2015).
Agreements and disagreements with other
studies or reviews
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The European Academy of Neurology published guidelines on the
use of neurostimulation therapy for chronic neuropathic pain in
2017 (Cruccu 2017). Based on anarrative synthesis of the evidence
gave “weak recommendations” for the use of rTMS in neuropathic
pain and fibromyalgia and “inconclusive recommendations” in
CRPS. They offered “inconclusive recommendations” regarding
tDCS for fibromyalgia and “weak recommendations” for the use of
tDCS for peripheral neuropathic pain. The ’weak’ descriptor term
used to describe the positive recommendations was based on the
low quality of the supporting evidence. Another recent guideline
specific to the use of rTMS (Lefaucheur 2014) concluded that
there was “level A evidence”, which represents “definite efficacy”
for the analgesic effect of high frequency rTMS applied to the
motor cortex contralateral to the side of pain. In light of our
findings we suggest that this assessment of the evidence may not
adequately reflect the numerous limitations of the evidence base.
Leung 2009 performed a meta-analysis of individual participant
data from studies of motor cortex rTMS for neuropathic pain con-
ditions. Whilst the analysis was restricted to studies that clearly re-
ported the neuroanatomical origin of noxious input (and therefore
excluded some of the studies included in the current analysis) the
overall analysis suggests a similar effect size of 13.7% improvement
in pain (excluding the study of Khedr 2005). The study authors
also performed an analysis of the influence of the neuroanatomical
origins of noxious input on the effect size. They noted a trend
suggestive of a larger treatment effect in central compared with
peripheral neuropathic pain states although this did not reach sta-
tistical significance. While the data in the current review were not
considered sufficient to support a detailed subgroup analysis by
neuro-anatomical origin of noxious input, the exclusion of stud-
ies that did not specifically investigate neuropathic pain did not
significantly affect the overall analysis and the two multiple-dose
studies of motor cortex rTMS for central neuropathic pain that
were included failed to demonstrate superiority of active over sham
stimulation (Defrin 2007; Kang 2009).
All but one of the included studies in the review by Leung 2009
delivered high-frequency (≥ 5Hz) rTMS and no clear influence of
frequency variations was observed within this group. The authors
suggest that the number of doses delivered may be more crucial
to the therapeutic response than the frequency (within the high-
frequency group), based on the larger therapeutic response seen in
the study of Khedr 2005, that was excluded from the current anal-
ysis. This review preceded the studies by Defrin 2007 and Kang
2009 that did not demonstrate superiority of active over sham
stimulation. While there are limited data to test this proposition
robustly the result of our subgroup analysis of studies of high-
frequency motor cortex rTMS does not suggest a benefit of active
stimulation over sham.
Lima and Fregni undertook a systematic review and meta-analysis
of motor cortex stimulation for chronic pain (Lima 2008). They
pooled data from rTMS and tDCS studies. While the report states
that data were collected on mean between-group pain scores they
are not presented. The authors present the pooled data for the
number of responders to treatment across studies. They conclude
that the number of responders is higher following active stimula-
tion compared with sham (risk ratio 2.64, 95% CI 1.63 to 4.30).
In their analysis the threshold for treatment response is defined as
a global response according to each study’s own definition and as
such it is difficult to interpret and may not be well standardised.
They note a greater response to multiple doses of stimulation,
an observation that is not reliably reflected in the current review.
Additionally they included the study of Khedr 2005 (excluded
from this review due to high risk of bias) and Canavero 2002 (ex-
cluded on title and abstract as it is not a randomised or quasi-ran-
domised study). The current review also includes a number of mo-
tor cortex rTMS studies in the main analysis published since that
review (André-Obadia 2008; Defrin 2007; Hosomi 2013; Jetté
2013; Kang 2009; Lefaucheur 2006; Lefaucheur 2008; Medeiros
2016;Mhalla 2011; Passard 2007; Saitoh 2007; Tekin 2014; Yagci
2014). Neither the review of Leung 2009 nor Lima 2008 applied
a formal quality or ’Risk of bias’ assessment. While the current
review also suggests a small, short-term benefit of high-frequency
motor cortex rTMS in the treatment of chronic pain the effect is
small, appears short-term and although the pooled estimate ap-
proaches the threshold of minimal clinical significance it is pos-
sible that it might be inflated by methodological biases in the in-
cluded studies.
A systematic review of tDCS and rTMS for the treatment of fi-
bromyalgia concluded that the evidence demonstrated reductions
in pain similar to US Food and Drug Administration (FDA)-ap-
proved pharmaceuticals for this condition and recommended that
rTMS or tDCS should be considered, particularly where other
therapies have failed (Marlow 2013). This review included ran-
domised and non-randomised studies, did not undertake meta-
analysis and took a ’vote-counting’ approach to identifying effects
based primarily on each included study’s report of statistical test-
ing. While our analysis did not specifically investigate a subgroup
of studies in fibromyalgia participants, we would suggest that the
methodology chosen byMarlow 2013 does not offer the most rig-
orous approach to establishing effect size, particularly in light of
the inconsistency seen among the included studies of that review.
Indeed, given the degree of uncertainty that remains regarding
the efficacy of these interventions, it could be suggested that the
application of tDCS or rTMS for this or other conditions would
ideally be limited to the clinical research situation.
Luedtke 2012 systematically reviewed studies of tDCS for chronic
pain and experimental pain. Unlike our review they excluded the
study by Fenton 2009, as it was judged to be at high risk of bias on
the grounds of unclear randomisation procedure and due to a lack
of clarity of participant withdrawal, and Boggio 2009 due to the
level of dropout. The results of theirmeta-analysis are broadly con-
sistent with those presented here in that the authors conclude that
the evidence is insufficient to allow definite conclusions but that
there is low-level evidence that tDCS may be effective for chronic
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pain. Moreno-Duarte 2013 recently reviewed the evidence for a
variety of electrical and magnetic neural stimulation techniques
for the treatment for chronic pain following spinal cord injury,
including rTMS, tDCS and CES, including both randomised and
non-randomised studies. They found that the results varied across
studies, though trials of tDCS were consistently positive, and con-
cluded that further research is needed and that there is a need to
develop methods to decrease the variability of treatment response
to these interventions. However, it is worth noting that this re-
view did not include the recent negative study of tDCS for post-
spinal cord injury pain by Wrigley 2014, and also that variability
in observed treatment ’responses’ may simply represent the play of
chance rather than evidence of a specific group of responders.
Kirsch 2000 reviewed studies of CES in the management of
chronic pain and concluded in favour of its use. The review did not
report any formalised search strategy, inclusion criteria or quality
assessment and discussed a number of unpublished studies that re-
main unpublished at the time of the current review. Using a more
systematic methodology and including papers published since that
review, we found that the data that were available for meta-analysis
did not suggest a clinically important benefit of active CES over
sham. Our analysis included 270 participants. While this is not
particularly large it does suggest that if there is an effect of CES on
chronic pain it is either small, or that the number of responders is
likely to be small.
A recent review of rTMS for chronic pain (Galhardoni 2015)
concluded that rTMS has potential utility. This review reported
that rTMS was frequently associated with greater that 30% pain
relief when compared with a control treatment, though no meta-
analysis was reported and no formal assessment of study quality
or risk of bias was presented. Our results suggest that, compared
with sham, rTMS is associated with somewhat smaller effects and
that the effect estimate may be exaggerated by various biases in the
literature.
While many reviews have concluded positively regarding the ef-
fectiveness and early promise of non-invasive brain stimulation
techniques this is frequently based on markers of statistical signif-
icance and arguably does not adequately consider the influence of
the various biases at play in the literature.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
For people with chronic pain
There is a lack of high-quality evidence to support or refute
the effectiveness of non-invasive brain stimulation techniques for
chronic pain. Due to the small size of included studies and limita-
tions in the way that many studies were conducted, future studies
may have a substantial impact upon the estimates of effects pre-
sented.
For clinicians
Low- or very low-quality evidence suggests that low-frequency
repetitive transcranial magnetic stimulation (rTMS), or rTMS ap-
plied to the prefrontal cortex,may not be effective for the treatment
of chronic pain. Subgroup analysis suggests that single doses of
high-frequency rTMS of the motor cortex may have small, short-
term effects on chronic pain that do not meet our threshold of
minimum clinical importance (low-quality evidence) and may be
exaggerated by the dominance of small studies and other sources
of bias. The pooled evidence from multiple-dose studies of high-
frequency rTMS to the motor cortex is heterogeneous but does
not demonstrate an effect (very low-quality evidence). Very low-
quality evidence suggests that transcranial direct current stimula-
tion (tDCS) may have short-term effects on chronic pain but these
observed effects may be exaggerated by the dominance of small
studies and other sources of bias. Low-quality evidence suggests
that cranial electrotherapy stimulation (CES) is not effective. Due
to this uncertainty, clinical application of non-invasive brain stim-
ulation techniques would be most appropriate within a clinical
research setting rather than in routine clinical care and it is not
currently clear if any form of non-invasive brain stimulation is a
useful clinical tool.
For policy makers and funders of the intervention
There is a lack of high-quality evidence to support or refute the
effectiveness of non-invasive brain stimulation techniques when
compared to sham stimulation for people with chronic pain. The
short-term effects observed for rTMS and tDCS on pain may be
exaggerated by the dominance of small studies and limitations in
study methods. There is not currently a strong evidence base for
routinely offering these options for the treatment of chronic pain.
Implications for research
General
The existing evidence across all forms of non-invasive brain stim-
ulation is dominated by small studies with unclear risk of bias and
there is a need for larger, rigorously controlled trials. It is notewor-
thy that in the seven years since our original review the number of
included studies has risen substantially but our conclusions have
not changed. Contrasting the large number of trials included in
this review with the persisting lack of certainty over its effective-
ness speaks to a problem of research waste.
After our first review of this evidence was completed in 2010 we
recommended that there was a need to examine the more promis-
ing findings within the existing data through more robust, large,
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rigorous, adequately blinded trials that deliver a reasonable dose
and investigate effects over a meaningful timescale (O’Connell
2011). Until a body of this type of research is generated there will
continue to be uncertainty over the clinical utility of any form of
non-invasive brain stimulation for chronic pain. This recommen-
dation is relevant to all other types of non-invasive brain stimu-
lation. The ongoing studies, identified from searching trials regis-
ters, predominantly consist of more, relatively small trials and it is
unlikely that the results will meaningfully change the findings of
this review. A recent consensus statement (Klein 2015) has pro-
duced guidelines for future rTMS research on clinical pain with
the goal of improving quality and these recommendations should
be taken under consideration.
The proliferation of small heterogeneous trials presents a challenge
to evidence synthesis. A robust, large scale trial of rTMS or tDCS
might fail to reduce uncertainty if included in the same analysis
as the existing trials. For future reviews of this evidence base, that
seek to answer the question of clinical effectiveness, there may be a
case for excluding single-dose trials on the basis of inadequate dose
and trials below a threshold size on the basis of imprecision. There
is also a case for not updating the current review until trials of
adequate size have been added to the evidence base, since anupdate
characterised by the inclusion of more, small heterogeneous trials
will sufficiently reduce uncertainty.
Design
Future rTMS research should consider employing recently devel-
oped sham coils that control for all of the sensory aspects of stim-
ulation. Such coil systems should be robustly validated as valid
sham controls. Future studies should have a strong theoretical basis
underpinning the choice of stimulation location and parameters
and ensure that stimulation delivered to high technical standards.
Future studies of tDCS should give consideration to the integrity
of participant blinding, particularly when utilising stimulation in-
tensities that exceed 1 mA. The field should seek to generate con-
sensus on optimal stimulation parameters and procedures.
Outcome measurement
Future trials should also consider the IMMPACT recommenda-
tions for the design of trials in chronic pain (Dworkin 2008;
Dworkin 2009; Dworkin 2010; Turk 2008), to ensure that out-
comes, thresholds for clinical importance and study designs are op-
timal, and should endeavour to ensure that published study reports
are compliant with the CONSORT statement (Schulz 2010). All
studies of non-invasive brain stimulation techniques should mea-
sure, record and clearly report adverse events from both active and
sham stimulation.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Ahmed 2011
Methods Parallel, quasi-RCT
Participants Country of study: Egypt
Setting: Dept of Neurology, hospital-based
Condition: chronic phantom limb pain
Prior management details: unresponsive to various pain medications
n = 27, 17 active and 10 sham
Age, mean (SD): active group 52.01 (12.7) years, sham group 53.3 (13.3) years
Duration of symptoms, mean (SD) months: active group 33.4 (39.3), sham group 31.9
(21.9)
Gender distribution: active group 13 M, 4 F; sham group 6 M, 4 F
Interventions Stimulation type: rTMS
Stimulation parameters: frequency 20Hz; coil orientation not specified, number of trains
10; duration of trains 10 s; ITI 50 s; total number of pulses 2000
Stimulation location: M1 stump region
Number of treatments: x 5, daily
Control type: sham - coil angled away from scalp
Outcomes Primary: pain VAS (anchors not reported), LANNS
When taken: poststimulation session 1 and 5 and at 1 month and 2 months post-
treatment
Secondary: none relevant
Notes AEs: not reported
COI: not reported
Sources of support: not reported
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
High risk Comment: not true randomisation
Quote: “patients were randomly assigned to 2 groups depending
on the day of the week on which they were recruited”
Allocation concealment (selection bias) High risk Comment: given method of randomisation allocation conceal-
ment not viable
Adequate blinding of participants? Unclear risk Comment: sham credibility assessment - suboptimal. Coil an-
gled away from scalp. Did not control for sensory characteristics
of active stimulation and was visually distinguishable
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Ahmed 2011 (Continued)
Adequate blinding of assessors? Low risk Quote: “The second author evaluated these measures blindly,
without knowing the type of TMS”
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Comment: levels of dropout not reported
Selective reporting (reporting bias) Low risk Comment: primary outcomes presented in full
Study Size High risk Comment: < 50 participants per treatment arm
Study duration Low risk > 8 weeks’ follow-up
Other bias Low risk Comment: no other bias detected
Ahn 2017
Methods Parallel RCT
Participants Country of study: USA
Setting: laboratory
Condition: OA knee
Prior management details: not reported
n = 41 randomised, 40 analysed
Age, mean (SD): active group 60.6 (9.8) years, sham group 59.3 (8.6) years
Duration of symptoms: not reported
Gender distribution: 19 M, 21 F
Interventions Stimulation type: tDCS
Stimulation parameters: tDCS 2mA intensity, 20 min
Stimulation location: M1 contralateral to painful side
Number of treatments: x 1 daily for 5 days
Control type: sham tDCS
Outcomes Primary: pain NRS anchors 0 = no pain, 10 = worst pain imaginable
When taken: 1 d postintervention, 3 weeks postintervention
Secondary: WOMAC function score
AEs
Notes Funding source: supported in part by the Claude D. Pepper Older American’s Indepen-
dence Center (P30 AG028740), the Universityof Florida Center for Cognitive Aging
and Memory, and NIA
Grants K07AG04637 and K01AG050707, and R01AG054077. This Work was also
partially supported by VA HSR&D Houston Center for Innovations in Quality, Effec-
tiveness and Safety (CIN# 13-413), Michael E. DeBakey VA Medical Center, Houston,
TX
COI: study authors declared no COI
Risk of bias
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Ahn 2017 (Continued)
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “randomly assigned with a ratio of 1 to 1 to either the
active tDCS (n ¼ 20) or sham tDCS group (n ¼ 20) using a co-
variate adaptive randomization procedure so that the two groups
had approximately equal distribution regarding age, gender and
race.”
Allocation concealment (selection bias) Low risk Quote “Allocation concealment was ensured as the randomiza-
tion codes were released only after all the interventions and as-
sessments were completed.”
Adequate blinding of participants? Unclear risk Comment: evidence that participant blinding can be inadequate
at intensity of 2 mA. No assessment of blinding success. No
formal assessment of blinding success
Adequate blinding of assessors? Unclear risk Comment: evidence that assessor blinding can be inadequate at
intensity of 2 mA.No assessment of blinding success. No formal
assessment of blinding success
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: only one participant withdrew.
Selective reporting (reporting bias) Low risk Comment: outcomes reported adequately
Study Size High risk Comment: n = 20
Study duration Unclear risk Comment: 3-week follow-up
Other bias Unclear risk Comment: statistically significant between-group difference in
pain NRS scores at baseline
André-Obadia 2006
Methods Cross-over RCT; 3 conditions
Participants Country of study: France
Setting: laboratory
Condition: neuropathic pain (mixed central, peripheral and facial)
Prior management details: refractory to drug management, candidates for invasive MCS
n = 14
Age: 31-66 years; mean 53 (SD 11)
Duration of symptoms: mean 6.9 years (SD 4)
Gender distribution: 10 M, 4 F
Interventions Stimulation type: rTMS figure-of-8 coil
Stimulation parameters:
Condition 1: frequency 20 Hz; coil orientation posteroanterior; 90% RMT; number of
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André-Obadia 2006 (Continued)
trains 20; duration of trains 4 s; ITI 84 s; total number of pulses 1600
Condition 2: frequency 1Hz; coil orientation lateromedial; number of trains 1; duration
of trains 26 min, total number of pulses 1600
Condition 3: sham - same as for condition 2 with coil angled away perpendicular to
scalp
Stimulation location: M1 contralateral to painful side
Number of treatments: 1 for each condition
Outcomes Primary: VAS 0-10 cm, anchors “no pain” to “unbearable pain”
When taken: immediately poststimulation then daily for 1 week
Secondary: none
Notes Data requested from study authors and received
Sources of support: Supported in part by a Grant from the Fondation pour la Recherche
Médicale (FRM), France
COI: no declaration made
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Participants were consecutively assigned to a
randomization scheme generated on the web site Ran-
domization.com (Dallal GE, http://www.randomiza-
tion.com, 2008). We used the second generator, with
random permutations for a 3-group trial. The random-
ization sequencewas concealed until interventionswere
assigned.”
Adequate blinding of participants? Unclear risk Comment: sham credibility assessment ’suboptimal’.
Coil angled away from scalp and not in contact in sham
condition. Did not control for sensory characteristics
of active stimulation and was visually distinguishable
Adequate blinding of assessors? Low risk Quote: “To ensure the double-blind evaluation effects,
the physician applying magnetic stimulation was dif-
ferent from the one collecting the clinical data, who in
turn was not aware of the modality of rTMS that had
been used in each session.”
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk 2 participants lost to follow-up and not accounted for
in the data analysis. Given the small sample size it may
influence the results
Selective reporting (reporting bias) Low risk Pain outcomes reported for all participants. Change
from baseline figures given; point measures requested
from study authors and received
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André-Obadia 2006 (Continued)
Free from carry-over effects? Low risk Comment: a 2-week washout period was observed be-
tween stimulation conditions and possible carry-over
effects were checked and ruled out in the analysis
Study Size High risk Comment: < 50 participants per treatment arm
Study duration High risk < 2 weeks’ follow-up
Other bias Low risk Comment: no significant other bias detected
André-Obadia 2008
Methods Cross-over RCT; 3 conditions
Participants Country of study: France
Setting: laboratory-based
Condition: neuropathic pain (mixed central, peripheral and facial)
Prior management details: refractory to drug management, candidates for invasive MCS
n = 30
Age: 31-72 years, mean 55 (SD 10.5)
Duration of symptoms: mean 5 years (SD 3.9)
Gender distribution: 23 M, 7 F
Interventions Stimulation type: rTMS, figure-of-8 coil
Stimulation parameters:
Condition 1: frequency 20 Hz; coil orientation posteroanterior; 90% RMT; number of
trains 20; duration of trains 4 s; ITI 84 s; total number of pulses 1600
Condition 2: frequency 20 Hz, coil orientation lateromedial; number of trains 20; du-
ration of trains 4 s; ITI 84 s; total number of pulses 1600
Condition 3: sham - same as for active conditions with coil angled away perpendicular
to scalp
Stimulation location: M1 contralateral to painful side
Number of treatments: 1 for each condition
Outcomes Primary: 0-10 NRS (anchors “no pain” to “unbearable pain”)
When taken: daily for 2 weeks poststimulation
Secondary: none
Notes Data requested from study authors
Sources of support: supported in part by a Grant from the Fondation pour la Recherche
Médicale (FRM), France
COI: study authors declared no COI
Risk of bias
Bias Authors’ judgement Support for judgement
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André-Obadia 2008 (Continued)
Random sequence generation (selection
bias)
Low risk Quote: “the order of sessions was randomised (by com-
puterized random-number generation)”
Adequate blinding of participants? Unclear risk Comments: sham credibility assessment - suboptimal.
Coil angled away from scalp and not in contact in sham
condition. Did not control for sensory characteristics
of active stimulation and was visually distinguishable
Adequate blinding of assessors? Low risk Quote: “The physician who applied the procedure re-
ceived from a research assistant one sealed envelope
containing the order of the rTMS sessions for a given
patient. The order remained unknown to the physician
collecting clinical data.”
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: 2 participants apparently lost to follow-
up and not obviously accounted for in the analysis.
However, this is less than 10% and is unlikely to have
strongly influenced the results
Selective reporting (reporting bias) Low risk Comment: medial-lateral coil orientation condition
data not presented but provided by study authors on
request
Free from carry-over effects? Low risk Comment: a 2-week washout period was observed be-
tween stimulation conditions and possible carry-over
effects were checked and ruled out in the analysis
Study Size High risk Comment: < 50 participants per treatment arm
Study duration Unclear risk Comment: ≥ 2 weeks but < 8 weeks’ follow-up
Other bias Low risk Comment: no significant other bias detected
André-Obadia 2011
Methods Cross-over RCT
Participants Country of study: France
Setting: laboratory-based
Condition: chronic neuropathic pain (mixed)
Prior management details: resistant to conventional pharmacological treatment
n = 45
Age: 31-72 years (mean 55)
Duration of symptoms: “chronic”
Gender distribution: 28 M, 17 F
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André-Obadia 2011 (Continued)
Interventions Stimulation type: rTMS
Stimulation parameters: frequency 20Hz; coil orientation not specified, number of trains
20; duration of trains 4 s; ITI 84 s; total number of pulses 1600
Stimulation location: M1 hand area
Number of treatments: 1 per group
Control type: sham coil - same sound and appearance, no control for sensory cues
Outcomes Primary: pain NRS anchors 0 = no pain, 10 = unbearable pain
When taken: daily for 2 weeks following each stimulation
Secondary: none relevant
Notes AEs: not reported
Funding source: charity-funded
COI: declaration - no COI
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Comment:method of randomisation not specified but less likely
to introduce bias in a cross-over design
Quote: “separated into 2 groups determined by the randomiza-
tion”
Adequate blinding of participants? Unclear risk Comment: the study authors state “Because the first step of the
procedure (motor hotspot and motor threshold determination)
that induced motor contractions was identical in placebo and
active sessions and the stimulation differed only when intensities
below motor threshold were applied, no patient perceived any
difference between the 2 types of rTMS”
However, the sensation on the scalp may differ and no formal
evaluation of blinding presented
Adequate blinding of assessors? Unclear risk Comment: no mention of blinded assessors
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Comment: no mention of dropout/withdrawal
Selective reporting (reporting bias) Low risk Comment: primary outcomes reported for all groups and further
data made available upon request to authors
Free from carry-over effects? Low risk Comment: 2-week washout period observed
Study Size High risk Comment: < 50 participants per treatment arm
Study duration Unclear risk Comment: ≥ 2 weeks but < 8 weeks’ follow-up
Other bias Low risk Comment: no other biases detected
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Antal 2010
Methods Cross-over RCT
Participants Country of study: Germany
Setting: laboratory setting
Condition: mixed chronic pain, neuropathic and non-neuropathic
Prior management details: therapy-resistant
n = 23, 10 in parallel (6 active, 4 sham), 13 crossed over
Age: active-only group 28-70 years, sham-only group 50-70 years, cross-over group 41-
70 years
Duration of symptoms: chronic 1.5-25 years (mean 7.4)
Gender distribution: 6 M, 17 F
Interventions Stimulation type: tDCS
Stimulation parameters: intensity 1 mA, 35 cm2 electrodes, duration 20 min
Stimulation location: anode - L M1 hand area, cathode right supraorbital
Number of treatments: x 5, daily
Control type: sham tDCS
Outcomes Primary: pain VAS 0-10; VAS anchors 0 = no pain, 10 = the worst pain possible
When taken: x 3, daily - averaged for daily pain
Secondary: none relevant
Notes Funding: government funding
COI: none declared
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “Randomization was performed using the order of en-
trance into the study.”
Comment: may not be truly random from description
Allocation concealment (selection bias) Unclear risk Comment: not mentioned though unlikely given the randomi-
sation technique. This is a potentially significant source of bias
given that only the parallel results were used in this review due
to high levels of attrition after the first phase
Adequate blinding of participants? Low risk Comment: see above
Adequate blinding of assessors? Low risk Comment: 1 mA intensity and operator blinded
Quote: “The stimulators were coded using a five letter code,
programmed by one of the department members who otherwise
did not participate in the study. Therefore neither the investiga-
tor not the patient knew the type of the stimulation”
Incomplete outcome data (attrition bias)
All outcomes
High risk Comment: the high level of dropout renders the cross-over re-
sults at high risk of bias. This is less of an issue where only the
parallel results from the first phase were used - first-phase data
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Antal 2010 (Continued)
only used in the analysis
Selective reporting (reporting bias) Low risk Comment: while not all outcomes at all time points were in-
cluded in the study report the authors have provided all requested
data
Free from carry-over effects? Low risk Comment: participants were excluded if pain had not returned
to normal. This, however, represents a threat with regard to
attrition bias
Study Size High risk Comment: < 50 participants per treatment arm
Study duration Unclear risk Comment: ≥ 2 weeks but < 8 weeks’ follow-up
Other bias Low risk Comment: no other sources of bias detected
Attal 2016
Methods Parallel RCT
Participants Country of study: France
Setting: hospital pain units
Condition: lumbar radicular pain
Prior management details: stable pharmacological treatment for pain and sleep disorders
for at least 1 month prior to study
n = 36
Age, mean (SD): active group 53.4 (8) years, sham group 51.5 (13) years
Duration of symptoms: not reported
Gender distribution: 17 F 18 M
Interventions Stimulation type: rTMS and tDCS (order randomised in active group)
Stimulation parameters: rTMS frequency 10 Hz; coil orientation anteroposterior in-
duced current; 80% RMT; number of trains 30; duration of trains 10 s; ITI 20 s; total
number of pulses 3000
tDCS: 2 mA intensity, 30 min
Stimulation location: M1 contralateral to painful side
Number of treatments: 3 stimulation visits on 3 consecutive days for each stimulation
type. 3 week washout period
Control type: sham coil - same sound and appearance, no control for sensory cues
Outcomes Primary: pain NRS anchors 0 = no pain, 10 = maximal pain imaginable
When taken: postintervention
Secondary: BPI interference scale
AEs
Notes Funding source: The study received financial support from the Institut National de la
Sante´ et de la Recherche Médicale (INSERM)
COI: the authors declared no COI
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Attal 2016 (Continued)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “The 2 successive randomisations were prepared by a
study nurse not involved in the running of the study or in data
analysis, using validated software and a centralised randomisa-
tion schedule.”
Allocation concealment (selection bias) Low risk Quote: “The treatment allocation code was kept in a sealed
envelope until the completion of the study.”
Adequate blinding of participants? Unclear risk Comment: rTMS sham described as controlling for sensory,
auditory and visual cues. tDCS 2 mA intensity - evidence that
blinding can be inadequate at intensity of 2 mA. No formal
assessment of blinding success
Adequate blinding of assessors? Unclear risk tDCS 2mA intensity - evidence that blinding can be inadequate
at intensity of 2 mA. No formal assessment of blinding success
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: ITT analysis used and low dropout
Selective reporting (reporting bias) High risk Comment: point estimates for pain scores not provided - only a
responder analysis was presented
Free from carry-over effects? Unclear risk Comment: the order of active stimulation types was randomised
but it is not clear that there were not baseline differences between
pre-rTMS and pre tDCS from the presented data
Study Size High risk n = 36
Study duration High risk Comment: 5 days post intervention was the longest follow up
Other bias Low risk Comment: no other bias detected
Avery 2013
Methods Parallel RCT
Participants Country of study: USA
Setting: unclear
Condition: chronic widespread pain
Prior management details: not reported
n = 19
Age mean (SD): active 54.86 (7.65) years, sham 52.09 (10.02) years
Duration of symptoms (months mean (SD)): active group 11 (4.26), sham group 15.64
(6.93)
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Gender distribution: all F
Interventions Stimulation type: rTMS
Stimulation parameters: frequency 10 Hz; coil orientation not specified; 120% RMT;
number of trains 75; duration of trains 4 s; ITI 26 s; total number of pulses 3000
Stimulation location: L DLPFC
Number of treatments: 15 sessions over 4 weeks
Control type: sham coil - controls for visual, auditory and scalp sensory cues
Outcomes Primary: pain NRS 0-10 anchors not reported
When taken: end of treatment period, 1 month following and 3 months following
Secondary: pain interference BPI
QoL SF-36
AEs: multiple minor; no clear difference in incidence between active and sham stimula-
tion
Notes Government-funded study, manufacturer loaned stimulators
COI: funded by the National Institute for Arthritis, Musculoskeletal and Skin Diseases,
R21 ART053963 and the Bipolar Illness Fund
Neuronetics, Inc. loaned the TMS machine to the study
Dr. Avery was a consultant for Neuronetics, Inc. for one day, is a member of the Data
and SafetyMonitoring Board for Cerval Neuortech, Inc., was on the speakers bureau for
Eli Lilly and Takeda, was a consultant for Takeda and received a grant from the National
Institute of Mental Health. Dr. Roy-Byrne is editor for Journal Watch, Depression and
Anxiety, and UpToDate and has stock in Valant Medical Systems. None of the other
authors has potential COI
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “At the completion of the baseline assessment, patients
were randomly assigned to either real TMS or sham stimula-
tion using a computerized randomization program that uses an
adaptive randomization and stratification strategy.”
Allocation concealment (selection bias) Unclear risk Quote: “Based on the randomization, a ”smart card“ which de-
termined whether the real TMS or sham coil would be admin-
istered was assigned to a particular patient. The card had only
a code number that did not reveal the randomization.” “The
research coordinator blind to the randomization repeated the
baseline assessments”
Comment: not entirely clear whether the personnel overseeing
randomisation was separate from that performing the screening
assessment
Adequate blinding of participants? Low risk Quote: “... sham stimulation with the electromagnet blocked
within the coil by a piece of metal so the cortex was not stim-
ulated. The coils appeared identical. Electrodes were attached
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Avery 2013 (Continued)
to the left side of the forehead for each subject for each ses-
sion. Those receiving the sham stimulation received an electrical
stimulus to the forehead during the sham stimulation. Those
receiving the real TMS received no electrical stimulation to the
electrodes. Both groups experienced a sensation in the area of the
left forehead. In addition, all subjects were given special earplugs
and received an audible noise during the stimulation to mask
any possible sound differences between the TMS and sham con-
ditions.”
Comment: optimal sham - controls for visual, sensory and au-
ditory cues Formal testing - blinding appears robust
Adequate blinding of assessors? Low risk Quote: “The research coordinator blind to the randomization
repeated the baseline assessments of pain, functional status, de-
pression, fatigue, and sleep before the 1st and after the 5th, the
10th, and the 15th TMS sessions as well as 1 week, 1 month,
and 3 months after the last TMS treatment except for the SF-
36, neuropsychological tests, audiometry and the dolorimetry
which were only done at baseline and one week after the 15th
TMS session.”
Comment: while TMS physicians guessed beyond chance the
raters were separate from this process
Incomplete outcome data (attrition bias)
All outcomes
Low risk Quote: “To examine differences in changes in outcomes over
time between TMS and comparison group subjects, we esti-
mated random coefficient models following the intent-to-treat
principle.”
“11 were randomized to the sham group and 8 were random-
ized to the TMS group. However, one subject randomized to
the TMS had a baseline BIRS score of 4 which was well below
the BIRS score of 8 required for randomization. Because of this
incorrect randomization, this subject was excluded from the ef-
ficacy analyses, but was included in the analysis of side effects.
The clinical characteristics of those correctly randomized are in
Table 1. One subject in the TMS dropped out after the 10th
session because of lack of response and is included in the analy-
ses.”
Comment: of 2 dropouts from the TMS group, 1 was excluded
(reasons given)
Selective reporting (reporting bias) Low risk Comment: all outcomes presented in full in study report
Study Size High risk Comment: < 50 participants per treatment arm
Study duration Low risk Comment: > 8 weeks’ follow-up
Other bias Low risk No other bias detected
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Ayache 2016
Methods Cross-over RCT
Participants Country of study: France
Setting: laboratory
Condition: MS-related neuropathic pain
Prior management details: concomitant medication intake stable throughout protocol
n = 16
Age, mean (SD) 48.9 (10) years
Duration of symptoms: mean (SD) 11.8 (9.4) months
Gender distribution: 13 F, 3 M
Interventions Stimulation type: tDCS
Stimulation parameters: intensity 2 mA, 25 cm2 electrodes, duration 20 min
Stimulation location: anode - L DLPFC, cathode right supraorbital
Number of treatments: x 3, daily
Control type: sham tDCS
Outcomes Primary: pain VAS 0 -10; VAS anchors not reported
When taken:
Postintervention, 7 days postintervention
Secondary: AEs
Notes COI:
“AC gave expert testimony for CSL Behring, Novartis, received grants from Biogen,
Novartis, CSLBehring, GENeuro, Octapharma, and gave lectures for Genzyme. The re-
maining authors declare that the research was conducted in the absence of any commer-
cial or financial relationships ”that could be construed as potential conflict of interest“
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote “The randomization schedule was generated by U.P.
prior to the beginning of the study using a dedicated soft-
ware (“true”random number generation without any restriction,
stored in a computer until the patient was assigned to the inter-
vention).”
Adequate blinding of participants? Unclear risk Comment: there is evidence that participant blinding of tDCS
may be inadequate at 2 mA intensity, particularly in cross-over
designs. Results of guessing mode of stimulation not reported
Adequate blinding of assessors? Unclear risk Quote: ”Only the performing physician (S.S.A) was aware of
the stimulation mode (real or sham tDCS). The evaluators (U.
P and M.A.C) and the patients were blind to it.”
Comment: there is evidence that assessor blinding of tDCS may
be inadequate at 2 mA intensity
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Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: no attrition reported
Selective reporting (reporting bias) Low risk Comment: results reported in full
Free from carry-over effects? Unclear risk Comment: baseline scores for each period not reported. No for-
mal analysis for carry-over effects presented
Study Size High risk Comment: n = 16
Study duration High risk Comment: longest follow-up 7 days after stimulation
Other bias Low risk No other bias detected
Bae 2014
Methods Parallel RCT
Participants Country of study: South Korea
Setting: laboratory
Condition: CPSP
Prior management details: not reported
n = 14
Age, mean (SD): active group 51.1 (3.1) years, sham group 52.3 (2.8) years
Duration of symptoms, mean (SD): active group 14.5 (3.2) months, sham group 14.7
(2.7)
Gender distribution: 7 M, 7 F
Interventions Stimulation type: tDCS
Stimulation parameters: intensity 2 mA, 35 cm2 electrodes, duration 20 min
Stimulation location: anode -M1 contralateral to painful side, cathode right supraorbital
Number of treatments: x 3 per week for 3 weeks
Control type: sham tDCS
Outcomes Primary: pain VAS anchors 0 = no pain, 10 = unbearable
When taken: “immediacy”, 1 week, 3 weeks (unclear if from end of intervention)
Secondary: None relevant
Notes COI: study authors declared no COI
Sources of support: none declared
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Comment: method of randomisation not reported
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Allocation concealment (selection bias) Unclear risk Comment: no mention of allocation concealment procedures
Adequate blinding of participants? Unclear risk Comment: blinding not reported. Evidence that blinding can
be inadequate at intensity of 2 mA
Adequate blinding of assessors? Unclear risk Comment: blinding not reported. Evidence that blinding can
be inadequate at intensity of 2 mA
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Comment: unable to clearly verify if there was any attrition
Selective reporting (reporting bias) Low risk Comment: adequate reporting of outcomes
Study Size High risk Comment: total n = 14
Study duration Unclear risk Comment: 3-week follow-up
Other bias Low risk Comment: no other bias detected
Boggio 2009
Methods Cross-over RCT; 3 conditions
Participants Country of study: Brazil
Setting: laboratory
Condition: neuropathic pain (mixed central, peripheral and facial)
Prior management details: refractory to drug management
n = 8
Age: 40-82 years; mean 63.3 (SD 5.6)
Duration of symptoms: 1-20 years; mean 8.3 (SD 5.6)
Gender distribution: 2 M, 6 F
Interventions Stimulation type: tDCS
Stimulation parameters: intensity 2 mA, 35 cm2 electrodes, duration 30 min
Condition 1: active tDCS/active TENS
Condition 2: active tDCS/sham TENS
Condition 3: sham tDCS/sham TENS
Stimulation location: M1 contralateral to painful side
Number of treatments: 1 for each condition
Control type: sham tDCS (switched off after 30 s stimulation)
Outcomes Primary: VAS 0-10 anchors “no pain” to “worst possible pain”
When taken: pre and post each stimulation
Secondary: none
Notes Sources of support: not declared
COI: not declared
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Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “All the patients received the 3 treatments....
in a randomised order (we used a computer generated
randomisation list with the order of entrance).”
Adequate blinding of participants? Unclear risk Comment: there is evidence that participant blinding
of tDCS may be inadequate at 2 mA intensity (see
Assessment of risk of bias in included studies)
Adequate blinding of assessors? Unclear risk Quote: “All evaluations were carried out by a blinded
rater”
Comment: there is evidence that assessor blinding
of tDCS may be inadequate at 2 mA intensity (see
Assessment of risk of bias in included studies)
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Comment: 2 participants lost to follow-up. It is unclear
how these data were accounted for as there were no
missing data apparent in the results tables. However,
this may have an impact given the small sample size
Selective reporting (reporting bias) Low risk Comment: primary outcomedata presented clearly and
in full
Free from carry-over effects? Low risk Comment: a 48-h washout period was observed be-
tween stimulation conditions and possible carry-over
effects were checked and ruled out in the analysis
Quote: “To analyzewhether therewas a carryover effect,
we initially performed and showed that the baselines
for the 3 conditions were not significantly different (P
= 0.51). We also included the variable order in our
model and this model also showed that order is not a
significant term (P = 0.7).”
Study Size High risk Comment: < 50 participants per treatment arm
Study duration High risk Comment: < 2 weeks’ follow-up
Other bias Low risk Comment: no significant other bias detected
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Borckardt 2009
Methods Cross-over RCT; 2 conditions
Participants Country of study: USA
Setting: laboratory
Condition: peripheral neuropathic pain
Prior management details: not specified
n = 4
Age: 33-58 years; mean 46 (SD 11)
Duration of symptoms: 5-12 years; mean 10.25 (SD 3.5)
Gender distribution: 1 M, 3 F
Interventions Stimulation type: rTMS, figure-of-8 coil
Stimulation parameters: frequency 10 Hz; coil orientation not specified; 100% RMT;
number of trains 40; duration of trains 10 s; ITI 20 s; total number of pulses 4000
Stimulation location: L PFC
Number of treatments: 3 over a 5-d period
Control type: neuronetics sham coil (looks and sounds identical)
Outcomes Primary: average daily pain 0-10 Likert scale, anchors “no pain at all” to “worst pain
imaginable”
When taken: post-stimulation for each condition (unclear how many days post) and
daily for 3 weeks poststimulation
Secondary: none
Notes AEs: not reported
Sources of support: no separate statement provided
COI: “Dr. Borckardt receives research funding from the National Institute for Neu-
rological Disorders and Stroke at NIH, Cyberonics Inc, the Neurosciences Institute at
MUSC, and is a consultant for Neuropace; however, he has no equity ownership in
any device or pharmaceutical company. Dr. George receives research funding from the
National Institute for Mental Health, NIDA, and NIAAA at NIH, Jazz Pharmaceuti-
cals, GlaxoSmithKline, and Cyberonics Inc. He is a consultant for Aspect Biomedical,
Argolyn, Aventis, Abbott, Bristol-Meyers Squibb, Cephos, Cyberonics, and Neuropace;
however, he has no equity ownership in any device or pharmaceutical company. Dr.
Nahas receives research funding from the National Institute for Mental Health at NIH
and Cyberonics Ind, and is a consultant for Neuropace. Dr. Kozel receives research fund-
ing from the National Institute for Mental Health at NIH and the U.S. Department
of Defense. MUSC has filed six patents or invention disclosures in one or more of the
authors’ names regarding brain imaging and stimulation.”
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “The order (real first or sham first) was ran-
domised”
Comment: method of randomisation not specified but
less critical in cross-over design
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Adequate blinding of participants? Unclear risk Quote: “Two of the four participants (50%) correctly
guessed which treatment periods were real and sham,
which is equal to chance. All four of the participants
initially said that they did not know which was which,
and it was not until they were pushed to ”make a guess“
that they were able to offer an opinion about which
sessions were real and which were sham.”
Comments: sham credibility assessment - suboptimal.
Sham coil controlled for auditory cues and was visually
indistinguishable from active stimulation but did not
control for sensory characteristics of active stimulation
Adequate blinding of assessors? Unclear risk Comment: not specified
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: no dropout
Selective reporting (reporting bias) Low risk Comment: all results reported clearly and in full
Free from carry-over effects? Low risk Comment: a 3-weekwashout periodwas observed. Pre-
sented average pain values were very similar pre- each
condition
Study Size High risk Comment: < 50 participants per treatment arm
Study duration Unclear risk Comment: ≥ 2 weeks but < 8 weeks’ follow-up
Other bias Low risk Comment: no significant other bias detected
Boyer 2014
Methods Parallel RCT
Participants Country of study: France
Setting: specialised pain treatment centre
Condition: fibromyalgia
Prior management details: stable treatment for more than 1 month before enrolment
n = 38
Age, mean (SD): active group 49.1(10.6) years, sham group 47.7 (10.4) years
Duration of symptoms, mean (SD): active group 3.7 (4.5) years, sham group 3.6 (3.8)
Gender distribution: 37 F, 1 M
Interventions Stimulation type: rTMS
Stimulation parameters: frequency 10 Hz; coil orientation anteroposterior; 90% RMT;
number of trains 20; duration of trains 10 s; ITI 50 s; total number of pulses 2000
Stimulation location: L M1
Number of treatments: 14 sessions. 10 sessions in 2 weeks followed by maintenance
phase of 1 session at weeks 4, 6, 8 and 10
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Control type: sham coil - did not control for sensory cues
Outcomes Primary: pain VAS 0 = no pain, 10 = maximal pain imaginable
When taken: 2 weeks, 11 weeks
Secondary: FIQ
AEs
Notes Funding source: Supported by Inserm (Centre d’Investigation Clinique, CIC, Hôpital
de la Conception, Marseille) and AP-HM (AORC 2008/01)
COI: the study authors report no disclosures relevant to the manuscript
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Individuals were randomized by a computer-generated
list…”
Allocation concealment (selection bias) Low risk Quote: “...which was maintained centrally so no investigators
knew the treatment allocation of any patient.”
Adequate blinding of participants? Unclear risk Quote: “Sham stimulation was conducted with a sham coil of
identical size, color, and shape, emitting a sound similar to that
emitted by the active coil. Stimulations were administered by
the same technologist.”
Comments: sham credibility assessment - suboptimal. Sham coil
controlled for auditory cues and was visually indistinguishable
from active stimulation but did not control for sensory charac-
teristics of active stimulation
Adequate blinding of assessors? Low risk Quote: “Patients and clinical raters were blinded to treatment”
Incomplete outcome data (attrition bias)
All outcomes
High risk Quote “All patients completed the induction phase, but 9 (23.
7%)were excluded during themaintenance phase (3 in the active
rTMS group and 6 in the sham rTMS group)“
Comment: dropout high, ITT analysis used but no information
with regards imputation approach taken (or not)
Selective reporting (reporting bias) Low risk Comment: all results reported clearly and in full
Study Size High risk Comment: n = 38
Study duration High risk Comment: no follow-up after end of maintenance phase
Other bias Low risk Comment: no other bias detected
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Brietzke 2016
Methods Parallel RCT
Participants Country of study: Brazil
Setting: laboratory
Condition: hepatitis C-related chronic pain
Prior management details: not reported
n = 28
Age, mean (SD): active group 53.86 (5.76) years, sham group 56.57 (8.52) years
Duration of symptoms: not reported
Gender distribution: 21 M, 7 F
Interventions Stimulation type: tDCS
Stimulation parameters: intensity 2 mA, 25-35 cm2 electrodes, duration 20 min
Stimulation location: anode - M1 L, cathode right supraorbital
Number of treatments: daily, x 5
Control type: sham tDCS
Outcomes Primary: pain VAS; anchors 0 = no pain, 10 = worst possible pain
When taken: end of intervention
Secondary: none relevant
Notes Funding from Brazilian funding agencies:
(i) Committee for the Development of Higher Education Personnel
(ii) National Council for Scientific and Technological Development-CNPq
(iii) Postgraduate Program in Medical Sciences of Medical School of the Federal Uni-
versity of
Rio Grande do Sul.
(iv) Postgraduate Research Group at the Hospital de Clínicas de Porto Alegre
(v) Laboratory of Neuromodulation & Center for Clinical Research Learning
(vi) Foundation for Support of Research at Rio Grande do Sul
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Randomized numbers in a 1:1 ratio were generated
using appropriate software (www.randomization.com) to assign
each
Participant to either active or sham-placebo group.”
Allocation concealment (selection bias) Low risk Quote: “Envelopes were prepared for randomization process and
sealed. After subject’s agreement to participate in the trial, one
investigator who was not involved with either stimulation or
assessments opened the envelope. The allocation concealment
was reached since no investigator (stimulators nor accessors) was
aware of treatment allocations and had no control over the order
of patients randomized.”
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Brietzke 2016 (Continued)
Adequate blinding of participants? Unclear risk Comment: evidence that blinding can be inadequate at intensity
of 2 mA
Adequate blinding of assessors? Unclear risk Quote: “Two independent blinded examiners were trained to
apply the pain scales and to conduct the psychological tests
Comment: evidence that assessor blinding can be inadequate at
intensity of 2 mA. No assessment of blinding success
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Comment: 3 participants dropped out (> 10%) reasons not
given. ITT analysis with LOCF
Selective reporting (reporting bias) Low risk Comment: outcome data adequately reported
Study Size High risk Comment n = 28
Study duration High risk Comment: no follow-up after immediate postintervention pe-
riod
Other bias Low risk No other bias detected
Capel 2003
Methods Partial cross-overRCT.NB:we only consideredfirst-phase results thereforewe considered
the trial as having a parallel design
Participants Country of study: UK
Setting: residential educational centre
Condition: post-SCI pain (unclear whether this was neuropathic or otherwise)
Prior management details: unclear
n = 30
Age: unclear
Duration of symptoms: unclear
Gender distribution: unclear
Interventions Stimulation type: CES
Stimulation parameters: frequency 10 Hz; pulse width 2 ms; intensity 1 2 µA; duration
53 min
Stimulation location: ear clip electrodes
Number of treatments: x 2, daily for 4 days
Control type: sham CES unit indistinguishable from active unit
Outcomes Primary: 0-10 VAS ’level of pain’, anchors not specified
When taken: daily during the treatment period
Secondary: none
Notes COI: no declaration made
Sources of support: Laing Foundation (charity) “financial assistance”
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Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Comment: method equivalent to picking
out of a hat
Quote: “Subjects would be randomly as-
signed into two groups according to their
choice of treatment device... The devices
were numbered for identification, but nei-
ther the administrators nor the recipients
of the treatment could distinguish between
the devices.”
Allocation concealment (selection bias) Low risk Comment: this is achieved through the
method of randomisation
Adequate blinding of participants? Low risk Quote: “neither the administrators nor the
recipients of the treatment could distin-
guish between the devices.”
Adequate blinding of assessors? Low risk Quote: “neither the administrators nor the
recipients of the treatment could distin-
guish between the devices.”
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: 3 participants withdrew (not
voluntarily) and while the data were not
clearly accounted for in the data analysis
this constituted 10% of the overall cohort
and was unlikely to have strongly influ-
enced the results
Quote: “Three of the 30 subjects included
were withdrawn from the study after com-
mencement, one of whom developed an
upper respiratory infection, and two oth-
ers were withdrawn from the study be-
cause their medication (either H2 antago-
nist anti-ulcer or steroidal inhalant) were
interacting with the TCET treatment.”
Selective reporting (reporting bias) High risk Comment: pain score values were not pro-
vided for any time point
Study Size High risk Comment: < 50 participants per treatment
arm
Study duration High risk Comment: < 2 weeks’ follow-up
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Other bias Low risk Comment: no significant other bias de-
tected
Carretero 2009
Methods Parallel randomised clinical trial
Participants Country of study: Spain
Setting: outpatient clinic
Condition: fibromyalgia (with major depression)
Prior management details: unclear
n = 26
Age: active group 47.5 (SD 5.7) years, sham group 54.9 (SD 4.9) years
Duration of symptoms: unclear “chronic”
Gender distribution: 2 M, 24 F
Interventions Stimulation type: rTMS
Stimulation parameters: frequency 1 Hz; coil orientation not specified; 110% RMT;
number of trains 20; duration of trains 60 s; ITI 45 s; number of pulses 1200
Stimulation location: R DLPFC
Number of treatments: up to 20 on consecutive working days
Control type: coil angled 45º from the scalp
Outcomes Primary: Likert pain scale 0-10, anchors “no pain” to “extreme pain”
When taken: 2 weeks, 4 weeks and 8 weeks from commencement of study
Secondary: none
Notes COI: no declaration made
Sources of support: IUNICS Institute, Research Institute of Health Sciences
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Comment: method of randomisation not specified
Allocation concealment (selection bias) Unclear risk Comment: allocation concealment not specified
Adequate blinding of participants? Unclear risk Comments: sham credibility assessment - subopti-
mal. Coil angled 45º away from scalp. Did not con-
trol for sensory characteristics of active stimulation
and was visually distinguishable
Adequate blinding of assessors? Low risk Quote: “patients and raters (but not the treating
physician) were blind to the procedure”
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Carretero 2009 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: only 1 participant in each group did not
complete the study. Unlikely to have strongly influ-
enced the findings
Selective reporting (reporting bias) Low risk Comment: outcomes presented clearly and in full
Study Size High risk Comment: < 50 participants per treatment arm
Study duration Unclear risk Comment: ≥ 2 weeks but < 8 weeks’ follow-up
Other bias Low risk Comment: no significant other bias detected
Chang 2017
Methods Parallel RCT
Participants Country of study: Australia
Setting: laboratory
Condition: knee OA
Prior management details: not reported
n = 30
Age, mean (SD): active group 59.8 (9.1) years, sham group 64.1 (11.1) years
Duration of symptoms mean (SD) years: active group: 7.2 (5.3), sham group 9.0 (7.3)
Gender distribution: 10 M, 19 F
Interventions Stimulation type: tDCS
Stimulation parameters:
tDCS: 1 mA intensity, 20 min
Stimulation location: M1 contralateral to painful side
Number of treatments: x 2 weekly for 8 weeks prior to a 30-min supervised strengthening
exercise session. 16 sessions
Control type: sham tDCS
Outcomes Primary: pain NRS anchors 0 = no pain, 10 = worst pain imaginable
When taken: postintervention
Secondary: WOMAC function
AEs
Notes Funding source: Trial funded byArthritis Australia (The Zimmer AustraliaGrant).W-JC
(1094434), PWH (1002190), KLB (1058440), MBL (1059116) and SMS (1105040)
receive salary support from the National Health and Medical Research Council of Aus-
tralia, RSH from the Australian Research Council (FT#130100175) and VB from a
Western Sydney University Postgraduate Research Award
COI: study authors declared no COI
Risk of bias
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Chang 2017 (Continued)
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Comment: method of randomisation not described
Allocation concealment (selection bias) Low risk Quote: “The randomisation schedule was concealed in con-
secutively numbered, sealed opaque envelopes. An investigator
not involved in recruitment and assessment prepared and pro-
vided the envelopes to the treating physiotherapists who revealed
group allocation.”
Adequate blinding of participants? Low risk Comment: blinding likely maintained at 1 mA intensity
Adequate blinding of assessors? Low risk Quote: “A single investigator (W-JC), blinded to the group al-
location of the participants, performed participant recruitment,
screening, and testing.”
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Comment: 2 (13% dropout from active group), 3 (20%) from
control group. ITTanalysiswith no imputationofmissing values
Selective reporting (reporting bias) Low risk Comment: outcomes reported adequately
Study Size High risk Comment: n = 30
Study duration High risk Comment: postintervention follow-up only (within 1 week)
Other bias Low risk Comment: no other bias detected
Cork 2004
Methods Cross-over RCT (to be considered as parallel - first treatment phase only as 2nd un-
blinded)
Participants Country of study: USA
Setting: pain clinic
Condition: fibromyalgia
Prior management details: unclear
n = 74
Age: 22-75 years; mean 53
Duration of symptoms: 1-21 years; mean 7.3
Gender distribution: 4 M, 70 F
Interventions Stimulation type: CES
Stimulation parameters: frequency 0.5 Hz; pulse width unclear; intensity 100 µA; wave-
form shape modified square wave biphasic 50% duty cycle; duration 60 min
Stimulation location: ear clip electrodes
Number of treatments: ? daily for 3 weeks
Control type: sham CES unit indistinguishable from active unit
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Cork 2004 (Continued)
Outcomes Primary: 0 -5 pain NRS, anchors “no pain” to “worst pain imaginable”
When taken: immediately following the 3-week treatment period
Secondary: Oswestry Disability Index
When taken: immediately following the 3-week treatment period
Notes AEs: not reported
COI: no declaration made
Sources of support: “Supported by a grant from the Department of Anesthesiology, LSU
Health Sciences Center. No financial support was received from themakers of the Alpha-
Stim™; however, Electromedical Products International, Inc. did loan the authors the
Alpha-Stim™ units necessary to do the study.”
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Comment: method of randomisation not
specified
Allocation concealment (selection bias) Unclear risk Comment: allocation concealment not
specified
Adequate blinding of participants? Low risk Quote: “All staff, the physicians, and the
patient were blind to the treatment condi-
tions.”
Adequate blinding of assessors? Low risk Quote: “All staff, the physicians, and the
patient were blind to the treatment condi-
tions.”
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Comment: dropout rate not reported
Selective reporting (reporting bias) High risk Comment: pain score numerical values not
provided clearly with measures of variance
for any time point
Study Size High risk Comment: < 50 participants per treatment
arm (considered as a parallel trial - 1st phase
only)
Study duration High risk Comment: < 2 weeks’ follow-up
Other bias Low risk Comment: no significant other bias de-
tected
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Curatolo 2017
Methods Parallel RCT
Participants Country of study: Italy
Setting: laboratory
Condition: fibromyalgia
Prior management details: not reported
n = 20
Age, mean (SD): active group 41.4 (10.25) years, sham group 44.2 (9.81) years
Duration of symptoms, mean (SD) years: active group 4.3 (2.62), sham group 5 (5.04)
Gender distribution: all F
Interventions Stimulation type: tRNS
Stimulation parameters:
tDCS: 1.5 mA intensity, 20 min (randomly oscillating in frequency range 101-640 Hz
for 10 min, offset set to 0 ma sham - stimulation turned on for 30 s only)
Stimulation location: M1 (side not reported)
Number of treatments: x 1 daily, 5 days a week for 2 weeks (x 10 sessions)
Control type: sham tRNS
Outcomes Primary: pain NRS anchors not reported
When taken: postintervention
Secondary: FIQ
AEs not reported
Notes Funding source: not reported
COI: not reported
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Comment: method of randomisation not described
Allocation concealment (selection bias) Unclear risk Comment: allocation concealment not described
Adequate blinding of participants? Unclear risk Comment: method of blinding not reported
Adequate blinding of assessors? Unclear risk Comment: method of blinding not reported
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: no dropout reported
Selective reporting (reporting bias) High risk Comment: no numeric reporting of primary outcomes
Study Size High risk Comment: n = 20
Study duration High risk Comment: postintervention follow-up only
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Curatolo 2017 (Continued)
Other bias Low risk Comment: no other bias detected
Dall’Agnol 2014
Methods Parallel RCT
Participants Country of study: Brazil
Setting: not specified
Condition: chronic myofascial pain in the upper body
Prior management details: not reported
n = 24
Age, mean (SD): active group 45.83 ( 9.63) years, sham group 44.83 (14.09) years
Duration of symptoms: not reported
Gender distribution: all F
Interventions Stimulation type: rTMS
Stimulation parameters: frequency 10Hz; coil orientation 45º frommidline, 80%RMT,
number of trains 16; duration of trains 10 s; ITI 26 s; total number of pulses 1600
Stimulation location: L M1
Number of treatments: 10 sessions, timescale not specified
Control type: sham coil - same sound and appearance and sensation
Outcomes Primary: pain NRS anchors 0 = no pain, 10 = worst possible pain
When taken: postintervention
Secondary: AEs
Notes Funding source: grants and material support from the following Brazilian agencies:
Brazilian Innovation Agency (FINEP), process number 1245/13; Committee for the
Development of Higher Education Personnel-PNPD/CAPES, process number 023-11,
and material support; National Council for Scientific and Technological Development-
CNPq (grants WC-301256/2013-6 and ILST- 302345/2011-6 ); Postgraduate Program
in Medical Sciences at the School of Medicine of the Federal University of Rio Grande
do Sul (material support); Postgraduate Research Group at the Hospital de Cl nicas de
Porto Alegre (grant number 120343 and material support); and Foundation for Support
of Research at Rio Grande do Sul (FAPERGS)
COI: study authors declared that there was no COI
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “A computer random number generator assigned pa-
tients to 1 of 2 groups: rTMS or placebo-sham using a block
randomization strategy.”
Allocation concealment (selection bias) Low risk Quote: “Before the recruitment phase, opaque envelopes con-
taining the protocol materials were prepared. Each opaque en-
velope was sealed and numbered sequentially, containing 1 in-
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Dall’Agnol 2014 (Continued)
tervention allocation.”
Adequate blinding of participants? Low risk Quote “we used an inactive rTMS coil (MagPro X100; MagVen-
ture Company, Lucernemarken, Denmark) as a sham method
by placing it in the identical area as the active coil. Thus,
sham patients underwent similar rTMS experience (including
rTMS sound) as those receiving active stimulation.....The pa-
tient recorded identical experiences (including sound effects and
somatic sensations caused by contraction of the muscles of the
scalp) as during active stimulation”
Comment: assessment indicates that blinding was successful.
Adequate blinding of assessors? Low risk Quote “Two independent evaluators who were blinded to the
group assignments(W.C. and another) were trained to apply the
pain scales and conduct psychophysical and psychological tests.
”
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: only 1 dropout
Selective reporting (reporting bias) High risk Comment: point estimates for outcomes only reported at one
time point
Study Size High risk n = 24
Study duration Low risk 12-week follow-up postintervention
Other bias Low risk Comment: no other bias detected
de Oliveira 2014
Methods Parallel RCT
Participants Country of study: Brazil
Setting: neurology dept
Condition: CPSP
Prior management details: stable medication for 30 d preceding baseline
n = 23
Age, mean (SD): active group 55 (9.67) years, sham group SD 57.8 (11.86) years
Duration of symptoms, mean (SD): active group 64.18 (49.27) months, sham group
50.1 (28.04)
Gender distribution:active group 45% M, sham group 50% M
Interventions Stimulation type: rTMS
Stimulation parameters: frequency 10 Hz; coil orientation not specified, 120% RMT,
number of trains 25; duration of trains 5 s; ITI 25s; total number of pulses 1250
Stimulation location: L premotor/DLPFC
Number of treatments: 10 sessions daily for 2 weeks
Control type: sham coil - same sound and appearance, no control for sensory cues
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de Oliveira 2014 (Continued)
Outcomes Primary: pain NRS anchors not reported
When taken: end of intervention, 1, 2 and 4 weeks postintervention
Secondary: AEs, QoL (SF-36)
Notes Funding source: studywas supported by the PainCenter of theDepartment ofNeurology
and by the Transcranial Magnetic Stimulation Laboratory of the Psychiatry Institute,
University of Sao Pau
COI: the study authors declared no COI
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote “Participants were randomly assigned into 2 groups, ac-
tive stimulation (a-rTMS) and sham stimulation
(s-rTMS), according to a list automatically generated by an in-
ternet-based tool (www.random.org)”
Allocation concealment (selection bias) Unclear risk Comment: allocation concealment not reported
Adequate blinding of participants? Unclear risk Quote “Sham stimulation was carried out with a sham coil of
identical size color and shape emitting a sound similar to that
emitted by the active coil (MC-P-B70).”
Comment: sham credibility assessment - suboptimal. Sham coil
controlled for auditory cues and was visually indistinguishable
from active stimulation but did not control for sensory charac-
teristics of active stimulation
Adequate blinding of assessors? Low risk Quote: “Pain intensity (VAS) was assessed daily, right before and
immediately after each rTMS session, from D1 to D10 by an
investigator (M.M.) blinded to the type of rTMS patients were
receiving. All clinical assessments were performed by a physician
and a neuropsychologist (T.L., M.L.M) who were blinded to the
type of treatment and had no other role in the study.”
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: 1 dropout per group
Selective reporting (reporting bias) Low risk Comment: outcomes reported adequately
Study Size High risk n = 21
Study duration Unclear risk Comment: 4-week follow-up
Other bias Low risk Comment: no other bias detected
88Non-invasive brain stimulation techniques for chronic pain (Review)
Copyright © 2018 The Authors. Cochrane Database of Systematic Reviews published by John Wiley & Sons, Ltd. on behalf of The
Deering 2017
Methods Parallel RCT
Participants Country of study: USA
Setting: “single clinical location”
Condition: fibromyalgia
Prior management details: FDA-approved fibromyalgia drugs and centrally active anal-
gesics or stimulants “prohibited”
n = 46
Age mean (SD) active 12-week programme group 55.7 (8.7) active 8-week programme
group 46.6 (10.3), sham group 47.9 (11.2)
Duration of symptoms: not reported
Gender distribution: reported for completers only 35 F, 3 M
Interventions Stimulation type: RINCE
Stimulation parameters: not reported
Stimulation location: parietal region (international 10/20 site PZ),“positioned to create
a conduction pathway that includes the primary somatosensory and motor cortex”
Number of treatments:
Active 12-week group: 24 treatments of 12 weeks
Active 8-week group: 16 treatments over 8 weeks followed by 8 sham sessions in 4 weeks
Sham group: 24 sham sesssions over 12 weeks
Control type: nonactivated identical stimulation unit
Outcomes Primary: pain VAS; 0 = no pain, 10 = worst pain imaginable
When taken: end of treatment period, 4 weeks post-treatment
Secondary: total FIQ score
AEs
Notes Sources of support: all funding for this study was provided by Cerephex Corporation
who manufacture the device
COI: no formal declaration. 5 study authors affiliated to funder - who manufacture the
RINCE technology
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Comment: method of random sequence generation unclear
Allocation concealment (selection bias) Unclear risk Comment: allocation concealment not clearly established
Adequate blinding of participants? Unclear risk Quote: “patients cannot feel the RINCE signal and are therefore
blinded to receiving treatment or not….no element of hardware
or software gave any indication of group assignment”
Adequate blinding of assessors? Unclear risk Quote: “The investigators were blinded to these codes and no
element of hardware or software gave any indication of group
assignment, thus maintaining a double blinded sham controlled
89Non-invasive brain stimulation techniques for chronic pain (Review)
Copyright © 2018 The Authors. Cochrane Database of Systematic Reviews published by John Wiley & Sons, Ltd. on behalf of The
Cochrane Collaboration.
Deering 2017 (Continued)
condition.”
Incomplete outcome data (attrition bias)
All outcomes
High risk Comment: 7/14participants not analysed in the shamgroup due
to “exposure to unexpected signal source”. These participants
not included in shamanalysis.Details onhow thiswas confirmed
or what the exposure was are not clear
Selective reporting (reporting bias) High risk Comment: point estimates with measures of variance not pro-
vided for all groups at all time points
Study Size High risk n = 46, divided into 3 groups
Study duration Unclear risk Comment: 4-week follow-up period
Other bias Unclear risk Comment: full baseline data not tested and only data with 8
excluded sham participants removed were presented
Defrin 2007
Methods Parallel RCT
Participants Country of study: Israel
Setting: outpatient department
Condition: post-SCI central neuropathic pain
Prior management details: refractory to drug, physical therapy and complementary ther-
apy management
n = 12
Age: 44-60 years; mean 54 (SD 6)
Duration of symptoms: > 12 months
Gender distribution: 7 M, 4 F
Interventions Stimulation type: rTMS, figure-of-8 coil
Stimulation parameters: frequency 5 Hz; coil orientation not specified; 115% RMT;
number of trains 500; duration of trains 10 s; ITI 30 s; total number of pulses 500
reported, likely to have been 25,000 judging by these parameters
Stimulation location: M1 - midline
Number of treatments: x 10, x 1 daily on consecutive days
Control type: sham coil - visually the same and makes similar background noise
Outcomes Primary: 15 cm 0-10 VAS pain intensity, anchors “no pain sensation” to “most intense
pain sensation”
When taken: pre and post each stimulation session
Secondary: McGill pain questionnaire
When taken: 2- and 6-week follow-up period
Notes AEs: not reported
Sources of support: supported by the National Association of the insurance companies
COI: study authors declared no COI
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Defrin 2007 (Continued)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Comment: method of randomisation not specified
Quote: “Patients were randomised into 2 groups that received
either real or sham rTMS”
Allocation concealment (selection bias) Unclear risk Comment: allocation concealment not specified
Adequate blinding of participants? Unclear risk Quote: “Two coils were used; real and sham, both of which were
identical in shape and produced a similar background noise.”
Comment: sham credibility assessment - suboptimal. Sham coil
controlled for auditory cues and was visually indistinguishable
from active stimulation, but did not control for sensory charac-
teristics of active stimulation over the scalp. Given that stimu-
lation was delivered at 110% RMT active stimulation, but not
sham, it is likely to have elicited muscle twitches in peripheral
muscles
Adequate blinding of assessors? Low risk Quote: “The patients as well as the person conducting the out-
comemeasurementswere blind to the type of treatment received.
”
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: only 1 participant withdrew for “logistic reasons”.
Unlikely to have strongly influenced the findings
Selective reporting (reporting bias) Low risk Comment: while group means/SD were not presented in the
study report, the study authors provided the requested data
Study Size High risk Comment: < 50 participants per treatment arm
Study duration Unclear risk Comment: ≥ 2 weeks but < 8 weeks’ follow-up
Other bias Unclear risk Comment: baseline differences observed in pain intensity levels
(higher in active group)
Donnell 2015
Methods Parallel RCT
Participants Country of study: USA
Setting: laboratory
Condition: chronic temperomandibular disorder
Prior management details: pain not adequately controlled by previous therapies for more
than 1 year
n = 24
Age range, mean (SD): active group 34.8 (13.7) years, sham group 35.6 (16.7) years
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Duration of symptoms: not reported
Gender distribution: all F
Interventions Stimulation type: HD-tDCS
Stimulation parameters: intensity 2 mA, 4 electrodes arranged at the corners of a 4 x 4
cm square centred over M1
Stimulation location: anode - M1 contralateral to painful side
Number of treatments: daily, x 5
Control type: sham tDCS
Outcomes Primary: pain VAS; anchors not reported - responder analysis only reported
When taken: 1-month follow-up
Secondary: AEs
Notes Sources of funding: this project was funded by grants from the American Academy of
Orofacial Pain and the University of Michigan Rackham Graduate School
Potential undisclosed COI: 1 study author (Biksom) worked for stimulation device
manufacturer Soterix
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote “participants were randomized to the treatment or
placebo group using the Taves covariate adaptive randomization
method.”
Allocation concealment (selection bias) Unclear risk Comment: no mention of allocation concealment procedures
Adequate blinding of participants? Unclear risk Comment: 2 mA intensity. Evidence that blinding can be inad-
equate at intensity of 2 mA
Adequate blinding of assessors? High risk Comment: study described as single blinded
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: no participant dropout
Selective reporting (reporting bias) High risk Comment: pain outcomes not presented for all follow-up time
points
Study Size High risk n = 24
Study duration Unclear risk 1-month follow-up postintervention
Other bias Low risk Comment: no other bias detected
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Fagerlund 2015
Methods Parallel RCT
Participants Country of study: Norway
Setting: university hospital
Condition: fibromyalgia
Prior management details: prescription medication stable for 3months prior to inclusion
n = 50
Age, mean (SD): active group 49/04 (8.63) years, sham group 48.17 (10.56) years
Duration of symptoms, mean (SD) sham group 17.73 (7.54) years, sham group 18.50
(11.48)
Gender distribution: 47 F, 3 M
Interventions Stimulation type: tDCS
Stimulation parameters: intensity 2 mA, 35 cm2 electrodes, duration 20 min
Stimulation location: anode - M1 side not reported, cathode supraorbital contralateral
to anode
Number of treatments: daily, x 5
Control type: sham tDCS
Outcomes Primary: pain VAS, anchors not reported
When taken: postintervention, mean 30 days postintervention
Secondary: FIQ, SF-36, AEs
Notes Sources of funding: study was funded by a grant from the Norwegian Extra Foundation
for Health and Rehabilitation through the Norwegian Fibromyalgia Association
Study authors declared no COI
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “The codes were associatedwith the active or sham tDCS
condition and randomized using the online Web service www.
randomize.org. The ratio of active and sham codes was 1:1.”
Allocation concealment (selection bias) Unclear risk Comment: not clearly stated that the sequence generation was
separated and concealed
Adequate blinding of participants? Unclear risk Comment: evidence that blinding can be inadequate at intensity
of 2 mA. Not formal assessment of blinding success
Adequate blinding of assessors? Low risk Comment: outcomes collected through text message with little
potential for assessors to influence process
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Comment: high noncompletion rate for some outcomes and
there is not full clarity on how many participants were analysed
Selective reporting (reporting bias) Low risk Comment: full reporting of key outcomes
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Fagerlund 2015 (Continued)
Study Size High risk n = 50
Study duration Unclear risk Comment: follow-up 30 days postintervention
Other bias Low risk Comment: no other bias detected
Fenton 2009
Methods Cross-over RCT
Participants Country of study: USA
Setting: unclear
Condition: chronic pelvic pain
Prior management details: refractory to treatment
n = 7
Age: mean 38 years
Duration of symptoms: mean 80 months
Gender distribution: all F
Interventions Stimulation type: tDCS
Stimulation parameters: intensity 1 mA, 35 cm2 electrodes, duration 20 min
Stimulation location: M1 dominant hemisphere
Number of treatments: 2
Control type: sham tDCS (switched off after 30 s stimulation)
Outcomes Primary: VAS overall pain, pelvic pain, back pain, migraine pain, bladder pain, bowel
pain, abdomen pain and pain with intercourse. Anchors not specified
When taken: daily during stimulation and then for 2 weeks post-each condition
Secondary: none
Notes Sources of support: no declaration made
COI: no declaration made
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Comment: method of randomisation not specified but less crit-
ical in cross-over design
Adequate blinding of participants? Low risk Quote: “All other personnel in the study, including the investi-
gators, study coordinators, participants, and their families, and
all primary medical caregivers, were blinded.”
Adequate blinding of assessors? Low risk Quote: “All other personnel in the study, including the investi-
gators, study coordinators, participants, and their families, and
all primary medical caregivers, were blinded.”
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Fenton 2009 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: no dropout reported
Selective reporting (reporting bias) Low risk Comment: variance measures not presented for group means
poststimulation but data provided by study author on request
Free from carry-over effects? Unclear risk Comments: pre-stimulation data not presented and no formal
investigation for carry-over effects discussed
Study Size High risk Comment: < 50 participants per treatment arm
Study duration Unclear risk Comment: < 2 weeks’ follow-up
Other bias Low risk Comment: no significant other bias detected
Fregni 2005
Methods Cross-over RCT
Participants Country of study: USA
Setting: laboratory
Condition: chronic pancreatitis pain
Prior management details: not specified
n = 5
Age: 44 (SD 11)
Duration of symptoms: not specified, “chronic”
Gender distribution: not specified
Interventions Stimulation type: rTMS, figure-of-8 coil
Stimulation parameters: frequency 1 Hz or 20 Hz; coil orientation not specified; 90%
RMT; number of trains not specified; duration of trains not specified; ITI not specified;
total number of pulses 1600
Stimulation location: L and R SII
Number of treatments: 1 for each condition
Control type: sham, “specially designed sham coil”. No further details
Outcomes Primary: pain VAS, anchors not specified
When taken: after each stimulation session
Secondary: none
Notes COI: no declaration made
Sources of support: National Pancreas Foundation/ NIH
Risk of bias
Bias Authors’ judgement Support for judgement
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Fregni 2005 (Continued)
Random sequence generation (selection
bias)
Low risk Quote: “The order of stimulation was randomised and counter-
balanced across patients using a Latin square design.”
Adequate blinding of participants? Unclear risk Comment: sham credibility assessment “unclear”. Type of sham
coil not specified
Adequate blinding of assessors? Low risk Quote: “Patients were blinded to treatment condition, and a
blinded rater evaluated analgesic use, patient’s responses in a
Visual Analogue Scale (VAS) of pain.... immediately after each
session of rTMS.”
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: no dropout reported
Selective reporting (reporting bias) High risk Comment: pain NRS values not provided clearly with measures
of variance for any time point for the sham condition
Free from carry-over effects? Low risk Quote: “Importantly, baseline pain scores were not significantly
different across the six conditions of stimulation... speaking
against carryover effect.”
Study Size High risk Comment: < 50 participants per treatment arm
Study duration High risk Comment: < 2 weeks’ follow-up
Other bias Low risk Comment: no significant other bias detected
Fregni 2006a
Methods Parallel RCT
Participants Country of study: Brazil
Setting: laboratory
Condition: post-SCI central neuropathic pain
Prior management details: refractory to drug management
n = 17
Age: mean 35.7 (SD 13.3) years
Duration of symptoms: chronic > 3/12
Gender distribution: 14 M, 3 F
Interventions Stimulation type: tDCS
Stimulation parameters: intensity 2 mA, 35 cm2 electrodes, duration 20 min
Stimulation location: M1 (contralateral to most painful side or dominant hand)
Number of treatments: 5, x 1 daily on consecutive days
Control type: sham tDCS (switched off after 30 s stimulation)
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Outcomes Primary: pain VAS 0-10 cm, anchors “no pain” to “worst pain possible”
When taken: before and after each stimulation and at 16-day follow-up
Secondary: none
Notes COI: no declaration made
Sources of support: support from Harvard Medical School Scholars in Clinical Science
programme
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Randomization was performed using the order of en-
trance in the study and a previous randomisation list generated
by a computer using random blocks of six (for each six patients,
two were randomised to sham and four to active tDCS) in order
to minimize the risk of unbalanced group sizes.”
Allocation concealment (selection bias) Low risk Comment: the use of a pre-generated randomisation list should
ensure this
Adequate blinding of participants? Unclear risk Comment: there is evidence that participant blinding of tDCS
may be inadequate at 2 mA intensity (see Assessment of risk of
bias in included studies)
Adequate blinding of assessors? Unclear risk Comment: there is evidence that assessor blinding of tDCS may
be inadequate at 2 mA intensity (see Assessment of risk of bias
in included studies)
Incomplete outcome data (attrition bias)
All outcomes
Low risk Quote: “... we analyzed the primary and secondary endpoints
using the intention-to-treat method including patients who re-
ceived at least one dose of the randomised treatment and had
at least one post-baseline efficacy evaluation. We used the last
evaluation carried out to the session before the missed session,
assuming no further improvement after the dropout, for this
calculation.”
Selective reporting (reporting bias) Unclear risk Comment: pain score numerical values not provided clearly in
the study report with measures of variance for any time point.
On request data were available for the primary outcome at one
follow-up point but not for other follow-up points
Study Size High risk Comment: < 50 participants per treatment arm
Study duration Unclear risk Comment: ≥ 2 weeks but < 8 weeks’ follow-up
Other bias Low risk Comment: no significant other bias detected
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Fregni 2006b
Methods Parallel RCT; 3 conditions
Participants Country of study: Brazil
Setting: laboratory
Condition: fibromyalgia
Prior management details: unclear
n = 32
Age: 53.4 (SD 8.9) years
Duration of symptoms: condition 1: 8.4 (SD 9.3) years; condition 2: 10.0 (SD 7.8)
years; condition 3: 8.1 (SD 7.5) years
Gender distribution: 32 F
Interventions Stimulation type: tDCS
Stimulation parameters: intensity 2 mA, 35 cm2 electrodes, duration 20 min
Stimulation location: condition 1: DLPFC; condition 2: M1; condition 3: sham M1.
All conditions contralateral to most painful side or dominant hand
Number of treatments: 5, x 1 daily on consecutive days
Control type: sham tDCS (switched off after 30 s stimulation)
Outcomes Primary: pain VAS 0-10 cm, anchors not specified
When taken: at the end of the stimulation period and at 21-day follow-up
Secondary: QoL: FIQ
Notes COI: no declaration made
Sources of support: support from Harvard Medical School Scholars in Clinical Science
programme/ NIH
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Randomization was performed using the order of
entry into the study and a previous computer-generated
randomisation list, using random blocks of 6 patients (for
each 6 patients, 2 were randomised to each group) in order
to minimize the risk of unbalanced group sizes.”
Allocation concealment (selection bias) Low risk Comment: the use of a pre-generated randomisation list
should have adequately ensured this
Adequate blinding of participants? Unclear risk Comment: there is evidence that participant blinding of
tDCSmay be inadequate at 2mA intensity (see Assessment
of risk of bias in included studies)
Adequate blinding of assessors? Unclear risk Comment: there is evidence that assessor blinding of tDCS
may be inadequate at 2 mA intensity (see Assessment of
risk of bias in included studies)
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Incomplete outcome data (attrition bias)
All outcomes
Low risk Quote: “One patient (in theM1 group) withdrew, and the
fewmissing data were considered to be missing at random.
We analyzed data using the intent-to-treat method and the
conservative last observation carried forward approach.”
Selective reporting (reporting bias) Unclear risk Comment: pain score numerical values not provided
clearly with measures of variance for most time points in
the study report. On request data were available for the
primary outcome at 1 follow-up point but not for other
follow-up points
Study Size High risk Comment: < 50 participants per treatment arm
Study duration Unclear risk Comment: ≥ 2 weeks but < 8 weeks’ follow-up
Other bias Low risk Comment: no significant other bias detected
Fregni 2011
Methods Parallel RCT
Participants Country of study: USA
Setting: laboratory
Condition: chronic visceral pain (chronic pancreatitis)
Prior management details: most on continuous opioid therapy,most had received surgery
for their pain
n = 17, 9 in active group, 8 in sham group
Age mean (SD): active group 41.11 (11.27) years, sham group 46.71 (13.03) years
Duration of symptoms: > 2 years
Gender distribution: 14 F, 3 M
Interventions Stimulation type: rTMS
Stimulation parameters:frequency 1 Hz; coil orientation not specified, number of trains
1; duration of trains not specified; intensity 70% maximum stimulator output, total
number of pulses 1600
Stimulation location: SII
Number of treatments: 10, x 1 daily (weekdays only)
Control type: sham rTMS coil
Outcomes Primary: pain VAS; 0 = no pain, 10 = most intense pain imaginable
When taken: daily pain logs for 3 weeks pre-intervention, daily post-stimulation during
intervention period and at 3-week follow-up
Secondary: none relevant
Notes COI: no declaration made
Sources of support: support from Harvard Thorndike Clinical Research Center/ NIH
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Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Patients were randomised (using a computer generated
list with blocks of 4)”
Allocation concealment (selection bias) Unclear risk Comment: allocation concealment not specified
Adequate blinding of participants? Low risk Quote “The sham and real TMS coils looked identical and were
matched for weight and acoustic artefact. This sham coil induces
a similar tapping sensation and generates the same clicking noise
as the real TMS coil, but without induction of a significant
magnetic field and secondary current.”
Comment: sham appears optimal
Adequate blinding of assessors? Low risk Quote: “The pain evaluation was carried out by a blinded asses-
sor”
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Comment: dropout/withdrawal not reported
Selective reporting (reporting bias) High risk Comment: reporting of pain scores incomplete across all time
points
Study Size High risk Comment: < 50 participants per treatment arm
Study duration Unclear risk Comment: ≥ 2 weeks but < 8 weeks’ follow-up
Other bias Unclear risk Comment: baseline values not presented by group for key out-
come variables
Gabis 2003
Methods Parallel RCT
Participants Country of study: USA
Setting: pain clinic
Condition: chronic back and neck pain
Prior management details: unclear
n = 20
Age: 20-77 years
Duration of symptoms: 0.5-40 years
Gender distribution: 9 M, 11 F
Interventions Stimulation type: CES
Stimulation parameters: frequency 77 Hz; pulse width 3.3 ms; intensity ≤ 4 mA; wave-
form shape biphasic asymmetric; duration 30 min
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Stimulation location: 3 electrodes, 1 attached to either mastoid process and 1 to the
forehead
Number of treatments: 8, x 1 daily on consecutive days
Control type: “active placebo” units visually indistinguishable. Delivered 50 Hz fre-
quency, intensity ≤ 0.75 mA. Note: may not be inert
Outcomes Primary: pain VAS, anchors not specified
When taken: pre and post each stimulation
Secondary: none
Notes COI: no declaration made
Sources of support: grant by Pulse Mazor instruments, Israel
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “The paramedic administered treatments based on a
computer-elicited randomisation list.”
Allocation concealment (selection bias) Low risk Quote: “The paramedic administered treatments based on a
computer-elicited randomisation list. At enrolment in the study,
the investigator assigned the next random number in that pa-
tient’s category. The investigator did not have access to the ran-
domisation list until after the study was completed.”
Adequate blinding of participants? Low risk Quote: “The active placebo device was indistinguishable to the
patient and medical team from the real TCES device - it was
designed to give the patient the feeling of being treated, inducing
an individual sensation of skin numbness ormuscle contraction”
Adequate blinding of assessors? Low risk Quote: “The active placebo device was indistinguishable to the
patient and medical team.”
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: all participants completed the study
Selective reporting (reporting bias) Low risk Comment: while pain score numerical values were not provided
clearly with measures of variance for most time points in the
study report, the study authors have provided the requested data
Study Size High risk Comment: < 50 participants per treatment arm
Study duration High risk Comment: < 2 weeks’ follow-up
Other bias Unclear risk Comment: an active placebo that delivers current may not be
inert and may bias against between group differences (0.75 mA
exceeds the intensity of the active arms of other CES trials)
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Methods Parallel RCT
Participants Country of study: Israel
Setting: pain clinic
Condition: chronic back and neck pain
Prior management details: unclear
n = 75 (excluding headache participants)
Age: mean 53.9 years, range 22-82
Duration of symptoms: 0.5-40 years
Gender distribution: 35 M, 40 F
Interventions Stimulation type: CES
Stimulation parameters: frequency 77 Hz; pulse width 3.3 ms; intensity ≤ 4 mA; wave-
form shape biphasic asymmetric; duration 30 min
Stimulation location: 3 electrodes, 1 attached to either mastoid process and 1 to the
forehead
Number of treatments: 8, x 1 daily on consecutive days
Control type: “active placebo” units visually indistinguishable. Delivered 50 Hz fre-
quency, intensity ≤ 0.75 mA. Note: may not be inert
Outcomes Primary: pain VAS, anchors not specified
When taken: pre and post each stimulation; 3 weeks and 3 months following treatment
Secondary: none
Notes AEs: not reported
COI: no declaration made
Sources of support: no declaration made
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “The paramedic administered treatments based on a
computer-elicited randomisation list”
Allocation concealment (selection bias) Low risk Quote: “The paramedic administered treatments based on a
computer-elicited randomisation list. At enrolment, the inves-
tigator assigned the next random number in that patient’s cate-
gory. The investigator did not have access to the randomisation
list until study completion.”
Adequate blinding of participants? Low risk Quote: “The placebo device was indistinguishable from the ac-
tive device”
Adequate blinding of assessors? Low risk Quote: “The investigator did not have access to the randomisa-
tion list until study completion”
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: no dropout is indicated, comparing the results with
the number enrolled
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Gabis 2009 (Continued)
Selective reporting (reporting bias) Low risk Comment: results for primary outcomes reported clearly and in
full
Study Size High risk Comment: < 50 participants per treatment arm
Study duration Low risk Comment: > 8 weeks’ follow-up
Other bias Unclear risk Comment: an active placebo that delivers current may not be
inert and may bias against between group differences (0.75 mA
exceeds the intensity of the active arms of other CES trials)
Hagenacker 2014
Methods Cross-over RCT
Participants Country of study: Germany
Setting: laboratory
Condition: trigeminal neuralgia
Prior management details: stable medication for 6 months prior to study, no invasive
procedures prior to study
n = 17
Age range: 32-72 years
Duration of symptoms: range 2-27 years, mean 13
Gender distribution: 7 M, 10 F
Interventions Stimulation type: tDCS
Stimulation parameters: intensity 1 mA, 40 cm2 electrodes, duration 20 min
Stimulation location: anode - M1 contralateral to painful side, cathode supraorbital
contralateral to anode
Number of treatments: daily, self-administered for 14 days
Control type: sham tDCS
Outcomes Primary: pain VAS
When taken: postintervention
Secondary: AEs
Notes Study authors’ COI statement: ”Tim Hagenacker has received research support from
Astellas and CSL Behring. Vera Bude, Steffen Naegel have nothing to disclose. Dagny
Holle has received research support from Grünental and Allergan. Mark Obermann has
received scientific support and/or honoraria from Biogen Idec, Novartis, Sanofi-Aventis,
Genzyme, Pfizer, Teva. He received research grants from Allergan, Electrocore, and the
German Ministry for Education and Research (BMBF). Hans-Christoph Diener has
received honoraria for participation in clinical trials, contribution to advisory boards
or lectures from Addex Pharma, Allergan, Almirall, AstraZeneca, Bayer Vital, Berlin
Chemie, CoherexMedical, CoLucid, Böhringer Ingelheim, Bristol-Myers Squibb, Glax-
oSmithKline, Grünenthal, Janssen-Cilag, Lilly, La Roche, 3M Medica, Minster, MSD,
Novartis, Johnson& Johnson, Pierre Fabre, Pfizer, Schaper and Brümmer, SanofiAventis,
and Weber & Weber; received research support from Allergan, Almirall, AstraZeneca,
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Bayer, Galaxo-Smith-Kline, Janssen-Cilag, and Pfizer
Sources of support: “Headache research at the Department of Neurology in Essen is
supported by the German Research Council (DFG), the GermanMinistry of Education
and Research (BMBF), and the European Union.”
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Comment: method of randomisation not reported
Adequate blinding of participants? Unclear risk Comment: method of blinding not clearly stated
Adequate blinding of assessors? Unclear risk Comment: method of blinding not clearly stated
Incomplete outcome data (attrition bias)
All outcomes
High risk Comment: 7/17 participants discontinued trial. Details of when
not clear. Per-protocol analysis
Selective reporting (reporting bias) Low risk Comment: all key outcomes reported
Free from carry-over effects? Unclear risk No formal assessment of baseline equivalence reported
Study Size High risk Comment: n = 17, 10 after attrition
Study duration High risk Comment: only immediate postintervention follow-up
Other bias Low risk Comment: no other bias detected
Hargrove 2012a
Methods Parallel RCT
Participants Country of study: USA
Setting: “professional clinical setting”
Condition: fibromyalgia
Prior management details: no recent remission of symptoms
n = 91
Age: active group 48-54.7 years, sham group 51-57 years
Duration of symptoms: active group mean 17.12 years, sham group mean 17.5 years
Gender distribution: reported for completers only 71 F, 6 M
Interventions Stimulation type: RINCE
Stimulation parameters: current density 0.3 mA/cm2, stimulation duration 11 min,
frequency 10 kHz carrier signal delivered at 40 Hz
Stimulation location: parietal region (international 10/20 site PZ), ground leads fixed to
earlobes
Number of treatments: x 2 weekly for 11 weeks
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Control type: non-activated identical stimulation unit
Outcomes Primary: FIQ pain VAS; 0 = no pain, 10 = unbearable pain
When taken: end of treatment period
Secondary: total FIQ score
Notes Lead author declared an intellectual property interest in the technology and is a share-
holder in a company seeking to develop the technology for commercialisation
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Comment: method of randomisation not specified
Allocation concealment (selection bias) Unclear risk Comment: allocation concealment not reported
Adequate blinding of participants? Low risk Quote: “The combined involvement of low driving potentials
and high carrier frequencies creates a signal that is subthreshold
for perceptibility.....Subjects could not feel the signal regardless
of group, and therefore could not tell if they were receiving
treatment or not”
Adequate blinding of assessors? Low risk Quote: “The investigators were blinded to the settings, and no
element of hardware or software gave any indication as to which
setting had been assigned to the subject.”
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Comment: per-protocol analysis used, dropout rate 6/45 (13%)
in active group and 8/46 (17%) in sham group
Selective reporting (reporting bias) Low risk Comment: data reported on all outcomes and supplementary
data made available by the study author
Study Size High risk Comment: < 50 participants per treatment arm
Study duration High risk Comment: < 2 weeks’ follow-up
Other bias Low risk Comment: no other biases detected
Harvey 2017
Methods Parallel RCT
Participants Country of study: Canada
Setting: laboratory
Condition: mixed chronic pain (in the over 60s)
Prior management details: not reported
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n = 16
Age, mean (SD): active group 72 (6) years, sham group 71 (8) years
Duration of symptoms mean (SD) years: active group 26 (24), sham group 15 (11)
Gender distribution: 11 F, 3 M
Interventions Stimulation type: tDCS
Stimulation parameters:
tDCS: 2 mA intensity, 20 min
Stimulation location: M1 contralateral to painful side
Number of treatments: x 1 daily for 5 days
Control type: sham tDCS
Outcomes Primary: pain NRS anchors 0 = no pain 10 = worst imaginable pain
When taken: postintervention
Secondary: none relevant
AEs not reported
Notes Funding source: G Léonard is supported by the Fonds de Recherche en Santé (FRQ-S,
Montréal,QC,Canada). This projectwas partially supported by theNeuroscienceCentre
of Excellence of the Université de Sherbrooke (CeNUS, Sherbrooke, QC, Canada) and
an internal start-up fund from the Research Centre on Aging (Initiatives stratégiques du
Centre de recherche sur le vieillissement, Sherbrooke, QC, Canada)
COI: study authors report no COI
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Randomization to sham or active tDCS was performed
using a random numbers table with a ratio of 1:1, based on order
of entry of the participants in the study.”
Allocation concealment (selection bias) Unclear risk Comment: allocation concealment not reported
Adequate blinding of participants? Unclear risk Comment: blinding can be compromised at 2 mA intensity. No
formal blinding assessment reported
Adequate blinding of assessors? Unclear risk Comment: blinding can be compromised at 2 mA intensity. No
formal blinding assessment reported
Incomplete outcome data (attrition bias)
All outcomes
High risk Comment: 2/8 (25%) in active group withdrew. Data appear to
have been excluded from analysis
Selective reporting (reporting bias) Low risk Comment: outcomes reported adequately
Study Size High risk Comment: n = 14
Study duration High risk Comment: 1 week postintervention follow-up
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Other bias High risk Comment: baseline imbalance in average daily pain
Hazime 2017
Methods Parallel RCT
Participants Country of study: Brazil
Setting: laboratory
Condition: chronic low back pain
Prior management details: not reported
n = 92, relevant to this review 46
Age, mean (SD): active group 51.9 (9.9) years, sham group 54.1 (9.8) years
Duration of symptoms mean (SD) months: active group 91.6 (108.3) sham group 69.2
(92.7) months
Gender distribution: 10 M, 36 F
Interventions Stimulation type: tDCS
Stimulation parameters:
tDCS: 2 mA intensity, 20 min
Stimulation location: M1 contralateral to painful side
Number of treatments: x 3 per week for 4 weeks. 12 sessions in total
Control type: sham tDCS
Outcomes Primary: pain NRS anchors 0 = no pain 10 = worst pain possible
When taken: postintervention, 3 months, 6 months
Secondary: disability (RMDQ)
AEs
Notes Funding source: none
COI: study authors declared no COI
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “The patients were allocated to one of the four treatment
groups by means of random-number-generating software.”
Allocation concealment (selection bias) Low risk Quote: “The randomization and allocation concealment were
carried out by an external collaborator, not a research participant,
who organized patients and their previously allocated treatments
in individual opaque envelopes.”
Adequate blinding of participants? Unclear risk Comment: evidence that blinding can be inadequate at intensity
of 2 mA. No formal assessment of blinding success
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Adequate blinding of assessors? Unclear risk Comment: evidence that blinding can be inadequate at intensity
of 2mA. No assessment of blinding success. No formal assess-
ment of blinding success
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: minimal loss to follow-up
Selective reporting (reporting bias) Low risk Comment: outcomes reported adequately
Study Size High risk Comment: n = 46
Study duration Low risk Comment: 6-month follow-up
Other bias Low risk Comment: no other bias detected
Hirayama 2006
Methods Cross-over RCT; 5 conditions
Participants Country of study: Japan
Setting: laboratory
Condition: intractable deafferentation pain (mixed central, peripheral and facial)
Prior management details: intractable
n = 20
Age: 28-72 years
Duration of symptoms: 1.5-24.3 years, mean 6.4 (SD 6)
Gender distribution: 13 M, 7 F
Interventions Stimulation type: rTMS, figure-of-8 coil
Stimulation parameters: frequency 5 Hz; coil orientation not specified; 90% RMT;
number of trains 10; duration of trains 10 s; ITI 50 s; total number of pulses 500
Stimulation location: condition 1: M1; condition 2: primary sensory cortex; condition
3: pre-motor area; condition 4: supplementary motor area; condition 5: sham
Number of treatments: 1 for each condition
Control type: coil angled 45º from scalp with synchronised electrical scalp stimulations
to mask sensation
Outcomes Primary: pain intensity VAS, anchors not specified
When taken: 0, 30, 60, 90, 180 min poststimulation
Secondary: none
Notes COI: no declaration made
Sources of support: no declaration made
Risk of bias
Bias Authors’ judgement Support for judgement
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Random sequence generation (selection
bias)
Low risk Quote: “All targets were stimulated in random order”
Comment: method of randomisation not specified but
less critical in cross-over design
Adequate blinding of participants? Unclear risk Quote: “The patients were unable to distinguish sham
stimulation from actual rTMS, because the synchro-
nized electrical stimulation applied to the forehead
made the forehead spasm, as was the case with actual
TMS”
Comment: sham credibility assessment - suboptimal.
Sensory and auditory aspects controlled for but angu-
lation of coil away from the scalp may be visually dis-
tinguishable
Adequate blinding of assessors? Unclear risk Comment: blinding of assessors not reported
Incomplete outcome data (attrition bias)
All outcomes
Low risk Quote: “All 20 patients underwent all planned sessions
of navigation- guided rTMS”
Selective reporting (reporting bias) Low risk Comment: pain score numerical values not provided
clearly with measures of variance for any time point but
data provided upon request
Free from carry-over effects? Low risk Comment: study authors provided requested data. Ap-
pears free of carry-over effects
Study Size High risk Comment: < 50 participants per treatment arm
Study duration High risk Comment: < 2 weeks’ follow-up
Other bias Low risk Comment: no significant other bias detected
Hosomi 2013
Methods Cross-over RCT
Participants Country of study: Japan
Setting: multicentre, laboratory-based
Condition: mixed neuropathic pain
Prior management details: pain persisted despite “adequate treatments”
n = 70 of whom 64 analysed
Age mean (SD): 60.7 (10.6) years
Duration of symptoms: 58.2 (10.6) months
Gender distribution: 40 M, 24 F
Interventions Stimulation type: rTMS
Stimulation parameters: frequency 5 Hz; coil orientation parasagittal, number of trains
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10; duration of trains 10 s; ITI 50 s, intensity 90% RMT, total number of pulses per
session 500
Stimulation location: M1 corresponding to painful region
Number of treatments: 10, x 1 daily (consecutive working days)
Control type: sham coil
Outcomes Current daily pain 0-100 VAS (anchors not reported), SF McGill
AEs
Notes COI: study authors declared no COI
Sources of support: “funded by the Japanese Ministry of Health, Labour and Welfare
with a Health and Labour Sciences Research Grant. This research was partly supported
by Japanese MEXT SRPBS”
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Before the patient enrolment, the independent data
center developed a randomization program to assign each pa-
tient to one of 2 treatment groups (1:1). A real rTMS period
was followed by a sham period in group A, and a real rTMS
period came after a sham period in group B. We used Pocock
and Simon’s minimization method to stratify treatment groups
according to institution, age (< 60 or P60 years), sex, and under-
lying disease (a cerebral lesion or not), and the Mersenne twister
for random number generation.”
Allocation concealment (selection bias) Low risk Quote: “After confirmation of patient eligibility, the data center
received a registration form from an assessor who collected ques-
tionnaires and assessed adverse events, and then sent an assign-
ment notice to an investigator who conducted the rTMS inter-
vention. Patientswere identified by sequential numbers thatwere
assigned by the data center. Patients and assessors were blind to
group assignment until the study was completed. The data cen-
ter was responsible for assigning patients to a treatment group,
data management, central monitoring, and statistical analyses.”
Adequate blinding of participants? Low risk Quote: “Realistic sham stimulation [32] was implemented in
this study. Ten trains of electrical stimuli at 2 times the intensity
of the sensory threshold (one train, 50 stimuli at 5 Hz; inter
train interval, 50 s) were delivered with a conventional electrical
stimulator through the electrodes fixed on the head. The cortical
effect of the cutaneous electrical stimulationwas considered to be
negligible at this intensity because of the high electrical resistance
of the skull and brief duration of the stimulation [32]. A figure-8
coil, which did not connect to a magnetic stimulator, was placed
on the head in the same manner as a real rTMS session. Another
coil, which discharged simultaneously with the electrical stimuli,
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was placed near the unconnected coil to produce the same sound
as real rTMS, but not to stimulate the brain.”
Comment: sham controls for sensory auditory and visual cues
Adequate blinding of assessors? Low risk Quote: “Patients and assessors were blind to group assignment
until the study was completed.”
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: dropout low (total 6 from recruited 70 participants)
Quote: “Seventy patients were enrolled and randomly assigned
to 2 groups. Of these patients, one patient never came to the
hospital after the registration, and a suicidal wish became ap-
parent before the start of the intervention in another patient.
Sixty-eight patients received the interventions and 64 patients
were included in the intention-to-treat analysis after excluding
4 patients without any data collection.”
Selective reporting (reporting bias) Low risk Comment: while full numerical means and SDs were not re-
ported for all time points all data were made available upon re-
quest to the study authors
Free from carry-over effects? Low risk Quote: “To evaluate carry-over effects, Grizzle’s test for carry-
over effect was applied to the values at day 0 for each period ...
Grizzle’s test showed no carry-over effects in VAS and SF-MPQ”
Study Size Unclear risk Comment: > 50 but < 200 participants per treatment condition
Study duration Unclear risk Comment: ≥ 2 weeks but < 8 weeks’ follow-up
Other bias Low risk Comment: no other bias detected
Irlbacher 2006
Methods Cross-over RCT; 3 conditions
Participants Country of study: Germany
Setting: laboratory
Condition: PLP and CNP
Prior management details: unclear
n = 27
Age: (median) PLP 46.6 years, CNP 51.1 years
Duration of symptoms: mean PLP 15.2 (SD 14.8), CNP 3.9 (SD 4.1) years
Gender distribution: 16 M, 11 F
Interventions Stimulation type: rTMS, figure-of-8 coil
Stimulation parameters:
Condition 1: frequency 1 Hz; coil orientation not specified; 95% RMT; number of
trains not specified; duration of trains not specified; ITI not specified; total number of
pulses 500
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Condition 2: frequency 5 Hz; coil orientation not specified; 95% RMT; number of
trains not specified; duration of trains not specified; ITI not specified; total number of
pulses 500
Condition 3: sham frequency 2 Hz; coil orientation not specified; number of trains not
specified; duration of trains not specified; ITI not specified; total number of pulses 500
Stimulation location: M1, contralateral to painful side
Number of treatments: x 1 for each condition
Control type: sham coil; mimics sight and sound of active treatment
Outcomes Primary: 0-100 mm VAS pain intensity, anchors “no pain” and “most intense pain
imaginable”
When taken: pre- and post-stimulation
Secondary: none
Notes Sources of support: no reporting of source of support
COI: study authors decare no COI
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Comment: method of randomisation not specified but
less critical in cross-over design
Adequate blinding of participants? Unclear risk Sham credibility assessment - suboptimal. Sham coil
controlled for auditory cues and was visually indistin-
guishable from active stimulation but did not control
for sensory characteristics of active stimulation
Adequate blinding of assessors? Unclear risk Comment: blinding of assessors not reported
Incomplete outcome data (attrition bias)
All outcomes
High risk Comment: 13 of 27 participants did not complete all
treatment conditions and this dropout is not clearly
accounted for in the analysis
Selective reporting (reporting bias) Low risk Comment: primary outcomedata presented clearly and
in full
Free from carry-over effects? Low risk Quote: “The VAS values before the stimulation showed
no significant differences in the various types of treat-
ment”
Study Size High risk Comment: < 50 participants per treatment arm
Study duration High risk Comment: < 2 weeks’ follow-up
Other bias Low risk Comment: no significant other bias detected
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Jales Junior 2015
Methods Parallel RCT
Participants Country of study: Brazil
Setting: laboratory
Condition: fibromyalgia
Prior management details: continued using pharmacological and nonpharmacological
therapies
n = 20
Age mean (SD): 46.4 (10.62) years
Duration of symptoms: not reported
Gender distribution: all F
Interventions Stimulation type: tDCS
Stimulation parameters: intensity 1 mA, 15 cm2 electrodes, duration 20 min
Stimulation location: anode - M1 L, cathode right supraorbital
Number of treatments: x 1 per week for 10 weeks
Control type: sham tDCS
Outcomes Primary: pain VAS; anchors not reported
When taken: postintervention
Secondary: FIQ, SF-36
Notes No reporting of sources of support or COI
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Comment: method of randomisation not reported
Allocation concealment (selection bias) Unclear risk Comment: no reporting of concealment procedures
Adequate blinding of participants? Low risk Quote “Patients, as well as investigator in charge and evaluators,
were blind to the nature of applied stimulation”
Comment: blinding likely at 1 mA intensity
Adequate blinding of assessors? Low risk Quote “Patients, as well as investigator in charge and evaluators,
were blind to the nature of applied stimulation”
Comment: blinding likely at 1 mA intensity
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Comment: attrition not reported
Selective reporting (reporting bias) Low risk Comment: results reported adequately
Study Size High risk Comment: n = 20
Study duration High risk Comment: postintervention follow-up only
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Jales Junior 2015 (Continued)
Other bias Unclear risk Comment: no reporting of baseline comparability
Jensen 2013
Methods Cross-over RCT
Participants Country of study: USA
Setting: laboratory
Condition: post-SCI pain (neuropathic and non-neuropathic)
Prior management details: not reported
n = 31 randomised
Age: 22-77 years
Duration of symptoms (months): > 6 months
Gender distribution: 22 M, 8 F
Interventions Stimulation type: tDCS
Stimulation parameters: intensity 2 mA, 35 cm2 electrodes, duration 20 min
Stimulation location: M1 contralateral to painful side or on L where pain bilateral
Number of treatments: 1
Control type: sham tDCS (switched off after 30 s stimulation)
Outcomes Primary: 0-10 NRS; 0 = no pain, 10 = most intense pain sensation imaginable. An
average of current, least, worst and average pain scores
When taken: poststimulation
Secondary: none relevant
Notes AEs not reported
Government-funded
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote “The remaining 31 individuals were randomly assigned
to receive the five procedure conditions in one of five orders,
using a Latin square design.”
Adequate blinding of participants? Unclear risk Comment: there is evidence that participant blinding of tDCS
may be inadequate at 2 mA intensity (see Assessment of risk of
bias in included studies)
Adequate blinding of assessors? Unclear risk Comment: there is evidence that assessor blinding of tDCS may
be inadequate at 2 mA intensity (see Assessment of risk of bias
in included studies)
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: of 31 randomised there were data from 28 following
active tDCS and 27 following sham
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Jensen 2013 (Continued)
Selective reporting (reporting bias) Low risk Comment: outcomes adequately reported
Free from carry-over effects? Low risk Comment: baseline pain levels pre active and sham tDCS session
appear equivalent
Study Size High risk Comment: < 50 participants per treatment arm
Study duration High risk Comment: < 2 weeks’ follow-up
Other bias Low risk Comment: no other bias detected
Jetté 2013
Methods Cross-over RCT
Participants Country of study: Canada
Setting: outpatient rehabilitation centre
Condition: post-SCI neuropathic pain
Prior management details: almost all participants in various medications
n = 18
Age: range 31-69 years, mean (SD) 50 (9)
Duration of symptoms: not reported
Gender distribution: 11 M, 5 F
Interventions Stimulation type: rTMS
Stimulation parameters: frequency 10Hz; coil orientation 45º posterolateral, 90% RMT
for hand, 110% RMTA for leg, number of trains 40; duration of trains 5 s; ITI 25 s;
total number of pulses 2000
Stimulation location: M1 hand or leg area with neuronavigation
Number of treatments: single session per condition, 1 session of sham
Control type: sham coil - same sound and appearance and sensation
Outcomes Primary: pain NRS anchors 0 = no pain, 10 = worst possible pain
When taken: immediately poststimulation, 20 min poststimulation
Secondary: AEs - though no formal assessment reported
Notes Funding source: supported by theCanadian Institutes ofHealthResearch (CIHR),Grant
Number MOP-79370. C. Mercier was supported by salary awards from the CIHR and
the Fonds de recherche du Québec, Santé (FRQS). F. Jetté was supported by a fellowship
from Université Laval and H. B. Meziane by a fellowship from the Réseau Provincial de
Recherche en Adaptation-Réadaptation (REPAR-FRQS). Support was provided by the
Consortium d’Imagerie en Neuroscience et Santé Mentale de Québec (CINQ) for MRI
acquisition
COI: the study authors declared no potential COI
Risk of bias
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Jetté 2013 (Continued)
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote “2 active rTMS sessions (hand/leg M1 area) and 1 sham
rTMS session in a randomized, counterbalanced order.”
Comment: method of randomisation not described
Adequate blinding of participants? Low risk Quote “Sham rTMS, using a sham coil (mimicking the noise
and scalp sensations), was applied over the hand area using the
same parameters
Adequate blinding of assessors? Low risk Quote “The researcher running the pre-post assessment (as well
as data analysis) was blind relative to the applied rTMS protocol
(as was the participant), with the rTMS application being per-
formed by a different researcher
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: dropout levels low - 2 in total
Selective reporting (reporting bias) Low risk Comment: data provided upon author request
Free from carry-over effects? Unclear risk Comment: 2-week washout period observed but no analysis or
data presented to confirm baseline comparability
Study Size High risk Comment: n = 16
Study duration High risk Comment: immediate poststimulation measurement only
Other bias Low risk Comment: no other bias detected
Kang 2009
Methods Cross-over RCT
Participants Country of study: South Korea
Setting: university hospital outpatient setting
Condition: post-SCI central neuropathic pain
Prior management details: resistant to drug, physical or complementary therapies
n = 11
Age: 33-75 years, mean 54.8
Duration of symptoms: chronic
Gender distribution: 6 M, 5 F
Interventions Stimulation type: rTMS
Stimulation parameters: frequency 10 Hz; coil orientation angled 45º posterolaterally;
80% RMT; number of trains 20; duration of trains 5 s; ITI 55 s; total number pulses
1000
Stimulation location: R M1, hand area
Number of treatments: 5, x 1 daily
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Kang 2009 (Continued)
Control type: coil elevated and angled away from the scalp
Outcomes Primary: NRS average pain over last 24 h, anchors “no pain sensation” to “most intense
pain sensation imaginable”
When taken: immediately after the 3rd and 5th treatments and 1, 3, 5 and 7 weeks after
the end of the stimulation period
Secondary: BPI - pain interference (surrogate measure of disability)
When taken: as for the NRS
Notes AEs: not reported
COI: studu authors declared no COI
Sources of support: supported by the Seoul National University Bundang Hospital
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “The real and sham rTMS stimulations were separated
by 12 weeks and performed in a random order according to the
prepared allocation code.”
Comment: method of randomisation not specified but less crit-
ical in cross-over design
Adequate blinding of participants? Unclear risk Comments: sham credibility assessment - suboptimal. Coil an-
gled away from scalp and not in contact in sham condition.
Didnot control for sensory characteristics of active stimulation
and was visually distinguishable
Adequate blinding of assessors? Low risk Quote: “... a different researcher collected the clinical data; the
latter researcher was not aware of the type of rTMS (real or
sham)”
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: no participants withdrew after receiving the first
treatment condition
Selective reporting (reporting bias) Low risk Comment: results for primary outcomes reported clearly and in
full
Free from carry-over effects? Low risk Comment: a 12-week washout period was observed. The pre-
stimulation baseline scores closely match
Study Size High risk Comment: < 50 participants per treatment arm
Study duration Unclear risk Comment: ≥ 2 weeks but < 8 weeks’ follow-up
Other bias Low risk Comment: no significant other bias detected
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Katsnelson 2004
Methods Parallel RCT; 3 conditions
Participants Country of study: Russia
Setting: unclear
Condition: hip and knee OA
Prior management details: unclear
n = 64
Age: unclear
Duration of symptoms: unclear
Gender distribution: unclear
Interventions Stimulation type: CES
Stimulation parameters: frequency not specified; pulse width not specified; intensity 11-
15 mA; waveform shape: condition 1 symmetric, condition 2 asymmetric; duration 40
min
Stimulation location: appears to be 1 electrode attached to either mastoid process and 1
to the forehead
Number of treatments: 5, x 1 daily for 5 consecutive
Control type: sham unit - visually indistinguishable from active units
Outcomes Primary: 0-10 NRS, anchors “no pain” to “very painful”
When taken: unclear. Likely to be pre and post each stimulation session and then daily
for 1 week after
Secondary: none
Notes AEs: not reported
COI: no declaration made
Sources of support: no declaration made
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “If subjects passed all criteria they were randomly
assigned to one of the two active treatments or the sham
treatment.”
Comment: method of randomisation not specified
Allocation concealment (selection bias) Unclear risk Comment: not specified
Adequate blinding of participants? Low risk Quote: “The physicians, like all other participants in the
study, were unaware of which treatment each subject re-
ceived.”
Adequate blinding of assessors? Low risk Quote: “The physicians, like all other participants in the
study, were unaware of which treatment each subject re-
ceived.”
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Katsnelson 2004 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Comment: dropout level not specified
Selective reporting (reporting bias) High risk Comment: it is unclear in the report which time points
were reported for primary outcomes
Study Size High risk Comment: < 50 participants per treatment arm
Study duration High risk Comment: < 2 weeks’ follow-up
Other bias Unclear risk Comment: the reporting of baseline group characteristics
is insufficient
Khedr 2005
Methods Parallel RCT
Participants Country of study: Egypt
Setting: university hospital neurology department
Condition: neuropathic pain,mixed central (poststroke) and facial (trigeminal neuralgia)
pain
Prior management details: refractory to drug management
n = 48
Age: poststroke 52.3 (SD 10.3) years, trigeminal neuralgia 51.5 (SD 10.7) years
Duration of symptoms: poststroke 39 months (SD 31), trigeminal neuralgia 18 months
(SD 17)
Gender distribution: 8 M, 16 F
Interventions Stimulation type: rTMS
Stimulation parameters: frequency 20 Hz; coil orientation not specified; 80% RMT;
number of trains 10; duration of trains 10 s; ITI 50 s; total number of pulses 2000
Stimulation location: M1 contralateral to the side of worst pain
Number of treatments: 5, x 1 on consecutive days
Control type: coil elevated and angled away from scalp
Outcomes Primary: pain VAS, anchors not specified
When taken: post 1st, 4th and 5th stimulation session and 15 days after the last session
Secondary: none
Notes AEs: not reported
COI: study authors declared no COI
Sources of support: no declaration made
Risk of bias
Bias Authors’ judgement Support for judgement
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Khedr 2005 (Continued)
Random sequence generation (selection
bias)
High risk Quote: “Patients were randomly assigned to one of the two
groups, depending on the day of the week on which they were
recruited.”
Comment: not truly random
Allocation concealment (selection bias) High risk Comment: the method of sequence generation makes conceal-
ment of allocation unlikely
Adequate blinding of participants? Unclear risk Comments: sham credibility assessment - suboptimal. Coil an-
gled away from scalp and not in contact in sham condition. Did
not control for sensory characteristics of active stimulation and
was visually distinguishable
Adequate blinding of assessors? Low risk Quote: “The second author evaluated these measures blindly-
that is, without knowing the type of rTMS”
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: no dropout apparent from the data presented
Selective reporting (reporting bias) Low risk Comment: while pain score numerical values were not provided
clearly with measures of variance for all time points in the study
report, the study authors have provided the requested data
Study Size High risk Comment: < 50 participants per treatment arm
Study duration Unclear risk Comment: ≥ 2 weeks but < 8 weeks’ follow-up
Other bias Low risk Comment: no significant other bias detected
Khedr 2017
Methods Parallel RCT
Participants Country of study: Egypt
Setting: laboratory
Condition: fibromyalgia
Prior management details: not reported
n = 40, 36 after attrition
Age, mean (SD): active group 31.3 (10.99) years, sham group 33.89 (11.18) years
Duration of symptoms, mean (SD) months, active group 6.1 (2.65), sham group 6.05
(2.5)
Gender distribution: 34 F, 2 M
Interventions Stimulation type: tDCS
Stimulation parameters:
tDCS: 2 mA intensity, 20 min
Stimulation location: L M1
Number of treatments: x 1 daily for 5 days per week for 2 weeks - 10 sessions in total
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Khedr 2017 (Continued)
Control type: sham tDCS
Outcomes Primary: pain VAS anchors not reported
When taken: postintervention, 2 weeks and 1 month postintervention
Secondary: none relevant
AEs
Notes Funding source: no funding reported
COI: study authors declared no COI
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Each patient was given a serial number from a computer
generated randomization table, and was placed in the appropri-
ate group after opening the corresponding sealed envelope.”
Allocation concealment (selection bias) Low risk Quote: “Allocation concealment was done using serially num-
bered closed, opaque envelopes.”
Adequate blinding of participants? Unclear risk Comment: evidence that blinding can be inadequate at intensity
of 2 mA. No formal assessment of blinding success
Adequate blinding of assessors? Unclear risk Comment: evidence that blinding can be inadequate at intensity
of 2 mA. No formal assessment of blinding success
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: 10% dropout per group
Selective reporting (reporting bias) Low risk Comment: outcomes reported adequately
Study Size High risk Comment: n = 20 per group
Study duration Unclear risk Comment: 1 month postintervention follow-up
Other bias Low risk Comment: no other bias detected
Kim 2013
Methods Parallel RCT
Participants Country of study: South Korea
Setting: laboratory
Condition: chronic painful diabetic polyneuropathy
Prior management details: persistent pain after taking medications. Stable doses of anal-
gesics for 2 months prior to commencement
n = 72, 60 after dropout, outcome data only given on this 60
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Kim 2013 (Continued)
Age, mean (SD): active M1 group 59.60 (13.15) years, active DLPFC group 63.5 (8.
75) years, sham group 61.6 (10.27) years
Duration of symptoms: all participants had had pain for > 2 years
Gender distribution: 25 M, 35 F (after dropout)
Interventions Stimulation type: tDCS
Stimulation parameters: intensity 2 mA, 25-35 cm2 electrodes, duration 20 min
Stimulation location: group 1: anode - M1, side not specified, group 2 anode DLPFC
side not specified, group 3 M1 sham, cathode contralateral supraorbital
Number of treatments: daily, x 5
Control type: sham tDCS
Outcomes Primary: pain VAS; 0 = no pain, 10 = “worst possible pain”
When taken: end of intervention, 2 weeks, 4 weeks
Secondary: AEs
Notes Funding: supported by Eulji University
COI: study authors declared no potential COI
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Randomization was performed using the order of entry
into the study and a computer-generated randomization chart
with random blocks of six patients each.”
Allocation concealment (selection bias) Unclear risk Comment: allocation concealment procedure not described
Adequate blinding of participants? Unclear risk Comment: blinding can be compromised at intensities of 2 mA,
no formal assessment of blinding success
Adequate blinding of assessors? Unclear risk Comment: blinding can be compromised at intensities of 2 mA,
no formal assessment of blinding success
Incomplete outcome data (attrition bias)
All outcomes
High risk Comment: 15% dropout, even across groups, analysis appears
to be per-protocol
Selective reporting (reporting bias) High risk Comment: point estimates andmeasures of variance for primary
outcome only reported at selected time points
Study Size High risk Comment: n = 72, 3 groups
Study duration Unclear risk Comment: 4-week follow-up
Other bias Low risk Comment: no other bias detected
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Lagueux 2017
Methods Parallel RCT
Participants Country of study: Canada
Setting: laboratory
Condition: CRPS type I
Prior management details: not reported
n = 22
Age, mean (SD): active group 40.9 (8.8) years, sham group 52.7 (10.5) years
Duration of symptoms, mean (SD) months: active group 36.3 (25.6), sham group 36.6
(25.8)
Gender distribution: 14 F, 8 M
Interventions Stimulation type: tDCS (combined with graded motor imagery)
Stimulation parameters:
tDCS: 2 mA intensity, 20 min
Stimulation location: M1 contralateral to painful side
Number of treatments: x 5 weekly for 2 weeks, x 1 weekly for 4 weeks - 14 sessions in
total over 6 weeks
Control type: sham tDCS (combined with grade motor imagery)
Outcomes Primary: average pain NRS anchors 0 = no pain, 10 = worst possible pain
When taken: 1 month post intervention
Secondary: physical function (BPI pain interference), QoL (SF36-SF)
AEs
Notes Funding source: this study was supported by grants from the Canadian Pain Society
(CPS), the Quebec Pain Research Network (QPRN), as well as the Inflammation and
Pain Axis and the Faculty of Medicine and Health Sciences from the Université de
Sherbrooke
COI: the study authors declared no COI
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Comment: precise method for randomisation not reported
Allocation concealment (selection bias) Low risk Quote: “order to avoid a potential concealment bias, the ran-
domization sequence was concealed from the investigators,
where only an independent research agent held the allocation
list.”
Adequate blinding of participants? Low risk Comment: 2 mA can affect blinding negatively but formal as-
sessment of participant blinding suggests success
Adequate blinding of assessors? Unclear risk Comment: evidence that assessor blinding can be inadequate at
intensity of 2 mA
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Lagueux 2017 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: no loss to follow-up
Selective reporting (reporting bias) Low risk Comment: results reported adequately
Study Size High risk Comment: n = 22
Study duration Unclear risk Comment: 1 month postinterventionfollow-up
Other bias Low risk Comment: no other bias detected
Lee 2012
Methods Parallel RCT
Participants Country of study: Korea
Setting: outpatient clinic
Condition: fibromyalgia
Prior management details: none reported
n = 22
Age mean (SD): low-frequency group 45.6 (9.6) years, high-frequency group 53 (4.2)
years, sham group 51.3 (6.2) years
Duration of symptoms (months mean (SD)): low-frequency group: 47.2 (20.1), high-
frequency group 57.1 (6.4), sham group 44.7 (10.3)
Gender distribution: all F
Interventions Stimulation type: rTMS
Stimulation parameters:
Low-frequency group: frequency 1 Hz; coil orientation not specified, number of trains
2; duration of trains 800 s; ITI 60 s; total number of pulses 1600
High-frequency group: frequency 10 Hz; coil orientation not specified, number of trains
25; duration of trains 8 s; ITI 10 s; total number of pulses 2000
Stimulation location: right DLPFC (low-frequency), L M1 (high-frequency)
Number of treatments: 10, x 1 daily (weekdays only) for 2 weeks
Control type: sham - coil orientated away from scalp
Outcomes Primary: 0-100 mm pain VAS; 0 = none, 100 = an extreme amount of pain
When taken: post-treatment and at 1 month follow-up
Secondary: FIQ
Notes Comment: no information on AEs given relating to those participants who did not
complete all sessions
COI: study authors declared no COI
Sources of support: no declaration made
Risk of bias
Bias Authors’ judgement Support for judgement
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Lee 2012 (Continued)
Random sequence generation (selection
bias)
Unclear risk Comment: method of randomisation not specified
Allocation concealment (selection bias) Unclear risk Comment: allocation concealment not specified
Adequate blinding of participants? Unclear risk Comment: sham credibility assessment - suboptimal. Coil an-
gled away from scalp. Did not control for sensory characteristics
of active stimulation and was visually distinguishable
Adequate blinding of assessors? Unclear risk Comment: blinding of assessors not specified
Incomplete outcome data (attrition bias)
All outcomes
High risk Comment: no ITT analysis described - appears to be per pro-
tocol. 3/8 in low-frequency group, 2/5 in high-frequency group
and 2/5 in sham group
Selective reporting (reporting bias) Low risk Comment: point measures presented in full for all outcomes
Study Size High risk Comment: < 50 participants per treatment arm
Study duration Unclear risk Comment: ≥ 2 weeks but < 8 weeks’ follow-up
Other bias Low risk Comment: no other biases detected
Lefaucheur 2001a
Methods Cross-over RCT
Participants Country of study: France
Setting: laboratory
Condition: intractable neuropathic pain (mixed central and facial)
Prior management details: refractory to drug management
n = 14
Age: 34-80 years, mean 57.2
Duration of symptoms: not specified “chronic”
Gender distribution: 6 M, 8 F
Interventions Stimulation type: rTMS, figure-of-8 coil
Stimulation parameters: frequency 10 Hz; coil orientation not specified; 80% RMT;
number of trains 20; duration of trains 5 s; ITI 55 s; total number of pulses 1000
Stimulation location: M1, contralateral to painful side
Number of treatments: x 1 for each condition
Control type: sham coil used (? inert)
Outcomes Primary: 0-10 VAS, anchors not specified
When taken: daily for 12 days poststimulation
Secondary: none
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Lefaucheur 2001a (Continued)
Notes COI: no declaration made
Sources of support: grant from the ‘Institut UPSA de la douleur’
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Two different sessions of rTMS separated by 3 weeks
at least were randomly performed in each patient.”
Comment: method of randomisation not specified but less crit-
ical in cross-over design
Adequate blinding of participants? Unclear risk Comments: sham credibility assessment - suboptimal. This
study used the same sham coil as that used in Lefaucheur 2004,
which in that paper was stated as not meeting the criteria for an
ideal sham
Adequate blinding of assessors? Unclear risk Comment: blinding of assessors not reported
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: no dropout apparent from the data presented
Selective reporting (reporting bias) Low risk Comment: pain score numerical values not provided clearly with
measures of variance for any time point in the report but were
provided by study authors on request
Free from carry-over effects? Low risk Comment: 3/52 washout period makes carry-over effects un-
likely
Study Size High risk Comment: < 50 participants per treatment arm
Study duration High risk Comment: < 2 weeks’ follow-up
Other bias Low risk Comment: no significant other bias detected
Lefaucheur 2001b
Methods Cross-over RCT
Participants Country of study: France
Setting: laboratory
Condition: neuropathic pain (mixed central and peripheral)
Prior management details: refractory to drug management
n = 18
Age: 28-75 years, mean 54.7
Duration of symptoms: not specified “chronic”
Gender distribution: 11 M, 7 F
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Lefaucheur 2001b (Continued)
Interventions Stimulation type: rTMS, figure-of-8 coil
Stimulation parameters:
Condition 1: frequency 10 Hz; coil orientation posteroanterior; 80% RMT; number of
trains 20; duration of trains 5 s; ITI 55 s; total number of pulses 1000
Condition 2: frequency 0.5 Hz; coil orientation posteroanterior; number of trains 1;
duration of trains 20 min; total number of pulses 600
Condition 3: sham - same as for condition 1 with sham coil
Stimulation location: M1 contralateral to painful side
Number of treatments: x 1 for each condition
Outcomes Primary: 0-10 VAS pain, anchors not specified
When taken: 5-10 min poststimulation
Secondary: none
Notes COI: no declaration made
Sources of support: grant from the ‘Institut UPSA de la douleur’
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “To study the influence of the frequency of stimulation,
three different sessions of rTMS separated by three weeks at least
were randomly performed in each patient”
Comment: method of randomisation not specified but less crit-
ical in cross-over design
Adequate blinding of participants? Unclear risk Comments: sham credibility assessment - suboptimal. This
study used the same sham coil as that used in Lefaucheur 2004,
which in that paper was stated as not meeting the criteria for an
ideal sham
Adequate blinding of assessors? Unclear risk Comment: blinding of assessors not reported
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: no dropout apparent from the data presented
Selective reporting (reporting bias) Low risk Comment: results for primary outcomes reported clearly and in
full
Free from carry-over effects? Low risk Comment: 3-week washout observed and no clear imbalance in
pre-stimulation pain scores between conditions
Study Size High risk Comment: < 50 participants per treatment arm
Study duration High risk Comment: < 2 weeks’ follow-up
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Lefaucheur 2001b (Continued)
Other bias Unclear risk Comment: the results of some of the planned data analysis
(ANOVA of group differences after each condition) not re-
ported. However, adequate data were available for inclusion in
the meta-analysis
Lefaucheur 2004
Methods Cross-over RCT
Participants Country of study: France
Setting: laboratory
Condition: neuropathic pain (mixed central, peripheral and facial)
Prior management details: refractory to drug management
n = 60
Age: 27-79 years, mean 54.6
Duration of symptoms: not specified “chronic”
Gender distribution: 28 M, 32 F
Interventions Stimulation type: rTMS, figure-of-8 coil
Stimulation parameters: frequency 10 Hz; coil orientation posteroanterior; 80% RMT;
number of trains 20; duration of trains 5 s; ITI 55 s; total number of pulses 1000
Stimulation location: M1 contralateral to painful side
Number of treatments: x 1 for each condition
Control type: sham coil
Outcomes Primary: 0-10 VAS pain, anchors not specified
When taken: 5 min poststimulation
Secondary: none
Notes COI: study authors declared no COI
Sources of support: grant from the ‘Institut UPSA de la douleur’
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “one of the following two protocols was applied in a
random order”
Comment: method of randomisation not specified but less crit-
ical in cross-over design
Adequate blinding of participants? Unclear risk Quote: “ideal sham...which should be performed by means of a
coil similar to the real one in shape, weight, and location on the
scalp, producing a similar sound and similar scalp skin sensation,
but generating no electrical field within the cortex. Such a sham
coil has not yet been designed, and at present, the sham coil
used in this study is to our knowledge the more valid for clinical
trials.”
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Lefaucheur 2004 (Continued)
Comments: sham credibility assessment - suboptimal
Adequate blinding of assessors? Unclear risk Comment: blinding of assessors not reported
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: no dropout apparent from the data presented
Selective reporting (reporting bias) Low risk Comment: results for primary outcomes reported clearly and in
full
Free from carry-over effects? Low risk Comment: 3-week washout observed and no clear imbalance in
pre-stimulation pain scores between conditions
Study Size Unclear risk Comment: > 50 but < 200 participants per treatment condition
Study duration High risk Comment: < 2 weeks’ follow-up
Other bias Low risk Comment: no significant other bias detected
Lefaucheur 2006
Methods Cross-over RCT, 3 conditions
Participants Country of study: France
Setting: laboratory
Condition: unilateral chronic neuropathic pain (mixed central and peripheral)
Prior management details: refractory to drug management
n = 22
Age: 28-75 years, mean 56.5 (SD 2.9)
Duration of symptoms: 2-18 years, mean 5.4 (SD 4.1)
Gender distribution: 12 M, 10 F
Interventions Stimulation type: rTMS, figure-of-8 coil
Stimulation parameters:
Condition 1: frequency 10 Hz; coil orientation posteroanterior; 90% RMT; number of
trains 20; duration of trains 6 s; ITI 54 s; total number of pulses 1200
Condition 2: frequency 1 Hz; coil orientation posteroanterior; 90% RMT; number of
trains 1; duration of trains 20 min; total number of pulses 1200
Condition 3: sham coil
Stimulation location: M1 contralateral to painful side
Number of treatments: x 1 for each condition
Outcomes Primary: 0-10 VAS pain, anchors not specified
When taken: pre- and poststimulation
Secondary: none
Notes AEs: not reported
COI: no declaration made
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Lefaucheur 2006 (Continued)
Sources of support: grant from the ‘Institut UPSA de la douleur’
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Three sessions of motor cortex rTMS, sepa-
rated by at least 3 weeks, were performed in random
order”
Comment: method of randomisation not specified but
less critical in cross-over design
Adequate blinding of participants? Unclear risk Comments: sham credibility assessment - suboptimal.
This study used the same sham as Lefaucheur 2004,
which in that paper was stated as not meeting the cri-
teria for an ideal sham
Adequate blinding of assessors? Unclear risk Comment: blinding of assessors only reported for mea-
sures of cortical excitability
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Comment: level of dropout not reported and unclear
from the data presented
Selective reporting (reporting bias) Low risk Comment: pain score numerical values not provided
clearly with measures of variance for any time point in
the study report but were provided by the study authors
on request
Free from carry-over effects? Low risk Quote: “Post hoc tests did not reveal any differences
between the three pre-rTMS assessments regarding ex-
citability values or pain levels”
Study Size High risk Comment: < 50 participants per treatment arm
Study duration High risk Comment: < 2 weeks’ follow-up
Other bias Low risk Comment: no significant other bias detected
Lefaucheur 2008
Methods Cross-over RCT, 3 conditions
Participants Country of study: France
Setting: laboratory
Condition: neuropathic pain (mixed central, peripheral and facial)
Prior management details: refractory to drug management for at least 1 year
n = 46
Age: 27-79 years, mean 54.2
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Lefaucheur 2008 (Continued)
Duration of symptoms: chronic > 1 year
Gender distribution: 23 M, 23 F
Interventions Stimulation type: rTMS, figure-of-8 coil
Stimulation parameters:
Condition 1: frequency 10 Hz; coil orientation posteroanterior; 90% RMT; number of
trains 20; duration of trains 6 s; ITI 54 s; total number of pulses 1200
Condition 2: frequency 1 Hz; coil orientation posteroanterior; 90% RMT; number of
trains 1; duration of trains 20 min; total number of pulses 1200
Condition 3: sham coil
Stimulation location: M1 contralateral to painful side
Number of treatments: x 1 for each condition
Outcomes Primary: 0-10 VAS, anchors not specified
When taken: pre- and poststimulation
Secondary: none
Notes AEs: not reported
COI: study authors declared no COI
Sources of support: grant from the ‘Institut UPSA de la douleur’
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Three different sessions of rTMS..... were per-
formed in a random order”
Comment: method of randomisation not specified but
less critical in cross-over design
Adequate blinding of participants? Unclear risk Comments: sham credibility assessment - suboptimal.
This study used the same sham coil as that used in
Lefaucheur 2004, which in that paper was stated as not
meeting the criteria for an ideal sham
Adequate blinding of assessors? Low risk Quote: “In all cases, the examiner was blinded to the
type of rTMS administered.”
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: 2 participants dropped out but this is < 5%
of the cohort. Unlikely to have strongly influenced the
findings
Selective reporting (reporting bias) Low risk Comment: results for all outcomes reported clearly and
in full
Free from carry-over effects? Low risk Comment: 3-week washout observed and no clear im-
balance in pre-stimulation pain scores between condi-
tions
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Lefaucheur 2008 (Continued)
Study Size High risk Comment: < 50 participants per treatment arm
Study duration High risk Comment: < 2 weeks’ follow-up
Other bias Low risk Comment: no significant other bias detected
Lichtbroun 2001
Methods Parallel RCT
Participants Country of study: USA
Setting: outpatient fibromyalgia clinic
Condition: fibromyalgia
Prior management details: unclear
n = 60
Age: 23-82 years, mean 50
Duration of symptoms: 1-40 years, mean 11
Gender distribution: 2 M, 58 F
Interventions Stimulation type: CES
Stimulation parameters: frequency 0.5 Hz; 50% duty cycle; intensity 100 µA; waveform
shape biphasic square wave; duration 60 min
Stimulation location: ear clip electrodes
Number of treatments: 30, x 1 daily for consecutive days
Control type: sham unit - indistinguishable from active unit
Outcomes Primary: 10-point self-rating pain scale, anchors not specified
When taken: poststimulation (not precisely defined)
Secondary: QoL: 0-10 VAS scale (data not reported)
Notes AEs: not reported
COI: no declaration made
Sources of support: no declaration made
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “the subjects were randomly assigned into three separate
groups by an office secretary who drew their names, which were
on separate sealed slips of paper in a container”
Allocation concealment (selection bias) Low risk Comment: probably, given the quote above
Adequate blinding of participants? Low risk Comment: see previous quote
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Lichtbroun 2001 (Continued)
Adequate blinding of assessors? Low risk Quote: “All subjects, staff, the examining physician and the psy-
chometrician remained blind to the treatment conditions”
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Dropout levels not specified in the report. ITT analysis not
discussed in the report
Selective reporting (reporting bias) High risk Comment: pain score numerical values not provided clearly with
measures of variance for any time points in the study report
Study Size High risk Comment: < 50 participants per treatment arm
Study duration High risk Comment: < 2 weeks’ follow-up
Other bias Low risk Comment: no significant other bias detected
Luedtke 2015
Methods Parallel RCT
Participants Country of study: Germany
Setting: back pain clinic
Condition: chronic nonspecific low back pain
Prior management details: excluded if had spinal surgery in previous 6 months
n = 135
Age range: 26-64 years, mean (SD) active group 45(9), sham group 44 (10)
Duration of symptoms, mean (SD) active group 45 (9) months, sham group 44 (10)
Gender distribution: 63 F, 72 M
Interventions Stimulation type: tDCS
Stimulation parameters: intensity 2 mA, 35 cm2 electrodes, duration 20 min
Stimulation location: anode L M1, cathode right supraorbital area
Number of treatments: x1 daIly for 5 d
Control type: sham tDCS
Outcomes Primary: pain VAS anchors not reported
When taken: end of intervention, 4, 12 and 24 weeks postintervention
Secondary: Oswestry Disability Index
Notes Sources of support: “This study was funded by the Deutsche Forschungsgemeinschaft
DFG (MA 1862/10-1).”
Competing interests: “AM, TJ, KL, and AP had financial support fromDFG (MA 1862/
10-1) and NeuroImageNord for the submitted work.”
Risk of bias
Bias Authors’ judgement Support for judgement
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Luedtke 2015 (Continued)
Random sequence generation (selection
bias)
Low risk Quote: “We randomised 160 stimulation codes (80 triggering
active stimulation, 80 triggering sham stimulation) by custom
written software into two separate lists.”
Allocation concealment (selection bias) Low risk Quote: “An independent researcher created the randomisation
lists. To achieve allocation concealment the recruiter provided
participants with the next unused stimulation code from the
randomised lists. The recruiter had no access to the randomisa-
tion list.”
Adequate blinding of participants? Low risk Quote: “Blinding of participants and the treating physiother-
apist was achieved by using a sham paradigm identical to the
anodal stimulation procedure…. “ kappa agreement -0.120
Comment While 2 mA intensity can be inadequately blinded,
assessment suggests blinding successful
Adequate blinding of assessors? Low risk Comment: while 2 mA intensity can be inadequately blinded,
formal assessment suggests blinding successful
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: only 3 in each group discontinued in stimulation
period. ITT approach
Selective reporting (reporting bias) Low risk Comment: reporting of all core outcomes
Study Size Unclear risk Comment: n = 67 and 68 per group
Study duration Low risk Comment: 24-week follow-up
Other bias Low risk Comment: no other bias detected
Malavera 2013
Methods Parallel RCT
Participants Country of study: Colombia
Setting: rehabilitation department
Condition: phantom limb pain
Prior management details: no difference across groups in use of NSAIDS, physical reha-
bilitation or psychological therapy
n = 54
Age, mean (SD): active group 33.1 (6.6) years, sham group 8.2 (6.3) years
Duration of symptoms: not reported
Gender distribution: 50 M, 4 F
Interventions Stimulation type: rTMS
Stimulation parameters: frequency 10 Hz; coil orientation 45° angle frommidline, 90%
RMT number of trains 20; duration of trains 6 s; ITI 54 s; total number of pulses 1200
Stimulation location: M1 contralateral to painful side, no neuronavigation
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Malavera 2013 (Continued)
Number of treatments: 10 sessions x 1 per work day for 2 weeks
Control type: sham coil - same sound and appearance, no control for sensory cues
Outcomes Primary: pain NRS anchors 0 = no pain, 10 = worst pain possible
When taken: 15 d and 30 d after treatment
Secondary: AEs
Notes Funding source: study was partially supported by a grant from the Colombian Science
and Technology Institute (COLCIENCIAS, project code: 6566-49-326169).
Felipe Fregni is the principal investigator at Spaulding Rehabilitation Hospital of a
research grant funded by NIH (5R01HD082302-02)
COI: study authors declared no COI
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “a computer-generated randomization method with a
permuted block size of 6 was used to allocate subjects to the
sham or active rTMS interventions”
Allocation concealment (selection bias) Low risk Quote: “The randomization code was only given to the treating
investigator on the first day of treatment session by an indepen-
dent investigator not involved with any other aspect of the trial.
”
Adequate blinding of participants? Low risk Comment: while sham coil did not control for scalp sensation
blinding assessment suggested adequate blinding
Quote: “Subjects and investigators did not guess correctly the
treatment allocation beyond chance (P = .704; P = .571).”
Adequate blinding of assessors? Low risk Quote: “All evaluations were performed by an investigator
blinded to treatment allocation.”
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: 1 participant per group dropped out at 15 days and
2 per group at 30 days. ITT analysis performed
Quote “We analyzed the end point of the study using the inten-
tion-to-treat method including patients who attended at least 1
of the rTMS sessions. The missing data were considered at ran-
dom, thus we used a regression imputation method to handle
this issue.”
Selective reporting (reporting bias) Low risk Comment: key outcomes presented at all follow-up points
Study Size High risk Comment: n = 27 per group
Study duration Unclear risk Comment: 15-day follow-up postintervention
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Malavera 2013 (Continued)
Other bias Low risk Comment: no other bias detected
Medeiros 2016
Methods Factorial RCT
Participants Country of study: Brazil
Setting: not specified
Condition: chronic myofascial pain syndrome
Prior management details: not reported
n = 46, of which 23 relevant to this review
Age, mean (SD): active group 45.83 (9.63) years, sham group 46.73 (13.09) years
Duration of symptoms: not reported
Gender distribution: all F
Interventions Stimulation type: rTMS
Stimulation parameters: frequency 10Hz; coil orientation 45° frommidline, 80% RMT,
number of trains not reported; duration of trains not reported; ITI s not reported; total
number of pulses 1600
Stimulation location: L M1
Number of treatments: 10 days of stimulation
Control type: sham coil - no details provided
Outcomes Primary: pain NRS anchors 0 = no pain, 10 = worst possible pain
When taken: at end of intervention
Secondary: none relevant
Notes Funding source: supported by Brazilian funding agencies: National Council for Scientific
and Technological Development-CNPq (Dr. I.L.S. Torres, W. Caumo, L.F. Medeiros; J.
Dussan-Sarria, A. Souza,V.L. Scarabelot);GraduateResearchGroup (GPPG) ofHospital
de Cl ´ nicas de Porto Alegre (Dr W. Caumo- Grant # 100196 and Dr. I.L.S. Torres
# 100276); Coordination for the Improvement of Higher Education Personnel-CAPES
(A. Deitos); International Cooperation Program-CAPES (n8023/11)
COI: authors declared no COI
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote “Participants were randomized to one of the four groups,
using a stratified blocked randomization scheme and appropriate
statistical Random Allocation Software.”
Allocation concealment (selection bias) Low risk Quote: “Each envelope was sealed and numbered sequentially
and contained the allocated treatment. During the entire proto-
col timeline, two investigators who were not involved in patient
evaluation were responsible for then blinding and randomiza-
tion procedures”
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Medeiros 2016 (Continued)
Adequate blinding of participants? Unclear risk Quote: “A sham coil was used”
Comment: insufficient description to know whether it con-
trolled for all aspects on the experience. No formal assessment
of blinding provided
Adequate blinding of assessors? Low risk Quote: “All participants were instructed not to discuss their
group assignment during the treatment sessions or with the
project staff collecting outcomes data, all of themwere also blind
to the group assignments. Independent evaluators’ blind to the
group assignments were trained to apply the pain scales and cor-
tical excitability parameter.”
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: low levels of dropout (2 participants in total)
Selective reporting (reporting bias) Unclear risk Comment: pain diary data not reported in the results with no
clear explanation offered for the omission
Study Size High risk Comment: group sizes ranged from 11-12 participants
Study duration High risk Comment: only follow-up immediately postintervention
Other bias Low risk Comment: no other bias detected
Mendonca 2011
Methods Parallel RCT
Participants Country of study: Brazil/USA
Setting: laboratory
Condition: fibromyalgia
Prior management details: not reported
n = 30 (6 per group)
Age, mean (SD): 43.2 (9.8) years
Duration of symptoms: not reported
Gender distribution: 28 F, 2 M
Interventions Stimulation type: tDCS
Stimulation parameters: simulation intensity 2 mA, 20 min duration
Stimulation location: Group 1 cathodal M1; Group 2 cathodal supraorbital; Group 3
anodal M1; Group 4 anodal supraorbital; Group 5 sham
Number of treatments: 1 session
Control type: sham tDCS (switched off after 30 s stimulation)
Outcomes Primary: pain VAS; 0 = no pain, 10 = worst possible pain
When taken: immediately poststimulation
Secondary: none relevant
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Mendonca 2011 (Continued)
Notes COI: study authors declared no COI
Sources of support: NIH
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Comment: method of randomisation not specified
Allocation concealment (selection bias) Unclear risk Comment: allocation concealment not specified
Adequate blinding of participants? Unclear risk Comment: 2 mA intensity used - empirical evidence that par-
ticipant blinding may be suboptimal at this intensity
Adequate blinding of assessors? Unclear risk Comment: 2mA intensity used - empirical evidence that assessor
blinding may be suboptimal at this intensity
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: no dropouts occurred
Selective reporting (reporting bias) High risk No numerical data provided for any post-treatment clinical out-
come. Data not provided upon request to study authors
Study Size High risk Comment: < 50 participants per treatment arm
Study duration High risk Comment: < 2 weeks’ follow-up
Other bias Low risk No other bias detected
Mendonca 2016
Methods Parallel RCT
Participants Country of study: Brazil
Setting: laboratory
Condition: fibromyalgia
Prior management details: excluded if undergoing physical treatment or were on stable
pain control medication for “less than 2 months”
n = 45 (of which 30 relevant to this review)
Age, mean (SD): active group 44.5 (14) years, sham group 48 (11.8) years
Duration of symptoms, mean (SD): active group 140.6 (72.2) months, sham group 149.
3 (111.1)
Gender distribution: 29 F, 1 M
Interventions Stimulation type: tDCS
Stimulation parameters: intensity 2 mA, 35 cm2 electrodes, duration 20 min
Stimulation location: anode L M1, cathode right supraorbital area
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Mendonca 2016 (Continued)
Number of treatments: x 1 daIly for 5 days
Control type: sham tDCS
Outcomes Primary: pain VAS, anchors 0 = no pain, 10 = worst pain imaginable
When taken: postintervention, 1 month postintervention, 2 months postintervention
Secondary: QoL SF-36
AEs
Notes Study authors declared that there were no COI
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “Randomization was performed by a blinded therapist
using sealed envelopes for each individual.”
Comment: no description of the actual allocation sequence gen-
eration
Allocation concealment (selection bias) Low risk Quote: “Randomization was performed by a blinded therapist
using sealed envelopes for each individual.”
Comment: likely to be a concealed process
Adequate blinding of participants? Unclear risk Quote: “Participants were blinded to the intervention groups,
as were the therapists who performed the evaluation.”
Comment: evidence that blinding can be inadequate at intensity
of 2 mA
No formal assessment of blinding success
Adequate blinding of assessors? Unclear risk Quote: “Participants were blinded to the intervention groups,
as were the therapists who performed the evaluation.”
Comment: Evidence that assessor blinding can be inadequate at
intensity of 2 mA. No formal assessment of blinding success
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Comment: ITT analysis using LOCF. Low for postintervention
(< 10%) and high for 2/12 follow-up
Selective reporting (reporting bias) Low risk Comment: adequate reporting of core outcomes
Study Size High risk n = 45 in 3 groups of which n = 30 relevant to this review
Study duration Low risk 2-month postintervention follow-up
Other bias Low risk Comment: no other bias detected
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Mhalla 2011
Methods Parallel RCT
Participants Country of study: France
Setting: laboratory
Condition: fibromyalgia
Prior management details: not reported but concomitant treatments allowed
n = 40
Age, mean (SD): active group 51.8 (11.6) years, sham group 49.6 (10) years
Duration of symptoms (mean (SD) years): active group 13 (12.9), sham group 14.1 (11.
9)
Gender distribution: all F
Interventions Stimulation type: rTMS
Stimulation parameters: frequency 10 Hz; coil orientation posteroanterior, number of
trains 15; duration of trains 10 s; ITI 50 s, intensity 80% RMT, total number of pulses
1500
Stimulation location: L M1
Number of treatments: 14, x 1 daily for 5 days, x 1 weekly for 3 weeks, x 1 every two
weeks for 6 weeks, x 1 monthly for 3 months
Control type: sham coil, did not control for sensory cues
Outcomes Primary: pain NRS; 0 = no pain, 10 = maximal pain imaginable
When taken: day 5, 3 weeks, 9 weeks, 21 weeks, 25 weeks
Secondary: BPI interference scale, FIQ
Notes COI: study authors declared no COI
Sources of support: Grants from the “Fondation APICIL” and the “Fondation de France
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Patients were randomly assigned to 2 groups...with
equal numbers in each group. A study nurse prepared the con-
cealed allocation schedule by computer randomisation of these
2 treatment groups to a consecutive number series; the nurse
had no further participation in the trial. Patients were assigned
in turn to the next consecutive number.”
Allocation concealment (selection bias) Low risk Comment: see quote above
Adequate blinding of participants? Unclear risk Comment: sham credibility assessment - sham coil controls for
sound and appearance but not the skin sensation of stimulation
Adequate blinding of assessors? Low risk Quote: “Both patients and investigators were blind to treatment
group. Cortical excitability measurements and transcranial stim-
ulation were performed by an independent investigator not in-
volved in the selection or clinical assessment of the patients.”
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Mhalla 2011 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: 25% dropout at long-term follow-up but intention-
to-treat analysis used with BOCF imputation
Selective reporting (reporting bias) Low risk Comment: no numeric point measures provided for the primary
outcome but provided upon request to the authors
Study Size High risk Comment: < 50 participants per treatment arm
Study duration Low risk Comment: > 8 weeks’ follow-up
Other bias Low risk Comment: no other biases detected
Mori 2010
Methods Parallel RCT
Participants Country of study: Italy
Setting: laboratory
Condition: neuropathic pain secondary to multiple sclerosis
Prior management details: refractory to drug management and medication discontinued
over previous month
n = 19
Age: 23-69 years, mean 44.8 (SD 27.5)
Duration of symptoms: 1-10 years, mean 2.79 (SD 2.64)
Gender distribution: 8 M, 11 F
Interventions Stimulation type: tDCS
Stimulation parameters: intensity 2 mA, 35 cm2 electrodes, duration 20 min
Stimulation location: M1, contralateral to painful side
Number of treatments: 5, x 1 daily on consecutive days
Control type: sham tDCS (switched off after 30 s stimulation)
Outcomes Primary: 0-100 mm VAS pain, anchors “no pain” to “worst possible pain”
When taken: end of treatment period and x 1 weekly over 3-week follow-up
Secondary: QoL, multiple sclerosis QoL-54 scale (MSQoL-54)
When taken: as for primary outcome
Notes AEs: none
COI: no declaration made
Sources of support: “Italian National Ministero dell’Universita‘ e della Ricerca, by the
Italian National Ministero della Salute, by the Fondazione Italiana Sclerosi Multipla
(FISM) to DC, and by the Agenzia Spaziale Italiana to GB”
Risk of bias
Bias Authors’ judgement Support for judgement
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Mori 2010 (Continued)
Random sequence generation (selection
bias)
Low risk Quote: “Randomization was performed using the order of en-
trance in the study and a previous randomization list generated
by a computer.”
Allocation concealment (selection bias) Low risk Comment: likely given that the randomisation list was generated
pre-study
Adequate blinding of participants? Unclear risk Comment: there is evidence that participant blinding of tDCS
may be inadequate at 2 mA intensity (see Assessment of risk of
bias in included studies)
Adequate blinding of assessors? Unclear risk Comment: there is evidence that assessor blinding of tDCS may
be inadequate at 2 mA intensity (see Assessment of risk of bias
in included studies)
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: no dropouts observed
Quote: “... none of the patients enrolled discontinued the study.
”
Selective reporting (reporting bias) Low risk Comment: between-group means not presented clearly to allow
meta-analysis but data provided on request
Study Size High risk Comment: < 50 participants per treatment arm
Study duration Unclear risk Comment: ≥ 2 weeks but < 8 weeks’ follow-up
Other bias Low risk Comment: no significant other bias detected
Nardone 2017
Methods Parallel RCT
Participants Country of study: Italy and Austria
Setting: laboratory
Condition: below level post SCI, predominantly neuropathic pain
Prior management details: > 4/10 pain despite rehabilitation and pharmacological treat-
ment. All participants previously treated with antidepressant, anticonvulsants and anal-
gesics for a minimum period of 6 months
n = 12
Age, mean (range): active group 43.7 (26-56) years, sham group 42.5 (24-62) years
Duration of symptoms: not reported
Gender distribution: 9 M, 3 F
Interventions Stimulation type: rTMS
Stimulation parameters: frequency 10 Hz; coil orientation AP direction, 120% RMT,
number of trains 25; duration of trains 5 s; ITI 25s; total number of pulses 1250
Stimulation location: L PFC (no neuronavigation)
Number of treatments: 10 sessions daily x 5 per week for 2 weeks
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Nardone 2017 (Continued)
Control type: sham coil - same sound and appearance, no control for sensory cues
Outcomes Primary: pain VAS anchors not reported
When taken: postintervention, 1 month postintervention
Secondary: none relevant
AEs
Notes Funding source: no statement provided regarding funding
COI: the study authors declared no COI
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Comment: method of randomisation not reported
Allocation concealment (selection bias) Unclear risk Comment: allocation concealment not reported
Adequate blinding of participants? Unclear risk Quote: “Sham stimulation was carried out with a sham coil of
identical size color and shape emitting a sound similar to that
emitted by the active coil.”
Comment: Sham suboptimal - no control for cutaneous sensa-
tion associated with stimulation
Adequate blinding of assessors? Low risk Quote “Pain was assessed by an investigator blinded to the type
of rTMS subjects were receiving.”
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: no loss to follow-up
Selective reporting (reporting bias) Low risk Comment: data reported adequately
Study Size High risk Comment: n = 12
Study duration Unclear risk Comment: 1 month postintervention follow-up
Other bias Low risk Comment: no other bias detected
Ngernyam 2015
Methods Cross-over RCT
Participants Country of study: Thailand
Setting: laboratory
Condition: neuropathic pain associated with SCI
Priormanagement details: refractory tomedication including antidepressants, antiepilep-
tics and opioids
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Ngernyam 2015 (Continued)
n = 20
Age, mean (SD) 44.5 (9.16) years
Duration of symptoms: 50.1 (37.05) months
Gender distribution: 15 M 5 F
Interventions Stimulation type: tDCS
Stimulation parameters: intensity 2 mA, 35 cm2 electrodes, duration 20 min
Stimulation location: anode M1 contralateral to most painful side, cathode supraorbital
area contralateral to anode
Number of treatments: x 1 session
Control type: sham tDCS
Outcomes Primary: pain VAS, anchors 0 = no pain, 10 = the most possible pain
When taken: immediately poststimulation
Secondary: AEs
Notes No author declaration of COI made
Sources of support “This work was supported by an invitation research grant, Faculty
of Medicine, Khon Kaen University, Thailand (Grant number I 55229), the Higher
Education Research Promotion and National Research University Project of Thailand,
Office of the Higher Education Commission and Faculty of Social Science, Naresuan
University, Phitsanulok, Thailand.”
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “participants were randomized to receive either active
tDCS followed by sham tDCS, or sham tDCS stimulation fol-
lowed by active tDCS in a 1:1 ratio using a computer generated
list of random numbers in blocks of four randomizations.”
Adequate blinding of participants? Unclear risk Comment: evidence that blinding can be inadequate at intensity
of 2 mA. No formal assessment of blinding success
Adequate blinding of assessors? Unclear risk Comment: evidence that assessor blinding can be inadequate at
intensity of 2 mA. No formal assessment of blinding success
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: < 10% dropout rate
Selective reporting (reporting bias) Low risk Comment: numeric data on pain outcomes not presented in the
paper. All data provided by study authors upon request
Free from carry-over effects? Low risk Comment: preliminary ANOVA analyses yielded no significant
main or interaction effects involving condition order
Study Size High risk Comment: n = 20
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Ngernyam 2015 (Continued)
Study duration High risk Comment: maximum follow-up 1 week postintervention
Other bias Low risk Comment: no other bias detected
Nurmikko 2016
Methods Cross-over RCT
Participants Country of study: UK
Setting: laboratory
Condition: mixed refractory neuropathic pain
Prior management details: no benefit from medication or other stimulation approaches
n = 40 (27 after loss to follow-up)
Age, range: 27-79 years
Duration of symptoms: not reported
Gender distribution: 23 M, 17 F
Interventions Stimulation type: rTMS
Stimulation parameters: frequency 10 Hz; coil orientation AP direction, 90% RMT,
number of trains 20; duration of trains 10 s; ITI 1 min; total number of pulses 2000
Stimulation location: Site A: M1 hotspot, Site B M1 reorganised area, Site C (sham)
occipital fissure
Number of treatments: 3-5 sessions per week for 5 sessions
Control type: sham active stimulation of occipital fissure
Outcomes Primary: pain NRS anchors 0 = no pain 10 = worst pain imagined
When taken: postintervention, 3 weeks postintervention
Secondary: none relevant
AEs
Notes Funding source: research funded by the National Institute for Health Research (NIHR)
under Research for Patient Benefit (RfPB) Programme (Grant Reference Number PB-
PG-0110-20321)
COI: Prof. Nurmikko has received travel sponsorship from Nexstim Ltd. None of the
other authors report any COI
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Patients were randomly allocated to receive three cycles
of rTMS in 5 sessions at sites A, B, and SHAM. Randomization
order was computer generated.”
Adequate blinding of participants? Low risk Comment: sham was active stimulation of a non target brain
area- likely indistinguishable from active stimulation
Adequate blinding of assessors? Low risk Comment: outcomes self-reported via pain diaries
145Non-invasive brain stimulation techniques for chronic pain (Review)
Copyright © 2018 The Authors. Cochrane Database of Systematic Reviews published by John Wiley & Sons, Ltd. on behalf of The
Cochrane Collaboration.
Nurmikko 2016 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
High risk Comment: 40 randomised, 38 received rTMS, 27 included in
per-protocol analysis (33% attrition). Responder analysis n = 33
(17% dropout)
Reasons for dropout not reported
Selective reporting (reporting bias) Low risk Comment: outcomes reported adequately
Free from carry-over effects? Low risk Comment: 3 weeks washout period observed. Baseline pain lev-
els for each condition appear equivalent
Study Size High risk Comment: n = 40, 27 after loss to follow-up
Study duration Unclear risk Comment: 3 week follow-up
Other bias Low risk Comment: no other bias detected
Oliveira 2015
Methods Parallel RCT
Participants Country of study: Brazil
Setting: laboratory
Condition: chronic temporomandibular disorder
Prior management details: excluded if received any type of physiotherapy in preceding
month
n = 32
Age, mean (SD): active group 23.80 (7.3) years sham group 25.5 (6.3) years
Duration of symptoms, months mean (SD): active group 29.8 (17.1), sham group 33.7
(22.8)
Gender distribution: 3 M, 29 F
Interventions Stimulation type: tDCS
Stimulation parameters: intensity 2 mA, 35 cm2 electrodes, duration 20 min
Stimulation location: anode M1 contralateral to painful side, cathode supraorbital area,
contralateral to anode
Number of treatments: daily sessions for 5 consecutive days. Then twice a week for 3
weeks, up to 10 sessions
Control type: sham tDCS
Outcomes Primary: pain VAS, anchors not reported
When taken: 5 months postintervention, no data reported from formal study period
Secondary: QoL WHO-QoL, AEs
Notes Sources of support: study was carried out without funding
COI: study authors decare no COI
Risk of bias
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Oliveira 2015 (Continued)
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “After the first comprehensive evaluation, the secretary
of the clinical facility, who was not involved with any other
procedures of the study, randomised participants who fulfilled
the inclusion criteria for treatment and accepted to participate
in the study. Randomisation occurred by the simple random
method, in which each subject was invited to remove a small
sealed envelope from a larger opaque envelope indicating two
treatment groups.”
Allocation concealment (selection bias) Low risk Quote: “After the first comprehensive evaluation, the secretary
of the clinical facility, who was not involved with any other
procedures of the study, randomised participants who fulfilled
the inclusion criteria for treatment and accepted to participate
in the study.”
Adequate blinding of participants? Unclear risk Comment: evidence that blinding can be inadequate at intensity
of 2 mA. 15 guessed stimulation condition correctly in active
group vs 7 in sham group
Adequate blinding of assessors? Unclear risk Comment: evidence that assessor blinding can be inadequate at
intensity of 2 mA. No formal assessment of blinding success
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: no attrition noted for core follow-up points
Selective reporting (reporting bias) Low risk Comment: no numeric reporting of point estimates for most
outcomes but data provided upon request
Study Size High risk Comment: n = 32
Study duration Unclear risk Comment: formal follow-up for 3 weeks postintervention
Other bias Low risk Commet: no other bias detected
Onesti 2013
Methods Cross-over RCT
Participants Country of study: Italy
Setting: laboratory
n = 25
Condition: neuropathic pain from diabetic neuropathy
Prior management details: resistant to standard therapies for at least 1 year
Age mean (SD): 70.6 (8.5) years
Duration of symptoms (months mean (SD)): not reported
Gender distribution: 9 F, 14 M
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Onesti 2013 (Continued)
Interventions Stimulation type: rTMS using H-coil
Stimulation parameters: frequency 20 Hz; coil orientation H coil, number of trains 30;
duration of trains 2.5 s; ITI 30 s, intensity 100% RMT, total number of pulses 1500
Stimulation location: M1 lower limb (deep in central sulcus)
Number of treatments: 5 per condition on consecutive days
Control type: sham coil, controlled for scalp sensory, auditory and visual cues
Outcomes Primary: pain VAS 0-100, no pain to worst possible pain
When taken: immediately poststimulation, 3 weeks poststimulation
Secondary: none relevant
Notes COI: 2 authors have links to the manufacturer of the H-coil
Sources of support: no declaration made
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “After enrolment, patients were randomly assigned in a
1:1 ratio to two counterbalanced arms by receiving a sequential
number from a computer-generated random list.”
Adequate blinding of participants? Low risk Quote: “Sham stimulation was delivered with a sham coil placed
in the helmet encasing the active rTMS coil. The sham coil
produced a similar acoustic artefact and scalp sensation as the
active coil and could also mimic the facial muscle activation
induced by the active coil. It induced only a negligible electric
field inside the brain because its non-tangential orientation on
the scalp and components cancelling the electric field ensured
that it rapidly reduced the field as a function of distance”
Comment: controlled for visual auditory and sensory aspects of
stimulation
Adequate blinding of assessors? Unclear risk Comment: while study described as “double blind” there was
no specific mention of blinding assessors
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: only 2 participants lost to follow-up
Selective reporting (reporting bias) High risk Comment: data not presented by stimulation condition - rather
they were grouped by the order in which interventions were
delivered. No SDs presented. Data requested
Free from carry-over effects? Low risk Comment: 5-week washout period observed with no difference
at T3
Study Size High risk Comment: < 50 participants per treatment arm
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Onesti 2013 (Continued)
Study duration Unclear risk Comment: ≥ 2 weeks but < 8 weeks’ follow-up
Other bias Low risk Comment: no other bias detected
Palm 2016
Methods Cross-over RCT
Participants Country of study: France
Setting: laboratory
Condition: MS-related neuropathic pain
Prior management details: stable pharmacological and physical therapies for at least 1
month
n = 16
Age, mean (SD) 47.4 (8.9) years
Duration of symptoms: not reported for pain
Gender distribution: 13 F, 3 M
Interventions Stimulation type: tRNS
Stimulation parameters: Intensity 1 mA, 25 cm2 electrodes, duration 20 min, VARI-
ANCE 650/2 µA
Stimulation location: M1 contralateral to most painful side
Number of treatments: x 1 daily for 3 days
Control type: sham tRNS
Outcomes Primary: pain VAS, anchors not reported
When taken: average for 7 days postintervention
Secondary: BPI interference, AEs
Notes COI: “FP has received grants from neuroConn GmbH, Ilmenau, Germany. The other
authors declare no conflict”
Sources of support: not reported
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Comment: method of randomisation not reported
Adequate blinding of participants? Low risk Quote: “Neither the patients nor the evaluatorswere aware about
the nature of the stimulation block.”
Comment: assessment of participant blinding integrity suggests
success
Adequate blinding of assessors? Low risk Quote: “Neither the patients nor the evaluatorswere aware about
the nature of the stimulation block.”
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Palm 2016 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
High risk Comment: 2 participants (13%) withdrew and data were ex-
cluded
Selective reporting (reporting bias) Low risk Comment: outcomes adequately reported
Free from carry-over effects? Unclear risk Comment: 3-week washout period observed but no formal as-
sessment of carry-over effects
Study Size High risk Comment: n = 16
Study duration High risk Comment: postintervention follow-up only
Other bias Low risk Comment: no other bias detected
Passard 2007
Methods Parallel RCT
Participants Country of study: France
Setting: laboratory
Condition: fibromyalgia
Prior management details: unclear
n = 30
Age: active group: 52.6 (SD 7.8) years, sham group 55.3 (SD 8.9) years
Duration of symptoms: active group: 8.1 (SD 7.9), sham group: 10.8 (SD 8.6)
Gender distribution: 1 M, 29 F
Interventions Stimulation type: rTMS, figure-of-8 coil
Stimulation parameters: frequency 10 Hz; coil orientation posteroanterior; 80% RMT;
number of trains 25; duration of trains 8 s; ITI 52 s; total number of pulses 2000
Stimulation location: M1 contralateral to painful side
Number of treatments: 10, x 1 daily for 10 working days
Control type: sham rTMS coil. Mimics sight and sound of active treatment
Outcomes Primary: 0-10NRSof average pain intensity over last 24h, anchors “nopain” to “maximal
pain imaginable”
When taken: daily during treatment period and at 15, 30 and 60 days post-treatment
follow-up
Secondary: FIQ
When taken: as for primary outcome
Notes COI: no declaration made
Sources of support: no declaration made
Risk of bias
Bias Authors’ judgement Support for judgement
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Passard 2007 (Continued)
Random sequence generation (selection
bias)
Low risk Quote: “patients who met all inclusion criteria were randomly
assigned, according to a computer-generated list, to two groups”
Allocation concealment (selection bias) Unclear risk Comment: allocation concealment not specified
Adequate blinding of participants? Unclear risk Quote: “Sham stimulation was carried out with the ’Magstim
placebo coil system’, which physically resembles the active coil
and makes similar sounds.”
Comment: sham credibility assessment - suboptimal. Sham coil
controlled for auditory cues and was visually indistinguishable
from active stimulation but did not control for sensory charac-
teristics of active stimulation over the scalp
Adequate blinding of assessors? Low risk Quote: “... investigators were blind to treatment group.”
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: equal dropout in each group and appropriately man-
aged in the data analysis
Quote: “All randomized patients with a baseline and at least one
post-baseline visit with efficacy datawere included in the efficacy
analyses (intent to treat analysis).”
“All the patients received the full course of treatment and were
assessed on D15 and D30. Four patients (two in each treatment
group) withdrew from the trial between days 30 and 60.”
Selective reporting (reporting bias) Low risk Comment: while pain score numerical values not provided
clearly with measures of variance for all time points in the study
report, the study authors provided the requested data
Study Size High risk Comment: < 50 participants per treatment arm
Study duration Low risk Comment: ≥ 8 weeks’ follow-up
Other bias Low risk Comment: no significant other bias detected
Picarelli 2010
Methods Parallel RCT
Participants Country of study: Brazil
Setting: laboratory
Condition: CRPS type I
Prior management details: refractory to best medical treatment
n = 23
Age mean (SD): active group 43.5 (12.1) years, sham group 40.6 (9.9) years
Duration of symptoms (months mean (SD)): active group 82.33 (34.5), sham group 79.
27 (32.1)
Gender distribution: 14 F, 9 M
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Picarelli 2010 (Continued)
Interventions Stimulation type: rTMS
Stimulation parameters: frequency 10 Hz; coil orientation posteroanterior, number of
trains 25; duration of trains 10 s; ITI 60 s, intensity 100% RMT, total number of pulses
2500
Stimulation location: M1 contralateral to painful limb
Number of treatments: 10, x 1 daily on consecutive weekdays
Control type: sham coil - did not control for sensory cues
Outcomes Primary: pain VAS; 0 = “no pain”, 10 = “most severe pain”
When taken: after first and last session then 1 and 3 months post-treatment
Secondary: QoL SF-36, not reported
Notes COI: study authors declared no COI
Sources of support: University of Sao Paolo, Brazil
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Comment: while stated “randomized” the method of randomi-
sation not reported
Allocation concealment (selection bias) Unclear risk Allocation concealment not reported
Adequate blinding of participants? Unclear risk Comment: sham suboptimal as it did not control for scalp sen-
sation. Study reported that number who guessed the condition
correctly was similar but no formal data or analysis reported
Adequate blinding of assessors? Unclear risk Comment: study described as “double-blinded” but assessor
blinding not specifically reported
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: only 1 participant dropped out at follow-up
Selective reporting (reporting bias) Low risk Comment: data presented for primary outcome. While this was
not adequate for meta-analysis it did not really constitute selec-
tivity. No response received to request for full data access
Study Size High risk Comment: < 50 participants per treatment arm
Study duration Low risk Comment: ≥ 8 weeks’ follow-up
Other bias Low risk Comment: no other biases detected
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Pleger 2004
Methods Cross-over RCT
Participants Country of study: Germany
Setting: laboratory
Condition: CRPS type I
Prior management details: drug management ceased for 48 h prior to study
n = 10
Age: 29-72 years, mean 51
Duration of symptoms: 24-72 months, mean 35
Gender distribution: 3 M, 7 F
Interventions Stimulation type: rTMS
Stimulation parameters: frequency 10 Hz; coil orientation unspecified; 110% RMT;
number of trains 10; duration of trains 1.2 s; ITI 10 s; total number of pulses 120
Stimulation location: M1 hand area
Number of treatments: 1 for each condition
Control type: coil angled 45º away from scalp
Outcomes Primary: 0-10 VAS current pain intensity, anchors “no pain” to “most extreme pain”
When taken: 30 s, 15, 45 and 90 min poststimulation
Secondary: none
When taken: 30 s, 15, 45 and 90 min poststimulation
Notes AEs: not reported
COI: no declaration made
Sources of support: “grant from the BMBF (NR. 01EM0102) and by a grant of the
Scientific Research
Council of BG-Kliniken Bergmannsheil, Bochum.”
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Using a computerized random generator, five patients
were first assigned to the placebo group (sham rTMS), while the
others were treated using verum rTMS”
Adequate blinding of participants? Unclear risk Comments: sham credibility assessment - suboptimal. Coil an-
gled 45º away from scalp. Did not control for sensory charac-
teristics of active stimulation and was visually distinguishable
Adequate blinding of assessors? Unclear risk Comment: blinding of assessors not reported
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: no dropout apparent from the data presented
Selective reporting (reporting bias) Low risk Comment: while sham group results not presented in the study
report, the study authors provided the requested data
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Pleger 2004 (Continued)
Free from carry-over effects? Low risk Quote: “The initial pain intensities (VAS) were similar prior to
verum and sham rTMS (Student’s paired t-test, P = 0.47). The
level of intensity was also independent of whether the patients
were first subjected to sham or verum rTMS (P > 0.05).”
Study Size High risk Comment: < 50 participants per treatment arm
Study duration High risk Comment: < 2 weeks’ follow-up
Other bias Low risk Comment: no significant other bias detected
Portilla 2013
Methods Cross-over RCT
Participants Country of study: USA
Setting: laboratory
Condition: postburn neuropathic pain
Prior management details: varied
n = 3
Age range: 34-52 years
Duration of symptoms: > 6 months
Gender distribution: 2 F, 1 M
Interventions Stimulation type: tDCS
Stimulation parameters: intensity 2 mA, duration 20 min
Stimulation location: M1 contralateral to most painful side
Number of treatments: 1 per condition
Control type: sham tDCS (switched off after 30 s stimulation)
Outcomes Primary: pain VAS; 0 = “no pain”, 10 = “worst pain ever felt”
When taken: before and after stimulation
Secondary: none relevant
Notes COI: study authors declared no COI
Sources of support: departmentally funded
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “subjects were randomized to either active tDCS or sham
stimulation.”
Comment: method of randomisation not specified but less crit-
ical in cross-over design
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Portilla 2013 (Continued)
Adequate blinding of participants? Unclear risk Comment: there is evidence that participant blinding of tDCS
may be inadequate at 2 mA intensity (see Assessment of risk of
bias in included studies)
Adequate blinding of assessors? Unclear risk Comment: there is evidence that participant blinding of tDCS
may be inadequate at 2 mA intensity (see Assessment of risk of
bias in included studies)
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: all 3 participants completed study
Selective reporting (reporting bias) High risk Comment: no numeric data provided for pain outcomes
Free from carry-over effects? Unclear risk Comment: 1-week washout observed but no data reported for
pain outcome so unable to assess this issue
Study Size High risk Comment: < 50 participants per treatment arm
Study duration High risk Comment: < 2 weeks’ follow-up
Other bias Low risk Comment: no other bias detected
Riberto 2011
Methods Parallel RCT
Participants Country of study: Brazil
Setting: rehabilitation clinic
Condition: fibromyalgia
Prior management details: none reported
n = 23
Age mean (SD): active group 58.3 (12.1) years, sham group 52.4 (11.5) years
Duration of symptoms, months (mean (SD)): active group 9.9 (11.8), sham group 6.4
(10.3)
Gender distribution: all F
Interventions Stimulation type: tDCS
Stimulation parameters: intensity 2 mA, duration 20 min
Stimulation location: M1 (contralateral to most painful side or dominant hand)
Number of treatments: 10, x 1 weekly for 10 weeks
Control type: sham tDCS (switched off after 30 s stimulation)
Both groups received 4 months rehabilitation programme
Outcomes Primary: pain VAS; 0 = “no pain”, 10 = “worst pain”
When taken: immediately at end of 4-month rehabilitation programme
Secondary: QoL SF36, FIQ
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Riberto 2011 (Continued)
Notes AEs: not reported
COI: study authors declared no COI
Sources of support: no declaration made
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Comment: stated simple randomisation method but method
not described
Allocation concealment (selection bias) Unclear risk Comment: allocation concealment not reported
Adequate blinding of participants? Unclear risk Comment: 2 mA used, which may threaten assessor blinding,
though formal analysis of blinding appears acceptable
Adequate blinding of assessors? Unclear risk Comment: 2mA intensity used - empirical evidence that assessor
blinding may be suboptimal at this intensity
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: no dropouts
Selective reporting (reporting bias) Low risk Comment: while numeric data on the primary outcome not
reported in study report the authors made it available upon
request
Study Size High risk Comment: < 50 participants per treatment arm
Study duration High risk Comment: < 2 weeks’ follow-up
Other bias Unclear risk Comment: there were group imbalances at baseline on the du-
ration of pain, education, age and economic activity
Rintala 2010
Methods Parallel RCT
Participants Country of study: USA
Setting: outpatient clinic, participants took device home
Condition: pain related to Parkinson’s disease
Prior management details: not reported
n = 19 (reduced to 13 through dropout)
Age mean (SD): active group 74.7 (7.8) years, sham group 74.4 (8.3) years
Duration of symptoms: > 6 months
Gender distribution: 15 M, 4 F
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Rintala 2010 (Continued)
Interventions Stimulation type: CES
Stimulation parameters: frequency not specified; pulse width not specified; intensity 100
µA; waveform shape not specified; duration 40 min per session
Stimulation location: earlobe clips
Number of treatments: 42, x 1 daily for 42 days
Control type: sham CES unit indistinguishable from active unit
Outcomes Primary: pain VAS 0 -10, anchors not reported
When taken: at the end of the treatment period
Secondary: none
Notes Sources of support: equipment provided by CES manufacturer as an “unrestricted gift”
COI: no declaration made
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Comment: stated randomised but method of randomisation not
reported
Allocation concealment (selection bias) Unclear risk Comment: allocation concealment not reported
Adequate blinding of participants? Low risk Comment: see above comment
Adequate blinding of assessors? Low risk Comment: participants and the study co-ordinator were blinded
to group assignment and the code sheet indicating which devices
were active and which were sham was kept by another person
who was not in contact with the participants
Incomplete outcome data (attrition bias)
All outcomes
High risk Comment: > 30% dropout
Selective reporting (reporting bias) Low risk Comment: mean (SD) pain scores reported for both groups pre-
and poststimulation
Study Size High risk Comment: < 50 participants per treatment arm
Study duration High risk Comment: < 2 weeks’ follow-up
Other bias Low risk Comment: no other bias detected
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Rollnik 2002
Methods Cross-over RCT
Participants Country of study: Germany
Setting: pain clinic
Condition: chronic pain (mixed musculoskeletal and neuropathic)
Prior management details: “intractable”
n = 12
Age: 33-67 years, mean 51.3 (SD 12.6)
Duration of symptoms: mean 2.7 (SD 2.4)
Gender distribution: 6 M, 6 F
Interventions Stimulation type: rTMS, circular coil for arm symptoms, double cone coil for leg symp-
toms
Stimulation parameters: frequency 20 Hz; coil orientation not specified; 80% RMT;
number of trains 20; duration of trains 2 s; ITI not specified; total number of pulses
800; treatment duration 20 min
Stimulation location: M1 (midline)
Number of treatments: x 1 for each condition
Control type: coil angled 45º away from the scalp
Outcomes Primary: 0-100 mm VAS pain intensity, anchors “no pain” to “unbearable pain”
When taken: 0, 5, 10 and 20 min post-stimulation
Secondary: none
Notes Sources of support: supported by Deutsche Forschungsgemeinschaft
COI: no declaration made
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “sham and active stimulation were given in a random
order”
Comment: method of randomisation not specified but less crit-
ical in cross-over design
Adequate blinding of participants? Unclear risk Comments: sham credibility assessment - suboptimal. Coil an-
gled 45º away from scalp. Did not control for sensory character-
istics of active stimulation over the scalp and was visually distin-
guishable. Given that stimulation was delivered at 110% RMT
active stimulation, but not sham, likely to have elicited muscle
twitches in peripheral muscles
Adequate blinding of assessors? Unclear risk Comment: blinding of assessors not reported
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: only 1 participant withdrewdue to “headaches”. Un-
likely to have strongly influenced the findings
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Rollnik 2002 (Continued)
Selective reporting (reporting bias) Low risk Comment: while pain score numerical values not provided
clearly with measures of variance for all time points in the study
report, the study authors provided the requested data
Free from carry-over effects? Low risk Comment: not clearly demonstrated in the study report but clear
from unpublished data provided by the study authors (baseline
mean group pain scores: active stimulation 65.1 (SD 16), sham
stimulation 66.9 (SD 17.4))
Study Size High risk Comment: < 50 participants per treatment arm
Study duration High risk Comment: < 2 weeks’ follow-up
Other bias Low risk Comment: no significant other bias detected
Saitoh 2007
Methods Cross-over RCT, 4 conditions
Participants Country of study: Japan
Setting: laboratory
Condition: neuropathic pain (mixed central and peripheral)
Prior management details: intractable
n = 13
Age: 29-76 years, mean 59.4
Duration of symptoms: 2-35 years, mean 10.2 (SD 9.7)
Gender distribution: 7 M, 6 F
Interventions Stimulation type: rTMS figure-of-8 coil
Stimulation parameters:
Condition 1: frequency 10 Hz; coil orientation not specified; 90% RMT; number of
trains 5; duration of trains 10 s; ITI 50 s; total number of pulses 500
Condition 2: frequency 5 Hz; coil orientation not specified; 90% RMT; number of
trains 10; duration of trains 10 s; ITI 50 s; total number of pulses 500
Condition 3: frequency 1 Hz; coil orientation not specified; 90% RMT; number of
trains 1; duration of trains 500 s; total number of pulses 500
Condition 4: sham, coil angled 45º from scalp with synchronised electrical scalp stimu-
lations to mask sensation
Stimulation location: M1 over the representation of the painful area
Number of treatments: 1 for each condition
Outcomes Primary: VAS pain, anchors not specified
When taken: 0, 15, 30, 60, 90 and 180 minutes poststimulation
Secondary: none
Notes Sources of support: no declaration made
COI: no declaration made
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Saitoh 2007 (Continued)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “rTMS was applied to all the patients at fre-
quencies of 1, 5, and 10 Hz and as a sham procedure
in random order”
Comment: method of randomisation not specified but
less critical in cross-over design
Adequate blinding of participants? Unclear risk Comment: sham credibility assessment - suboptimal.
Sensory and auditory aspects controlled for but angu-
lation of coil away from the scalp may be visually dis-
tinguishable
Adequate blinding of assessors? Unclear risk Comment: blinding of assessors not reported
Incomplete outcome data (attrition bias)
All outcomes
Low risk Quote: “All 13 patients participated in all planned ses-
sions of navigation-guided rTMS”
Comment: no dropouts observed
Selective reporting (reporting bias) Low risk Comment: while pain score numerical values not pro-
vided clearly with measures of variance for all time
points in the study report, the study authors provided
the requested data
Free from carry-over effects? Low risk Comment: not clearly demonstrated in the study re-
port but paired t-tests on unpublished baseline data
provided by the study authors suggest that carry-over
was not a significant issue
Study Size High risk Comment: < 50 participants per treatment arm
Study duration High risk Comment: < 2 weeks’ follow-up
Other bias Low risk Comment: no significant other bias detected
Sakrajai 2014
Methods Parallel RCT
Participants Country of study: Thailand
Setting: laboratory
Condition: myofascial pain syndrome (affecting shoulder)
Prior management details: stable analgesic use for 3 months preceding study
n = 31
Age mean (SD): active group 49.94 (8.25) years, sham group 45.93 (10.24) years
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Sakrajai 2014 (Continued)
Duration of symptoms, mean(SD) active group 5.91 (2.55) months, sham group 45.93
(10.24)
Gender distribution: 22 F, 9 M
Interventions Stimulation type: tDCS
Stimulation parameters: intensity 1 mA, 35 cm2 electrodes, duration 20 min
Stimulation location: anode M1 contralateral to most painful side, cathode supraorbital
area contralateral to anode
Number of treatments: x 1 daily for 5 days
Control type: sham tDCS
Outcomes Primary: pain VAS, anchors 0 = no pain, 10 = the most possible pain
When taken: post-treatment, average of daily score in week 1 postintervention, week 2,
3, 4 postintervention. Only responder analysis presented
Secondary: QoL WHO-QoL, data not reported
AEs
Notes COI: “M.P.J. is a consultant to Noninvasive Brain Stimulation Research Group of Thai-
land. The remaining authors declare no conflict of interest.”
Sources of support: “Supported in part by Grant Number R21 HD058049 from theNa-
tional Institutes ofHealth,National Institute of ChildHealth andHumanDevelopment,
Rockville, MD; and National Center for Medical Rehabilitation Research, Rockville,
MD.”
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Comment: method of sequence generation not described
Allocation concealment (selection bias) Unclear risk Comment: allocation concealment procedures not described
Adequate blinding of participants? Low risk Comment: “The tDCS device was designed to allow for masked
(sham) stimulation. Specifically, the control switch was in front
of the instrument, which was covered by an opaque adhesive
during stimulation. The power indicator was on the front of the
machine, which lit up during the time of stimulation both in
active and sham stimulations.”
Adequate blinding of assessors? Unclear risk Comment: blinding of assessors not described
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: only 1 dropout
Selective reporting (reporting bias) Low risk Comment: no numeric reporting of pain score or QoL point
estimates in the paper. All data provided by study authors upon
request
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Sakrajai 2014 (Continued)
Study Size High risk Comment: n = 31
Study duration Unclear risk Comment: 4-week follow-up postintervention
Other bias Low risk Comment: no other bias detected
Short 2011
Methods Parallel RCT
Participants Country of study: USA
Setting: laboratory
Condition: fibromyalgia
Prior management details: naive to TMS
n = 20
Age mean (SD): active group 54.2 (8.28) years, sham group 51.67 (18.19) years
Duration of symptoms, years mean (SD): active group 12.1 (7.75), sham group 10.10
(12.81)
Gender distribution: 84% F
Interventions Stimulation type: rTMS
Stimulation parameters: frequency 10 Hz; coil orientation parasagittal, number of trains
80; duration of trains 5 s; ITI 10 s, intensity 120% RMT, total number of pulses per
session 4000
Stimulation location: L DLPFC
Number of treatments: 10, x 1 daily (working days) for 2 weeks
Control type: sham coil
Outcomes Primary: pain VAS; 0 = “no pain”, 10 = “worst pain”
When taken: after 1 and 2 weeks of treatment, then 1 week and 2 weeks posttreatment
Secondary: FIQ, BPI function scale
Notes AEs: no data provided
COI: 1 researcher received research grants from the device manufacturer and holds
patents for TMS technology
Sources of support: Multidisciplinary Clinical, Research Center Grant P60 AR049459
The Office of the Provost and Vice President for Research
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Patients were randomly assigned (random generator
software developed by JJB in the Brain Stimulation Laboratory)
”
Allocation concealment (selection bias) Low risk Quote: “A co investigator not directly involved in ratings or
treatment released treatment condition to the TMS operator”
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Short 2011 (Continued)
Adequate blinding of participants? Low risk Quote: “A specially designed shamTMS coil is used for all sham
conditions that produces auditory signals identical to active coils
but shielded so that actual stimulation does not occur. However,
subjects do experience sensory stimulation that is difficult to
distinguish from real rTMS”
Comment: sensory, auditory and visual cues controlled for
Adequate blinding of assessors? Low risk Quote: “Amasked continuous rater assessed patients at baseline,
at the end of each treatment week, and at the 2 follow-up weeks.
Importantly the continuous rater did not administer the TMS,
minimizing the chances of unmasking due to events during the
TMS treatment session.”
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: no loss to follow-up
Selective reporting (reporting bias) Low risk Comment: full reporting of primary outcomes
Study Size High risk Comment: < 50 participants per treatment arm
Study duration High risk Comment: < 2 weeks’ follow-up
Other bias Low risk Comment: no other biases detected
Soler 2010
Methods Parallel RCT
Participants Country of study: Spain
Setting: laboratory
Condition: post-SCI neuropathic pain
Prior management details: stable pharmacological treatment for at least 2 weeks prior to
start of treatment. Unresponsive to medication
n = 39
Age mean (SD): 45 (15.5) years
Duration of symptoms: not reported
Gender distribution: 30 M, 9 F
Interventions Stimulation type: tDCS
Stimulation parameters: intensity 2 mA, duration 20 min
Stimulation location: M1 (contralateral to most painful side or dominant hand)
Number of treatments: 10, x 1 daily (working days) for 2 weeks
Control type: 4 groups, tDCS + visual illusion, sham tDCS + visual illusion, tDCS +
control illusion, sham tDCS + control illusion
Outcomes Primary: pain VAS; 0 = no pain, 10 = unbearable pain; mean over previous 24 h
When taken: end of treatment period, 12 and 24 d post-treatment
Secondary: BPI pain interference scale
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Soler 2010 (Continued)
Notes COI: no declaration made
Sources of support: “grants from a BBVA Translational Research Chair in Biomedicine,
the International Brain Research Foundation (IBRF) and National Institutes of Health
grant K 24 RR018875 to A.P.L., the Foundation La Marato´ TV3 (071931) and grant
PI082004 and TERCEL funds from the Instituto de Salud Carlos III”
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “We used a computer generated list as randomisation
strategy.”
Allocation concealment (selection bias) Unclear risk Comment: allocation concealment not reported
Adequate blinding of participants? Unclear risk Comment: 2mAmay threaten blinding but assessment of blind-
ing seemed OK
Adequate blinding of assessors? Unclear risk Comment: 2mA intensity used - empirical evidence that assessor
blinding may be suboptimal at this intensity
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: only 3 dropouts, 1 in each group
Selective reporting (reporting bias) Low risk Comment: all main outcomes reported
Study Size High risk Comment: < 50 participants per treatment arm
Study duration Unclear risk Comment: ≥ 2 weeks but < 8 weeks’ follow-up
Other bias Low risk Comment: no other biases detected
Souto 2014
Methods Parallel RCT
Participants Country of study: Brazil
Setting: reference centre for integrated and multidisciplinary treatment for human T-
lymphotropic virus 1 (HTLV-1) and viral hepatitis
Condition: JTLVI-infected patients with chronic low back or lower limb pain
Prior management details: stable pharmacotherapy in the preceding month
n = 20
Age, mean (SD): active group 48.8 (11.6) years, sham group 56.2 (14) years
Duration of symptoms: not reported
Gender distribution: 15 F, 5 M
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Souto 2014 (Continued)
Interventions Stimulation type: tDCS
Stimulation parameters: intensity 2 mA, 25 cm2 electrodes, duration 20 min
Stimulation location: anode L M1, cathode right supraorbital area
Number of treatments: x 1 daIly for 5 days
Control type: sham tDCS
Outcomes Primary: pain VAS; 0 = no pain, 10 = worst possible pain
When taken: postintervention, responder analysis 30%, 50% pain relief
Secondary: AEs
Notes COI: the study authors declared no COI
Sources of support: “G.S.G. was funded by FAPESB, Salvador, BA/Brazil (Fundação
de Amparo à Pesquisa do Estado da Bahia) and M.E.M by CAPES, Brasília, DF/Brazil
(Coordenação de Aperfeiçoamento Pessoal de Nível Superior)”
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Participantswere randomizedusing a stratified random-
ization strategy with pain as the stratification factor.”
Allocation concealment (selection bias) Low risk Quote “A previously generated randomization list was used to
allocate the patients to each stratum, in accordance with the
order of their entrance into the study. A researcher who was
not involved with assessments or interaction with participants
randomized and allocated the patients”
Adequate blinding of participants? Unclear risk Comment: evidence that blinding can be inadequate at intensity
of 2 mA. No formal assessment of blinding success
Adequate blinding of assessors? Unclear risk Comment: evidence that assessor blinding can be inadequate at
intensity of 2 mA. No formal assessment of blinding success
Incomplete outcome data (attrition bias)
All outcomes
High risk Comment: 2 dropouts (20%) from sham group, imputation
with LOCF
Selective reporting (reporting bias) Low risk Comment: outcomes reported adequately
Study Size High risk Comment: n = 20
Study duration High risk Comment: postintervention follow-up only
Other bias Low risk Comment: no other bias detected
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Tan 2000
Methods Cross-over RCT
Participants Country of study: USA
Setting: tertiary care teaching hospital
Condition: neuromuscular pain (excluding fibromyalgia)
Prior management details: unclear
n = 28
Age: 45-65 years, mean 55.6
Duration of symptoms: 4-45 years, mean 15
Gender distribution: 25 M, 3 F
Interventions Stimulation type: CES
Stimulation parameters: frequency 0.5 Hz; pulse width not specified; intensity 10-600
µA; waveform shape not specified
Stimulation location: ear clip electrodes
Number of treatments: 12, frequency of treatment not specified
Control type: sham CES unit indistinguishable from active unit
Outcomes Primary: VAS 0-5 pain intensity
When taken: pre- and post- each treatment
Secondary: life interference scale, sickness impact profile - Roland Scale
When taken: not specified
Notes AEs: not reported
COI: no declaration made
Sources of support: no declaration made
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “each subject was randomly assigned to receive either
the active or the sham treatment first”
Comment: method of randomisation not specified but less crit-
ical in cross-over design
Adequate blinding of participants? Low risk Quote: “sham treatment was made possible by having the treat-
ment delivered via a black box”
Comment: sham and active stimulators visually indistinguish-
able
Adequate blinding of assessors? Unclear risk Comment: blinding of assessors not reported
Incomplete outcome data (attrition bias)
All outcomes
High risk Comment: only 17 participants completed the study and this
dropout (over 50%) is not clearly accounted for in the analysis
Selective reporting (reporting bias) Low risk Comment: primary outcome data presented clearly
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Free from carry-over effects? Low risk Quote: “Note that there were no significant differences in pain
ratings pre-post changes between the active and sham groups”
Study Size High risk Comment: < 50 participants per treatment arm
Study duration High risk Comment: < 2 weeks’ follow-up
Other bias Unclear risk Comment: participants also received local stimulation to the
painful area that may have elicited a therapeutic effect
Tan 2006
Methods Parallel RCT
Participants Country of study: USA
Setting: medical centre
Condition: post-SCI pain (not clearly neuropathic)
Prior management details: unclear
n = 40
Age: 38-82 years
Duration of symptoms: chronic > 6 months
Gender distribution: all M
Interventions Stimulation type: CES
Stimulation parameters: frequency not specified; pulse width not specified; intensity
100-500 µA; waveform shape not specified; duration 1 h per session
Stimulation location: ear clip electrodes
Number of treatments: 21, x 1 daily for consecutive days
Control type: sham CES unit indistinguishable from active unit
Outcomes Primary: BPI (0-10 NRS), anchors “no pain” to “pain as bad as you can imagine”
When taken: post-treatment period
Secondary: pain interference subscale of BPI
When taken: as for primary outcome
Notes AEs: not reported
COI: no declaration made
Sources of support: no declaration made
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “The participants were then randomly assigned to either
the active or sham CES treatment groups”
Comment: method of randomisation not specified
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Tan 2006 (Continued)
Allocation concealment (selection bias) Unclear risk Comment: allocation concealment not specified
Adequate blinding of participants? Low risk Comment: see quote above
Adequate blinding of assessors? Low risk Quote: “The investigators,research assistant (RA), and partici-
pants were blinded to treatment type until the end of the initial
phase.”
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: only 2 (5%) participants withdrew from the study.
Unlikely to have strongly influenced the findings
Selective reporting (reporting bias) Low risk Comment: primary outcomes presented clearly and in full
Study Size High risk Comment: < 50 participants per treatment arm
Study duration High risk Comment: < 2 weeks’ follow-up
Other bias Low risk Comment: no significant other bias detected
Tan 2011
Methods Parallel RCT
Participants Country of study: USA
Setting: 4 Veterans Affairs medical centres and 1 private rehabilitation clinic
Condition: post-SCI neuropathic pain
Prior management details: not reported
n = 105
Age mean (SD): active group 52.1 (10.5) years, sham group 52.5 (11.7) years
Gender distribution: 90 M, 15 F
Interventions Stimulation type: CES
Stimulation parameters: frequency not specified; pulse width not specified; intensity 100
µA; waveform shape not specified; duration 1 h per session
Stimulation location: earlobe clips
Number of treatments: 21, x 1 daily
Control type: sham CES unit indistinguishable from active unit
Outcomes Primary: BPIpain intensity VAS 0-100, anchors not reported
When taken: at end of treatment period
Secondary: QoL SF-12 physical and mental component subscales
Notes COI: study authors declared no COI
Sources of support: funded by Veterans Affairs rehabilitation research and development
service
Risk of bias
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Tan 2011 (Continued)
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “The equipment was set up for a double-blind study by
the manufacturer such that the participants could not differ-
entiate active from sham CES devices. Research staff members
who interacted with the participants (e.g. recruited and trained
participants, administered questionnaires, followed up by tele-
phone) did not know which devices were sham and which were
active. Randomization was achieved by selecting a device from
a box initially containing equal numbers of active and sham de-
vices.”
Comment: whilst unconventional it appeared to avoid a system-
atic bias
Allocation concealment (selection bias) Low risk Comment: see quote/comment above
Adequate blinding of participants? Low risk Comment: stimulation subsensory and units indistinguishable
Adequate blinding of assessors? Low risk Comment: stimulation subsensory and units indistinguishable
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: available case analysis with small loss to follow-up
Selective reporting (reporting bias) Low risk Comment: key outcomes fully reported
Study Size Unclear risk Comment: > 50 but < 200 participants per treatment condition
Study duration High risk Comment: < 2 weeks’ follow-up
Other bias Unclear risk Comment: baseline between-group imbalances on BPI pain in-
terference, SF-36 pain subscale and coping strategies
Taylor 2013
Methods Parallel RCT
Participants Country of study: USA
Setting: community rheumatology practices
Condition: fibromyalgia
Prior management details: not reported but continued stable medication usage
n = 57 (46 after dropout)
Age mean (SD): active group 51 (10.6) years, sham group 51.5 (10.9) years, usual care
group 48.6 (9.8) years
Duration of symptoms: not reported
Gender distribution: 43 F, 3 M (data reported on completers)
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Interventions Stimulation type: CES
Stimulation parameters: frequency 0.5 Hz; pulse width not specified; intensity 100 µA;
waveform shape square wave biphasic, duration 1 h per session
Stimulation location: earlobe clip electrodes
Number of treatments: x 1 daily for 8 weeks
Control type: sham CES unit indistinguishable from active unit
Outcomes Primary: pain VAS, anchors not reported
When taken: at the end of each week of treatment period
Secondary: FIQ
Notes COI: no declaration made
Sources of support: University of Virginia. Center for the study of Complementary and
Alternative Therapies. Devices loaned by Electromedical Products International
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Comment: described as randomised but method of randomisa-
tion not reported
Allocation concealment (selection bias) Unclear risk Comment: allocation concealment not reported
Adequate blinding of participants? Low risk Comment: identical devices given to sham and active group with
subsensory stimulation parameters
Adequate blinding of assessors? Low risk Comment: participants self-rated at home
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: of 57, 11 did not complete - unclear if ITT analysis
employed. However, only 2-4 per group and balanced, mostly
due to assessment burden
Selective reporting (reporting bias) Low risk Comment: while no numeric data were provided on primary
outcomes in the study report, these data were provided upon
request to the authors
Study Size High risk Comment: < 50 participants per treatment arm
Study duration High risk Comment: < 2 weeks’ follow-up
Other bias Low risk Comment: no other source of bias detected
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Tekin 2014
Methods Parallel RCT
Participants Country of study: Turkey
Setting: Rehabilitation outpatient unit
Condition: fibromyalgia
Prior management details: no analgesic use for 1 month prior to enrolment
n = 51
Age mean (SD): active group 42.4 (78.63) years, sham group 46.5 (8.36) years
Duration of symptoms: mean (SD) active group 10.81 (6.31) years, sham group 13.33
(6.65)
Gender distribution: 47 F, 4 M
Interventions Stimulation type: rTMS
Stimulation parameters: frequency 10 Hz; coil orientation 45º angle from the midline,
100% RMT number of trains 30; duration of trains 5 s; ITI 12 s; total number of pulses
1500
Stimulation location: M1 midline, no neuronavigation
Number of treatments: 10 sessions daily - unclear whether only work days
Control type: sham coil - same sound and appearance, no control for sensory cues
Outcomes Primary: pain NRS anchors 0 = no pain, 10 = most severe pain
When taken: end of intervention
Secondary: WHQoL-BREF
Notes Funding source: none reported
COI: the study authors declared no COI
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote “Randomisation was completed with the help of a soft-
ware programme that produces random allocation”
Allocation concealment (selection bias) Unclear risk Comment: allocation concealment not reported
Adequate blinding of participants? Unclear risk Comment: placebo coil did not control for the sensory aspects of
stimulation. No formal assessment of blinding success reported
Adequate blinding of assessors? Low risk Quote: “the investigator who conducted the clinical evaluation
received no information about patient admission, randomisa-
tion or mode of treatment”
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: only 1 participant lost to follow-up
Selective reporting (reporting bias) Low risk Comment: no suggestion of selective outcome reporting
Study Size High risk Comment: 25 and 27 participants in each group
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Tekin 2014 (Continued)
Study duration High risk Comment: only immediate postintervention follow-up
Other bias Low risk Comment: no other bias detected
Thibaut 2017
Methods Parallel RCT
Participants Country of study: USA
Setting: laboratory
Condition: post-SCI neuropathic pain (sublesion)
Prior management details: not reported
n = 33 (14 after loss to follow-up in phase one)
Age, mean (SD): active group 51.38 (14.89) years, sham group 51 (10.11) years
Duration of symptoms: not reported
Gender distribution: 24 M, 9 F
Interventions Stimulation type: tDCS
Stimulation parameters:
tDCS: 2 mA intensity, 20 min
Stimulation location: M1 contralateral to painful side
Number of treatments: x1 daily for 5 days in phase one. Phase 2 not relevant to this
review
Control type: sham tDCS
Outcomes Primary: pain VAS anchors 0 = no pain 10 = pain as bad as you can imagine
When taken: postintervention, 1 week postintervention, 3 months postintervention
Secondary: QoL (PHQ-9)
AEs
Notes Funding source: this project was supported by the National Institute on Disability,
Independent Living, and Rehabilitation Research (NIDILRR grant numbers 90DP0035
and H133N110010)
COI: study authors declared no COI
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Comment: method of randomisation not reported
Allocation concealment (selection bias) Unclear risk Comment: allocation concealment not reported
Adequate blinding of participants? Unclear risk Comment: blinding can be compromised at 2 mA intensity. No
formal blinding assessment reported
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Adequate blinding of assessors? Unclear risk Comment: blinding can be compromised at 2 mA intensity. No
formal blinding assessment reported
Incomplete outcome data (attrition bias)
All outcomes
High risk Comment: while ITT analysis reported with multiple imputa-
tion, at the end of phase one, dropout was 57%
Selective reporting (reporting bias) Low risk Comment: data reported adequately
Study Size High risk Comment: n = 33 (14 after loss to follow-up)
Study duration Low risk Comment: 3-month follow-up for phase 1
Other bias Low risk Comment: no other bias detected
Tzabazis 2013
Methods Unclear, likely parallel RCT (for 1 Hz only), 10 Hz data open-label therefore excluded
from this review
Participants Country of study: USA
Setting: not reported, likely laboratory
Condition: fibromyalgia
Prior management details: “moderate to severe despite current and stable treatment
regime”
n = unclear, abstract report (Schneider 2012 (see Tzabazis 2013)) stated 45, but full
paper stated 16
Age mean (SD): 53.2 (8.9) years
Duration of symptoms, years mean (SD): not reported
Gender distribution: 14 F, 2 M
Interventions Stimulation type: rTMS 4-coil configuration
Stimulation parameters: frequency 1 Hz; no of trains not reported; duration of trains
not reported; ITI not reported, intensity 110% RMT, total number of pulses per session
1800, stimulation duration 30 min
Stimulation location: targeted to the anterior cingulate cortex
Number of treatments: 20, x 1 daily (working days) for 4 weeks
Control type: sham coil
Outcomes Primary: BPI average pain last 24 h, NRS, anchors not reported
When taken: end of treatment, 4 weeks post-treatment
Secondary: FIQ
Notes COI: 3 study authors have acted as paid consultants to the manufacturer of the stimu-
lation device, of which 2 hold stock in the company and 1 founded the company, is its
chief medical officer and has intellectual property rights
Sources of support: no declaration made
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Tzabazis 2013 (Continued)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Comment: no description of the sequence
generation process used
Allocation concealment (selection bias) Unclear risk Comment: no description of allocation
concealment
Adequate blinding of participants? Unclear risk Comment: no description of blinding of
participants for clinical part of study. Sham
coil controlled for auditory cues andwas vi-
sually indistinguishable from active stimu-
lation but did not control for sensory char-
acteristics of active stimulation over the
scalp
Adequate blinding of assessors? Unclear risk Comment: no description or mention of
blinding assessors for clinical part of study
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Comment: no mention of the degree of
dropout or how it was managed. However,
45 participants with fibromyalgia reported
in the abstract of the same study (Schnei-
der 2012 (Tzabazis 2013)), but only 16 re-
ported in the full paper
Selective reporting (reporting bias) High risk Comment: no presentation of numeric
pain data with measures of variance
Study Size High risk Comment: < 50 participants per treatment
arm
Study duration Unclear risk Comment: ≥ 2 weeks but < 8 weeks’ fol-
low-up
Other bias Unclear risk Comment: baseline and demographic data
not presented for clinical group
Umezaki 2016
Methods Parallel RCT
Participants Country of study: USA
Setting: not reported
Condition: burning mouth syndrome
Prior management details: not reported
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n = 26
Age mean (SD): active group 63.36 (10.78) years, sham group 64.42 (8.35) years
Duration of symptoms, mean (SD): active group 61.57 (32.10) months, sham group
65.58 (55.52)
Gender distribution: active group 93% F, sham group 92% F
Interventions Stimulation type: rTMS
Stimulation parameters: frequency 10 Hz; coil orientation not specified, 100% RMT,
number of trains 10; duration of trains 5 s; ITI 10 s; total number of pulses 3000
Stimulation location: L DLPFC
Number of treatments: 10 x 1 daily on work days
Control type: sham coil - same sound and appearance and sensory cues
Outcomes Primary: pain NRS anchors 0 = no pain, 10 = extreme amount
When taken: end of stimulation and 15, 30, 60 days after start of treatment
Secondary: AEs
Notes Funding source: no information provided
COI: no information provided
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Patients who met all inclusion criteria were randomly
assigned to one of two groups - one given active and the other
sham stimulation - using a web-based randomization generator”
Allocation concealment (selection bias) Unclear risk Comment: allocation concealment procedures not reported
Adequate blinding of participants? Low risk Comment: sham controls for all aspects of stimulation
Quote: “The coil used in the sham group was the same config-
uration as that used with the real group but shielded so that ac-
tual stimulation does not occur. All subjects had ECT electrodes
placed under the TMS coil. For those receiving active TMS,
the electrodes were disconnected, such that there was no current
flowing through during stimulation. In contrast, the electrodes
were connected during sham, so participants received a small
electrical stimulation through the electrodes, precisely when the
TMS was being triggered.”
“Ten of 12 (83%) patients in the real group and 4 of 8 (50%)
patients in the sham group thought that they were in the real
group. There was no significant difference for the belief of the
allocated group between two groups (χ2 = 2.54,1, NS), sug-
gesting that blinding for the subjects in this study was kept. The
high percentage of correct guessing in the active group is con-
cerning. However, when asked why they guessed the way they
did, it was based on whether they had BMS symptom reduction.
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Umezaki 2016 (Continued)
If this occurred, then they guessed the active group. There were
no instances of patient unblinding.”
Adequate blinding of assessors? High risk Comment: assessor was not blinded to group allocation
Incomplete outcome data (attrition bias)
All outcomes
High risk Comment: 2/14 (14%) randomised did not receive active stim,
4/12 (33%) randomised to sham did not receive sham. Excluded
from the analysis
Selective reporting (reporting bias) High risk Comment: pain intensity data only presented in graphical form
without numeric point estimates/precision estimates
Study Size High risk Comment: combined n = 26 (per protocol = 20)
Study duration Unclear risk Comment: 7-week follow-up
Other bias Low risk Comment: no other risks of bias detected
Valle 2009
Methods Parallel RCT, 3 conditions
Participants Country of study: Brazil
Setting: laboratory
Condition: fibromyalgia
Prior management details: refractory to medical intervention
n = 41
Age: mean 54.8 (SD 9.6) years
Duration of symptoms: condition 1: 7.54 (SD 3.93) years; condition 2: 8.39 (SD 2.06)
years; condition 3: 8.69 (SD 3.61) years
Gender distribution: 0 M, 41 F
Interventions Stimulation type: tDCS
Stimulation parameters: intensity 2 mA, 35 cm2 electrodes, duration 20 min
Stimulation location: condition 1: L DLPFC; condition 2: L M1, condition 3; sham L
M1
Number of treatments: 10, x 1 daily on consecutive working days
Control type: sham tDCS (switched off after 30 s stimulation)
Outcomes Primary: pain VAS 0-10 cm, anchors not specified
When taken: immediately post-treatment, averaged over 3 d post-treatment, 30 and 60
d post-treatment
Secondary: QoL; FIQ
Notes COI: no declaration made
Sources of support: no declaration made
Risk of bias
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Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Randomization was performed using the order of
entrance in the study and a previous randomisation list
generated by a computer”
Allocation concealment (selection bias) Low risk Comment: the use of a pregenerated randomisation list
should have adequately ensured this
Adequate blinding of participants? Unclear risk Comment: there is evidence that participant blinding of
tDCSmay be inadequate at 2mA intensity (see Assessment
of risk of bias in included studies)
Adequate blinding of assessors? Unclear risk Comment: there is evidence that assessor blinding of tDCS
may be inadequate at 2 mA intensity (see Assessment of
risk of bias in included studies)
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: no dropout occurred
Selective reporting (reporting bias) High risk Comment: pain score numerical values not provided
clearly with measures of variance for any post-treatment
time point in the study report
Study Size High risk Comment: < 50 participants per treatment arm
Study duration Low risk Comment: ≥ 8 weeks’ follow-up
Other bias Low risk Comment: no significant other bias detected
Villamar 2013
Methods Cross-over RCT
Participants Country of study: USA
Setting: laboratory
Condition: fibromyalgia
Prior management details: pain refractory to common analgesics and muscle relaxants
n = 18 randomised of which 17 allocated
Age mean (SD): 50.3 (8.5) years
Duration of symptoms (years) mean (SD): 10.7 (6.8)
Gender distribution: 15 F, 3 M
Interventions Stimulation type: HD-tDCS
Stimulation parameters: intensity 2 mA, duration 20 min, anodal/cathodal/sham 4 x 1-
ring configuration
Stimulation location: L M1
Number of treatments: x 1 per condition
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Villamar 2013 (Continued)
Control type: sham tDCS
Outcomes Primary: pain visual numerical scale; 0 = complete absence of pain, 10 = worst pain
imaginable
When taken: baseline, immediately poststimulation, 30 min poststimulation
Secondary: adapted QoL scale for persons with chronic illness (7 points: 1 = terrible, 7
= delighted)
Notes COI: no declaration made
Sources of support: no declaration made
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “the order of stimulation was counterbalanced and ran-
domly assigned for each individual”
Comment:method of randomisation not specified but less likely
to introduce bias in a cross-over design
Adequate blinding of participants? Unclear risk Comment: there is evidence that participant blinding of tDCS
may be inadequate at 2 mA intensity (see Assessment of risk of
bias in included studies)
Adequate blinding of assessors? Unclear risk Comment: there is evidence that participant blinding of tDCS
may be inadequate at 2 mA intensity (see Assessment of risk of
bias in included studies)
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: only 1 loss to follow-up and multiple imputation
used
Selective reporting (reporting bias) Low risk Comment: primary outcomes reported in full
Free from carry-over effects? Low risk Comment: 7-day washout periods observed. Data similar at
baseline
Study Size High risk Comment: < 50 participants per treatment arm
Study duration High risk Comment: < 2 weeks’ follow-up
Other bias Low risk Comment: no other bias detected
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Volz 2016
Methods Parallel RCT
Participants Country of study: Germany
Setting: laboratory
Condition: chronic abdominal pain with inflammatory bowel disease
Prior management details: participants allowed to continue anti-inflammatory drugs and
acute pain medication
n = 20
Age, mean (SD) active group 40.6 (12.5) years, sham group 34.4 (13.2) years
Duration of symptoms: active group 10 (8.9) years, sham group 34.4 (13.2)
Gender distribution: 13 F, 7 M
Interventions Stimulation type: tDCS
Stimulation parameters: intensity 2 mA, 35 cm2 electrodes, duration 20 min
Stimulation location: anode M1 contralateral to painful side, cathode supraorbital area,
contralateral to anode
Number of treatments: x 1 daIly for 5 days
Control type: sham tDCS
Outcomes Primary: pain VAS, anchors 0 = no pain, 10 = the worst pain possible
When taken: postintervention, 1 week postintervention
Secondary: inflammatory bowel disease QoL questionnaire
AEs
Notes COI: study authors declared no COI
Sources of support: ”This study has been supported by the grant “Patientenorientierte
Forschung beiCED2014” of the “DeutscheMorbusCrohn/Colitis ulcerosaVereinigung
e.V.” (Not industry)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Randomization was performed by the unblinded re-
searcher (A.F.) in blocks of 4 generated from a computer-based
random allocation.”
Allocation concealment (selection bias) Unclear risk Quote: “Quote: “Randomization was performed by the un-
blinded researcher (A.F.)”
Comment: no apparent steps to conceal allocation
Adequate blinding of participants? Unclear risk Evidence that assessor blinding can be inadequate at intensity of
2 mA. No formal assessment of blinding success
Adequate blinding of assessors? Unclear risk Evidence that assessor blinding can be inadequate at intensity of
2 mA. No formal assessment of blinding success
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Comment: levels of dropout, if any, not reported
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Volz 2016 (Continued)
Selective reporting (reporting bias) Low risk Comment: outcomes reported adequately
Study Size High risk Comment: n = 20
Study duration High risk Comment: 1-week postintervention maximum follow-up.
Other bias Low risk Comment: no further bias detected
Wrigley 2014
Methods Cross-over RCT
Participants Country of study: Australia
Setting: laboratory
Condition: chronic neuropathic pain post-SCI
Prior management details; none
n = 10
Age mean (SD): 56.1 (14.9) years
Duration of symptoms: 15.8 (11.3) years
Gender distribution: 8 M, 2 F
Interventions Stimulation type: tDCS
Stimulation parameters: intensity 2 mA, duration 20 min
Stimulation location: M1 (contralateral to most painful side or dominant hand)
Number of treatments: 5, x 1 daily 5 days
Control type: sham tDCS (switched off after 30 s stimulation)
Outcomes Primary: pain VAS; 0 = “no pain”, 10 = “worst possible pain”
When taken: at end of treatment, 4 weeks post-treatment
Secondary: none relevant
Notes COI: no declaration made
Sources of support: no declaration made
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Comment: method of randomisation not specified but less im-
portant for cross-over design
Quote: “A randomized crossover design was used so that all sub-
jects participated in an active treatment (transcranial direct cur-
rent stimulation) and sham treatment period. Both the subject
and the response assessor were blinded to the randomization se-
quence.”
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Wrigley 2014 (Continued)
Adequate blinding of participants? Unclear risk Comment: there is evidence that participant blinding of tDCS
may be inadequate at 2 mA intensity (see Assessment of risk of
bias in included studies)
Adequate blinding of assessors? Unclear risk Comment: there is evidence that assessor blinding of tDCS may
be inadequate at 2 mA intensity (see Assessment of risk of bias
in included studies)
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: no loss to follow-up
Selective reporting (reporting bias) Low risk Comment: primary outcomes reported in full
Free from carry-over effects? Low risk Comment: 4-week washout period observed and data appear
free of carry-over effects
Study Size High risk Comment: < 50 participants per treatment arm
Study duration Unclear risk Comment: ≥ 2 weeks but < 8 weeks’ follow-up
Other bias Low risk Comment: no other bias detected
Yagci 2014
Methods Parallel RCT
Participants Country of study: Turkey
Setting: not reported
Condition: fibromyalgia
Prior management details: no improvement in cases of using medical treatment for
fibromyalgia for at least 3 months
n = 28
Age mean (SD): active group 45.25 (9.33) years, sham group 43 (7.63) years
Duration of symptoms, mean(SD): active group 53 (29.15) months, sham group 54.92
(30.44)
Gender distribution: all F
Interventions Stimulation type: rTMS
Stimulation parameters: frequency 1 Hz; coil orientation not reported, 90% RMT,
number of trains 20; duration of trains 60 s; ITI 45 s; total number of pulses 1200
Stimulation location: L M1, no neuronavigation
Number of treatments: 10 sessions, weekdays for 2 weeks
Control type: sham coil - same sound and appearance, no control for sensory cues
Outcomes Primary: pain NRS anchors 0 = no pain, 10 = maximum pain imaginable
When taken: end of intervention, 1 month, 3 months
Secondary: FIQ
AEs
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Yagci 2014 (Continued)
Notes Funding source: the study authors declared that this study received no financial support
COI: no COI was declared by the authors
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Comment: method of randomisation not outlined
Quote: “patients were randomly assigned to be in either a real
stimulation group or a sham stimulation group by another clin-
ician”
Allocation concealment (selection bias) Low risk Quote: “masked clinician evaluated the patients clinically and
provided the diagnosis of FM. The patients were randomly as-
signed to be in either a real stimulation group or a sham stimu-
lation group by another clinician.”
Adequate blinding of participants? Unclear risk Comment: sham coil did not control for sensory aspects of stim-
ulation
Quote: “Sham stimulation was carried out with the same
parabolic coil, which was placed at 90° angles to the motor cor-
tex area”
Adequate blinding of assessors? Low risk Quote: “A masked clinician evaluated the patients clinically and
provided the diagnosis of FM [fibromyalgia]”
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Comment: 3 participants dropped out though this exceeds 10%
of total number, the group they withdrew from and point of
withdrawal were not clear
Selective reporting (reporting bias) Low risk Comment: outcomes adequately reported
Study Size High risk N = 28 (per protocol 25)
Study duration Low risk Comment: 3-month follow-up
Other bias Low risk Comment: no other risk of bias detected
Yilmaz 2014
Methods Parallel RCT
Participants Country of study: Turkey
Setting: rehabilitation unit
Condition: post-SCI below lesion neuropathic pain
Prior management details: pain that is resistant to pharmacological (anticonvulsants,
antidepressants, narcotics) and interventional treatments
n = 17
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Age mean (SD): active group: 40 (5.1) years, sham group 36.94 (8) years
Duration of symptoms mean (SD): active group 32.3 (25.9) months, sham group 35.4
(17.9)
Gender distribution: all M
Interventions Stimulation type: rTMS
Stimulation parameters: frequency 10 Hz; coil orientation handle pointing posteriorly,
number of trains 30; duration of trains 5 s; ITI 25 s; total number of pulses 1500
Stimulation location: M1 midline
Number of treatments: daily for 10 weekdays
Control type: coil angled away - same sound and appearance, did not control for visual
or sensory cues
Outcomes Primary: pain NRS anchors 0 = no pain, 10 = worst pain imaginable
When taken: end of intervention, 6 weeks, 6 months postintervention
Secondary: none relevant
Notes Funding source: no information reported
COI: no information reported
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “A computer-generated randomization schedule was
used.”
Allocation concealment (selection bias) Unclear risk Comment: allocation concealment not reported
Adequate blinding of participants? Unclear risk Comment: sham condition did not control for visual or sensory
aspects of stimulation
Adequate blinding of assessors? Low risk Quote: “The patients and the researcher evaluating the patients
were blinded to type of rTMS.”
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: only one participant dropped out
Selective reporting (reporting bias) Low risk Comment: key outcomes adequately reported
Study Size High risk Comment: n = 16
Study duration Low risk Comment: 6-month follow-up
Other bias Low risk Comment: no other bias detected
AE: adverse event; ANOVA: analysis of variance; BIRS: Gracely Box Intensity Scale (BIRS); BOCF: baseline observation carried
forward; BPI: Brief Pain Inventory; CES: cranial electrotherapy stimulation; CNP: central neuropathic pain; COI: conflict of
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interest; CPSP: central poststroke pain; CRPS: complex regional pain syndrome;DLPFC: dorsolateral prefrontal cortex; F: female;
FIQ: Fibromyalgia Impact Questionnaire; HD-tDCS: High definition tDCS; ITI: inter-train interval; ITT: intention-to-treat; L:
left; LANSS: Leeds Assessment of Neuropathic Symptoms and Signs pain scale; LOCF: last observation carried forward; M: male;
M1: primarymotor cortex;MCS: motor cortex stimulation (MCS);NIH: National Institutes ofHealth;NRS: numerical rating scale;
NSAIDS: nonsteroidal anti-imflammatory drugs;OA: osteoarthritis;PFC: prefrontal cortex;PLP: phantom limbpain;QoL:Quality
of Life; R: right; RCT: randomised controlled trial; RINCE: reduced impedance non-invasive cortical electrostimulation; RMDQ:
Roland Morris Disability Questionnaire; RMT: resting motor threshold; rTMS: repetitive transcranial magnetic stimulation; SCI:
spinal cord injury; SII: secondary somatosensory area; SD: standard deviation; TCES: transcranial electrical stimulation; tDCS:
transcranial direct current stimulation; TENS: transcutaneous electrical nerve stimulation; TMS: transcranial magnetic stimulation;
VAS: visual analogue scale;WOMAC: Western Ontario and McMaster Universities Arthritis Index
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Avery 2007 The duration of painful symptoms is unclear. May not be exclusively chronic pain
Belci 2004 Pain is not measured as an outcome
Bolognini 2013 Inclusion of acute and chronic pain patients
Bolognini 2015 Not clearly a chronic population
Carraro 2010 Not a study of electrical brain stimulation
Choi 2012b Study of acute pain
Choi 2012a Study of acute pain
Choi 2014 Not clearly a chronic population
Cummiford 2016 Allocation not randomised
Evtiukhin 1998 A study of postoperative pain. No sham control employed
Frentzel 1989 Not a study of brain stimulation
Hargrove 2012b Uncontrolled long-term follow-up data from Hargrove 2012a
Johnson 2006 Self-reported pain is not measured
Katz 1991 Study not confined to chronic pain
Khedr 2015 Not clearly a chronic population
Lindholm 2015 Allocation not randomised
Longobardi 1989 Not clearly studying chronic pain
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(Continued)
Ma 2015 Not clearly a chronic population
Maestu 2013 Not electrical brain stimulation - magnetic fields unlikely to induce electrical currents
Morin 2017 Not clearly a chronic pain population - provoked vestibulodynia
Nelson 2010 Intervention not designed to alter cortical activity directly by electrical stimulation - a neuro feedback intervention
O’Connell 2013 Not a RCT or quasi-RCT - no randomisation specifically to treatment group or order
Pujol 1998 Participants are a mixture of acute and chronic pain patients
Schabrun 2014 Not clearly a chronic population
Seada 2013 No sham control employed
Sichinava 2012 No sham control employed
Silva 2007 A single case report
Smania 2005 Not a study of brain stimulation
Yoon 2014 Allocation not randomised
Zaghi 2009 Single case study
RCT: randomised controlled trial
Characteristics of studies awaiting assessment [ordered by study ID]
Acler 2012
Methods Parallel RCT
Participants Post-polio patients, n = 32
Interventions tDCS, bi-anodal, bilateral motor cortex, 1.5 mA, 20 min, daily for 5 days
Outcomes Pain, QoL
Notes Published as conference abstract only. Attempts to contact study authors currently unsuccessful
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Albu 2011
Methods Sham-controlled study, unclear whether randomised
Participants Post-SCI chronic neuropathic pain, n = 30
Interventions tDCS motor cortex, 2 mA, 10 sessions
Outcomes Pain intensity
Notes Published as conference abstract only. Attempts to contact study authors currently unsuccessful
Fricova 2009
Methods Sham-controlled trial, unclear whether randomised
Participants Chronic neurogenic orofacial pain, n = 26
Interventions rTMS motor cortex, frequency unclear, appears to be a single session of stimulation per condition
Outcomes Pain VAS
Notes Published as conference abstract only. Attempts to contact study authors currently unsuccessful
Fricova 2011
Methods Sham-controlled trial, unclear whether randomised, likely to be a cross-over design
Participants Chronic neurogenic orofacial pain, n = 26
Interventions rTMS motor cortex, frequency unclear, appears to be a single session of stimulation per condition
Outcomes Pain VAS
Notes Published as conference abstract only. Likely to be a duplicate report of Fricova 2009. Attempts to contact study
authors currently unsuccessful
Fricová 2013
Methods Sham-controlled parallel trial - unclear if randomised
Participants Chronic orofacial pain n = 59
Interventions rTMS, 10 Hz and 20 Hz, location not clear
Outcomes Pain VAS
Notes Published as conference abstract only. Attempt to contact study authors currently unsuccessful
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Hwang 2015
Methods Parallel RCT
Participants CRPS type I, n = 18
Interventions rTMS, 10 Hz, 10 treatment sessions
Outcomes Pain, disability, QoL
Notes Published as conference abstract only. Attempts to contact study author currently unsuccessful
Klirova 2010
Methods Parallel RCT
Participants Neuropathic orofacial pain, n = 29
Interventions rTMS, motor cortex, 10 Hz, 5 treatment sessions
Outcomes Pain VAS
Notes Published as conference abstract only. Attempts to contact study authors currently unsuccessful
Klirova 2011
Methods Parallel RCT
Participants Neuropathic orofacial pain, medication resistant, n = 29
Interventions rTMS, motor cortex, 10 Hz, 5 treatment sessions
Outcomes Pain VAS
Notes Published as conference abstract only. Likely to be a duplicate report of Klirova 2010. Attempts to contact authors
currently unsuccessful
Knotkova 2011
Methods Parallel RCT
Participants CRPS type I, n = 25
Interventions tDCS, motor cortex, 2 mA, 20 min per session, daily for 5 days
Outcomes Pain, QoL, physical activity
Notes Currently published as conference abstract only. Correspondence with study authors - data unavailable as currently
being re-analysed
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Mattoo 2017
Methods Parallel RCT
Participants Fibromyalgia n = 50
Interventions Low-frequency rTMS DLPFC
Outcomes Pain
Notes Published as conference abstract only. Attempt to contact study authors currently unsuccessful
Moreno-Duarte 2013a
Methods Cross-over RCT
Participants Post-SCI pain, n = 6
Interventions tDCS and visual illusion
Outcomes Pain
Notes Published as conference abstract only. Attempt to contact study authors currently unsuccessful
Mylius 2013
Methods Parallel RCT
Participants Chronic neuropathic pain
Interventions Low-frequency rTMS, M1 or DLPFC
Outcomes Pain
Notes Published as conference abstract only. Attempts to contact study authors currently unsuccessful
Parhizgar 2011
Methods Parallel RCT
Participants Current and former opioid abusers - pain status unclear. n = 60
Interventions tDCS M1, number of sessions unclear
Outcomes Not clear whether pain intensity was measured
Notes Published as conference abstract only. Attempts to contact study authors currently unsuccessful
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Pellaprat 2012
Methods Cross-over RCT
Participants Parkinson’s disease with related pain, n = 19
Interventions rTMS 20 Hz motor cortex, ? whether single session
Outcomes Pain VAS
Notes Published as conference abstract only. Attempts to contact study authors currently unsuccessful
Shklar 1997
Methods Unable to retrieve study report
Participants -
Interventions -
Outcomes -
Notes -
Tanwar 2016
Methods Parallel RCT
Participants Fibromyalgia n = 48
Interventions Low-frequency rTMS DLPFC
Outcomes Pain
Notes Published as conference abstract only. Attempt to contact study authors currently unsuccessful
Vatashsky 1997
Methods Unable to retrieve study report
Participants -
Interventions -
Outcomes -
Notes -
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Williams 2014
Methods Parallel RCT
Participants Fibromyalgia n = 20
Interventions rTMS, L DLPFC, 10 treatment sessions
Outcomes ? whether pain intensity measured as an outcome
Notes Published as conference abstract only. Attempt to contact study authors currently unsuccessful
CRPS: complex regional pain syndrome;DLPFC: dorsolateral prefrontal cortex; FIQ: Fibromyalgia Impact Questionnaire: L: left;M1:
primary motor cortex; QoL: quality of life; RCT: randomised controlled trial; rTMS: repetitive transcranial magnetic stimulation;
SCI: spinal cord injury; tDCS: transcranial direct current stimulation; VAS: visual analogue scale
Characteristics of ongoing studies [ordered by study ID]
ACTRN12612001155886
Trial name or title Investigating the role of transcranial direct current stimulation for pain relief in fibromyalgia and myalgic
encephalomyelitis/chronic fatigue syndrome patients
Methods Parallel RCT
Participants Fibromyalgia syndrome
Myalgic encephalomyelitis/chronic fatigue syndrome
Interventions tDCS
Sham tDCS
Outcomes Pain, fatigue, FIQ, stimulation condition
Starting date
Contact information Ms Hannah Bereznicki, hannah.bereznicki@deakin.edu.au
Notes TRIAL WITHDRAWN
ACTRN12613000561785
Trial name or title The effectiveness of repetitive transcranial magnetic stimulation in the treatment of fibromyalgia
Methods Parallel RCT
Participants Fibromyalgia
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ACTRN12613000561785 (Continued)
Interventions rTMS to DLPFC 10 Hz
sham rTMS
Outcomes Pain severity
QoL
Starting date 17 May 2013
Contact information Dr Bernadette Fitzgibbon, bernadette.fitzgibbon@monash.edu
Notes Correspondence with authors 21 December 2016 - data collection ongoing
ACTRN12613001232729
Trial name or title Modulation of chronic pain perception with noninvasive central and peripheral nervous system stimulation
Methods RCT
Participants Chronic musculoskeletal pain
Interventions Intervention group 1: participants receive tDCS and TENS only
Comparator group 1: participants receive tDCS and sham TENS only
Comparator group 2: participants receive TENS and sham tDCS only
Control group 1: participants receive sham tDCSand sham TENS only
Outcomes Pain VAS
WHO-QOL
Starting date 11 November 2013
Contact information Prof Allan Abbott, aabbott@bond.edu.au
Notes Correspondence with authors 22 December 2016- trial did not go ahead due to “changes in project personnel
and funding.”
ACTRN12614001247662
Trial name or title The effects of non-invasive brain stimulation on chronic arm pain
Methods RCT
Participants Neuropathic pain in the upper limb
Interventions tDCS
Sham
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ACTRN12614001247662 (Continued)
Outcomes Arm pain
Upper limb function
Starting date 16 April 2014
Contact information A/Prof Gwyn Lewis, gwyn.lewis@aut.ac.nz
Notes Correspondence with authors 21 December 2016, data collection ongoing
ACTRN12615000110583
Trial name or title The impact of non-invasive brain stimulation on motor cortex excitability and cognition in chronic lower
back pain
Methods RCT
Participants Chronic low back pain
Interventions tDCS
Sham
Outcomes Pain,
HR-QoL
Starting date 9 March 2015
Contact information Dr Andrea Loftus, andrea.loftus@curtin.edu.au
Notes Correspondence with authors 3 January 2017, data collection ongoing
ACTRN12616000624482
Trial name or title Safety and feasibility of transcranial direct current stimulation (tDCS) combined with sensorimotor retraining
in chronic low back pain: a pilot randomised controlled trial
Methods RCT
Participants Chronic nonspecific low back pain
Interventions tDCS + sensorimotor training
sham tDCS + sensorimotor training
Outcomes Pain severity
Physical function
Starting date 8 August 2016
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ACTRN12616000624482 (Continued)
Contact information Dr Siobhan Schabrun, s.schabrun@westernsydney.edu.au
Notes Correspondance with authors 22 December 2016, trial beginning recruitment
Ansari 2013
Trial name or title
Methods Parallel RCT
Participants Fibromyalgia, n = 118
Interventions rTMS right DLPFC, low-frequency, 20 sessions
Outcomes Unclear whether self-reported pain scores were collected
Starting date
Contact information
Notes Published as conference abstract only. Correspondance with study authors - paper currently in press awaiting
publication
ChiCTR-INR-17011706
Trial name or title Transcranial magnetic stimulation induced motor evoked potential in the expression of brain-derived neu-
rotrophic factor BDNF, pathological pain and quality of life in patients with spinal cord injury
Methods Parallel RCT
Participants Post-SCI pain, n = 60
Interventions rTMS
Outcomes Pain, QoL
Starting date 01 July 2017
Contact information Dr Shi Jiajia 707529535@qq.com
Notes Contact with study authors unsuccessful
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CTRI/2013/12/004228
Trial name or title Effect of transcranial magnetic stimulation on pain modulation status in fibromyalgia patients
Methods Parallel RCT
Participants Fibromyalgia
Interventions rTMS
Outcomes Pain
Starting date 01 September 2013
Contact information Dr Rathmi Mashur, mathurashmi@yahoo.co.in
Notes Contact with study authors unsuccessful
Muniswamy 2016
Trial name or title
Methods Parallel RCT
Participants Mixed chronic pain
Interventions tDCS, M1, DLPFC, number of sessions not clear
Outcomes Pain, QoL
Starting date
Contact information
Notes Published as conference abstract only. Correspondence with study authors - study ongoing
NCT00815932
Trial name or title The effect of transcranial direct current stimulation (t-DCS) On the P300 component of event-related
potentials in patients with chronic neuropathic pain due to CRPS or diabetic neuropathy
Methods Cross-over RCT
Participants Chronic neuropathic pain due to CRPS or diabetic neuropathy
Interventions tDCS or sham, 2 mA, 20 min, x 1 session, location not specified
Outcomes Pain intensity
Starting date February 2009
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NCT00815932 (Continued)
Contact information Dr Pesach Schvartzman, spesah@bgu.ac.il
Notes Contact in 2010 - study ongoing, recent attempts to contact for update unsuccessful
NCT00947622
Trial name or title Occipital transcranial direct current stimulation in fibromyalgia
Methods Cross-over RCT
Participants Fibromyalgia
Interventions tDCS or sham, parameters not specified
Outcomes Pain VAS and FIQ
Starting date July 2009
Contact information Dr Mark Plazier, mark.plazier@uza.be
Notes Attempts to contact study authors currently unsuccessful
NCT01112774
Trial name or title Application of transcranial direct current stimulation in patients with chronic pain after spinal cord injury
Methods Parallel RCT
Participants Chronic pain after SCI, proposed n = 60
Interventions tDCS 2 mA, 10 sessions
Outcomes Pain VAS, QoL
Starting date April 2010
Contact information Dr Felipe Fregni, ffregni@neuromodulationlab.org, Kayleen Weaver, kmweaver@partners.org
Notes Contact with study author - study at “to be analysed and reported” stage
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NCT01220323
Trial name or title Transcranial direct current stimulation for chronic pain relief
Methods Cross-over RCT
Participants Chronic pain patients, proposed n = 100
Interventions tDCS, motor cortex, 2 mA, daily for 5 days
Outcomes Pain relief
Starting date November 2010
Contact information Dr Silvio Brill, Tel Aviv Sourasky Medical Centre
Notes Correspondence with study authors: study ongoing
NCT01402960
Trial name or title Exploration of parameters of transcranial direct current stimulation in chronic pain
Methods Parallel RCT
Participants Chronic pain following traumatic SCI, n = 60
Interventions tDCS or sham, 2 mA, motor cortex, 20 min, x 1 daily for 5 days
Outcomes Pain
Starting date April 2010
Contact information Dr Felipe Fregni, ffregni@partners.org; Kayleen Weaver, kmweaver@partners.org
Notes Contact with study author - study at “to be analysed and reported” stage
NCT01404052
Trial name or title Effects of transcranial direct current stimulation and transcranial ultrasound on osteoarthritis pain of the knee
Methods Parallel RCT
Participants Chronic knee OA pain, n = 30
Interventions tDCS or sham, 20 min, 2 mA, motor cortex, 5 sessions
Outcomes Pain
Starting date January 2011
196Non-invasive brain stimulation techniques for chronic pain (Review)
Copyright © 2018 The Authors. Cochrane Database of Systematic Reviews published by John Wiley & Sons, Ltd. on behalf of The
Cochrane Collaboration.
NCT01404052 (Continued)
Contact information Dr Felipe Fregni, ffregni@partners.org; Kayleen Weaver, kmweaver@partners.org
Notes Contact with study author - study at “to be analysed and reported” stage
NCT01575002
Trial name or title Effects of transcranial direct current stimulation in chronic corneal pain
Methods Cross-over RCT
Participants Chronic corneal pain
Interventions tDCS, active or sham, 1 session of each, parameters not reported
Outcomes Pain VAS
Starting date January 2012
Contact information Dr Felipe Fregni, ffregni@partners.org; Kayleen Weaver, kmweaver@partners.org
Notes Contact with study author - study at “to be analysed and reported” stage
NCT01746355
Trial name or title Assessment and treatment patients with atypical facial pain through repetitive transcranial magnetic stimula-
tion
Methods Parallel RCT
Participants Atypical facial pain, n = 40
Interventions rTMS or sham, parameters not reported, 5 sessions
Outcomes Pain VAS
Starting date March 2011
Contact information Ricardo Galhardoni
Notes Correspondence with study authors: study near completion
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NCT01747070
Trial name or title Effect of cranial stimulation and acupuncture on pain, functional capability and cerebral function in os-
teoarthritis
Methods Parallel RCT
Participants Chronic OA pain, n = 80
Interventions 4 groups, real tDCS + electroacupuncture sham; sham tDCS + electroacupuncture sham, sham tDCS +
electroacupuncture, real tDCS + electroacupuncture
tDCS 2 mA motor cortex. All single session
Outcomes Daily pain intensity, WOMAC
Starting date January 2012
Contact information Dr Wolnei Caumo, caumo@cpovo.net
Notes Correspondence with study authors: study ongoing
NCT01781065
Trial name or title The effects of transcranial direct current stimulation on central pain in patients with spinal cord injury
Methods RCT
Participants Central neuropathic pain post-SCI
Interventions tDCS
Sham
Outcomes Pain, average 24 h
Pain interference
Starting date March 2008
Contact information Hyung-Ik Shin, Associate Professor, Seoul National University Bundang Hospital
Notes Contact with study authors unsuccessful
NCT01795079
Trial name or title Effects of transcranial direct current stimulation (tDCS) on neuropathic symptoms following burn injury
Methods RCT
Participants Burn injury
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NCT01795079 (Continued)
Interventions tDCS
Sham
Outcomes Pain
QoL
Starting date January 2013
Contact information Dr Felipe Fregni, ffregni@partners.org
Notes Contact with authors unsuccessful
NCT01857492
Trial name or title tDCS for the management of chronic visceral pain in patients with chronic pancreatitis (tDCS)
Methods RCT
Participants Chronic pancreatitis pain
Interventions tDCS
Sham
Outcomes Pain
QoL
Starting date March 2013
Contact information Steven Freedman, MD PhD
Notes Contact with study author 20 December 2016 - stated all results published but did not respond to request to
identify the published paper. Trial register record implies the study was withdrawn prior to enrolment
NCT01875029
Trial name or title tDCS effects on chronic low back pain
Methods RCT
Participants Chronic nonspecific low back pain, n = 45
Interventions Real-tDCS + back school
Sham tDCS + back school
Outcomes Pain
Starting date January 2012
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NCT01875029 (Continued)
Contact information Sofia Straudi, MD
Notes Contact with study authors unsuccessful
NCT01904097
Trial name or title Functional neuroimaging in fibromyalgia patients receiving tDCS
Methods RCT
Participants Fibromyalgia, n = 34
Interventions tDCS + pregabalin
Sham tDCS + pregabalin
Outcomes Pain
FIQ
WH-QoL
Starting date March 2013
Contact information Wolnei Caumo, MD, caumo@cpovo.net
Notes Contact with study authors unsuccessful
NCT01932905
Trial name or title Deep rTMS in central neuropathic pain syndromes (DRTMS)
Methods RCT
Participants Central pain, n = 90
Interventions rTMS double cone coil
rTMS H-coil
Sham rTMS
Outcomes Pain VAS
Starting date March 2011
Contact information Daniel Ciampi, MD, PhD, ciampi@usp.br
Notes Correspondence with authors 22 December 2016, data collection complete, analysis ongoing
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NCT01960400
Trial name or title Investigation of the efficacy of tDCS in the treatment of complex regional pain syndrome (CRPS) Type 1
Methods RCT
Participants CRPS type 1, n = 22
Interventions tDCS + GMI
Outcomes sham tDCS + GMI
Starting date April 2013
Contact information Yannick Tousignant-Laflamme, PT Ph.D, Université de Sherbrooke
Notes Correspondence with study authors - manuscript under review for publication
NCT02051959
Trial name or title Long-term effects of transcranial direct current stimulation (tDCS) on patients with phantom limb pain
(PLP)
Methods Cross-over RCT
Participants Phantom limb pain, n = 24
Interventions Anodal tDCS
Cathodal tDCS
Sham TDCS
Outcomes Pain
AEs
Starting date May 2015
Contact information Itzhak Siev-Ner, MD
Notes Contact with study authors unsuccessful
NCT02059096
Trial name or title Analgesic dffect of repetitive transcranialmagnetic stimulation (rTMS) for central neuropathic pain inmultiple
sclerosis (STIMASEP)
Methods RCT
Participants Central neuropathic pain due to multiple sclerosis, n = 66
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NCT02059096 (Continued)
Interventions rTMS
Theta burst TMS
Sham rTMS
Outcomes Pain
Starting date February 2014
Contact information Patrick Lacarin placarin@chu-clermontferrand.fr
Notes Contact with study authors unsuccessful
NCT02070016
Trial name or title Transcranial magnetic stimulation for low back pain
Methods Cross-over RCT
Participants Chronic low back pain
Interventions rTMS
? comparator
Outcomes Pain
Starting date January 2014
Contact information Sean Mackey, Chief, Division of Pain Medicine, Stanford University
Notes Contact with study authors unsuccessful. Register record states this study was withdrawn prior to enrolment.
Reasons not given
NCT02161302
Trial name or title The effect of tDCS in the treatment of chronic pelvic pain associated with endometriosis (tDCS)
Methods Parallel RCT
Participants Painful endometriosis, n = 30
Interventions tDCS
Sham tDCS
Outcomes Pain
AEs
QoL
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NCT02161302 (Continued)
Starting date June 2014
Contact information Wolnei Caumo, MD, PhD, caumo@cpovo.net
Notes Contact with study authors unsuccessful
NCT02277912
Trial name or title Efficacy of transcranial magnetic stimulation (TMS) in central post stroke pain (CPSP)
Methods RCT
Participants Central poststroke pain, n = 20
Interventions Navigated rTMS
Sham rTMS
Outcomes Pain intensity
QoL
AEs
Starting date June 2013
Contact information Eija Kalso, PhD, Helsinki University Central Hospital
Notes Register record notes “The recruitment status of this study is unknown. The completion date has passed and
the status has not been verified in more than two years.”
Correspondence with study authors 05 January 2017: data analysis ongoing
NCT02330315
Trial name or title Effects of tDCS and tUS on pain perception in OA of the knee
Methods Parallel RCT
Participants OA of the knee, n = 28
Interventions Active tDCS + active tUS
Sham tDCS + sham tUS
Outcomes Pain
AEs
QoL
Starting date March 2015
Contact information Felipe Fregni, Principal Investigator, Spaulding Rehabilitation Hospital
203Non-invasive brain stimulation techniques for chronic pain (Review)
Copyright © 2018 The Authors. Cochrane Database of Systematic Reviews published by John Wiley & Sons, Ltd. on behalf of The
Cochrane Collaboration.
NCT02330315 (Continued)
Notes Contact with study authors unsuccessful
NCT02386969
Trial name or title Repetitive transcranial magnetic stimulation in central neuropathic pain
Methods Cross-over RCT
Participants Central neuropathic pain, n = 50
Interventions rTMS
Sham rTMS
Outcomes Pain VAS, average and responder analysis
Starting date November 2015
Contact information Charles Quesada, Roland Peyron
Notes Contact with study authors unsuccessful
NCT02393391
Trial name or title A novel non invasive brain stimulation based treatment for chronic low back pain (CLBP)
Methods Parallel RCT
Participants Chronic low back pain, n = 80
Interventions tDCS/tACS stimulation
Sham tDCS
Outcomes Pain
Starting date May 2015
Contact information Dr Silviu Brill, paincenter@tlvmc.gov.il
Notes Contact with study authors unsuccessful
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NCT02483468
Trial name or title The effects of cognitive behavioral therapy and transcranial current stimulation (tDCS) on chronic lower
back pain
Methods Parallel RCT
Participants Chronic low back pain, n = 120
Interventions tDCS of DLPFC + CBT
Sham tDCS + CBT
Outcomes Pain
Starting date January 2015
Contact information Jeffrey Borckardt, Professor, Medical University of South Carolina
Notes Contact with study authors unsuccessful
NCT02487966
Trial name or title Optimizing rehabilitation for phantom limb pain using mirror therapy and transcranial direct current stim-
ulation (tDCS)
Methods Factorial RCT
Participants Chronic phantom limb pain, n = 132
Interventions Active tDCS and active mirror therapy
Active tDCS and sham mirror therapy
Sham tDCS and active mirror therapy
Sham tDCS and sham mirrory therapy
Outcomes Pain
QoL (short version SF-36)
AEs
Starting date July 2015
Contact information Dr Felipe Fregni ffregni@partners.org
Notes Contact with study authors unsuccessful
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NCT02615418
Trial name or title Non invasive brain stimulation treatment for CLBP (NIBSTCLBP)
Methods Cross-over RCT
Participants Chronic low back pain, n = 60
Interventions tDCS
Sham tDCS “partially active- first 2.5 weeks will receive sham treatment followed by active”
Outcomes Pain
Disability
Starting date January 2016
Contact information Iftach Dolev, PhD
Notes Contact with study authors unsuccessful
NCT02652988
Trial name or title Home-based transcranial direct current stimulation in fibromyalgia patients
Methods Parallel RCT
Participants Fibromyalgia, n = 32
Interventions tDCS
Sham tDCS
Outcomes Pain
Functional capacity
Starting date January 2016
Contact information Wolnei Caumo caumo@cpovo.net
Aline Brietzke aline brietzke@yahoo.com.br
Notes Contact with study authors unsuccessful
NCT02665988
Trial name or title Adjunctive transcranial direct current stimulation (tDCS)
Methods Parallel RCT
Participants Chronic pain, n = 36
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NCT02665988 (Continued)
Interventions tDCS
Sham tDCS
Outcomes Pain
Physical activity
Starting date January 2016
Contact information Alok Madan, PhD amadan@menninger.edu
Gladys Jimenez, PhD gjtorres@menninger.edu
Notes Correspondance with study authors 20 December 2016 - data collection ongoing
NCT02687360
Trial name or title Imaging the effects of rTMS on chronic pain
Methods Parallel RCT
Participants Chronic neuropathic pain, n = 60
Interventions Active rTMS, prefrontal
Sham rTMS
Outcomes Pain
QoL
Starting date March 2016
Contact information Diana Martinez, MD, dm437@cumc.columbia.edu
Notes Contact with study authors unsuccessful
NCT02723175
Trial name or title The effects of CBT and (tDCS) on fibromyalgia patients
Methods Parallel RCT
Participants Fibromyalgia, n = 72
Interventions tDCS + CBT
Sham tDCS + CBT
Outcomes Pain
QoL
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NCT02723175 (Continued)
Starting date November 2014
Contact information Jeffrey Borckardt, Ph.D. borckard@musc.edu
Notes Contact with study authors unsuccessful
NCT02723929
Trial name or title Effects of tDCS and tUS on pain perception in OA of the knee
Methods Parallel RCT
Participants OA knee, n = 64
Interventions Active tDCS/active tUS
Sham tDCS/sham tUS
Outcomes Pain
Starting date September 2016
Contact information Felipe Fregni, Spaulding Rehabilitation Hospital
Notes Contact with study authors unsuccessful
NCT02768129
Trial name or title Transcranial direct current stimulation for chronic low back pain
Methods Parallel RCT
Participants Chronic low back pain, n = 60
Interventions tDCS
Sham tDCS
Outcomes Pain
Starting date November 2014
Contact information Butler Hospital, individual not specified
Notes Contact with study authors unsuccessful
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NCT02771990
Trial name or title tDCS for chronic low back pain
Methods Parallel RCT
Participants Chronic low back pain, n = 40
Interventions tDCS
Sham tDCS
Outcomes Pain
Starting date October 2013
Contact information Frederick Burgess, MD, PhD
Benjamin Greenberg, MD, PhD Providence VA Medical Center
Notes Correspondence with study authors 21 December 2017, study in progress
NCT02813629
Trial name or title tDCS associated with peripheral electrical stimulation for pain control in individuals with sickle cell disease
(tDCS/PES SCD)
Methods Parallel RCT
Participants Sickle cell disease, n = 80
Interventions ss-tDCS (active) plus PES (active)
ss-tDCS (active) plus PES (simulated)
ss-tDCS (simulated) plus PES (active)
ss-tDCS (simulated) plus PES (simulated)
sc-tDCS (active) plus PES (active)
sc-tDCS (active) plus PES (simulated)
sc-tDCS (simulated) plus PES (active)
sc-TDCS (simulated) plus PES (simulated)
Outcomes Pain
Function
Starting date March 2016
Contact information Prof. Abrahão F Baptista, afbaptista@ufba.br
Tiago S. Lopes, Sr, tiago.lopes56@yahoo.com
Notes Contact with study authors unsuccessful
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NCT03015558
Trial name or title Analgesic effect of non invasive stimulation: transcranial direct current stimulation of opercular-insular cortex
Methods Parallel RCT
Participants CRPS, n = 40
Interventions tDCS of operculo-insular cortex
Outcomes Pain
Starting date November 2016
Contact information luis.garcia-larrea@univ-lyon1.fr
Notes
NCT03137472
Trial name or title TMS for complex regional pain syndrome
Methods Parallel RCT
Participants CRPS, n = 40
Interventions Theta-burst rTMS
Outcomes Pain
Starting date 24 April 2017
Contact information vsalmasi@stanford.edu
Notes
RBR-9dxp3k
Trial name or title Effectiveness of transcranial direct current stimulation combined with kinesiotherapy in patients with chronic
temporomandibular disorders (TMJ): clinical, randomized, double-blind, placebo controlled trial
Methods Parallel RCT
Participants Chronic temporomandibular pain
Interventions tDCS + kinesiotherapy
Sham tDCS + kinesiotherapy
Outcomes Pain
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RBR-9dxp3k (Continued)
Starting date December 2013
Contact information Maitê de Freitas, maite famaral@hotmail.com
Notes Correspondence with study authors 31 December 2016 - study report under peer review for publication
AE: adverse events; CBT: cognitive behavioural therapy; CRPS: complex regional pain syndrome; DLPFC: dorsolateral prefrontal
cortex; FIQ: Fibromyalgia Impact Questionnaire; GMI: graded motor imagery; HR-QoL: health-related quality of life; OA: os-
teoarthritis; PES: peripheral electrical stimulation; QoL: quality of life; RCT: randomised controlled trial; rTMS: repetitive tran-
scranial magnetic stimulation; SCI: spinal cord injury; tACS: transcranial alternating current stimulation; tDCS: transcranial direct
current stimulation; TENS: transcutaneous electrical nerve stimulation; tUS: transcranial ultrasound; VAS: visual analogue scale;
WHO-QOL: World Health Organization-QoL; WOMAC: Western Ontario and McMaster Universities Arthritis Index
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D A T A A N D A N A L Y S E S
Comparison 1. Repetitive transcranial magnetic stimulation (rTMS)
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Pain: short-term follow-up 27 Std. Mean Difference (Fixed, 95% CI) -0.22 [-0.29, -0.16]
1.1 Low-frequency ≤ 1 Hz 7 Std. Mean Difference (Fixed, 95% CI) 0.13 [-0.03, 0.28]
1.2 High-frequency ≥ 5 Hz 25 Std. Mean Difference (Fixed, 95% CI) -0.30 [-0.37, -0.23]
2 Pain: short-term follow-up,
subgroup analysis:
multiple-dose vs single-dose
studies
27 Std. Mean Difference (Random, 95% CI) -0.26 [-0.40, -0.13]
2.1 Single-dose studies 13 Std. Mean Difference (Random, 95% CI) -0.23 [-0.36, -0.10]
2.2 Multiple-dose studies 14 Std. Mean Difference (Random, 95% CI) -0.40 [-0.76, -0.05]
3 Pain: short-term follow-up,
subgroup analysis, neuropathic
pain participants only
17 Std. Mean Difference (Fixed, 95% CI) -0.20 [-0.28, -0.13]
3.1 Low-frequency ≤ 1 Hz 5 Std. Mean Difference (Fixed, 95% CI) 0.15 [-0.02, 0.32]
3.2 High-frequency ≥ 5 Hz 17 Std. Mean Difference (Fixed, 95% CI) -0.28 [-0.36, -0.20]
4 Pain: short-term follow-up,
subgroup analysis,
non-neuropathic pain
participants only
8 Std. Mean Difference (Fixed, 95% CI) -0.39 [-0.61, -0.17]
4.1 Low-frequency ≤ 1 Hz 1 Std. Mean Difference (Fixed, 95% CI) 0.16 [-0.29, 0.61]
4.2 High-frequency ≥ 5 Hz 7 Std. Mean Difference (Fixed, 95% CI) -0.56 [-0.81, -0.31]
5 Pain: short-term follow-up,
subgroup analysis: motor cortex
studies only, low-frequency
studies excluded
21 Std. Mean Difference (Random, 95% CI) -0.37 [-0.51, -0.22]
5.1 Single-dose studies 13 Std. Mean Difference (Random, 95% CI) -0.38 [-0.49, -0.27]
5.2 Multiple-dose studies 8 Std. Mean Difference (Random, 95% CI) -0.34 [-0.73, 0.05]
6 Sensitivity analysis - imputed
correlation coefficient
increased. Pain: short-term
follow-up
29 Std. Mean Difference (Random, 95% CI) -0.27 [-0.40, -0.14]
6.1 Low-frequency ≤ 1 Hz 7 Std. Mean Difference (Random, 95% CI) 0.15 [0.01, 0.29]
6.2 High-frequency ≥ 5 Hz 28 Std. Mean Difference (Random, 95% CI) -0.35 [-0.49, -0.22]
7 Sensitivity analysis - imputed
correlation coefficient
decreased. Pain: short-term
follow-up
28 Std. Mean Difference (Random, 95% CI) -0.26 [-0.40, -0.13]
7.1 Low-frequency ≤ 1 Hz 7 Std. Mean Difference (Random, 95% CI) 0.13 [-0.06, 0.33]
7.2 High-frequency ≥ 5 Hz 26 Std. Mean Difference (Random, 95% CI) -0.34 [-0.49, -0.19]
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8 Sensitivity analysis - imputed
correlation increased. Pain:
short-term follow-up, subgroup
analysis: motor cortex studies
only, low-frequency studies
excluded
20 Std. Mean Difference (Random, 95% CI) -0.37 [-0.50, -0.24]
8.1 Single-dose studies 13 Std. Mean Difference (Random, 95% CI) -0.39 [-0.50, -0.28]
8.2 Multiple-dose studies 7 Std. Mean Difference (Random, 95% CI) -0.33 [-0.71, 0.04]
9 Sensitivity analysis - imputed
correlation decreased. Pain:
short-term follow-up, subgroup
analysis: motor cortex studies
only, low-frequency studies
excluded
20 Std. Mean Difference (Random, 95% CI) -0.37 [-0.52, -0.22]
9.1 Single-dose studies 13 Std. Mean Difference (Random, 95% CI) -0.37 [-0.47, -0.26]
9.2 Multiple-dose studies 7 Std. Mean Difference (Random, 95% CI) -0.36 [-0.81, 0.09]
10 Sensitivity analysis - inclusion
of high risk of bias studies.
Pain: short-term follow-up
31 Std. Mean Difference (Fixed, 95% CI) -0.27 [-0.34, -0.20]
10.1 Low-frequency ≤ 1 Hz 10 Std. Mean Difference (Fixed, 95% CI) 0.07 [-0.07, 0.22]
10.2 High-frequency ≥ 5 Hz 28 Std. Mean Difference (Fixed, 95% CI) -0.36 [-0.44, -0.29]
11 Sensitivity analysis - inclusion
of high risk of bias studies.
Pain: short-term follow-up,
subgroup analysis: motor cortex
studies only, low-frequency
studies excluded
24 Std. Mean Difference (Random, 95% CI) -0.41 [-0.55, -0.26]
11.1 Single-dose studies 15 Std. Mean Difference (Random, 95% CI) -0.35 [-0.46, -0.24]
11.2 Multiple-dose studies 10 Std. Mean Difference (Random, 95% CI) -0.53 [-0.91, -0.15]
12 Pain: short-term follow-up,
subgroup analysis: prefrontal
cortex studies only
6 Std. Mean Difference (Random, 95% CI) -0.67 [-1.48, 0.15]
12.1 Low frequency ≤ 1 Hz 1 Std. Mean Difference (Random, 95% CI) 0.16 [-0.29, 0.61]
12.2 High frequency ≥ 5 Hz 5 Std. Mean Difference (Random, 95% CI) -0.92 [-1.95, 0.12]
13 Sensitivity analysis - inclusion
of high risk of bias studies.
Pain: short-term follow-up,
subgroup analysis: prefrontal
cortex studies only
7 Std. Mean Difference (Random, 95% CI) -0.64 [-1.36, 0.08]
13.1 Multiple-dose studies 7 Std. Mean Difference (Random, 95% CI) -0.64 [-1.36, 0.08]
14 Pain: short term responder
analysis 30% pain reduction
2 89 Risk Ratio (M-H, Random, 95% CI) 2.11 [1.17, 3.80]
15 Sensitivity analysis- inclusion
of high risk of bias studies.
Disability: medium-term
follow-up
5 Std. Mean Difference (Random, 95% CI) -0.42 [-1.01, 0.17]
16 Pain: medium-term follow-up 11 Std. Mean Difference (Random, 95% CI) -0.28 [-0.61, 0.05]
16.1 Low-frequency ≤ 1 Hz 2 Std. Mean Difference (Random, 95% CI) 0.14 [-0.41, 0.69]
16.2 High-frequency ≥ 5 Hz 9 Std. Mean Difference (Random, 95% CI) -0.36 [-0.73, 0.00]
17 Sensitivity analysis - inclusion
of high risk of bias studies.
Pain: medium-term follow-up
15 Std. Mean Difference (Random, 95% CI) -0.50 [-0.80, -0.20]
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17.1 Low-frequency ≤ 1 Hz 3 Std. Mean Difference (Random, 95% CI) 0.02 [-0.52, 0.56]
17.2 High-frequency ≥ 5 Hz 13 Std. Mean Difference (Random, 95% CI) -0.57 [-0.90, -0.25]
18 Pain: medium-term follow-up,
subgroup analysis: motor
cortex studies only
6 Std. Mean Difference (Random, 95% CI) -0.22 [-0.46, 0.02]
18.1 Low frequency ≤ 1Hz 1 Std. Mean Difference (Random, 95% CI) -0.08 [-0.86, 0.70]
18.2 High-frequency ≥ 5 Hz 5 Std. Mean Difference (Random, 95% CI) -0.23 [-0.49, 0.03]
19 Pain: medium-term follow-up,
subgroup analysis: prefrontal
cortex studies only
5 Std. Mean Difference (Random, 95% CI) -1.08 [-2.49, 0.32]
19.1 Low frequency ≤ 1 Hz 1 Std. Mean Difference (Random, 95% CI) 0.36 [-0.41, 1.13]
19.2 High-frequency ≥ 5 Hz 4 Std. Mean Difference (Random, 95% CI) -1.74 [-3.66, 0.19]
20 Pain: long-term follow-up 4 Std. Mean Difference (Random, 95% CI) -0.14 [-0.44, 0.17]
21 Sensitivity analysis - inclusion
of high risk of bias studies.
Pain: long-term follow-up
5 Std. Mean Difference (Random, 95% CI) -0.40 [-0.89, 0.10]
22 Disability: short-term
follow-up
5 Std. Mean Difference (Random, 95% CI) -0.29 [-0.87, 0.29]
23 Sensitivity analysis- inclusion
of high risk of bias studies.
Disability: short-term
follow-up
7 Std. Mean Difference (Random, 95% CI) -0.30 [-0.72, 0.12]
24 Disability: medium-term
follow-up
4 Std. Mean Difference (Random, 95% CI) -0.37 [-1.07, 0.33]
25 Pain: short term responder
analysis 50% pain reduction
1 54 Risk Ratio (M-H, Random, 95% CI) 1.89 [1.03, 3.47]
26 Disability: long-term follow-up 3 Std. Mean Difference (Random, 95% CI) -0.23 [-0.62, 0.16]
27 Sensitivity analysis - inclusion
of high risk of bias studies.
Disability: long-term follow-up
4 Std. Mean Difference (Random, 95% CI) -0.41 [-0.87, 0.05]
28 Quality of life: short-term
follow-up (Fibromyalgia
Impact Questionnaire)
4 105 Mean Difference (IV, Random, 95% CI) -10.80 [-15.04, -6.
55]
29 Quality of life: medium-term
follow-up (Fibromyalgia
Impact Questionnaire)
4 105 Mean Difference (IV, Fixed, 95% CI) -11.49 [-16.73, -6.
25]
30 Sensitivity analysis - inclusion
of high risk of bias studies.
Quality of life: medium-term
follow-up (Fibromyalgia
Impact Questionnaire)
5 143 Mean Difference (IV, Fixed, 95% CI) -8.93 [-13.49, -4.37]
31 Quality of life: long-term
follow-up
2 51 Mean Difference (IV, Fixed, 95% CI) -6.78 [-13.43, -0.14]
32 Sensitivity analysis - inclusion
of high risk of bias studies.
Quality of life: long-term
follow-up
3 89 Mean Difference (IV, Fixed, 95% CI) -8.58 [-13.84, -3.33]
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Comparison 2. Cranial electrotherapy stimulation (CES)
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Pain: short-term follow-up 5 270 Std. Mean Difference (IV, Random, 95% CI) -0.24 [-0.48, 0.01]
2 Quality of life: short term follow
up
1 Mean Difference (IV, Random, 95% CI) Subtotals only
Comparison 3. Transcranial direct current stimulation (tDCS)
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Pain: short-term follow-up 26 Std. Mean Difference (Random, 95% CI) -0.43 [-0.63, -0.22]
1.1 Single-dose studies 4 Std. Mean Difference (Random, 95% CI) -0.18 [-0.38, 0.02]
1.2 Multiple-dose studies 22 Std. Mean Difference (Random, 95% CI) -0.51 [-0.77, -0.25]
2 Pain: short-term sensitivity
analysis: correlation increased
26 Std. Mean Difference (Random, 95% CI) -0.43 [-0.62, -0.23]
3 Pain: short-term sensitivity
analysis: correlation decreased
26 Std. Mean Difference (Random, 95% CI) -0.44 [-0.64, -0.23]
4 Pain: short term sensitivity
analysis, inclusion of high risk
of bias studies
31 Std. Mean Difference (Random, 95% CI) -0.48 [-0.67, -0.29]
4.1 Single-dose studies 4 Std. Mean Difference (Random, 95% CI) -0.18 [-0.38, 0.02]
4.2 Multiple-dose studies 27 Std. Mean Difference (Random, 95% CI) -0.56 [-0.79, -0.32]
5 Pain: short-term follow-up,
subgroup analysis: motor
cortex studies only
25 Std. Mean Difference (Random, 95% CI) -0.47 [-0.67, -0.28]
5.1 Single-dose studies 4 Std. Mean Difference (Random, 95% CI) -0.18 [-0.38, 0.02]
5.2 Multiple-dose studies 21 Std. Mean Difference (Random, 95% CI) -0.58 [-0.84, -0.33]
6 Pain: short-term follow-up,
subgroup analysis: motor
cortex studies only, sensitivity
analysis: correlation increased
26 Std. Mean Difference (Random, 95% CI) -0.45 [-0.64, -0.26]
6.1 Single-dose studies 4 Std. Mean Difference (Random, 95% CI) -0.18 [-0.37, 0.01]
6.2 Multiple-dose studies 22 Std. Mean Difference (Random, 95% CI) -0.55 [-0.81, -0.30]
7 Pain: short-term follow-up,
subgroup analysis: motor
cortex studies only, sensitivity
analysis: correlation decreased
26 Std. Mean Difference (Random, 95% CI) -0.40 [-0.58, -0.22]
7.1 Single-dose studies 4 Std. Mean Difference (Random, 95% CI) -0.18 [-0.38, 0.03]
7.2 Multiple-dose studies 22 Std. Mean Difference (Random, 95% CI) -0.49 [-0.72, -0.26]
8 Pain: short-term follow-up,
subgroup analysis, neuropathic
and non neuropathic pain
25 Std. Mean Difference (Random, 95% CI) -0.37 [-0.56, -0.19]
8.1 Neuropathic 9 Std. Mean Difference (Random, 95% CI) -0.26 [-0.53, 0.01]
8.2 Non neuropathic 16 Std. Mean Difference (Random, 95% CI) -0.42 [-0.67, -0.17]
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9 Pain: short term follow-up
responder analysis 30% pain
reduction
2 Risk Ratio (M-H, Random, 95% CI) Subtotals only
10 Pain: short term follow-up
responder analysis 50% pain
reduction
2 Risk Ratio (M-H, Random, 95% CI) Subtotals only
11 Pain: medium-term follow-up 14 Std. Mean Difference (Random, 95% CI) -0.43 [-0.72, -0.13]
12 Pain: medium term follow-up
responder analysis 30% pain
reduction
1 Risk Ratio (M-H, Random, 95% CI) Subtotals only
13 Pain: medium term follow-up
responder analysis 50% pain
reduction
2 Risk Ratio (M-H, Random, 95% CI) Subtotals only
14 Sensitivity analysis - inclusion
of high risk of bias studies.
Pain: medium-term follow-up
16 Std. Mean Difference (Random, 95% CI) -0.45 [-0.72, -0.18]
15 Pain: long-term follow-up 3 Std. Mean Difference (Random, 95% CI) -0.01 [-0.43, 0.41]
16 Disability: short-term
follow-up
4 212 Std. Mean Difference (IV, Random, 95% CI) -0.01 [-0.28, 0.26]
17 Disability: medium-term
follow-up
1 Std. Mean Difference (IV, Random, 95% CI) Subtotals only
18 Quality of life: short-term
follow-up
4 82 Std. Mean Difference (IV, Random, 95% CI) 0.66 [0.21, 1.11]
19 Quality of life: medium-term
follow-up
3 87 Std. Mean Difference (IV, Random, 95% CI) 0.34 [-0.09, 0.76]
Comparison 4. Reduced impedance non-invasive cortical electrostimulation (RINCE)
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Pain: short-term follow-up 1 Mean Difference (IV, Fixed, 95% CI) Subtotals only
2 Sensitivity analysis - inclusion of
high risk of bias studies. Pain:
short-term follow-up
2 115 Std. Mean Difference (IV, Random, 95% CI) -0.59 [-0.99, -0.18]
3 Quality of Life: short term
follow-up
1 Mean Difference (IV, Fixed, 95% CI) Subtotals only
4 Sensitivity analysis - inclusion
of high risk of bias studies.
Quality of life: short term
follow-up
2 115 Std. Mean Difference (IV, Random, 95% CI) -0.45 [-0.91, 0.02]
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Comparison 5. Transcranial random noise stimulation
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Pain 1 Std. Mean Difference (Fixed, 95% CI) -0.19 [-0.64, 0.26]
Analysis 1.1. Comparison 1 Repetitive transcranial magnetic stimulation (rTMS), Outcome 1 Pain: short-
term follow-up.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 1 Repetitive transcranial magnetic stimulation (rTMS)
Outcome: 1 Pain: short-term follow-up
Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Fixed,95% CI IV,Fixed,95% CI
1 Low-frequency≤ 1 Hz
Andr -Obadia 2006 -0.016296 (0.259415) 1.7 % -0.02 [ -0.52, 0.49 ]
Carretero 2009 0.15649 (0.230164) 2.1 % 0.16 [ -0.29, 0.61 ]
Lefaucheur 2001b 0.156 (0.162229) 4.3 % 0.16 [ -0.16, 0.47 ]
Lefaucheur 2006 (1) 0.37847 (0.21421) 2.5 % 0.38 [ -0.04, 0.80 ]
Lefaucheur 2008 0.14778 (0.140854) 5.7 % 0.15 [ -0.13, 0.42 ]
Saitoh 2007 -0.169857 (0.332186) 1.0 % -0.17 [ -0.82, 0.48 ]
Yagci 2014 -0.46 (0.408163) 0.7 % -0.46 [ -1.26, 0.34 ]
Subtotal (95% CI) 18.0 % 0.13 [ -0.03, 0.28 ]
Heterogeneity: Chi2 = 4.62, df = 6 (P = 0.59); I2 =0.0%
Test for overall effect: Z = 1.59 (P = 0.11)
2 High-frequency≥ 5 Hz
Andr -Obadia 2006 -0.066506 (0.259685) 1.7 % -0.07 [ -0.58, 0.44 ]
Andr -Obadia 2008 (2) -0.287518 (0.187174) 3.2 % -0.29 [ -0.65, 0.08 ]
Andr -Obadia 2008 (3) -0.41092 (0.191008) 3.1 % -0.41 [ -0.79, -0.04 ]
Andr -Obadia 2011 -0.383319 (0.105999) 10.1 % -0.38 [ -0.59, -0.18 ]
Avery 2013 0.57 (0.494898) 0.5 % 0.57 [ -0.40, 1.54 ]
Borckardt 2009 -2.717609 (0.743356) 0.2 % -2.72 [ -4.17, -1.26 ]
-2 -1 0 1 2
Favours active Favours sham
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(. . . Continued)
Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Fixed,95% CI IV,Fixed,95% CI
de Oliveira 2014 -0.33 (0.438776) 0.6 % -0.33 [ -1.19, 0.53 ]
Defrin 2007 (4) 1.12 (0.642857) 0.3 % 1.12 [ -0.14, 2.38 ]
Hirayama 2006 (5) -0.38726 (0.318223) 1.1 % -0.39 [ -1.01, 0.24 ]
Hirayama 2006 (6) 0.19336 (0.309779) 1.2 % 0.19 [ -0.41, 0.80 ]
Hirayama 2006 (7) 0.23554 (0.311152) 1.2 % 0.24 [ -0.37, 0.85 ]
Hirayama 2006 (8) 0.18872 (0.309645) 1.2 % 0.19 [ -0.42, 0.80 ]
Hosomi 2013 (9) -0.11985 (0.116422) 8.3 % -0.12 [ -0.35, 0.11 ]
Hosomi 2013 (10) -0.057109 (0.127547) 7.0 % -0.06 [ -0.31, 0.19 ]
Jett 2013 (11) -0.301786 (0.248108) 1.8 % -0.30 [ -0.79, 0.18 ]
Jett 2013 (12) -0.191079 (0.244849) 1.9 % -0.19 [ -0.67, 0.29 ]
Kang 2009 0.43402 (0.216454) 2.4 % 0.43 [ 0.01, 0.86 ]
Lefaucheur 2001a -0.9332 (0.219757) 2.3 % -0.93 [ -1.36, -0.50 ]
Lefaucheur 2001b -0.274478 (0.233036) 2.1 % -0.27 [ -0.73, 0.18 ]
Lefaucheur 2004 -0.344828 (0.091197) 13.6 % -0.34 [ -0.52, -0.17 ]
Lefaucheur 2006 -0.64827 (0.227633) 2.2 % -0.65 [ -1.09, -0.20 ]
Lefaucheur 2008 -0.334132 (0.143948) 5.5 % -0.33 [ -0.62, -0.05 ]
Medeiros 2016 -0.57 (0.42602) 0.6 % -0.57 [ -1.40, 0.26 ]
Mhalla 2011 -0.58 (0.32398) 1.1 % -0.58 [ -1.21, 0.05 ]
Nardone 2017 -2.16 (0.72449) 0.2 % -2.16 [ -3.58, -0.74 ]
Passard 2007 -1.04 (0.392857) 0.7 % -1.04 [ -1.81, -0.27 ]
Pleger 2004 -0.138771 (0.21807) 2.4 % -0.14 [ -0.57, 0.29 ]
Rollnik 2002 -0.150199 (0.199233) 2.8 % -0.15 [ -0.54, 0.24 ]
Saitoh 2007 (13) -1.158204 (0.426308) 0.6 % -1.16 [ -1.99, -0.32 ]
Saitoh 2007 (14) -1.110603 (0.419362) 0.6 % -1.11 [ -1.93, -0.29 ]
Short 2011 -0.55 (0.456633) 0.5 % -0.55 [ -1.44, 0.34 ]
Tekin 2014 -1.76 (0.334184) 1.0 % -1.76 [ -2.41, -1.11 ]
Subtotal (95% CI) 82.0 % -0.30 [ -0.37, -0.23 ]
Heterogeneity: Chi2 = 96.63, df = 31 (P<0.00001); I2 =68%
Test for overall effect: Z = 8.04 (P < 0.00001)
Total (95% CI) 100.0 % -0.22 [ -0.29, -0.16 ]
Heterogeneity: Chi2 = 124.75, df = 38 (P<0.00001); I2 =70%
Test for overall effect: Z = 6.61 (P < 0.00001)
-2 -1 0 1 2
Favours active Favours sham
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Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Fixed,95% CI IV,Fixed,95% CI
Test for subgroup differences: Chi2 = 23.50, df = 1 (P = 0.00), I2 =96%
-2 -1 0 1 2
Favours active Favours sham
(1) 1Hz
(2) medial-lateral coil orientation
(3) antero-posterior coil orientation
(4) Pain score higher at baseline in active stim group
(5) M1
(6) PMA
(7) S1
(8) SMA
(9) M1 Group B (sham followed by real)
(10) M1 Group A (real followed by sham)
(11) hand area M1
(12) Leg area M1
(13) 5Hz
(14) 10 Hz
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Analysis 1.2. Comparison 1 Repetitive transcranial magnetic stimulation (rTMS), Outcome 2 Pain: short-
term follow-up, subgroup analysis: multiple-dose vs single-dose studies.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 1 Repetitive transcranial magnetic stimulation (rTMS)
Outcome: 2 Pain: short-term follow-up, subgroup analysis: multiple-dose vs single-dose studies
Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
1 Single-dose studies
Andr -Obadia 2006 (1) -0.066506 (0.259685) 2.8 % -0.07 [ -0.58, 0.44 ]
Andr -Obadia 2006 (2) -0.016296 (0.259415) 2.8 % -0.02 [ -0.52, 0.49 ]
Andr -Obadia 2008 (3) -0.287518 (0.187174) 3.4 % -0.29 [ -0.65, 0.08 ]
Andr -Obadia 2008 (4) -0.41092 (0.191008) 3.3 % -0.41 [ -0.79, -0.04 ]
Andr -Obadia 2011 -0.383319 (0.105999) 4.0 % -0.38 [ -0.59, -0.18 ]
Hirayama 2006 (5) 0.18872 (0.309645) 2.4 % 0.19 [ -0.42, 0.80 ]
Hirayama 2006 (6) 0.23554 (0.311152) 2.4 % 0.24 [ -0.37, 0.85 ]
Hirayama 2006 (7) 0.19336 (0.309779) 2.4 % 0.19 [ -0.41, 0.80 ]
Hirayama 2006 (8) -0.38726 (0.318223) 2.3 % -0.39 [ -1.01, 0.24 ]
Jett 2013 -0.301786 (0.248108) 2.9 % -0.30 [ -0.79, 0.18 ]
Jett 2013 -0.191079 (0.244849) 2.9 % -0.19 [ -0.67, 0.29 ]
Lefaucheur 2001a -0.9332 (0.219757) 3.1 % -0.93 [ -1.36, -0.50 ]
Lefaucheur 2001b (9) 0.156 (0.230164) 3.0 % 0.16 [ -0.30, 0.61 ]
Lefaucheur 2001b (10) -0.274478 (0.233036) 3.0 % -0.27 [ -0.73, 0.18 ]
Lefaucheur 2004 -0.344828 (0.091197) 4.1 % -0.34 [ -0.52, -0.17 ]
Lefaucheur 2006 (11) 0.37847 (0.21421) 3.1 % 0.38 [ -0.04, 0.80 ]
Lefaucheur 2006 (12) -0.64827 (0.227633) 3.0 % -0.65 [ -1.09, -0.20 ]
Lefaucheur 2008 (13) -0.334132 (0.143948) 3.8 % -0.33 [ -0.62, -0.05 ]
Lefaucheur 2008 (14) 0.14778 (0.140854) 3.8 % 0.15 [ -0.13, 0.42 ]
Pleger 2004 -0.138771 (0.21807) 3.1 % -0.14 [ -0.57, 0.29 ]
Rollnik 2002 -0.150199 (0.199233) 3.3 % -0.15 [ -0.54, 0.24 ]
Saitoh 2007 (15) -0.169857 (0.332186) 2.2 % -0.17 [ -0.82, 0.48 ]
Saitoh 2007 (16) -1.158204 (0.426308) 1.7 % -1.16 [ -1.99, -0.32 ]
-4 -2 0 2 4
Favours active Favours sham
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Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
Saitoh 2007 (17) -1.110603 (0.419362) 1.7 % -1.11 [ -1.93, -0.29 ]
Subtotal (95% CI) 70.4 % -0.23 [ -0.36, -0.10 ]
Heterogeneity: Tau2 = 0.05; Chi2 = 53.59, df = 23 (P = 0.00030); I2 =57%
Test for overall effect: Z = 3.45 (P = 0.00056)
2 Multiple-dose studies
Avery 2013 0.57 (0.494898) 1.4 % 0.57 [ -0.40, 1.54 ]
Borckardt 2009 -2.717609 (0.743356) 0.7 % -2.72 [ -4.17, -1.26 ]
Carretero 2009 0.6 (0.403061) 1.8 % 0.60 [ -0.19, 1.39 ]
de Oliveira 2014 -0.33 (0.438776) 1.6 % -0.33 [ -1.19, 0.53 ]
Defrin 2007 1.12 (0.642857) 0.9 % 1.12 [ -0.14, 2.38 ]
Hosomi 2013 (18) -0.057109 (0.127547) 3.9 % -0.06 [ -0.31, 0.19 ]
Hosomi 2013 (19) -0.019928 (0.116018) 4.0 % -0.02 [ -0.25, 0.21 ]
Kang 2009 0.43402 (0.216454) 3.1 % 0.43 [ 0.01, 0.86 ]
Medeiros 2016 -0.57 (0.42602) 1.7 % -0.57 [ -1.40, 0.26 ]
Mhalla 2011 -0.58 (0.32397959) 2.3 % -0.58 [ -1.21, 0.05 ]
Nardone 2017 -2.16 (0.72449) 0.8 % -2.16 [ -3.58, -0.74 ]
Passard 2007 -1.04 (0.392857) 1.9 % -1.04 [ -1.81, -0.27 ]
Short 2011 -0.55 (0.456633) 1.5 % -0.55 [ -1.44, 0.34 ]
Tekin 2014 -1.76 (0.334184) 2.2 % -1.76 [ -2.41, -1.11 ]
Yagci 2014 -0.46 (0.408163) 1.8 % -0.46 [ -1.26, 0.34 ]
Subtotal (95% CI) 29.6 % -0.40 [ -0.76, -0.05 ]
Heterogeneity: Tau2 = 0.33; Chi2 = 70.76, df = 14 (P<0.00001); I2 =80%
Test for overall effect: Z = 2.21 (P = 0.027)
Total (95% CI) 100.0 % -0.26 [ -0.40, -0.13 ]
Heterogeneity: Tau2 = 0.11; Chi2 = 125.74, df = 38 (P<0.00001); I2 =70%
Test for overall effect: Z = 3.76 (P = 0.00017)
Test for subgroup differences: Chi2 = 0.79, df = 1 (P = 0.37), I2 =0.0%
-4 -2 0 2 4
Favours active Favours sham
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(1) 20Hz
(2) 1Hz
(3) 20 Hz medial-lateral coil orientation
(4) 20Hz antero-posterior coil orientation
(5) SMA
(6) S1
(7) PMA
(8) M1
(9) 0.5 Hz
(10) 10Hz
(11) 1Hz
(12) 10Hz
(13) 10 Hz
(14) 1Hz
(15) 1Hz
(16) 5Hz
(17) 10Hz
(18) M1 Sham followed by real
(19) M1 Group A real followed by sham
222Non-invasive brain stimulation techniques for chronic pain (Review)
Copyright © 2018 The Authors. Cochrane Database of Systematic Reviews published by John Wiley & Sons, Ltd. on behalf of The
Cochrane Collaboration.
Analysis 1.3. Comparison 1 Repetitive transcranial magnetic stimulation (rTMS), Outcome 3 Pain: short-
term follow-up, subgroup analysis, neuropathic pain participants only.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 1 Repetitive transcranial magnetic stimulation (rTMS)
Outcome: 3 Pain: short-term follow-up, subgroup analysis, neuropathic pain participants only
Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Fixed,95% CI IV,Fixed,95% CI
1 Low-frequency≤ 1 Hz
Andr -Obadia 2006 -0.016296 (0.259415) 1.9 % -0.02 [ -0.52, 0.49 ]
Lefaucheur 2001b 0.156 (0.162229) 4.9 % 0.16 [ -0.16, 0.47 ]
Lefaucheur 2006 (1) 0.37847 (0.21421) 2.8 % 0.38 [ -0.04, 0.80 ]
Lefaucheur 2008 0.14778 (0.140854) 6.5 % 0.15 [ -0.13, 0.42 ]
Saitoh 2007 -0.169857 (0.332186) 1.2 % -0.17 [ -0.82, 0.48 ]
Subtotal (95% CI) 17.3 % 0.15 [ -0.02, 0.32 ]
Heterogeneity: Chi2 = 2.48, df = 4 (P = 0.65); I2 =0.0%
Test for overall effect: Z = 1.71 (P = 0.087)
2 High-frequency≥ 5 Hz
Andr -Obadia 2006 -0.066506 (0.259685) 1.9 % -0.07 [ -0.58, 0.44 ]
Andr -Obadia 2008 (2) -0.41092 (0.191008) 3.5 % -0.41 [ -0.79, -0.04 ]
Andr -Obadia 2008 (3) -0.287518 (0.187174) 3.7 % -0.29 [ -0.65, 0.08 ]
Andr -Obadia 2011 -0.383319 (0.105999) 11.5 % -0.38 [ -0.59, -0.18 ]
Borckardt 2009 -2.717609 (0.743356) 0.2 % -2.72 [ -4.17, -1.26 ]
de Oliveira 2014 -0.33 (0.438776) 0.7 % -0.33 [ -1.19, 0.53 ]
Defrin 2007 (4) 1.12 (0.642857) 0.3 % 1.12 [ -0.14, 2.38 ]
Hirayama 2006 (5) 0.23554 (0.311152) 1.3 % 0.24 [ -0.37, 0.85 ]
Hirayama 2006 (6) 0.19336 (0.309779) 1.3 % 0.19 [ -0.41, 0.80 ]
Hirayama 2006 (7) 0.18872 (0.309645) 1.3 % 0.19 [ -0.42, 0.80 ]
Hirayama 2006 (8) -0.38726 (0.318223) 1.3 % -0.39 [ -1.01, 0.24 ]
Hosomi 2013 (9) -0.11985 (0.116422) 9.5 % -0.12 [ -0.35, 0.11 ]
Hosomi 2013 (10) -0.057109 (0.127547) 7.9 % -0.06 [ -0.31, 0.19 ]
Jett 2013 -0.301786 (0.248108) 2.1 % -0.30 [ -0.79, 0.18 ]
Jett 2013 -0.191079 (0.244849) 2.2 % -0.19 [ -0.67, 0.29 ]
-4 -2 0 2 4
Favours active Favours sham
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Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Fixed,95% CI IV,Fixed,95% CI
Kang 2009 0.43402 (0.216454) 2.8 % 0.43 [ 0.01, 0.86 ]
Lefaucheur 2001a -0.9332 (0.219757) 2.7 % -0.93 [ -1.36, -0.50 ]
Lefaucheur 2001b -0.274478 (0.233036) 2.4 % -0.27 [ -0.73, 0.18 ]
Lefaucheur 2004 -0.344828 (0.091197) 15.5 % -0.34 [ -0.52, -0.17 ]
Lefaucheur 2006 -0.64827 (0.227633) 2.5 % -0.65 [ -1.09, -0.20 ]
Lefaucheur 2008 -0.334132 (0.143948) 6.2 % -0.33 [ -0.62, -0.05 ]
Nardone 2017 -2.16 (0.72449) 0.2 % -2.16 [ -3.58, -0.74 ]
Saitoh 2007 (11) -1.158204 (0.426308) 0.7 % -1.16 [ -1.99, -0.32 ]
Saitoh 2007 (12) -1.110603 (0.419362) 0.7 % -1.11 [ -1.93, -0.29 ]
Subtotal (95% CI) 82.7 % -0.28 [ -0.36, -0.20 ]
Heterogeneity: Chi2 = 68.06, df = 23 (P<0.00001); I2 =66%
Test for overall effect: Z = 7.05 (P < 0.00001)
Total (95% CI) 100.0 % -0.20 [ -0.28, -0.13 ]
Heterogeneity: Chi2 = 90.72, df = 28 (P<0.00001); I2 =69%
Test for overall effect: Z = 5.70 (P < 0.00001)
Test for subgroup differences: Chi2 = 20.19, df = 1 (P = 0.00), I2 =95%
-4 -2 0 2 4
Favours active Favours sham
(1) 1Hz
(2) antero-posterior coil orientation
(3) medial-lateral coil orientation
(4) Pain score higher at baseline in active stim group
(5) S1
(6) PMA
(7) SMA
(8) M1
(9) M1 Group B (sham followed by real)
(10) M1 Group A (real followed by sham)
(11) 5Hz
(12) 10 Hz
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Analysis 1.4. Comparison 1 Repetitive transcranial magnetic stimulation (rTMS), Outcome 4 Pain: short-
term follow-up, subgroup analysis, non-neuropathic pain participants only.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 1 Repetitive transcranial magnetic stimulation (rTMS)
Outcome: 4 Pain: short-term follow-up, subgroup analysis, non-neuropathic pain participants only
Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Fixed,95% CI IV,Fixed,95% CI
1 Low-frequency≤ 1 Hz
Carretero 2009 0.15649 (0.230164) 23.7 % 0.16 [ -0.29, 0.61 ]
Subtotal (95% CI) 23.7 % 0.16 [ -0.29, 0.61 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.68 (P = 0.50)
2 High-frequency≥ 5 Hz
Avery 2013 0.57 (0.494898) 5.1 % 0.57 [ -0.40, 1.54 ]
Mhalla 2011 -0.58 (0.32398) 11.9 % -0.58 [ -1.21, 0.05 ]
Passard 2007 -1.04 (0.392857) 8.1 % -1.04 [ -1.81, -0.27 ]
Pleger 2004 -0.138771 (0.21807) 26.4 % -0.14 [ -0.57, 0.29 ]
Short 2011 -0.55 (0.456633) 6.0 % -0.55 [ -1.44, 0.34 ]
Tekin 2014 -1.76 (0.334184) 11.2 % -1.76 [ -2.41, -1.11 ]
Yagci 2014 -0.46 (0.408163) 7.5 % -0.46 [ -1.26, 0.34 ]
Subtotal (95% CI) 76.3 % -0.56 [ -0.81, -0.31 ]
Heterogeneity: Chi2 = 23.40, df = 6 (P = 0.00067); I2 =74%
Test for overall effect: Z = 4.36 (P = 0.000013)
Total (95% CI) 100.0 % -0.39 [ -0.61, -0.17 ]
Heterogeneity: Chi2 = 30.77, df = 7 (P = 0.00007); I2 =77%
Test for overall effect: Z = 3.48 (P = 0.00051)
Test for subgroup differences: Chi2 = 7.37, df = 1 (P = 0.01), I2 =86%
-4 -2 0 2 4
Favours active Favours sham
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Analysis 1.5. Comparison 1 Repetitive transcranial magnetic stimulation (rTMS), Outcome 5 Pain: short-
term follow-up, subgroup analysis: motor cortex studies only, low-frequency studies excluded.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 1 Repetitive transcranial magnetic stimulation (rTMS)
Outcome: 5 Pain: short-term follow-up, subgroup analysis: motor cortex studies only, low-frequency studies excluded
Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
1 Single-dose studies
Andr -Obadia 2006 -0.066506 (0.259685) 3.8 % -0.07 [ -0.58, 0.44 ]
Andr -Obadia 2008 (1) -0.41092 (0.191008) 4.9 % -0.41 [ -0.79, -0.04 ]
Andr -Obadia 2008 (2) -0.287518 (0.187174) 4.9 % -0.29 [ -0.65, 0.08 ]
Andr -Obadia 2011 -0.383319 (0.105999) 6.3 % -0.38 [ -0.59, -0.18 ]
Hirayama 2006 -0.38726 (0.318223) 3.1 % -0.39 [ -1.01, 0.24 ]
Jett 2013 -0.301786 (0.248108) 4.0 % -0.30 [ -0.79, 0.18 ]
Jett 2013 -0.191079 (0.244849) 4.0 % -0.19 [ -0.67, 0.29 ]
Lefaucheur 2001a -0.9332 (0.219757) 4.4 % -0.93 [ -1.36, -0.50 ]
Lefaucheur 2001b -0.274478 (0.233036) 4.2 % -0.27 [ -0.73, 0.18 ]
Lefaucheur 2004 -0.344828 (0.091197) 6.5 % -0.34 [ -0.52, -0.17 ]
Lefaucheur 2006 -0.64827 (0.227633) 4.3 % -0.65 [ -1.09, -0.20 ]
Lefaucheur 2008 -0.334132 (0.143948) 5.7 % -0.33 [ -0.62, -0.05 ]
Pleger 2004 -0.138771 (0.21807) 4.4 % -0.14 [ -0.57, 0.29 ]
Rollnik 2002 -0.150199 (0.199233) 4.7 % -0.15 [ -0.54, 0.24 ]
Saitoh 2007 -1.110603 (0.419362) 2.2 % -1.11 [ -1.93, -0.29 ]
Saitoh 2007 -1.158204 (0.426308) 2.1 % -1.16 [ -1.99, -0.32 ]
Subtotal (95% CI) 69.6 % -0.38 [ -0.49, -0.27 ]
Heterogeneity: Tau2 = 0.01; Chi2 = 19.48, df = 15 (P = 0.19); I2 =23%
Test for overall effect: Z = 6.75 (P < 0.00001)
2 Multiple-dose studies
Defrin 2007 1.12 (0.642857) 1.1 % 1.12 [ -0.14, 2.38 ]
Hosomi 2013 (3) -0.057109 (0.127547) 5.9 % -0.06 [ -0.31, 0.19 ]
Hosomi 2013 (4) -0.019928 (0.116018) 6.1 % -0.02 [ -0.25, 0.21 ]
Kang 2009 0.43402 (0.216454) 4.5 % 0.43 [ 0.01, 0.86 ]
-4 -2 0 2 4
Favours active Favours sham
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Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
Medeiros 2016 -0.57 (0.42602) 2.1 % -0.57 [ -1.40, 0.26 ]
Mhalla 2011 -0.58 (0.32397959) 3.0 % -0.58 [ -1.21, 0.05 ]
Passard 2007 -1.04 (0.392857) 2.4 % -1.04 [ -1.81, -0.27 ]
Tekin 2014 -1.76 (0.334184) 2.9 % -1.76 [ -2.41, -1.11 ]
Yagci 2014 -0.46 (0.408163) 2.3 % -0.46 [ -1.26, 0.34 ]
Subtotal (95% CI) 30.4 % -0.34 [ -0.73, 0.05 ]
Heterogeneity: Tau2 = 0.25; Chi2 = 44.59, df = 8 (P<0.00001); I2 =82%
Test for overall effect: Z = 1.71 (P = 0.086)
Total (95% CI) 100.0 % -0.37 [ -0.51, -0.22 ]
Heterogeneity: Tau2 = 0.08; Chi2 = 71.66, df = 24 (P<0.00001); I2 =67%
Test for overall effect: Z = 4.93 (P < 0.00001)
Test for subgroup differences: Chi2 = 0.03, df = 1 (P = 0.87), I2 =0.0%
-4 -2 0 2 4
Favours active Favours sham
(1) antero-posterior coil orientation
(2) medial-lateral coil orientation
(3) Group B sham followed by real
(4) Group A real followed by sham
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Analysis 1.6. Comparison 1 Repetitive transcranial magnetic stimulation (rTMS), Outcome 6 Sensitivity
analysis - imputed correlation coefficient increased. Pain: short-term follow-up.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 1 Repetitive transcranial magnetic stimulation (rTMS)
Outcome: 6 Sensitivity analysis - imputed correlation coefficient increased. Pain: short-term follow-up
Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
1 Low-frequency≤ 1 Hz
Andr -Obadia 2006 -0.016296 (0.200013) 2.9 % -0.02 [ -0.41, 0.38 ]
Carretero 2009 0.6 (0.403061) 1.6 % 0.60 [ -0.19, 1.39 ]
Lee 2012 -0.59 (0.760204) 0.6 % -0.59 [ -2.08, 0.90 ]
Lefaucheur 2001b 0.15649 (0.17746) 3.1 % 0.16 [ -0.19, 0.50 ]
Lefaucheur 2006 (1) 0.37847 (0.165159) 3.2 % 0.38 [ 0.05, 0.70 ]
Lefaucheur 2008 0.14778 (0.097135) 3.7 % 0.15 [ -0.04, 0.34 ]
Saitoh 2007 -0.169857 (0.256121) 2.5 % -0.17 [ -0.67, 0.33 ]
Subtotal (95% CI) 17.4 % 0.15 [ 0.01, 0.29 ]
Heterogeneity: Tau2 = 0.00; Chi2 = 6.36, df = 6 (P = 0.38); I2 =6%
Test for overall effect: Z = 2.13 (P = 0.033)
2 High-frequency≥ 5 Hz
Andr -Obadia 2006 -0.066506 (0.200221) 2.9 % -0.07 [ -0.46, 0.33 ]
Andr -Obadia 2008 (2) -0.287518 (0.144314) 3.3 % -0.29 [ -0.57, 0.00 ]
Andr -Obadia 2008 (3) -0.41092 (0.14727) 3.3 % -0.41 [ -0.70, -0.12 ]
Andr -Obadia 2011 -0.383319 (0.081727) 3.8 % -0.38 [ -0.54, -0.22 ]
Avery 2013 0.57 (0.494898) 1.2 % 0.57 [ -0.40, 1.54 ]
Borckardt 2009 -2.717609 (0.57314) 1.0 % -2.72 [ -3.84, -1.59 ]
de Oliveira 2014 -0.33 (0.438776) 1.4 % -0.33 [ -1.19, 0.53 ]
Defrin 2007 1.12 (0.642857) 0.8 % 1.12 [ -0.14, 2.38 ]
Fregni 2005 0 (0) Not estimable
Hirayama 2006 (4) 0.18872 (0.238741) 2.6 % 0.19 [ -0.28, 0.66 ]
Hirayama 2006 (5) -0.38726 (0.245355) 2.5 % -0.39 [ -0.87, 0.09 ]
Hirayama 2006 (6) 0.23554 (0.239903) 2.6 % 0.24 [ -0.23, 0.71 ]
Hirayama 2006 (7) 0.19336 (0.238845) 2.6 % 0.19 [ -0.27, 0.66 ]
-4 -2 0 2 4
Favours active Favours sham
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Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
Hosomi 2013 (8) -0.057109 (0.098341) 3.7 % -0.06 [ -0.25, 0.14 ]
Hosomi 2013 (9) -0.11985 (0.089763) 3.7 % -0.12 [ -0.30, 0.06 ]
Jett 2013 (10) -0.191079 (0.188783) 3.0 % -0.19 [ -0.56, 0.18 ]
Jett 2013 (11) -0.301786 (0.191295) 3.0 % -0.30 [ -0.68, 0.07 ]
Kang 2009 0.43402 (0.166889) 3.2 % 0.43 [ 0.11, 0.76 ]
Lee 2012 -0.4 (0.742347) 0.6 % -0.40 [ -1.85, 1.05 ]
Lefaucheur 2001a -0.9332 (0.169436) 3.1 % -0.93 [ -1.27, -0.60 ]
Lefaucheur 2001b -0.274478 (0.179675) 3.1 % -0.27 [ -0.63, 0.08 ]
Lefaucheur 2004 -0.344828 (0.070314) 3.8 % -0.34 [ -0.48, -0.21 ]
Lefaucheur 2006 -0.64827 (0.175508) 3.1 % -0.65 [ -0.99, -0.30 ]
Lefaucheur 2008 -0.334132 (0.099269) 3.7 % -0.33 [ -0.53, -0.14 ]
Medeiros 2016 -0.57 (0.42602) 1.5 % -0.57 [ -1.40, 0.26 ]
Mhalla 2011 -0.58 (0.32398) 2.0 % -0.58 [ -1.21, 0.05 ]
Nardone 2017 -2.16 (0.72449) 0.7 % -2.16 [ -3.58, -0.74 ]
Passard 2007 -1.04 (0.392857) 1.6 % -1.04 [ -1.81, -0.27 ]
Pleger 2004 -0.138771 (0.168136) 3.1 % -0.14 [ -0.47, 0.19 ]
Rollnik 2002 -0.150199 (0.153612) 3.3 % -0.15 [ -0.45, 0.15 ]
Saitoh 2007 (12) -1.158204 (0.323335) 2.0 % -1.16 [ -1.79, -0.52 ]
Saitoh 2007 (13) -1.110603 (0.32869) 2.0 % -1.11 [ -1.75, -0.47 ]
Short 2011 -0.55 (0.456633) 1.3 % -0.55 [ -1.44, 0.34 ]
Tekin 2014 -1.76 (0.334184) 1.9 % -1.76 [ -2.41, -1.11 ]
Yagci 2014 -0.46 (0.408163) 1.5 % -0.46 [ -1.26, 0.34 ]
Subtotal (95% CI) 82.6 % -0.35 [ -0.49, -0.22 ]
Heterogeneity: Tau2 = 0.09; Chi2 = 136.26, df = 33 (P<0.00001); I2 =76%
Test for overall effect: Z = 5.18 (P < 0.00001)
Total (95% CI) 100.0 % -0.27 [ -0.40, -0.14 ]
Heterogeneity: Tau2 = 0.10; Chi2 = 179.43, df = 40 (P<0.00001); I2 =78%
Test for overall effect: Z = 4.21 (P = 0.000025)
Test for subgroup differences: Chi2 = 26.16, df = 1 (P = 0.00), I2 =96%
-4 -2 0 2 4
Favours active Favours sham
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(1) 1Hz
(2) medial-lateral coil orientation
(3) antero-posterior coil orientation
(4) SMA
(5) M1
(6) S1
(7) PMA
(8) M1 Group A (real followed by sham)
(9) M1 Group B (sham followed by real)
(10) M1 leg area
(11) M1 hand area
(12) 10 Hz
(13) 5Hz
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Analysis 1.7. Comparison 1 Repetitive transcranial magnetic stimulation (rTMS), Outcome 7 Sensitivity
analysis - imputed correlation coefficient decreased. Pain: short-term follow-up.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 1 Repetitive transcranial magnetic stimulation (rTMS)
Outcome: 7 Sensitivity analysis - imputed correlation coefficient decreased. Pain: short-term follow-up
Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
1 Low-frequency≤ 1 Hz
Andr -Obadia 2006 -0.016296 (0.311698) 2.3 % -0.02 [ -0.63, 0.59 ]
Carretero 2009 0.6 (0.403061) 1.8 % 0.60 [ -0.19, 1.39 ]
Lefaucheur 2001b 0.15649 (0.276551) 2.6 % 0.16 [ -0.39, 0.70 ]
Lefaucheur 2006 0.37847 (0.257382) 2.7 % 0.38 [ -0.13, 0.88 ]
Lefaucheur 2008 0.14778 (0.151374) 3.6 % 0.15 [ -0.15, 0.44 ]
Saitoh 2007 -0.169857 (0.355683) 2.0 % -0.17 [ -0.87, 0.53 ]
Yagci 2014 -0.46 (0.408163) 1.7 % -0.46 [ -1.26, 0.34 ]
Subtotal (95% CI) 16.9 % 0.13 [ -0.06, 0.33 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 5.33, df = 6 (P = 0.50); I2 =0.0%
Test for overall effect: Z = 1.35 (P = 0.18)
2 High-frequency≥ 5 Hz
Andr -Obadia 2006 -0.066506 (0.312022) 2.3 % -0.07 [ -0.68, 0.55 ]
Andr -Obadia 2008 (1) -0.287518 (0.224898) 3.0 % -0.29 [ -0.73, 0.15 ]
Andr -Obadia 2008 (2) -0.41092 (0.229504) 3.0 % -0.41 [ -0.86, 0.04 ]
Andr -Obadia 2011 -0.383319 (0.127363) 3.8 % -0.38 [ -0.63, -0.13 ]
Avery 2013 0.57 (0.494898) 1.4 % 0.57 [ -0.40, 1.54 ]
Borckardt 2009 -2.717609 (0.893174) 0.5 % -2.72 [ -4.47, -0.97 ]
de Oliveira 2014 -0.33 (0.438776) 1.6 % -0.33 [ -1.19, 0.53 ]
Defrin 2007 1.12 (0.642857) 0.9 % 1.12 [ -0.14, 2.38 ]
Hirayama 2006 (3) 0.18872 (0.238741) 2.9 % 0.19 [ -0.28, 0.66 ]
Hirayama 2006 (4) 0.19336 (0.238845) 2.9 % 0.19 [ -0.27, 0.66 ]
Hirayama 2006 (5) -0.38726 (0.245355) 2.8 % -0.39 [ -0.87, 0.09 ]
Hirayama 2006 (6) 0.23554 (0.239903) 2.9 % 0.24 [ -0.23, 0.71 ]
Hosomi 2013 (7) -0.057109 (0.153253) 3.6 % -0.06 [ -0.36, 0.24 ]
-2 -1 0 1 2
Favours active Favours sham
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Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
Hosomi 2013 (8) -0.11985 (0.139886) 3.7 % -0.12 [ -0.39, 0.15 ]
Jett 2013 -0.191079 (0.294197) 2.5 % -0.19 [ -0.77, 0.39 ]
Jett 2013 -0.301786 (0.298112) 2.4 % -0.30 [ -0.89, 0.28 ]
Kang 2009 0.43402 (0.166889) 3.5 % 0.43 [ 0.11, 0.76 ]
Lee 2012 -0.4 (0.742347) 0.7 % -0.40 [ -1.85, 1.05 ]
Lefaucheur 2001a -0.9332 (0.169436) 3.5 % -0.93 [ -1.27, -0.60 ]
Lefaucheur 2001b -0.274478 (0.179675) 3.4 % -0.27 [ -0.63, 0.08 ]
Lefaucheur 2004 -0.344828 (0.070314) 4.2 % -0.34 [ -0.48, -0.21 ]
Lefaucheur 2006 -0.64827 (0.175508) 3.4 % -0.65 [ -0.99, -0.30 ]
Lefaucheur 2008 -0.334132 (0.099269) 4.0 % -0.33 [ -0.53, -0.14 ]
Medeiros 2016 -0.57 (0.42602) 1.7 % -0.57 [ -1.40, 0.26 ]
Mhalla 2011 -0.58 (0.32398) 2.3 % -0.58 [ -1.21, 0.05 ]
Nardone 2017 -2.16 (0.72449) 0.8 % -2.16 [ -3.58, -0.74 ]
Passard 2007 -1.04 (0.392857) 1.8 % -1.04 [ -1.81, -0.27 ]
Pleger 2004 -0.138771 (0.21807) 3.1 % -0.14 [ -0.57, 0.29 ]
Rollnik 2002 -0.150199 (0.199233) 3.2 % -0.15 [ -0.54, 0.24 ]
Saitoh 2007 (9) -1.158204 (0.426308) 1.7 % -1.16 [ -1.99, -0.32 ]
Saitoh 2007 (10) -1.110603 (0.419362) 1.7 % -1.11 [ -1.93, -0.29 ]
Short 2011 -0.55 (0.456633) 1.5 % -0.55 [ -1.44, 0.34 ]
Tekin 2014 -1.76 (0.334184) 2.2 % -1.76 [ -2.41, -1.11 ]
Subtotal (95% CI) 83.1 % -0.34 [ -0.49, -0.19 ]
Heterogeneity: Tau2 = 0.10; Chi2 = 111.78, df = 32 (P<0.00001); I2 =71%
Test for overall effect: Z = 4.51 (P < 0.00001)
Total (95% CI) 100.0 % -0.26 [ -0.40, -0.13 ]
Heterogeneity: Tau2 = 0.11; Chi2 = 134.49, df = 39 (P<0.00001); I2 =71%
Test for overall effect: Z = 3.80 (P = 0.00015)
Test for subgroup differences: Chi2 = 14.44, df = 1 (P = 0.00), I2 =93%
-2 -1 0 1 2
Favours active Favours sham
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(1) medial-lateral coil orientatioin
(2) antero-posterior coil orientation
(3) SMA
(4) PMA
(5) M1
(6) S1
(7) M1 Group A (real followed by sham)
(8) M1 Group B (sham followed by real)
(9) 5Hz
(10) 10 Hz
Analysis 1.8. Comparison 1 Repetitive transcranial magnetic stimulation (rTMS), Outcome 8 Sensitivity
analysis - imputed correlation increased. Pain: short-term follow-up, subgroup analysis: motor cortex studies
only, low-frequency studies excluded.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 1 Repetitive transcranial magnetic stimulation (rTMS)
Outcome: 8 Sensitivity analysis - imputed correlation increased. Pain: short-term follow-up, subgroup analysis: motor cortex studies only, low-frequency studies excluded
Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
1 Single-dose studies
Andr -Obadia 2006 -0.066506 (0.200221) 4.2 % -0.07 [ -0.46, 0.33 ]
Andr -Obadia 2008 (1) -0.41092 (0.14727) 5.1 % -0.41 [ -0.70, -0.12 ]
Andr -Obadia 2008 (2) -0.287518 (0.144314) 5.1 % -0.29 [ -0.57, 0.00 ]
Andr -Obadia 2011 -0.383319 (0.081727) 6.0 % -0.38 [ -0.54, -0.22 ]
Hirayama 2006 -0.38726 (0.245355) 3.6 % -0.39 [ -0.87, 0.09 ]
Jett 2013 (3) -0.191079 (0.188783) 4.4 % -0.19 [ -0.56, 0.18 ]
Jett 2013 (4) -0.301786 (0.191295) 4.3 % -0.30 [ -0.68, 0.07 ]
Lefaucheur 2001a -0.9332 (0.169436) 4.7 % -0.93 [ -1.27, -0.60 ]
-1 -0.5 0 0.5 1
Favours active Favours sham
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Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
Lefaucheur 2001b -0.274478 (0.179675) 4.5 % -0.27 [ -0.63, 0.08 ]
Lefaucheur 2004 -0.344828 (0.070314) 6.2 % -0.34 [ -0.48, -0.21 ]
Lefaucheur 2006 -0.64827 (0.175508) 4.6 % -0.65 [ -0.99, -0.30 ]
Lefaucheur 2008 -0.334132 (0.099269) 5.8 % -0.33 [ -0.53, -0.14 ]
Pleger 2004 -0.138771 (0.168136) 4.7 % -0.14 [ -0.47, 0.19 ]
Rollnik 2002 -0.150199 (0.153612) 5.0 % -0.15 [ -0.45, 0.15 ]
Saitoh 2007 -1.110603 (0.323335) 2.7 % -1.11 [ -1.74, -0.48 ]
Saitoh 2007 -1.158204 (0.32869) 2.6 % -1.16 [ -1.80, -0.51 ]
Subtotal (95% CI) 73.4 % -0.39 [ -0.50, -0.28 ]
Heterogeneity: Tau2 = 0.02; Chi2 = 32.80, df = 15 (P = 0.01); I2 =54%
Test for overall effect: Z = 6.84 (P < 0.00001)
2 Multiple-dose studies
Defrin 2007 1.12 (0.642857) 1.0 % 1.12 [ -0.14, 2.38 ]
Hosomi 2013 (5) -0.057109 (0.098341) 5.8 % -0.06 [ -0.25, 0.14 ]
Hosomi 2013 (6) -0.11985 (0.089763) 5.9 % -0.12 [ -0.30, 0.06 ]
Kang 2009 0.43402 (0.166889) 4.7 % 0.43 [ 0.11, 0.76 ]
Medeiros 2016 -0.57 (0.42602) 1.8 % -0.57 [ -1.40, 0.26 ]
Mhalla 2011 -0.58 (0.32397959) 2.6 % -0.58 [ -1.21, 0.05 ]
Passard 2007 -1.08 (0.393857) 2.1 % -1.08 [ -1.85, -0.31 ]
Tekin 2014 -1.76 (0.334184) 2.6 % -1.76 [ -2.41, -1.11 ]
Subtotal (95% CI) 26.6 % -0.33 [ -0.71, 0.04 ]
Heterogeneity: Tau2 = 0.20; Chi2 = 48.30, df = 7 (P<0.00001); I2 =86%
Test for overall effect: Z = 1.75 (P = 0.081)
Total (95% CI) 100.0 % -0.37 [ -0.50, -0.24 ]
Heterogeneity: Tau2 = 0.07; Chi2 = 95.35, df = 23 (P<0.00001); I2 =76%
Test for overall effect: Z = 5.43 (P < 0.00001)
Test for subgroup differences: Chi2 = 0.07, df = 1 (P = 0.79), I2 =0.0%
-1 -0.5 0 0.5 1
Favours active Favours sham
(1) antero-posterior coil orientation
(2) medial-lateral coil orientation
(3) M1 leg area
(4) m1 hand area
(5) Group A (real followed by sham)
(6) Group B (sham followed by real)
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Analysis 1.9. Comparison 1 Repetitive transcranial magnetic stimulation (rTMS), Outcome 9 Sensitivity
analysis - imputed correlation decreased. Pain: short-term follow-up, subgroup analysis: motor cortex studies
only, low-frequency studies excluded.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 1 Repetitive transcranial magnetic stimulation (rTMS)
Outcome: 9 Sensitivity analysis - imputed correlation decreased. Pain: short-term follow-up, subgroup analysis: motor cortex studies only, low-frequency studies excluded
Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
1 Single-dose studies
Andr -Obadia 2006 -0.066506 (0.312022) 3.6 % -0.07 [ -0.68, 0.55 ]
Andr -Obadia 2008 (1) -0.41092 (0.229504) 4.9 % -0.41 [ -0.86, 0.04 ]
Andr -Obadia 2008 (2) -0.287518 (0.224898) 5.0 % -0.29 [ -0.73, 0.15 ]
Andr -Obadia 2011 -0.383319 (0.127363) 6.9 % -0.38 [ -0.63, -0.13 ]
Hirayama 2006 -0.38726 (0.382358) 2.8 % -0.39 [ -1.14, 0.36 ]
Jett 2013 -0.191079 (0.294197) 3.9 % -0.19 [ -0.77, 0.39 ]
Jett 2013 -0.301786 (0.298112) 3.8 % -0.30 [ -0.89, 0.28 ]
Lefaucheur 2001a -0.9332 (0.264047) 4.3 % -0.93 [ -1.45, -0.42 ]
Lefaucheur 2001b -0.274478 (0.280003) 4.1 % -0.27 [ -0.82, 0.27 ]
Lefaucheur 2004 -0.344828 (0.109577) 7.2 % -0.34 [ -0.56, -0.13 ]
Lefaucheur 2006 -0.64827 (0.312022) 3.6 % -0.65 [ -1.26, -0.04 ]
Lefaucheur 2008 -0.334132 (0.1547) 6.3 % -0.33 [ -0.64, -0.03 ]
Pleger 2004 -0.138771 (0.262021) 4.4 % -0.14 [ -0.65, 0.37 ]
Rollnik 2002 -0.150199 (0.239386) 4.7 % -0.15 [ -0.62, 0.32 ]
Saitoh 2007 -1.110603 (0.503881) 1.9 % -1.11 [ -2.10, -0.12 ]
Saitoh 2007 -1.158204 (0.512227) 1.8 % -1.16 [ -2.16, -0.15 ]
Subtotal (95% CI) 69.3 % -0.37 [ -0.47, -0.26 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 13.26, df = 15 (P = 0.58); I2 =0.0%
Test for overall effect: Z = 6.79 (P < 0.00001)
2 Multiple-dose studies
Defrin 2007 1.12 (0.642857) 1.3 % 1.12 [ -0.14, 2.38 ]
Hosomi 2013 (3) -0.057109 (0.153253) 6.4 % -0.06 [ -0.36, 0.24 ]
-4 -2 0 2 4
Favours active Favours sham
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Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
Hosomi 2013 (4) -0.11985 (0.139886) 6.6 % -0.12 [ -0.39, 0.15 ]
Kang 2009 0.43402 (0.260078) 4.4 % 0.43 [ -0.08, 0.94 ]
Medeiros 2016 -0.57 (0.42602) 2.4 % -0.57 [ -1.40, 0.26 ]
Mhalla 2011 -0.58 (0.32397959) 3.5 % -0.58 [ -1.21, 0.05 ]
Passard 2007 -1.08 (0.392857) 2.7 % -1.08 [ -1.85, -0.31 ]
Tekin 2014 -1.76 (0.334184) 3.3 % -1.76 [ -2.41, -1.11 ]
Subtotal (95% CI) 30.7 % -0.36 [ -0.81, 0.09 ]
Heterogeneity: Tau2 = 0.31; Chi2 = 40.25, df = 7 (P<0.00001); I2 =83%
Test for overall effect: Z = 1.58 (P = 0.11)
Total (95% CI) 100.0 % -0.37 [ -0.52, -0.22 ]
Heterogeneity: Tau2 = 0.07; Chi2 = 55.72, df = 23 (P = 0.00015); I2 =59%
Test for overall effect: Z = 4.70 (P < 0.00001)
Test for subgroup differences: Chi2 = 0.00, df = 1 (P = 0.98), I2 =0.0%
-4 -2 0 2 4
Favours active Favours sham
(1) antero-posterior coil orientation
(2) medial-lateral coil orientation
(3) Group A (real followed by sham)
(4) Group A (sham followed by real)
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Analysis 1.10. Comparison 1 Repetitive transcranial magnetic stimulation (rTMS), Outcome 10 Sensitivity
analysis - inclusion of high risk of bias studies. Pain: short-term follow-up.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 1 Repetitive transcranial magnetic stimulation (rTMS)
Outcome: 10 Sensitivity analysis - inclusion of high risk of bias studies. Pain: short-term follow-up
Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Fixed,95% CI IV,Fixed,95% CI
1 Low-frequency≤ 1 Hz
Andr -Obadia 2006 -0.016296 (0.259415) 1.7 % -0.02 [ -0.52, 0.49 ]
Carretero 2009 0.15649 (0.230164) 2.2 % 0.16 [ -0.29, 0.61 ]
Fregni 2011 0 (0) Not estimable
Irlbacher 2006 -0.178283 (0.188266) 3.3 % -0.18 [ -0.55, 0.19 ]
Lee 2012 (1) -0.59 (0.760204) 0.2 % -0.59 [ -2.08, 0.90 ]
Lefaucheur 2001b 0.156 (0.162229) 4.4 % 0.16 [ -0.16, 0.47 ]
Lefaucheur 2006 (2) 0.37847 (0.21421) 2.5 % 0.38 [ -0.04, 0.80 ]
Lefaucheur 2008 0.14778 (0.140854) 5.9 % 0.15 [ -0.13, 0.42 ]
Saitoh 2007 -0.169857 (0.332186) 1.1 % -0.17 [ -0.82, 0.48 ]
Yagci 2014 -0.46 (0.408163) 0.7 % -0.46 [ -1.26, 0.34 ]
Subtotal (95% CI) 22.0 % 0.07 [ -0.07, 0.22 ]
Heterogeneity: Chi2 = 7.61, df = 8 (P = 0.47); I2 =0.0%
Test for overall effect: Z = 1.02 (P = 0.31)
2 High-frequency≥ 5 Hz
Ahmed 2011 -3.58 (0.660714) 0.3 % -3.58 [ -4.87, -2.29 ]
Andr -Obadia 2006 -0.066506 (0.259685) 1.7 % -0.07 [ -0.58, 0.44 ]
Andr -Obadia 2008 (3) -0.41092 (0.191008) 3.2 % -0.41 [ -0.79, -0.04 ]
Andr -Obadia 2008 (4) -0.287518 (0.187174) 3.3 % -0.29 [ -0.65, 0.08 ]
Andr -Obadia 2011 -0.383319 (0.105999) 10.4 % -0.38 [ -0.59, -0.18 ]
Avery 2013 0.57 (0.494898) 0.5 % 0.57 [ -0.40, 1.54 ]
Borckardt 2009 -2.717609 (0.743356) 0.2 % -2.72 [ -4.17, -1.26 ]
Dall’Agnol 2014 -0.59 (0.418367) 0.7 % -0.59 [ -1.41, 0.23 ]
de Oliveira 2014 -0.33 (0.438776) 0.6 % -0.33 [ -1.19, 0.53 ]
Defrin 2007 (5) 1.12 (0.642857) 0.3 % 1.12 [ -0.14, 2.38 ]
-4 -2 0 2 4
Favours active Favours sham
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(. . . Continued)
Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Fixed,95% CI IV,Fixed,95% CI
Hirayama 2006 (6) 0.18872 (0.309645) 1.2 % 0.19 [ -0.42, 0.80 ]
Hirayama 2006 (7) 0.19336 (0.309779) 1.2 % 0.19 [ -0.41, 0.80 ]
Hirayama 2006 (8) 0.23554 (0.311152) 1.2 % 0.24 [ -0.37, 0.85 ]
Hirayama 2006 (9) -0.38726 (0.318223) 1.2 % -0.39 [ -1.01, 0.24 ]
Irlbacher 2006 -0.0702 (0.187018) 3.3 % -0.07 [ -0.44, 0.30 ]
Jett 2013 -0.191079 (0.244849) 1.9 % -0.19 [ -0.67, 0.29 ]
Jett 2013 -0.301786 (0.248108) 1.9 % -0.30 [ -0.79, 0.18 ]
Kang 2009 0.43402 (0.216454) 2.5 % 0.43 [ 0.01, 0.86 ]
Khedr 2005 -1.59 (0.334) 1.0 % -1.59 [ -2.24, -0.94 ]
Lee 2012 (10) 0.31 (0.739796) 0.2 % 0.31 [ -1.14, 1.76 ]
Lefaucheur 2001a -0.9332 (0.219757) 2.4 % -0.93 [ -1.36, -0.50 ]
Lefaucheur 2001b -0.274478 (0.233036) 2.1 % -0.27 [ -0.73, 0.18 ]
Lefaucheur 2004 -0.344828 (0.091197) 14.0 % -0.34 [ -0.52, -0.17 ]
Lefaucheur 2006 -0.64827 (0.227633) 2.2 % -0.65 [ -1.09, -0.20 ]
Lefaucheur 2008 -0.334132 (0.143948) 5.6 % -0.33 [ -0.62, -0.05 ]
Mhalla 2011 -0.58 (0.32398) 1.1 % -0.58 [ -1.21, 0.05 ]
Nardone 2017 -2.16 (0.72449) 0.2 % -2.16 [ -3.58, -0.74 ]
Nurmikko 2016 (11) -0.684323 (0.207507) 2.7 % -0.68 [ -1.09, -0.28 ]
Nurmikko 2016 (12) -0.679031 (0.207203) 2.7 % -0.68 [ -1.09, -0.27 ]
Passard 2007 -1.04 (0.392857) 0.8 % -1.04 [ -1.81, -0.27 ]
Pleger 2004 -0.138771 (0.21807) 2.4 % -0.14 [ -0.57, 0.29 ]
Rollnik 2002 -0.150199 (0.199233) 2.9 % -0.15 [ -0.54, 0.24 ]
Saitoh 2007 (13) -1.158204 (0.426308) 0.6 % -1.16 [ -1.99, -0.32 ]
Saitoh 2007 (14) -1.110603 (0.419362) 0.7 % -1.11 [ -1.93, -0.29 ]
Short 2011 -0.55 (0.456633) 0.6 % -0.55 [ -1.44, 0.34 ]
Subtotal (95% CI) 78.0 % -0.36 [ -0.44, -0.29 ]
Heterogeneity: Chi2 = 117.32, df = 34 (P<0.00001); I2 =71%
Test for overall effect: Z = 9.44 (P < 0.00001)
Total (95% CI) 100.0 % -0.27 [ -0.34, -0.20 ]
Heterogeneity: Chi2 = 153.30, df = 43 (P<0.00001); I2 =72%
Test for overall effect: Z = 7.86 (P < 0.00001)
Test for subgroup differences: Chi2 = 28.38, df = 1 (P = 0.00), I2 =96%
-4 -2 0 2 4
Favours active Favours sham
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(1) right DLPFC
(2) 1Hz
(3) antero-posterior coil orientation
(4) medial-lateral coil orientation
(5) Pain score higher at baseline in active stim group
(6) SMA
(7) PMA
(8) S1
(9) M1
(10) left M1
(11) M1 hotspot
(12) M1 reorganised area
(13) 5Hz
(14) 10 Hz
239Non-invasive brain stimulation techniques for chronic pain (Review)
Copyright © 2018 The Authors. Cochrane Database of Systematic Reviews published by John Wiley & Sons, Ltd. on behalf of The
Cochrane Collaboration.
Analysis 1.11. Comparison 1 Repetitive transcranial magnetic stimulation (rTMS), Outcome 11 Sensitivity
analysis - inclusion of high risk of bias studies. Pain: short-term follow-up, subgroup analysis: motor cortex
studies only, low-frequency studies excluded.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 1 Repetitive transcranial magnetic stimulation (rTMS)
Outcome: 11 Sensitivity analysis - inclusion of high risk of bias studies. Pain: short-term follow-up, subgroup analysis: motor cortex studies only, low-frequency studies
excluded
Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
1 Single-dose studies
Andr -Obadia 2006 -0.066506 (0.259685) 3.4 % -0.07 [ -0.58, 0.44 ]
Andr -Obadia 2008 (1) -0.41092 (0.191008) 4.1 % -0.41 [ -0.79, -0.04 ]
Andr -Obadia 2008 (2) -0.287518 (0.187174) 4.2 % -0.29 [ -0.65, 0.08 ]
Andr -Obadia 2011 -0.383319 (0.149906) 4.6 % -0.38 [ -0.68, -0.09 ]
Hirayama 2006 -0.38726 (0.318223) 2.8 % -0.39 [ -1.01, 0.24 ]
Irlbacher 2006 -0.0702 (0.187018) 4.2 % -0.07 [ -0.44, 0.30 ]
Jett 2013 -0.301786 (0.248108) 3.5 % -0.30 [ -0.79, 0.18 ]
Jett 2013 -0.191079 (0.244849) 3.5 % -0.19 [ -0.67, 0.29 ]
Lefaucheur 2001a -0.9332 (0.219757) 3.8 % -0.93 [ -1.36, -0.50 ]
Lefaucheur 2001b -0.274478 (0.233036) 3.6 % -0.27 [ -0.73, 0.18 ]
Lefaucheur 2004 -0.344828 (0.091197) 5.2 % -0.34 [ -0.52, -0.17 ]
Lefaucheur 2006 -0.64827 (0.227633) 3.7 % -0.65 [ -1.09, -0.20 ]
Lefaucheur 2008 -0.334132 (0.143948) 4.6 % -0.33 [ -0.62, -0.05 ]
Mhalla 2011 -0.21 (0.316327) 2.8 % -0.21 [ -0.83, 0.41 ]
Pleger 2004 -0.138771 (0.21807) 3.8 % -0.14 [ -0.57, 0.29 ]
Rollnik 2002 -0.150199 (0.199233) 4.0 % -0.15 [ -0.54, 0.24 ]
Saitoh 2007 -1.110603 (0.419362) 2.0 % -1.11 [ -1.93, -0.29 ]
Saitoh 2007 -1.158204 (0.426308) 2.0 % -1.16 [ -1.99, -0.32 ]
Subtotal (95% CI) 65.7 % -0.35 [ -0.46, -0.24 ]
Heterogeneity: Tau2 = 0.01; Chi2 = 22.07, df = 17 (P = 0.18); I2 =23%
Test for overall effect: Z = 6.36 (P < 0.00001)
2 Multiple-dose studies
Ahmed 2011 -3.58 (0.660714) 1.0 % -3.58 [ -4.87, -2.29 ]
-4 -2 0 2 4
Favours active Favours sham
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Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
Dall’Agnol 2014 -0.59 (0.418367) 2.0 % -0.59 [ -1.41, 0.23 ]
Defrin 2007 1.12 (0.642857) 1.1 % 1.12 [ -0.14, 2.38 ]
Hosomi 2013 (3) -0.057109 (0.127547) 4.8 % -0.06 [ -0.31, 0.19 ]
Hosomi 2013 (4) -0.11985 (0.116422) 4.9 % -0.12 [ -0.35, 0.11 ]
Kang 2009 0.43402 (0.216454) 3.8 % 0.43 [ 0.01, 0.86 ]
Khedr 2005 -1.59 (0.334) 2.7 % -1.59 [ -2.24, -0.94 ]
Lee 2012 0.26 (0.635204) 1.1 % 0.26 [ -0.98, 1.50 ]
Mhalla 2011 -0.58 (0.32397959) 2.7 % -0.58 [ -1.21, 0.05 ]
Nurmikko 2016 (5) -0.679031 (0.207203) 3.9 % -0.68 [ -1.09, -0.27 ]
Nurmikko 2016 (6) -0.684323 (0.207507) 3.9 % -0.68 [ -1.09, -0.28 ]
Passard 2007 -1.04 (0.392857) 2.2 % -1.04 [ -1.81, -0.27 ]
Subtotal (95% CI) 34.3 % -0.53 [ -0.91, -0.15 ]
Heterogeneity: Tau2 = 0.32; Chi2 = 74.26, df = 11 (P<0.00001); I2 =85%
Test for overall effect: Z = 2.75 (P = 0.0059)
Total (95% CI) 100.0 % -0.41 [ -0.55, -0.26 ]
Heterogeneity: Tau2 = 0.10; Chi2 = 96.89, df = 29 (P<0.00001); I2 =70%
Test for overall effect: Z = 5.41 (P < 0.00001)
Test for subgroup differences: Chi2 = 0.79, df = 1 (P = 0.37), I2 =0.0%
-4 -2 0 2 4
Favours active Favours sham
(1) antero-posterior coil orientation
(2) medial-lateral coil orientation
(3) Group B (real followed by sham)
(4) Group A (sham followed by real)
(5) M1 hotspot
(6) M1 reogranised area
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Analysis 1.12. Comparison 1 Repetitive transcranial magnetic stimulation (rTMS), Outcome 12 Pain: short-
term follow-up, subgroup analysis: prefrontal cortex studies only.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 1 Repetitive transcranial magnetic stimulation (rTMS)
Outcome: 12 Pain: short-term follow-up, subgroup analysis: prefrontal cortex studies only
Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
1 Low frequency≤ 1 Hz
Carretero 2009 0.15649 (0.230164) 21.0 % 0.16 [ -0.29, 0.61 ]
Subtotal (95% CI) 21.0 % 0.16 [ -0.29, 0.61 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.68 (P = 0.50)
2 High frequency≥ 5 Hz
Avery 2013 (1) 0.57 (0.494898) 17.0 % 0.57 [ -0.40, 1.54 ]
Borckardt 2009 (2) -2.7017609 (0.743356) 13.0 % -2.70 [ -4.16, -1.24 ]
de Oliveira 2014 -0.33 (0.438776) 17.9 % -0.33 [ -1.19, 0.53 ]
Nardone 2017 -2.16 (0.72449) 13.3 % -2.16 [ -3.58, -0.74 ]
Short 2011 (3) -0.55 (0.456633) 17.7 % -0.55 [ -1.44, 0.34 ]
Subtotal (95% CI) 79.0 % -0.92 [ -1.95, 0.12 ]
Heterogeneity: Tau2 = 1.07; Chi2 = 18.60, df = 4 (P = 0.00094); I2 =78%
Test for overall effect: Z = 1.73 (P = 0.083)
Total (95% CI) 100.0 % -0.67 [ -1.48, 0.15 ]
Heterogeneity: Tau2 = 0.77; Chi2 = 24.13, df = 5 (P = 0.00021); I2 =79%
Test for overall effect: Z = 1.61 (P = 0.11)
Test for subgroup differences: Chi2 = 3.46, df = 1 (P = 0.06), I2 =71%
-10 -5 0 5 10
Favours active Favours sham
(1) 10Hz
(2) 10Hz
(3) 10Hz
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Analysis 1.13. Comparison 1 Repetitive transcranial magnetic stimulation (rTMS), Outcome 13 Sensitivity
analysis - inclusion of high risk of bias studies. Pain: short-term follow-up, subgroup analysis: prefrontal cortex
studies only.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 1 Repetitive transcranial magnetic stimulation (rTMS)
Outcome: 13 Sensitivity analysis - inclusion of high risk of bias studies. Pain: short-term follow-up, subgroup analysis: prefrontal cortex studies only
Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
1 Multiple-dose studies
Avery 2013 (1) 0.57 (0.494898) 14.9 % 0.57 [ -0.40, 1.54 ]
Borckardt 2009 (2) -2.7017609 (0.743356) 11.1 % -2.70 [ -4.16, -1.24 ]
Carretero 2009 (3) 0.15649 (0.230164) 18.9 % 0.16 [ -0.29, 0.61 ]
de Oliveira 2014 -0.33 (0.438776) 15.8 % -0.33 [ -1.19, 0.53 ]
Lee 2012 (4) -0.6 (0.655612) 12.4 % -0.60 [ -1.88, 0.68 ]
Nardone 2017 -2.16 (0.72449) 11.4 % -2.16 [ -3.58, -0.74 ]
Short 2011 (5) -0.55 (0.456633) 15.5 % -0.55 [ -1.44, 0.34 ]
Total (95% CI) 100.0 % -0.64 [ -1.36, 0.08 ]
Heterogeneity: Tau2 = 0.66; Chi2 = 24.44, df = 6 (P = 0.00043); I2 =75%
Test for overall effect: Z = 1.75 (P = 0.080)
Test for subgroup differences: Not applicable
-10 -5 0 5 10
Favours active Favours sham
(1) 10Hz
(2) 10Hz
(3) 1 Hz
(4) 1Hz
(5) 10Hz
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Analysis 1.14. Comparison 1 Repetitive transcranial magnetic stimulation (rTMS), Outcome 14 Pain: short
term responder analysis 30% pain reduction.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 1 Repetitive transcranial magnetic stimulation (rTMS)
Outcome: 14 Pain: short term responder analysis 30% pain reduction
Study or subgroup Active Sham Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Attal 2016 0/23 0/12 Not estimable
Malavera 2013 19/27 9/27 100.0 % 2.11 [ 1.17, 3.80 ]
Total (95% CI) 50 39 100.0 % 2.11 [ 1.17, 3.80 ]
Total events: 19 (Active), 9 (Sham)
Heterogeneity: not applicable
Test for overall effect: Z = 2.50 (P = 0.013)
Test for subgroup differences: Not applicable
0.5 0.7 1 1.5 2
Favours sham Favours active
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Analysis 1.15. Comparison 1 Repetitive transcranial magnetic stimulation (rTMS), Outcome 15 Sensitivity
analysis- inclusion of high risk of bias studies. Disability: medium-term follow-up.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 1 Repetitive transcranial magnetic stimulation (rTMS)
Outcome: 15 Sensitivity analysis- inclusion of high risk of bias studies. Disability: medium-term follow-up
Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
Avery 2013 (1) 0.01 (0.482143) 16.6 % 0.01 [ -0.93, 0.95 ]
Kang 2009 (2) 0.233504 (0.209504) 25.4 % 0.23 [ -0.18, 0.64 ]
Mhalla 2011 (3) -1.16 (0.344388) 21.0 % -1.16 [ -1.83, -0.49 ]
Passard 2007 (4) -0.6 (0.375) 20.0 % -0.60 [ -1.33, 0.13 ]
Umezaki 2016 -0.68 (0.471939) 16.9 % -0.68 [ -1.60, 0.24 ]
Total (95% CI) 100.0 % -0.42 [ -1.01, 0.17 ]
Heterogeneity: Tau2 = 0.32; Chi2 = 14.30, df = 4 (P = 0.01); I2 =72%
Test for overall effect: Z = 1.38 (P = 0.17)
Test for subgroup differences: Not applicable
-2 -1 0 1 2
Favours active Favours sham
(1) BPI interference 1 month follow up
(2) BPI total (excl. walking subscale) 1 week post stim period
(3) BPI interference 1 month post treatment
(4) BPI general activity subscale. 16 days post stim period
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Analysis 1.16. Comparison 1 Repetitive transcranial magnetic stimulation (rTMS), Outcome 16 Pain:
medium-term follow-up.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 1 Repetitive transcranial magnetic stimulation (rTMS)
Outcome: 16 Pain: medium-term follow-up
Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
1 Low-frequency≤ 1 Hz
Carretero 2009 (1) 0.36 (0.3954) 7.7 % 0.36 [ -0.41, 1.13 ]
Yagci 2014 -0.08 (0.40051) 7.6 % -0.08 [ -0.86, 0.70 ]
Subtotal (95% CI) 15.3 % 0.14 [ -0.41, 0.69 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.61, df = 1 (P = 0.43); I2 =0.0%
Test for overall effect: Z = 0.51 (P = 0.61)
2 High-frequency≥ 5 Hz
Avery 2013 (2) -0.11 (0.484694) 6.3 % -0.11 [ -1.06, 0.84 ]
de Oliveira 2014 -9.55 (1.691327) 0.9 % -9.55 [ -12.86, -6.24 ]
Hosomi 2013 (3) 0.12839 (0.127967) 12.6 % 0.13 [ -0.12, 0.38 ]
Hosomi 2013 (4) -0.14898 (0.116648) 12.7 % -0.15 [ -0.38, 0.08 ]
Kang 2009 (5) -0.126074 (0.207526) 11.2 % -0.13 [ -0.53, 0.28 ]
Lefaucheur 2001a (6) -0.77794 (0.209117) 11.2 % -0.78 [ -1.19, -0.37 ]
Malavera 2013 -0.32 (0.27551) 9.9 % -0.32 [ -0.86, 0.22 ]
Nardone 2017 -0.19 (0.579082) 5.1 % -0.19 [ -1.32, 0.94 ]
Passard 2007 (7) -0.4 (0.367347) 8.2 % -0.40 [ -1.12, 0.32 ]
Short 2011 (8) -0.46 (0.454082) 6.7 % -0.46 [ -1.35, 0.43 ]
Subtotal (95% CI) 84.7 % -0.36 [ -0.73, 0.00 ]
Heterogeneity: Tau2 = 0.22; Chi2 = 45.83, df = 9 (P<0.00001); I2 =80%
Test for overall effect: Z = 1.95 (P = 0.052)
Total (95% CI) 100.0 % -0.28 [ -0.61, 0.05 ]
Heterogeneity: Tau2 = 0.20; Chi2 = 47.65, df = 11 (P<0.00001); I2 =77%
Test for overall effect: Z = 1.69 (P = 0.092)
Test for subgroup differences: Chi2 = 2.25, df = 1 (P = 0.13), I2 =56%
-4 -2 0 2 4
Favours active Favours sham
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(1) DLPFC, 1 Hz 4 weeks post treatment
(2) DLPFC 10Hz 1 month follow up
(3) M1 10Hz, Group A real followed by sham, 17 days post treatment
(4) M1 10Hz, Group B sham followed by real, 17 days post treatment
(5) M1, 10Hz, 3 week follow up
(6) M1, 10HZ, 12 days post stimulation
(7) M1, 10Hz, 15 days post first stim (likely 2 weeks post intervention)
(8) DLPFC,10Hz, 2 weeks post treatment
Analysis 1.17. Comparison 1 Repetitive transcranial magnetic stimulation (rTMS), Outcome 17 Sensitivity
analysis - inclusion of high risk of bias studies. Pain: medium-term follow-up.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 1 Repetitive transcranial magnetic stimulation (rTMS)
Outcome: 17 Sensitivity analysis - inclusion of high risk of bias studies. Pain: medium-term follow-up
Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
1 Low-frequency≤ 1 Hz
Carretero 2009 (1) 0.36 (0.3954) 5.5 % 0.36 [ -0.41, 1.13 ]
Lee 2012 (2) -0.9 (0.795918) 2.6 % -0.90 [ -2.46, 0.66 ]
Yagci 2014 -0.08 (0.40051) 5.4 % -0.08 [ -0.86, 0.70 ]
Subtotal (95% CI) 13.5 % 0.02 [ -0.52, 0.56 ]
Heterogeneity: Tau2 = 0.02; Chi2 = 2.14, df = 2 (P = 0.34); I2 =6%
Test for overall effect: Z = 0.07 (P = 0.95)
2 High-frequency≥ 5 Hz
Ahmed 2011 -2.61 (0.558673) 4.0 % -2.61 [ -3.70, -1.52 ]
Avery 2013 (3) -0.11 (0.484694) 4.6 % -0.11 [ -1.06, 0.84 ]
de Oliveira 2014 -9.55 (1.691327) 0.7 % -9.55 [ -12.86, -6.24 ]
Hosomi 2013 (4) -0.14898 (0.116648) 8.3 % -0.15 [ -0.38, 0.08 ]
Hosomi 2013 (5) 0.12839 (0.127967) 8.2 % 0.13 [ -0.12, 0.38 ]
-2 -1 0 1 2
Favours active Favours sham
(Continued . . . )
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(. . . Continued)
Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
Kang 2009 (6) -0.126074 (0.207526) 7.5 % -0.13 [ -0.53, 0.28 ]
Khedr 2005 -1.16 (0.313776) 6.4 % -1.16 [ -1.77, -0.55 ]
Lee 2012 0.06 (0.729592) 2.9 % 0.06 [ -1.37, 1.49 ]
Lefaucheur 2001a (7) -0.77794 (0.209117) 7.5 % -0.78 [ -1.19, -0.37 ]
Malavera 2013 -0.32 (0.27551) 6.8 % -0.32 [ -0.86, 0.22 ]
Nardone 2017 -0.19 (0.579082) 3.8 % -0.19 [ -1.32, 0.94 ]
Nurmikko 2016 (8) -0.716703 (0.209405) 7.5 % -0.72 [ -1.13, -0.31 ]
Nurmikko 2016 (9) -0.55342 (0.200581) 7.6 % -0.55 [ -0.95, -0.16 ]
Passard 2007 (10) -0.4 (0.367347) 5.8 % -0.40 [ -1.12, 0.32 ]
Short 2011 (11) -0.46 (0.454082) 4.9 % -0.46 [ -1.35, 0.43 ]
Subtotal (95% CI) 86.5 % -0.57 [ -0.90, -0.25 ]
Heterogeneity: Tau2 = 0.28; Chi2 = 79.44, df = 14 (P<0.00001); I2 =82%
Test for overall effect: Z = 3.44 (P = 0.00059)
Total (95% CI) 100.0 % -0.50 [ -0.80, -0.20 ]
Heterogeneity: Tau2 = 0.26; Chi2 = 83.18, df = 17 (P<0.00001); I2 =80%
Test for overall effect: Z = 3.29 (P = 0.0010)
Test for subgroup differences: Chi2 = 3.35, df = 1 (P = 0.07), I2 =70%
-2 -1 0 1 2
Favours active Favours sham
(1) DLPFC 4 weeks post treatment
(2) dlpfc 4 weeks post treatment
(3) 10Hz DLPFC 1 month follow up
(4) M1 Group B sham followed by real, around 17 days post treatment
(5) M1 Group A real followed by sham, around 17 days post treatment
(6) M1 3 week follow up
(7) M1 12 days post
(8) M1 hotspot
(9) M1 reorganised area
(10) M1 15 days post first stim (likely 2 weeks post internvetion)
(11) DLPFC 2 weeks post treatment
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Analysis 1.18. Comparison 1 Repetitive transcranial magnetic stimulation (rTMS), Outcome 18 Pain:
medium-term follow-up, subgroup analysis: motor cortex studies only.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 1 Repetitive transcranial magnetic stimulation (rTMS)
Outcome: 18 Pain: medium-term follow-up, subgroup analysis: motor cortex studies only
Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
1 Low frequency≤ 1Hz
Yagci 2014 -0.08 (0.40051) 7.0 % -0.08 [ -0.86, 0.70 ]
Subtotal (95% CI) 7.0 % -0.08 [ -0.86, 0.70 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.20 (P = 0.84)
2 High-frequency≥ 5 Hz
Hosomi 2013 (1) 0.12839 (0.127967) 21.1 % 0.13 [ -0.12, 0.38 ]
Hosomi 2013 (2) -0.14898 (0.116648) 21.9 % -0.15 [ -0.38, 0.08 ]
Kang 2009 (3) -0.126074 (0.207526) 15.3 % -0.13 [ -0.53, 0.28 ]
Lefaucheur 2001a (4) -0.77794 (0.209117) 15.2 % -0.78 [ -1.19, -0.37 ]
Malavera 2013 -0.32 (0.27551) 11.5 % -0.32 [ -0.86, 0.22 ]
Passard 2007 (5) -0.4 (0.367347) 7.9 % -0.40 [ -1.12, 0.32 ]
Subtotal (95% CI) 93.0 % -0.23 [ -0.49, 0.03 ]
Heterogeneity: Tau2 = 0.06; Chi2 = 14.60, df = 5 (P = 0.01); I2 =66%
Test for overall effect: Z = 1.74 (P = 0.083)
Total (95% CI) 100.0 % -0.22 [ -0.46, 0.02 ]
Heterogeneity: Tau2 = 0.05; Chi2 = 14.64, df = 6 (P = 0.02); I2 =59%
Test for overall effect: Z = 1.77 (P = 0.076)
Test for subgroup differences: Chi2 = 0.13, df = 1 (P = 0.72), I2 =0.0%
-4 -2 0 2 4
Favours active Favours sham
(1) M1 10Hz, Group A real followed by sham, 17 days post treatment
(2) M1 10Hz, Group B sham followed by real, 17 days post treatment
(3) M1, 10Hz, 3 week follow up
(4) M1, 10HZ, 12 days post stimulation
(5) M1, 10Hz, 15 days post first stim (likely 2 weeks post intervention)
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Analysis 1.19. Comparison 1 Repetitive transcranial magnetic stimulation (rTMS), Outcome 19 Pain:
medium-term follow-up, subgroup analysis: prefrontal cortex studies only.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 1 Repetitive transcranial magnetic stimulation (rTMS)
Outcome: 19 Pain: medium-term follow-up, subgroup analysis: prefrontal cortex studies only
Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
1 Low frequency≤ 1 Hz
Carretero 2009 0.36 (0.3954) 23.1 % 0.36 [ -0.41, 1.13 ]
Subtotal (95% CI) 23.1 % 0.36 [ -0.41, 1.13 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.91 (P = 0.36)
2 High-frequency≥ 5 Hz
Avery 2013 -0.11 (0.484694) 22.4 % -0.11 [ -1.06, 0.84 ]
de Oliveira 2014 -9.55 (1.691327) 10.4 % -9.55 [ -12.86, -6.24 ]
Nardone 2017 -0.19 (0.579082) 21.4 % -0.19 [ -1.32, 0.94 ]
Short 2011 -0.46 (0.454082) 22.6 % -0.46 [ -1.35, 0.43 ]
Subtotal (95% CI) 76.9 % -1.74 [ -3.66, 0.19 ]
Heterogeneity: Tau2 = 3.18; Chi2 = 29.56, df = 3 (P<0.00001); I2 =90%
Test for overall effect: Z = 1.77 (P = 0.077)
Total (95% CI) 100.0 % -1.08 [ -2.49, 0.32 ]
Heterogeneity: Tau2 = 2.07; Chi2 = 32.91, df = 4 (P<0.00001); I2 =88%
Test for overall effect: Z = 1.51 (P = 0.13)
Test for subgroup differences: Chi2 = 3.93, df = 1 (P = 0.05), I2 =75%
-10 -5 0 5 10
Favours active Favours sham
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Analysis 1.20. Comparison 1 Repetitive transcranial magnetic stimulation (rTMS), Outcome 20 Pain: long-
term follow-up.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 1 Repetitive transcranial magnetic stimulation (rTMS)
Outcome: 20 Pain: long-term follow-up
Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
Avery 2013 (1) -0.27 (0.484694) 10.6 % -0.27 [ -1.22, 0.68 ]
Kang 2009 (2) -0.100705 (0.207229) 57.8 % -0.10 [ -0.51, 0.31 ]
Passard 2007 (3) -0.11 (0.390306) 16.3 % -0.11 [ -0.87, 0.65 ]
Yagci 2014 -0.2 (0.403061) 15.3 % -0.20 [ -0.99, 0.59 ]
Total (95% CI) 100.0 % -0.14 [ -0.44, 0.17 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.14, df = 3 (P = 0.99); I2 =0.0%
Test for overall effect: Z = 0.86 (P = 0.39)
Test for subgroup differences: Not applicable
-2 -1 0 1 2
Favours active Favours sham
(1) 3 month follow up
(2) 7 week follow up
(3) 60 day follow up
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Analysis 1.21. Comparison 1 Repetitive transcranial magnetic stimulation (rTMS), Outcome 21 Sensitivity
analysis - inclusion of high risk of bias studies. Pain: long-term follow-up.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 1 Repetitive transcranial magnetic stimulation (rTMS)
Outcome: 21 Sensitivity analysis - inclusion of high risk of bias studies. Pain: long-term follow-up
Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
Ahmed 2011 (1) -1.62 (0.464286) 16.4 % -1.62 [ -2.53, -0.71 ]
Avery 2013 (2) -0.27 (0.484694) 15.6 % -0.27 [ -1.22, 0.68 ]
Kang 2009 (3) -0.100705 (0.207229) 29.4 % -0.10 [ -0.51, 0.31 ]
Passard 2007 (4) -0.11 (0.390306) 19.6 % -0.11 [ -0.87, 0.65 ]
Yagci 2014 -0.2 (0.403061) 19.0 % -0.20 [ -0.99, 0.59 ]
Total (95% CI) 100.0 % -0.40 [ -0.89, 0.10 ]
Heterogeneity: Tau2 = 0.18; Chi2 = 9.30, df = 4 (P = 0.05); I2 =57%
Test for overall effect: Z = 1.57 (P = 0.12)
Test for subgroup differences: Not applicable
-4 -2 0 2 4
Favours active Favours sham
(1) 20Hz, M1, 2 month follow up
(2) 10Hz DLPFC 3 month follow up
(3) 10Hz, M1, 7 week follow up
(4) 10Hz, M1, 60 day follow up
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Analysis 1.22. Comparison 1 Repetitive transcranial magnetic stimulation (rTMS), Outcome 22 Disability:
short-term follow-up.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 1 Repetitive transcranial magnetic stimulation (rTMS)
Outcome: 22 Disability: short-term follow-up
Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
Avery 2013 (1) 0.38 (0.489796) 16.3 % 0.38 [ -0.58, 1.34 ]
Kang 2009 (2) 0.29605 (0.211186) 25.4 % 0.30 [ -0.12, 0.71 ]
Mhalla 2011 (3) -0.98 (0.336735) 21.2 % -0.98 [ -1.64, -0.32 ]
Passard 2007 (4) -0.55 (0.372449) 20.0 % -0.55 [ -1.28, 0.18 ]
Short 2011 (5) -0.64 (0.461735) 17.1 % -0.64 [ -1.54, 0.26 ]
Total (95% CI) 100.0 % -0.29 [ -0.87, 0.29 ]
Heterogeneity: Tau2 = 0.30; Chi2 = 13.99, df = 4 (P = 0.01); I2 =71%
Test for overall effect: Z = 0.98 (P = 0.33)
Test for subgroup differences: Not applicable
-4 -2 0 2 4
Favours active Favours sham
(1) BPI interference end of treatment period
(2) BPI total (excl. walking subscale) end of 5 day stim period
(3) BPI interference end of 9 week treatment period (only monthly maintenance stim to go)
(4) BPI general activity subscale. 1 day post stim period
(5) BPI functional impairment end of 2 week treatment period
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Analysis 1.23. Comparison 1 Repetitive transcranial magnetic stimulation (rTMS), Outcome 23 Sensitivity
analysis- inclusion of high risk of bias studies. Disability: short-term follow-up.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 1 Repetitive transcranial magnetic stimulation (rTMS)
Outcome: 23 Sensitivity analysis- inclusion of high risk of bias studies. Disability: short-term follow-up
Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
Attal 2016 -0.28 (0.352041) 15.1 % -0.28 [ -0.97, 0.41 ]
Avery 2013 (1) 0.38 (0.489796) 10.9 % 0.38 [ -0.58, 1.34 ]
Kang 2009 (2) 0.29605 (0.211186) 20.5 % 0.30 [ -0.12, 0.71 ]
Mhalla 2011 (3) -0.98 (0.336735) 15.7 % -0.98 [ -1.64, -0.32 ]
Passard 2007 (4) -0.55 (0.372449) 14.4 % -0.55 [ -1.28, 0.18 ]
Short 2011 (5) -0.64 (0.461735) 11.7 % -0.64 [ -1.54, 0.26 ]
Umezaki 2016 -0.47 (0.464286) 11.6 % -0.47 [ -1.38, 0.44 ]
Total (95% CI) 100.0 % -0.30 [ -0.72, 0.12 ]
Heterogeneity: Tau2 = 0.18; Chi2 = 14.47, df = 6 (P = 0.02); I2 =59%
Test for overall effect: Z = 1.41 (P = 0.16)
Test for subgroup differences: Not applicable
-2 -1 0 1 2
Favours active Favours sham
(1) BPI interference end of treatment period
(2) BPI total (excl. walking subscale) end of 5 day stim period
(3) BPI interference end of 9 week treatment period (only monthly maintenance stim to go)
(4) BPI general activity subscale. 1 day post stim period
(5) BPI functional impairment end of 2 week treatment period
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Analysis 1.24. Comparison 1 Repetitive transcranial magnetic stimulation (rTMS), Outcome 24 Disability:
medium-term follow-up.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 1 Repetitive transcranial magnetic stimulation (rTMS)
Outcome: 24 Disability: medium-term follow-up
Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
Avery 2013 (1) 0.01 (0.482143) 20.6 % 0.01 [ -0.93, 0.95 ]
Kang 2009 (2) 0.233504 (0.209504) 29.8 % 0.23 [ -0.18, 0.64 ]
Mhalla 2011 (3) -1.16 (0.344388) 25.3 % -1.16 [ -1.83, -0.49 ]
Passard 2007 (4) -0.6 (0.375) 24.3 % -0.60 [ -1.33, 0.13 ]
Total (95% CI) 100.0 % -0.37 [ -1.07, 0.33 ]
Heterogeneity: Tau2 = 0.38; Chi2 = 13.38, df = 3 (P = 0.004); I2 =78%
Test for overall effect: Z = 1.03 (P = 0.30)
Test for subgroup differences: Not applicable
-2 -1 0 1 2
Favours active Favours sham
(1) BPI interference 1 month follow up
(2) BPI total (excl. walking subscale) 1 week post stim period
(3) BPI interference 1 month post treatment
(4) BPI general activity subscale. 16 days post stim period
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Analysis 1.25. Comparison 1 Repetitive transcranial magnetic stimulation (rTMS), Outcome 25 Pain: short
term responder analysis 50% pain reduction.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 1 Repetitive transcranial magnetic stimulation (rTMS)
Outcome: 25 Pain: short term responder analysis 50% pain reduction
Study or subgroup Active Sham Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Malavera 2013 17/27 9/27 100.0 % 1.89 [ 1.03, 3.47 ]
Total (95% CI) 27 27 100.0 % 1.89 [ 1.03, 3.47 ]
Total events: 17 (Active), 9 (Sham)
Heterogeneity: not applicable
Test for overall effect: Z = 2.05 (P = 0.040)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours sham Favours active
Analysis 1.26. Comparison 1 Repetitive transcranial magnetic stimulation (rTMS), Outcome 26 Disability:
long-term follow-up.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 1 Repetitive transcranial magnetic stimulation (rTMS)
Outcome: 26 Disability: long-term follow-up
Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
Avery 2013 (1) -0.67 (0.5) 14.4 % -0.67 [ -1.65, 0.31 ]
Kang 2009 (2) -0.01742 (0.206721) 61.2 % -0.02 [ -0.42, 0.39 ]
Passard 2007 (3) -0.51 (0.372449) 24.4 % -0.51 [ -1.24, 0.22 ]
Total (95% CI) 100.0 % -0.23 [ -0.62, 0.16 ]
Heterogeneity: Tau2 = 0.02; Chi2 = 2.36, df = 2 (P = 0.31); I2 =15%
Test for overall effect: Z = 1.17 (P = 0.24)
Test for subgroup differences: Not applicable
-2 -1 0 1 2
Favours active Favours sham
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(1) BPI interference 3 month follow up
(2) BPI total (excl. walking subscale) 7 weeks post stim period
(3) BPI general activity subscale. 46 days post stim period
Analysis 1.27. Comparison 1 Repetitive transcranial magnetic stimulation (rTMS), Outcome 27 Sensitivity
analysis - inclusion of high risk of bias studies. Disability: long-term follow-up.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 1 Repetitive transcranial magnetic stimulation (rTMS)
Outcome: 27 Sensitivity analysis - inclusion of high risk of bias studies. Disability: long-term follow-up
Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
Avery 2013 (1) -0.67 (0.5) 16.3 % -0.67 [ -1.65, 0.31 ]
Kang 2009 (2) -0.01742 (0.206721) 42.6 % -0.02 [ -0.42, 0.39 ]
Passard 2007 (3) -0.51 (0.372449) 24.4 % -0.51 [ -1.24, 0.22 ]
Umezaki 2016 -1.03 (0.492347) 16.7 % -1.03 [ -1.99, -0.07 ]
Total (95% CI) 100.0 % -0.41 [ -0.87, 0.05 ]
Heterogeneity: Tau2 = 0.09; Chi2 = 4.92, df = 3 (P = 0.18); I2 =39%
Test for overall effect: Z = 1.76 (P = 0.078)
Test for subgroup differences: Not applicable
-4 -2 0 2 4
Favours active Favours sham
(1) BPI interference 3 month follow up
(2) BPI total (excl. walking subscale) 7 weeks post stim period
(3) BPI general activity subscale. 46 days post stim period
257Non-invasive brain stimulation techniques for chronic pain (Review)
Copyright © 2018 The Authors. Cochrane Database of Systematic Reviews published by John Wiley & Sons, Ltd. on behalf of The
Cochrane Collaboration.
Analysis 1.28. Comparison 1 Repetitive transcranial magnetic stimulation (rTMS), Outcome 28 Quality of
life: short-term follow-up (Fibromyalgia Impact Questionnaire).
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 1 Repetitive transcranial magnetic stimulation (rTMS)
Outcome: 28 Quality of life: short-term follow-up (Fibromyalgia Impact Questionnaire)
Study or subgroup Active stimulation Sham stimulation
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Mhalla 2011 (1) 16 55 (16.6) 14 65.7 (11) 18.1 % -10.70 [ -20.67, -0.73 ]
Passard 2007 (2) 15 47.4 (8.1) 15 57.8 (6.8) 62.9 % -10.40 [ -15.75, -5.05 ]
Short 2011 (3) 10 42.07 (18.13) 10 51.5 (17.32) 7.5 % -9.43 [ -24.97, 6.11 ]
Yagci 2014 (4) 13 44.8 (15.77) 12 58.8 (16.1) 11.5 % -14.00 [ -26.51, -1.49 ]
Total (95% CI) 54 51 100.0 % -10.80 [ -15.04, -6.55 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.30, df = 3 (P = 0.96); I2 =0.0%
Test for overall effect: Z = 4.99 (P < 0.00001)
Test for subgroup differences: Not applicable
-50 -25 0 25 50
Favours active Favours sham
(1) M1, 10Hz
(2) M1, 10Hz
(3) DLPFC, 10Hz
(4) M1, 1Hz
258Non-invasive brain stimulation techniques for chronic pain (Review)
Copyright © 2018 The Authors. Cochrane Database of Systematic Reviews published by John Wiley & Sons, Ltd. on behalf of The
Cochrane Collaboration.
Analysis 1.29. Comparison 1 Repetitive transcranial magnetic stimulation (rTMS), Outcome 29 Quality of
life: medium-term follow-up (Fibromyalgia Impact Questionnaire).
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 1 Repetitive transcranial magnetic stimulation (rTMS)
Outcome: 29 Quality of life: medium-term follow-up (Fibromyalgia Impact Questionnaire)
Study or subgroup Active stimulation Sham stimulation
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Mhalla 2011 (1) 16 56 (17.7) 14 63.3 (15) 20.1 % -7.30 [ -19.00, 4.40 ]
Passard 2007 (2) 15 48.7 (10.4) 15 62.2 (8.9) 57.3 % -13.50 [ -20.43, -6.57 ]
Short 2011 (3) 10 38.99 (19.44) 10 47.93 (14.7) 12.0 % -8.94 [ -24.05, 6.17 ]
Yagci 2014 13 38.35 (23.25) 12 49.8 (17.7) 10.6 % -11.45 [ -27.58, 4.68 ]
Total (95% CI) 54 51 100.0 % -11.49 [ -16.73, -6.25 ]
Heterogeneity: Chi2 = 0.93, df = 3 (P = 0.82); I2 =0.0%
Test for overall effect: Z = 4.29 (P = 0.000018)
Test for subgroup differences: Not applicable
-100 -50 0 50 100
Favours active Favours sham
(1) M1, 10Hz
(2) M1, 10Hz
(3) DLPFC, 10Hz
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Analysis 1.30. Comparison 1 Repetitive transcranial magnetic stimulation (rTMS), Outcome 30 Sensitivity
analysis - inclusion of high risk of bias studies. Quality of life: medium-term follow-up (Fibromyalgia Impact
Questionnaire).
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 1 Repetitive transcranial magnetic stimulation (rTMS)
Outcome: 30 Sensitivity analysis - inclusion of high risk of bias studies. Quality of life: medium-term follow-up (Fibromyalgia Impact Questionnaire)
Study or subgroup Active stimulation Sham stimulation
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Boyer 2014 19 0.3 (18.2) 19 1.3 (9.5) 24.4 % -1.00 [ -10.23, 8.23 ]
Mhalla 2011 (1) 16 56 (17.7) 14 63.3 (15) 15.2 % -7.30 [ -19.00, 4.40 ]
Passard 2007 (2) 15 48.7 (10.4) 15 62.2 (8.9) 43.3 % -13.50 [ -20.43, -6.57 ]
Short 2011 (3) 10 38.99 (19.44) 10 47.93 (14.7) 9.1 % -8.94 [ -24.05, 6.17 ]
Yagci 2014 13 38.35 (23.25) 12 49.8 (17.7) 8.0 % -11.45 [ -27.58, 4.68 ]
Total (95% CI) 73 70 100.0 % -8.93 [ -13.49, -4.37 ]
Heterogeneity: Chi2 = 4.68, df = 4 (P = 0.32); I2 =14%
Test for overall effect: Z = 3.84 (P = 0.00012)
Test for subgroup differences: Not applicable
-100 -50 0 50 100
Favours active Favours sham
(1) M1, 10Hz
(2) M1, 10Hz
(3) DLPFC, 10Hz
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Analysis 1.31. Comparison 1 Repetitive transcranial magnetic stimulation (rTMS), Outcome 31 Quality of
life: long-term follow-up.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 1 Repetitive transcranial magnetic stimulation (rTMS)
Outcome: 31 Quality of life: long-term follow-up
Study or subgroup Experimental Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Passard 2007 13 57.2 (10.1) 13 63.1 (8.8) 83.3 % -5.90 [ -13.18, 1.38 ]
Yagci 2014 13 36.95 (24.27) 12 48.13 (16.79) 16.7 % -11.18 [ -27.44, 5.08 ]
Total (95% CI) 26 25 100.0 % -6.78 [ -13.43, -0.14 ]
Heterogeneity: Chi2 = 0.34, df = 1 (P = 0.56); I2 =0.0%
Test for overall effect: Z = 2.00 (P = 0.045)
Test for subgroup differences: Not applicable
-100 -50 0 50 100
Favours active Favours sham
Analysis 1.32. Comparison 1 Repetitive transcranial magnetic stimulation (rTMS), Outcome 32 Sensitivity
analysis - inclusion of high risk of bias studies. Quality of life: long-term follow-up.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 1 Repetitive transcranial magnetic stimulation (rTMS)
Outcome: 32 Sensitivity analysis - inclusion of high risk of bias studies. Quality of life: long-term follow-up
Study or subgroup Experimental Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Boyer 2014 19 -9.6 (16.7) 19 2 (9.3) 37.4 % -11.60 [ -20.19, -3.01 ]
Passard 2007 13 57.2 (10.1) 13 63.1 (8.8) 52.1 % -5.90 [ -13.18, 1.38 ]
Yagci 2014 13 36.95 (24.27) 12 48.13 (16.79) 10.5 % -11.18 [ -27.44, 5.08 ]
Total (95% CI) 45 44 100.0 % -8.58 [ -13.84, -3.33 ]
Heterogeneity: Chi2 = 1.09, df = 2 (P = 0.58); I2 =0.0%
Test for overall effect: Z = 3.20 (P = 0.0014)
Test for subgroup differences: Not applicable
-100 -50 0 50 100
Favours active Favours sham
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Analysis 2.1. Comparison 2 Cranial electrotherapy stimulation (CES), Outcome 1 Pain: short-term follow-
up.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 2 Cranial electrotherapy stimulation (CES)
Outcome: 1 Pain: short-term follow-up
Study or subgroup Active stimulation Sham stimulation
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Gabis 2003 10 2.83 (2.07) 10 2.65 (2.49) 7.6 % 0.08 [ -0.80, 0.95 ]
Gabis 2009 (1) 17 3.82 (2.86) 16 5.25 (2.29) 12.0 % -0.54 [ -1.23, 0.16 ]
Gabis 2009 (2) 19 3.26 (2.79) 23 4.65 (2.62) 15.3 % -0.51 [ -1.12, 0.11 ]
Tan 2006 18 5.73 (2.56) 20 6 (2.41) 14.3 % -0.11 [ -0.74, 0.53 ]
Tan 2011 45 5 (1.92) 55 5 (1.93) 37.5 % 0.0 [ -0.39, 0.39 ]
Taylor 2013 (3) 19 5.12 (1.69) 18 6.36 (2.11) 13.3 % -0.64 [ -1.30, 0.03 ]
Total (95% CI) 128 142 100.0 % -0.24 [ -0.48, 0.01 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 4.87, df = 5 (P = 0.43); I2 =0.0%
Test for overall effect: Z = 1.91 (P = 0.056)
Test for subgroup differences: Not applicable
-2 -1 0 1 2
Favours active Favours sham
(1) back pain
(2) neck pain
(3) Effect predominantly due to increase in pain in sham group
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Analysis 2.2. Comparison 2 Cranial electrotherapy stimulation (CES), Outcome 2 Quality of life: short
term follow up.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 2 Cranial electrotherapy stimulation (CES)
Outcome: 2 Quality of life: short term follow up
Study or subgroup Active stimulation Sham stimulation
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Taylor 2013 (1) 18 45.05 (16.27) 18 70.1 (22.34) -25.05 [ -37.82, -12.28 ]
Test for subgroup differences: Not applicable
-100 -50 0 50 100
Favours active Favours sham
(1) Fibromyalgia Impact Questionnaire
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Analysis 3.1. Comparison 3 Transcranial direct current stimulation (tDCS), Outcome 1 Pain: short-term
follow-up.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 3 Transcranial direct current stimulation (tDCS)
Outcome: 1 Pain: short-term follow-up
Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
1 Single-dose studies
Boggio 2009 -0.417904 (0.314924) 4.1 % -0.42 [ -1.04, 0.20 ]
Jensen 2013 -0.146424 (0.165274) 5.7 % -0.15 [ -0.47, 0.18 ]
Ngernyam 2015 -0.17 (0.192387) 5.4 % -0.17 [ -0.55, 0.21 ]
Villamar 2013 (1) 0.11545 (0.285689) 4.4 % 0.12 [ -0.44, 0.68 ]
Villamar 2013 (2) -0.393703 (0.29557) 4.3 % -0.39 [ -0.97, 0.19 ]
Subtotal (95% CI) 23.9 % -0.18 [ -0.38, 0.02 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 2.21, df = 4 (P = 0.70); I2 =0.0%
Test for overall effect: Z = 1.75 (P = 0.080)
2 Multiple-dose studies
Ahn 2017 -0.88 (0.334184) 3.9 % -0.88 [ -1.53, -0.23 ]
Ayache 2016 -0.3 (0.354592) 3.7 % -0.30 [ -0.99, 0.39 ]
Bae 2014 0.15 (0.556122) 2.3 % 0.15 [ -0.94, 1.24 ]
Brietzke 2016 -0.51 (0.535714) 2.4 % -0.51 [ -1.56, 0.54 ]
Chang 2017 -0.45 (0.405612) 3.3 % -0.45 [ -1.24, 0.34 ]
Fagerlund 2015 -0.37 (0.290816) 4.3 % -0.37 [ -0.94, 0.20 ]
Fenton 2009 0.06593 (0.323217) 4.0 % 0.07 [ -0.57, 0.70 ]
Fregni 2006a -1.32 (0.568878) 2.2 % -1.32 [ -2.43, -0.21 ]
Fregni 2006b (3) -0.73 (0.556122) 2.3 % -0.73 [ -1.82, 0.36 ]
Fregni 2006b (4) 1.11 (0.477041) 2.7 % 1.11 [ 0.18, 2.04 ]
Hazime 2017 -0.85 (0.308763) 4.2 % -0.85 [ -1.46, -0.24 ]
Jales Junior 2015 -0.87 (0.471939) 2.8 % -0.87 [ -1.79, 0.05 ]
Khedr 2017 -1.81 (0.403061) 3.3 % -1.81 [ -2.60, -1.02 ]
Lagueux 2017 -0.56 (0.436224) 3.0 % -0.56 [ -1.41, 0.29 ]
Luedtke 2015 0.04 (0.181122) 5.5 % 0.04 [ -0.31, 0.39 ]
-4 -2 0 2 4
Favours active Favours sham
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Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
Mendonca 2016 -0.3 (0.367347) 3.6 % -0.30 [ -1.02, 0.42 ]
Mori 2010 -1.19 (0.507653) 2.5 % -1.19 [ -2.18, -0.20 ]
Oliveira 2015 -0.97 (0.378) 3.5 % -0.97 [ -1.71, -0.23 ]
Riberto 2011 0.02 (0.4158) 3.2 % 0.02 [ -0.79, 0.83 ]
Sakrajai 2014 -1.58 (0.418367) 3.2 % -1.58 [ -2.40, -0.76 ]
Soler 2010 (5) -0.55 (0.45663) 2.9 % -0.55 [ -1.44, 0.34 ]
Volz 2016 -0.85 (0.471939) 2.8 % -0.85 [ -1.77, 0.07 ]
Wrigley 2014 0.35377 (0.278353) 4.5 % 0.35 [ -0.19, 0.90 ]
Subtotal (95% CI) 76.1 % -0.51 [ -0.77, -0.25 ]
Heterogeneity: Tau2 = 0.25; Chi2 = 61.73, df = 22 (P = 0.00001); I2 =64%
Test for overall effect: Z = 3.79 (P = 0.00015)
Total (95% CI) 100.0 % -0.43 [ -0.63, -0.22 ]
Heterogeneity: Tau2 = 0.16; Chi2 = 67.25, df = 27 (P = 0.00003); I2 =60%
Test for overall effect: Z = 4.14 (P = 0.000035)
Test for subgroup differences: Chi2 = 3.90, df = 1 (P = 0.05), I2 =74%
-4 -2 0 2 4
Favours active Favours sham
(1) anodal
(2) cathodal
(3) M1
(4) DLPFC
(5) tDCS+ sham illusion vs sham tDCS + sham illusion
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Analysis 3.2. Comparison 3 Transcranial direct current stimulation (tDCS), Outcome 2 Pain: short-term
sensitivity analysis: correlation increased.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 3 Transcranial direct current stimulation (tDCS)
Outcome: 2 Pain: short-term sensitivity analysis: correlation increased
Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
Ahn 2017 -0.88 (0.334184) 3.7 % -0.88 [ -1.53, -0.23 ]
Ayache 2016 -0.3 (0.354592) 3.5 % -0.30 [ -0.99, 0.39 ]
Bae 2014 0.15 (0.556122) 2.1 % 0.15 [ -0.94, 1.24 ]
Boggio 2009 -0.417904 (0.268318) 4.4 % -0.42 [ -0.94, 0.11 ]
Brietzke 2016 -0.51 (0.385204) 3.3 % -0.51 [ -1.26, 0.24 ]
Chang 2017 -0.45 (0.405612) 3.1 % -0.45 [ -1.24, 0.34 ]
Fagerlund 2015 -0.37 (0.290816) 4.1 % -0.37 [ -0.94, 0.20 ]
Fenton 2009 0.06593 (0.275383) 4.3 % 0.07 [ -0.47, 0.61 ]
Fregni 2006a -1.32 (0.568878) 2.1 % -1.32 [ -2.43, -0.21 ]
Fregni 2006b (1) 1.11 (0.477041) 2.6 % 1.11 [ 0.18, 2.04 ]
Fregni 2006b (2) -0.73 (0.556122) 2.1 % -0.73 [ -1.82, 0.36 ]
Hazime 2017 -0.85 (0.308673) 4.0 % -0.85 [ -1.45, -0.25 ]
Jales Junior 2015 -0.87 (0.471939) 2.6 % -0.87 [ -1.79, 0.05 ]
Jensen 2013 -0.146424 (0.140815) 5.7 % -0.15 [ -0.42, 0.13 ]
Khedr 2017 -1.81 (0.403061) 3.1 % -1.81 [ -2.60, -1.02 ]
Lagueux 2017 -0.56 (0.436224) 2.9 % -0.56 [ -1.41, 0.29 ]
Luedtke 2015 0.04 (0.181122) 5.3 % 0.04 [ -0.31, 0.39 ]
Mendonca 2016 -0.3 (0.367347) 3.4 % -0.30 [ -1.02, 0.42 ]
Mori 2010 -1.19 (0.507653) 2.4 % -1.19 [ -2.18, -0.20 ]
Ngernyam 2015 -0.17 (0.163915) 5.5 % -0.17 [ -0.49, 0.15 ]
Oliveira 2015 -0.97 (0.3775) 3.3 % -0.97 [ -1.71, -0.23 ]
Riberto 2011 0.02 (0.4158) 3.0 % 0.02 [ -0.79, 0.83 ]
Sakrajai 2014 -1.58 (0.418367) 3.0 % -1.58 [ -2.40, -0.76 ]
Soler 2010 (3) -0.55 (0.45663) 2.7 % -0.55 [ -1.44, 0.34 ]
-2 -1 0 1 2
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Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
Soler 2010 (4) -0.74 (0.479592) 2.6 % -0.74 [ -1.68, 0.20 ]
Villamar 2013 (5) 0.11545 (0.298113) 4.1 % 0.12 [ -0.47, 0.70 ]
Villamar 2013 (6) -0.393703 (0.308424) 4.0 % -0.39 [ -1.00, 0.21 ]
Volz 2016 -0.85 (0.471939) 2.6 % -0.85 [ -1.77, 0.07 ]
Wrigley 2014 0.35377 (0.237244) 4.7 % 0.35 [ -0.11, 0.82 ]
Total (95% CI) 100.0 % -0.43 [ -0.62, -0.23 ]
Heterogeneity: Tau2 = 0.15; Chi2 = 71.32, df = 28 (P = 0.00001); I2 =61%
Test for overall effect: Z = 4.33 (P = 0.000015)
Test for subgroup differences: Not applicable
-2 -1 0 1 2
Favours active Favours sham
(1) DLPFC
(2) M1
(3) tDCS+ sham illusion vs sham TDCS + sham illusion
(4) tDCS+ illusion vs sham TDCS + illusion
(5) anodal
(6) cathodal
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Analysis 3.3. Comparison 3 Transcranial direct current stimulation (tDCS), Outcome 3 Pain: short-term
sensitivity analysis: correlation decreased.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 3 Transcranial direct current stimulation (tDCS)
Outcome: 3 Pain: short-term sensitivity analysis: correlation decreased
Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
Ahn 2017 -0.88 (0.334184) 4.0 % -0.88 [ -1.53, -0.23 ]
Ayache 2016 -0.3 (0.354592) 3.8 % -0.30 [ -0.99, 0.39 ]
Bae 2014 0.15 (0.556122) 2.3 % 0.15 [ -0.94, 1.24 ]
Boggio 2009 -0.417904 (0.355472) 3.8 % -0.42 [ -1.11, 0.28 ]
Brietzke 2016 -0.51 (0.385204) 3.5 % -0.51 [ -1.26, 0.24 ]
Chang 2017 -0.45 (0.405612) 3.3 % -0.45 [ -1.24, 0.34 ]
Fagerlund 2015 -0.37 (0.290816) 4.4 % -0.37 [ -0.94, 0.20 ]
Fenton 2009 0.06593 (0.364833) 3.7 % 0.07 [ -0.65, 0.78 ]
Fregni 2006a -1.32 (0.568878) 2.2 % -1.32 [ -2.43, -0.21 ]
Fregni 2006b (1) -0.73 (0.556122) 2.3 % -0.73 [ -1.82, 0.36 ]
Fregni 2006b (2) 1.11 (0.477041) 2.8 % 1.11 [ 0.18, 2.04 ]
Hazime 2017 -0.85 (0.308673) 4.3 % -0.85 [ -1.45, -0.25 ]
Jales Junior 2015 -0.55 (1.13) 0.7 % -0.55 [ -2.76, 1.66 ]
Jensen 2013 -0.146424 (0.186554) 5.6 % -0.15 [ -0.51, 0.22 ]
Khedr 2017 -1.81 (0.403061) 3.4 % -1.81 [ -2.60, -1.02 ]
Lagueux 2017 -0.56 (0.436224) 3.1 % -0.56 [ -1.41, 0.29 ]
Luedtke 2015 0.04 (0.181122) 5.7 % 0.04 [ -0.31, 0.39 ]
Mendonca 2016 -0.3 (0.367347) 3.7 % -0.30 [ -1.02, 0.42 ]
Mori 2010 -1.19 (0.507653) 2.6 % -1.19 [ -2.18, -0.20 ]
Ngernyam 2015 -0.17 (0.21716) 5.3 % -0.17 [ -0.60, 0.26 ]
Oliveira 2015 -0.97 (0.3775) 3.6 % -0.97 [ -1.71, -0.23 ]
Riberto 2011 0.02 (0.4158) 3.3 % 0.02 [ -0.79, 0.83 ]
Sakrajai 2014 -1.58 (0.418367) 3.2 % -1.58 [ -2.40, -0.76 ]
Soler 2010 (3) -0.55 (0.45663) 2.9 % -0.55 [ -1.44, 0.34 ]
-2 -1 0 1 2
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Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
Soler 2010 (4) -0.74 (0.479592) 2.8 % -0.74 [ -1.68, 0.20 ]
Villamar 2013 (5) 0.11545 (0.394946) 3.4 % 0.12 [ -0.66, 0.89 ]
Villamar 2013 (6) -0.393703 (0.408606) 3.3 % -0.39 [ -1.19, 0.41 ]
Volz 2016 -0.85 (0.471939) 2.8 % -0.85 [ -1.77, 0.07 ]
Wrigley 2014 0.35377 (0.314305) 4.2 % 0.35 [ -0.26, 0.97 ]
Total (95% CI) 100.0 % -0.44 [ -0.64, -0.23 ]
Heterogeneity: Tau2 = 0.16; Chi2 = 63.46, df = 28 (P = 0.00014); I2 =56%
Test for overall effect: Z = 4.21 (P = 0.000025)
Test for subgroup differences: Not applicable
-2 -1 0 1 2
Favours active Favours sham
(1) M1
(2) DLPFC
(3) tDCS+ sham illusion vs sham TDCS + sham illusion
(4) tDCS+ illusion vs sham TDCS + illusion
(5) anodal
(6) cathodal
269Non-invasive brain stimulation techniques for chronic pain (Review)
Copyright © 2018 The Authors. Cochrane Database of Systematic Reviews published by John Wiley & Sons, Ltd. on behalf of The
Cochrane Collaboration.
Analysis 3.4. Comparison 3 Transcranial direct current stimulation (tDCS), Outcome 4 Pain: short term
sensitivity analysis, inclusion of high risk of bias studies.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 3 Transcranial direct current stimulation (tDCS)
Outcome: 4 Pain: short term sensitivity analysis, inclusion of high risk of bias studies
Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
1 Single-dose studies
Boggio 2009 -0.417904 (0.314924) 3.4 % -0.42 [ -1.04, 0.20 ]
Jensen 2013 -0.146424 (0.165274) 4.7 % -0.15 [ -0.47, 0.18 ]
Ngernyam 2015 -0.17 (0.192387) 4.5 % -0.17 [ -0.55, 0.21 ]
Villamar 2013 (1) 0.11545 (0.285689) 3.7 % 0.12 [ -0.44, 0.68 ]
Villamar 2013 (2) -0.393703 (0.29557) 3.6 % -0.39 [ -0.97, 0.19 ]
Subtotal (95% CI) 19.8 % -0.18 [ -0.38, 0.02 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 2.21, df = 4 (P = 0.70); I2 =0.0%
Test for overall effect: Z = 1.75 (P = 0.080)
2 Multiple-dose studies
Ahn 2017 -0.88 (0.344184) 3.2 % -0.88 [ -1.55, -0.21 ]
Antal 2010 -0.38 (0.673469) 1.5 % -0.38 [ -1.70, 0.94 ]
Ayache 2016 -0.3 (0.354592) 3.1 % -0.30 [ -0.99, 0.39 ]
Bae 2014 0.15 (0.556122) 1.9 % 0.15 [ -0.94, 1.24 ]
Brietzke 2016 -0.51 (0.385204) 2.9 % -0.51 [ -1.26, 0.24 ]
Chang 2017 -0.45 (0.405612) 2.8 % -0.45 [ -1.24, 0.34 ]
Fagerlund 2015 -0.37 (0.290816) 3.6 % -0.37 [ -0.94, 0.20 ]
Fenton 2009 0.06593 (0.323217) 3.4 % 0.07 [ -0.57, 0.70 ]
Fregni 2006a -1.32 (0.568878) 1.9 % -1.32 [ -2.43, -0.21 ]
Fregni 2006b (3) -0.73 (0.556122) 1.9 % -0.73 [ -1.82, 0.36 ]
Fregni 2006b (4) 1.11 (0.477041) 2.3 % 1.11 [ 0.18, 2.04 ]
Hagenacker 2014 -1.1137 (0.343836) 3.2 % -1.11 [ -1.79, -0.44 ]
Hazime 2017 -0.85 (0.308673) 3.5 % -0.85 [ -1.45, -0.25 ]
Jales Junior 2015 -0.87 (0.471939) 2.4 % -0.87 [ -1.79, 0.05 ]
Khedr 2017 -1.81 (0.403061) 2.8 % -1.81 [ -2.60, -1.02 ]
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Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
Kim 2013 (5) -1.76 (0.456633) 2.4 % -1.76 [ -2.65, -0.87 ]
Kim 2013 (6) -0.48 (0.392587) 2.9 % -0.48 [ -1.25, 0.29 ]
Lagueux 2017 -0.56 (0.436224) 2.6 % -0.56 [ -1.41, 0.29 ]
Luedtke 2015 0.04 (0.181122) 4.5 % 0.04 [ -0.31, 0.39 ]
Mendonca 2016 -0.3 (0.367347) 3.0 % -0.30 [ -1.02, 0.42 ]
Mori 2010 -1.19 (0.507653) 2.2 % -1.19 [ -2.18, -0.20 ]
Oliveira 2015 -0.97 (0.3775) 3.0 % -0.97 [ -1.71, -0.23 ]
Riberto 2011 0.02 (0.4158) 2.7 % 0.02 [ -0.79, 0.83 ]
Sakrajai 2014 -1.58 (0.418367) 2.7 % -1.58 [ -2.40, -0.76 ]
Soler 2010 (7) -0.55 (0.45663) 2.4 % -0.55 [ -1.44, 0.34 ]
Souto 2014 -0.67 (0.464286) 2.4 % -0.67 [ -1.58, 0.24 ]
Thibaut 2017 -0.06 (0.40051) 2.8 % -0.06 [ -0.84, 0.72 ]
Volz 2016 -0.85 (0.471939) 2.4 % -0.85 [ -1.77, 0.07 ]
Wrigley 2014 0.35377 (0.278353) 3.7 % 0.35 [ -0.19, 0.90 ]
Subtotal (95% CI) 80.2 % -0.56 [ -0.79, -0.32 ]
Heterogeneity: Tau2 = 0.24; Chi2 = 75.03, df = 28 (P<0.00001); I2 =63%
Test for overall effect: Z = 4.69 (P < 0.00001)
Total (95% CI) 100.0 % -0.48 [ -0.67, -0.29 ]
Heterogeneity: Tau2 = 0.17; Chi2 = 82.78, df = 33 (P<0.00001); I2 =60%
Test for overall effect: Z = 4.97 (P < 0.00001)
Test for subgroup differences: Chi2 = 5.93, df = 1 (P = 0.01), I2 =83%
-4 -2 0 2 4
Favours active Favours sham
(1) anodal
(2) cathodal
(3) M1
(4) DLPFC
(5) M1
(6) DLPFC
(7) tDCS+ sham illusion vs sham tDCS + sham illusion
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Analysis 3.5. Comparison 3 Transcranial direct current stimulation (tDCS), Outcome 5 Pain: short-term
follow-up, subgroup analysis: motor cortex studies only.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 3 Transcranial direct current stimulation (tDCS)
Outcome: 5 Pain: short-term follow-up, subgroup analysis: motor cortex studies only
Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
1 Single-dose studies
Boggio 2009 -0.417904 (0.314924) 4.3 % -0.42 [ -1.04, 0.20 ]
Jensen 2013 -0.146424 (0.165274) 6.2 % -0.15 [ -0.47, 0.18 ]
Ngernyam 2015 -0.17 (0.192387) 5.8 % -0.17 [ -0.55, 0.21 ]
Villamar 2013 (1) 0.11545 (0.285689) 4.7 % 0.12 [ -0.44, 0.68 ]
Villamar 2013 (2) -0.393703 (0.29557) 4.5 % -0.39 [ -0.97, 0.19 ]
Subtotal (95% CI) 25.6 % -0.18 [ -0.38, 0.02 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 2.21, df = 4 (P = 0.70); I2 =0.0%
Test for overall effect: Z = 1.75 (P = 0.080)
2 Multiple-dose studies
Ahn 2017 -0.88 (0.334184) 4.1 % -0.88 [ -1.53, -0.23 ]
Bae 2014 0.15 (0.556122) 2.3 % 0.15 [ -0.94, 1.24 ]
Brietzke 2016 -0.51 (0.385204) 3.6 % -0.51 [ -1.26, 0.24 ]
Chang 2017 -0.45 (0.405612) 3.4 % -0.45 [ -1.24, 0.34 ]
Fagerlund 2015 -0.37 (0.290816) 4.6 % -0.37 [ -0.94, 0.20 ]
Fenton 2009 0.06593 (0.323217) 4.2 % 0.07 [ -0.57, 0.70 ]
Fregni 2006a -1.32 (0.568878) 2.2 % -1.32 [ -2.43, -0.21 ]
Fregni 2006b -0.73 (0.556122) 2.3 % -0.73 [ -1.82, 0.36 ]
Hazime 2017 -0.85 (0.308673) 4.4 % -0.85 [ -1.45, -0.25 ]
Jales Junior 2015 -0.87 (0.471939) 2.8 % -0.87 [ -1.79, 0.05 ]
Khedr 2017 -1.81 (0.403061) 3.4 % -1.81 [ -2.60, -1.02 ]
Lagueux 2017 -0.56 (0.436224) 3.1 % -0.56 [ -1.41, 0.29 ]
Luedtke 2015 0.04 (0.181122) 6.0 % 0.04 [ -0.31, 0.39 ]
Mendonca 2016 -0.3 (0.367347) 3.8 % -0.30 [ -1.02, 0.42 ]
Mori 2010 -1.19 (0.507653) 2.6 % -1.19 [ -2.18, -0.20 ]
-2 -1 0 1 2
Favours active Favours sham
(Continued . . . )
272Non-invasive brain stimulation techniques for chronic pain (Review)
Copyright © 2018 The Authors. Cochrane Database of Systematic Reviews published by John Wiley & Sons, Ltd. on behalf of The
Cochrane Collaboration.
(. . . Continued)
Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
Oliveira 2015 -0.97 (0.3775) 3.7 % -0.97 [ -1.71, -0.23 ]
Riberto 2011 0.02 (0.4158) 3.3 % 0.02 [ -0.79, 0.83 ]
Sakrajai 2014 -1.58 (0.418367) 3.3 % -1.58 [ -2.40, -0.76 ]
Soler 2010 -0.55 (0.45663) 3.0 % -0.55 [ -1.44, 0.34 ]
Volz 2016 -0.85 (0.367347) 3.8 % -0.85 [ -1.57, -0.13 ]
Wrigley 2014 0.35377 (0.278353) 4.8 % 0.35 [ -0.19, 0.90 ]
Subtotal (95% CI) 74.4 % -0.58 [ -0.84, -0.33 ]
Heterogeneity: Tau2 = 0.21; Chi2 = 51.60, df = 20 (P = 0.00013); I2 =61%
Test for overall effect: Z = 4.45 (P < 0.00001)
Total (95% CI) 100.0 % -0.47 [ -0.67, -0.28 ]
Heterogeneity: Tau2 = 0.14; Chi2 = 58.85, df = 25 (P = 0.00015); I2 =58%
Test for overall effect: Z = 4.69 (P < 0.00001)
Test for subgroup differences: Chi2 = 6.01, df = 1 (P = 0.01), I2 =83%
-2 -1 0 1 2
Favours active Favours sham
(1) anodal
(2) cathodal
273Non-invasive brain stimulation techniques for chronic pain (Review)
Copyright © 2018 The Authors. Cochrane Database of Systematic Reviews published by John Wiley & Sons, Ltd. on behalf of The
Cochrane Collaboration.
Analysis 3.6. Comparison 3 Transcranial direct current stimulation (tDCS), Outcome 6 Pain: short-term
follow-up, subgroup analysis: motor cortex studies only, sensitivity analysis: correlation increased.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 3 Transcranial direct current stimulation (tDCS)
Outcome: 6 Pain: short-term follow-up, subgroup analysis: motor cortex studies only, sensitivity analysis: correlation increased
Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
1 Single-dose studies
Boggio 2009 -0.417904 (0.314924) 4.2 % -0.42 [ -1.04, 0.20 ]
Jensen 2013 -0.146424 (0.165274) 6.0 % -0.15 [ -0.47, 0.18 ]
Ngernyam 2015 -0.170115 (0.163915) 6.0 % -0.17 [ -0.49, 0.15 ]
Villamar 2013 (1) 0.11545 (0.285689) 4.5 % 0.12 [ -0.44, 0.68 ]
Villamar 2013 (2) -0.393703 (0.29557) 4.4 % -0.39 [ -0.97, 0.19 ]
Subtotal (95% CI) 25.2 % -0.18 [ -0.37, 0.01 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 2.21, df = 4 (P = 0.70); I2 =0.0%
Test for overall effect: Z = 1.83 (P = 0.067)
2 Multiple-dose studies
Ahn 2017 -0.88 (0.334184) 4.0 % -0.88 [ -1.53, -0.23 ]
Bae 2014 0.15 (0.556122) 2.2 % 0.15 [ -0.94, 1.24 ]
Brietzke 2016 -0.51 (0.385204) 3.5 % -0.51 [ -1.26, 0.24 ]
Chang 2017 -0.45 (0.405612) 3.3 % -0.45 [ -1.24, 0.34 ]
Fagerlund 2015 -0.37 (0.290816) 4.5 % -0.37 [ -0.94, 0.20 ]
Fenton 2009 0.06593 (0.323217) 4.1 % 0.07 [ -0.57, 0.70 ]
Fregni 2006a -1.32 (0.568878) 2.1 % -1.32 [ -2.43, -0.21 ]
Fregni 2006b -0.73 (0.556122) 2.2 % -0.73 [ -1.82, 0.36 ]
Hazime 2017 -0.85 (0.308673) 4.2 % -0.85 [ -1.45, -0.25 ]
Jales Junior 2015 -0.87 (0.471939) 2.7 % -0.87 [ -1.79, 0.05 ]
Khedr 2017 -1.81 (0.403061) 3.3 % -1.81 [ -2.60, -1.02 ]
Lagueux 2017 -0.56 (0.436224) 3.0 % -0.56 [ -1.41, 0.29 ]
Luedtke 2015 0.04 (0.181122) 5.8 % 0.04 [ -0.31, 0.39 ]
Mendonca 2016 -0.3 (0.367347) 3.6 % -0.30 [ -1.02, 0.42 ]
Mori 2010 -1.19 (0.507653) 2.5 % -1.19 [ -2.18, -0.20 ]
-2 -1 0 1 2
Favours active Favours sham
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Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
Oliveira 2015 -0.97 (0.3775) 3.5 % -0.97 [ -1.71, -0.23 ]
Riberto 2011 0.02 (0.4158) 3.2 % 0.02 [ -0.79, 0.83 ]
Sakrajai 2014 -1.58 (0.418367) 3.2 % -1.58 [ -2.40, -0.76 ]
Soler 2010 -0.55 (0.45663) 2.8 % -0.55 [ -1.44, 0.34 ]
Thibaut 2017 -0.06 (0.40051) 3.3 % -0.06 [ -0.84, 0.72 ]
Volz 2016 -0.85 (0.471939) 2.7 % -0.85 [ -1.77, 0.07 ]
Wrigley 2014 0.35377 (0.237244) 5.1 % 0.35 [ -0.11, 0.82 ]
Subtotal (95% CI) 74.8 % -0.55 [ -0.81, -0.30 ]
Heterogeneity: Tau2 = 0.21; Chi2 = 55.10, df = 21 (P = 0.00007); I2 =62%
Test for overall effect: Z = 4.28 (P = 0.000019)
Total (95% CI) 100.0 % -0.45 [ -0.64, -0.26 ]
Heterogeneity: Tau2 = 0.13; Chi2 = 61.24, df = 26 (P = 0.00011); I2 =58%
Test for overall effect: Z = 4.56 (P < 0.00001)
Test for subgroup differences: Chi2 = 5.46, df = 1 (P = 0.02), I2 =82%
-2 -1 0 1 2
Favours active Favours sham
(1) anodal
(2) cathodal
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Analysis 3.7. Comparison 3 Transcranial direct current stimulation (tDCS), Outcome 7 Pain: short-term
follow-up, subgroup analysis: motor cortex studies only, sensitivity analysis: correlation decreased.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 3 Transcranial direct current stimulation (tDCS)
Outcome: 7 Pain: short-term follow-up, subgroup analysis: motor cortex studies only, sensitivity analysis: correlation decreased
Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
1 Single-dose studies
Boggio 2009 -0.417904 (0.314924) 4.3 % -0.42 [ -1.04, 0.20 ]
Jensen 2013 -0.146424 (0.165274) 6.8 % -0.15 [ -0.47, 0.18 ]
Ngernyam 2015 -0.17 (0.217158) 5.9 % -0.17 [ -0.60, 0.26 ]
Villamar 2013 (1) 0.11545 (0.285689) 4.7 % 0.12 [ -0.44, 0.68 ]
Villamar 2013 (2) -0.393703 (0.29557) 4.6 % -0.39 [ -0.97, 0.19 ]
Subtotal (95% CI) 26.3 % -0.18 [ -0.38, 0.03 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 2.21, df = 4 (P = 0.70); I2 =0.0%
Test for overall effect: Z = 1.70 (P = 0.089)
2 Multiple-dose studies
Ahn 2017 -0.88 (0.334184) 4.0 % -0.88 [ -1.53, -0.23 ]
Bae 2014 0.15 (0.556122) 2.1 % 0.15 [ -0.94, 1.24 ]
Brietzke 2016 -0.51 (0.385204) 3.4 % -0.51 [ -1.26, 0.24 ]
Chang 2017 -0.45 (0.405612) 3.2 % -0.45 [ -1.24, 0.34 ]
Fagerlund 2015 -0.37 (0.290816) 4.6 % -0.37 [ -0.94, 0.20 ]
Fenton 2009 0.06593 (0.323217) 4.2 % 0.07 [ -0.57, 0.70 ]
Fregni 2006a -1.32 (0.568878) 2.0 % -1.32 [ -2.43, -0.21 ]
Fregni 2006b -0.73 (0.556122) 2.1 % -0.73 [ -1.82, 0.36 ]
Hazime 2017 -0.85 (0.308673) 4.4 % -0.85 [ -1.45, -0.25 ]
Jales Junior 2015 -0.87 (0.471939) 2.6 % -0.87 [ -1.79, 0.05 ]
Khedr 2017 -1.81 (0.403061) 3.2 % -1.81 [ -2.60, -1.02 ]
Lagueux 2017 -0.56 (0.436224) 2.9 % -0.56 [ -1.41, 0.29 ]
Luedtke 2015 0.04 (0.181122) 6.5 % 0.04 [ -0.31, 0.39 ]
Mendonca 2016 -0.3 (0.367347) 3.6 % -0.30 [ -1.02, 0.42 ]
Mori 2010 -1.19 (0.507653) 2.4 % -1.19 [ -2.18, -0.20 ]
-2 -1 0 1 2
Favours active Favours sham
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Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
Oliveira 2015 -0.97 (0.3775) 3.5 % -0.97 [ -1.71, -0.23 ]
Riberto 2011 0.02 (0.4158) 3.1 % 0.02 [ -0.79, 0.83 ]
Sakrajai 2014 -0.158 (0.418367) 3.1 % -0.16 [ -0.98, 0.66 ]
Soler 2010 -0.55 (0.45663) 2.7 % -0.55 [ -1.44, 0.34 ]
Thibaut 2017 -0.06 (0.40051) 3.3 % -0.06 [ -0.84, 0.72 ]
Volz 2016 -0.85 (0.471939) 2.6 % -0.85 [ -1.77, 0.07 ]
Wrigley 2014 0.35377 (0.314305) 4.3 % 0.35 [ -0.26, 0.97 ]
Subtotal (95% CI) 73.7 % -0.49 [ -0.72, -0.26 ]
Heterogeneity: Tau2 = 0.14; Chi2 = 43.20, df = 21 (P = 0.003); I2 =51%
Test for overall effect: Z = 4.19 (P = 0.000028)
Total (95% CI) 100.0 % -0.40 [ -0.58, -0.22 ]
Heterogeneity: Tau2 = 0.09; Chi2 = 48.49, df = 26 (P = 0.005); I2 =46%
Test for overall effect: Z = 4.44 (P < 0.00001)
Test for subgroup differences: Chi2 = 3.97, df = 1 (P = 0.05), I2 =75%
-2 -1 0 1 2
Favours active Favours sham
(1) anodal
(2) cathodal
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Analysis 3.8. Comparison 3 Transcranial direct current stimulation (tDCS), Outcome 8 Pain: short-term
follow-up, subgroup analysis, neuropathic and non neuropathic pain.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 3 Transcranial direct current stimulation (tDCS)
Outcome: 8 Pain: short-term follow-up, subgroup analysis, neuropathic and non neuropathic pain
Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
1 Neuropathic
Ayache 2016 -0.3 (0.354592) 3.8 % -0.30 [ -0.99, 0.39 ]
Bae 2014 0.15 (0.556122) 2.1 % 0.15 [ -0.94, 1.24 ]
Boggio 2009 -0.417904 (0.314924) 4.2 % -0.42 [ -1.04, 0.20 ]
Fregni 2006a -1.32 (0.568878) 2.0 % -1.32 [ -2.43, -0.21 ]
Jensen 2013 -0.146424 (0.165274) 6.4 % -0.15 [ -0.47, 0.18 ]
Mori 2010 -1.19 (0.507653) 2.4 % -1.19 [ -2.18, -0.20 ]
Ngernyam 2015 -0.17 (0.192387) 6.0 % -0.17 [ -0.55, 0.21 ]
Soler 2010 (1) -0.55 (0.45663) 2.8 % -0.55 [ -1.44, 0.34 ]
Wrigley 2014 0.35377 (0.278353) 4.7 % 0.35 [ -0.19, 0.90 ]
Subtotal (95% CI) 34.6 % -0.26 [ -0.53, 0.01 ]
Heterogeneity: Tau2 = 0.06; Chi2 = 13.30, df = 8 (P = 0.10); I2 =40%
Test for overall effect: Z = 1.91 (P = 0.056)
2 Non neuropathic
Ahn 2017 -0.88 (0.334184) 4.0 % -0.88 [ -1.53, -0.23 ]
Brietzke 2016 -0.51 (0.385204) 3.4 % -0.51 [ -1.26, 0.24 ]
Chang 2017 -0.45 (0.405612) 3.2 % -0.45 [ -1.24, 0.34 ]
Fagerlund 2015 -0.37 (0.290816) 4.6 % -0.37 [ -0.94, 0.20 ]
Fenton 2009 0.06593 (0.323217) 4.1 % 0.07 [ -0.57, 0.70 ]
Fregni 2006b (2) -0.73 (0.556122) 2.1 % -0.73 [ -1.82, 0.36 ]
Fregni 2006b (3) 1.11 (0.477041) 2.6 % 1.11 [ 0.18, 2.04 ]
Hazime 2017 -0.85 (0.308673) 4.3 % -0.85 [ -1.45, -0.25 ]
Jales Junior 2015 -0.87 (0.471939) 2.7 % -0.87 [ -1.79, 0.05 ]
Lagueux 2017 -0.56 (0.436224) 3.0 % -0.56 [ -1.41, 0.29 ]
Luedtke 2015 0.04 (0.181122) 6.2 % 0.04 [ -0.31, 0.39 ]
-4 -2 0 2 4
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Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
Mendonca 2016 -0.3 (0.367347) 3.6 % -0.30 [ -1.02, 0.42 ]
Oliveira 2015 -0.97 (0.3775) 3.5 % -0.97 [ -1.71, -0.23 ]
Riberto 2011 0.02 (0.4158) 3.1 % 0.02 [ -0.79, 0.83 ]
Sakrajai 2014 -1.58 (0.418367) 3.1 % -1.58 [ -2.40, -0.76 ]
Villamar 2013 (4) 0.11545 (0.285689) 4.6 % 0.12 [ -0.44, 0.68 ]
Villamar 2013 (5) -0.393703 (0.29557) 4.5 % -0.39 [ -0.97, 0.19 ]
Volz 2016 -0.85 (0.471939) 2.7 % -0.85 [ -1.77, 0.07 ]
Subtotal (95% CI) 65.4 % -0.42 [ -0.67, -0.17 ]
Heterogeneity: Tau2 = 0.15; Chi2 = 38.90, df = 17 (P = 0.002); I2 =56%
Test for overall effect: Z = 3.30 (P = 0.00096)
Total (95% CI) 100.0 % -0.37 [ -0.56, -0.19 ]
Heterogeneity: Tau2 = 0.11; Chi2 = 53.51, df = 26 (P = 0.001); I2 =51%
Test for overall effect: Z = 3.92 (P = 0.000087)
Test for subgroup differences: Chi2 = 0.68, df = 1 (P = 0.41), I2 =0.0%
-4 -2 0 2 4
Favours active Favours sham
(1) tDCS+ sham illusion vs sham tDCS + sham illusion
(2) M1
(3) DLPFC
(4) anodal
(5) cathodal
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Analysis 3.9. Comparison 3 Transcranial direct current stimulation (tDCS), Outcome 9 Pain: short term
follow-up responder analysis 30% pain reduction.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 3 Transcranial direct current stimulation (tDCS)
Outcome: 9 Pain: short term follow-up responder analysis 30% pain reduction
Study or subgroup Active Sham Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Sakrajai 2014 12/16 0/15 23.53 [ 1.51, 365.50 ]
Souto 2014 8/10 7/10 1.14 [ 0.69, 1.90 ]
Test for subgroup differences: Not applicable
0.001 0.01 0.1 1 10 100 1000
Favours sham Favours active
Analysis 3.10. Comparison 3 Transcranial direct current stimulation (tDCS), Outcome 10 Pain: short term
follow-up responder analysis 50% pain reduction.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 3 Transcranial direct current stimulation (tDCS)
Outcome: 10 Pain: short term follow-up responder analysis 50% pain reduction
Study or subgroup Active Sham Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Sakrajai 2014 0/16 0/15 Not estimable
Souto 2014 8/10 3/10 2.67 [ 0.98, 7.22 ]
Test for subgroup differences: Not applicable
0.002 0.1 1 10 500
Favours sham Favours active
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Analysis 3.11. Comparison 3 Transcranial direct current stimulation (tDCS), Outcome 11 Pain: medium-
term follow-up.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 3 Transcranial direct current stimulation (tDCS)
Outcome: 11 Pain: medium-term follow-up
Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
Ahn 2017 -0.52 (0.32398) 8.0 % -0.52 [ -1.15, 0.11 ]
Ayache 2016 -0.35 (0.357143) 7.4 % -0.35 [ -1.05, 0.35 ]
Bae 2014 -0.88 (0.568878) 4.5 % -0.88 [ -1.99, 0.23 ]
Fagerlund 2015 -0.55 (0.295918) 8.5 % -0.55 [ -1.13, 0.03 ]
Fenton 2009 0.23766 (0.327394) 8.0 % 0.24 [ -0.40, 0.88 ]
Khedr 2017 -2.06 (0.420918) 6.4 % -2.06 [ -2.88, -1.24 ]
Lagueux 2017 -0.29 (0.428571) 6.3 % -0.29 [ -1.13, 0.55 ]
Luedtke 2015 0.14 (0.186224) 10.7 % 0.14 [ -0.22, 0.50 ]
Mendonca 2016 -0.34 (0.387755) 6.9 % -0.34 [ -1.10, 0.42 ]
Mori 2010 -0.96 (0.492347) 5.4 % -0.96 [ -1.92, 0.00 ]
Sakrajai 2014 -0.38 (0.354796) 7.5 % -0.38 [ -1.08, 0.32 ]
Soler 2010 (1) -0.32 (0.464286) 5.7 % -0.32 [ -1.23, 0.59 ]
Volz 2016 -0.67 (0.464286) 5.7 % -0.67 [ -1.58, 0.24 ]
Wrigley 2014 0.04612 (0.270273) 9.0 % 0.05 [ -0.48, 0.58 ]
Total (95% CI) 100.0 % -0.43 [ -0.72, -0.13 ]
Heterogeneity: Tau2 = 0.17; Chi2 = 32.13, df = 13 (P = 0.002); I2 =60%
Test for overall effect: Z = 2.84 (P = 0.0045)
Test for subgroup differences: Not applicable
-4 -2 0 2 4
Favours active Favours sham
(1) tDCS+sham illusion versus sham tDCS + sham illusion
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Analysis 3.12. Comparison 3 Transcranial direct current stimulation (tDCS), Outcome 12 Pain: medium
term follow-up responder analysis 30% pain reduction.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 3 Transcranial direct current stimulation (tDCS)
Outcome: 12 Pain: medium term follow-up responder analysis 30% pain reduction
Study or subgroup Active Sham Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Sakrajai 2014 16/16 15/15 1.00 [ 0.89, 1.13 ]
Test for subgroup differences: Not applicable
0.5 0.7 1 1.5 2
Favours sham Favours active
Analysis 3.13. Comparison 3 Transcranial direct current stimulation (tDCS), Outcome 13 Pain: medium
term follow-up responder analysis 50% pain reduction.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 3 Transcranial direct current stimulation (tDCS)
Outcome: 13 Pain: medium term follow-up responder analysis 50% pain reduction
Study or subgroup Active Sham Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Donnell 2015 9/12 4/12 2.25 [ 0.95, 5.34 ]
Sakrajai 2014 15/16 7/15 2.01 [ 1.15, 3.50 ]
Test for subgroup differences: Not applicable
0.001 0.01 0.1 1 10 100 1000
Favours sham Favours active
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Analysis 3.14. Comparison 3 Transcranial direct current stimulation (tDCS), Outcome 14 Sensitivity
analysis - inclusion of high risk of bias studies. Pain: medium-term follow-up.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 3 Transcranial direct current stimulation (tDCS)
Outcome: 14 Sensitivity analysis - inclusion of high risk of bias studies. Pain: medium-term follow-up
Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
Ahn 2017 -0.52 (0.32398) 7.3 % -0.52 [ -1.15, 0.11 ]
Antal 2010 -0.87 (0.701531) 3.0 % -0.87 [ -2.24, 0.50 ]
Ayache 2016 -0.35 (0.357143) 6.7 % -0.35 [ -1.05, 0.35 ]
Bae 2014 -0.88 (0.568878) 4.0 % -0.88 [ -1.99, 0.23 ]
Fagerlund 2015 -0.55 (0.295918) 7.8 % -0.55 [ -1.13, 0.03 ]
Fenton 2009 0.23766 (0.327394) 7.2 % 0.24 [ -0.40, 0.88 ]
Hazime 2017 -0.32 (0.298469) 7.8 % -0.32 [ -0.90, 0.26 ]
Khedr 2017 -2.06 (0.420918) 5.7 % -2.06 [ -2.88, -1.24 ]
Lagueux 2017 -0.29 (0.428571) 5.6 % -0.29 [ -1.13, 0.55 ]
Luedtke 2015 0.14 (0.186224) 9.9 % 0.14 [ -0.22, 0.50 ]
Mendonca 2016 -0.34 (0.387755) 6.2 % -0.34 [ -1.10, 0.42 ]
Mori 2010 -0.96 (0.492347) 4.8 % -0.96 [ -1.92, 0.00 ]
Soler 2010 (1) -0.32 (0.464286) 5.1 % -0.32 [ -1.23, 0.59 ]
Thibaut 2017 -0.84 (0.451531) 5.3 % -0.84 [ -1.72, 0.04 ]
Volz 2016 -0.67 (0.464286) 5.1 % -0.67 [ -1.58, 0.24 ]
Wrigley 2014 0.04612 (0.270273) 8.3 % 0.05 [ -0.48, 0.58 ]
Total (95% CI) 100.0 % -0.45 [ -0.72, -0.18 ]
Heterogeneity: Tau2 = 0.16; Chi2 = 34.09, df = 15 (P = 0.003); I2 =56%
Test for overall effect: Z = 3.26 (P = 0.0011)
Test for subgroup differences: Not applicable
-4 -2 0 2 4
Favours active Favours sham
(1) tDCS+sham illusion versus sham tDCS + sham illusion
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Analysis 3.15. Comparison 3 Transcranial direct current stimulation (tDCS), Outcome 15 Pain: long-term
follow-up.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 3 Transcranial direct current stimulation (tDCS)
Outcome: 15 Pain: long-term follow-up
Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
Hazime 2017 -0.32 (0.298469) 32.6 % -0.32 [ -0.90, 0.26 ]
Luedtke 2015 0.29 (0.214286) 47.1 % 0.29 [ -0.13, 0.71 ]
Mendonca 2016 -0.2 (0.418367) 20.2 % -0.20 [ -1.02, 0.62 ]
Total (95% CI) 100.0 % -0.01 [ -0.43, 0.41 ]
Heterogeneity: Tau2 = 0.05; Chi2 = 3.14, df = 2 (P = 0.21); I2 =36%
Test for overall effect: Z = 0.04 (P = 0.97)
Test for subgroup differences: Not applicable
-2 -1 0 1 2
Favours active Favours sham
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Analysis 3.16. Comparison 3 Transcranial direct current stimulation (tDCS), Outcome 16 Disability: short-
term follow-up.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 3 Transcranial direct current stimulation (tDCS)
Outcome: 16 Disability: short-term follow-up
Study or subgroup Active Sham
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Ahn 2017 20 -2.4 (10.4) 20 -0.1 (7.3) 18.8 % -0.25 [ -0.87, 0.37 ]
Chang 2017 15 26 (10.42) 15 27.8 (9.6) 14.2 % -0.17 [ -0.89, 0.54 ]
Luedtke 2015 (1) 61 15 (7) 61 14 (6) 57.7 % 0.15 [ -0.20, 0.51 ]
Soler 2010 (2) 10 4 (3.4) 10 4.9 (2.8) 9.4 % -0.28 [ -1.16, 0.60 ]
Total (95% CI) 106 106 100.0 % -0.01 [ -0.28, 0.26 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 1.93, df = 3 (P = 0.59); I2 =0.0%
Test for overall effect: Z = 0.07 (P = 0.94)
Test for subgroup differences: Not applicable
-4 -2 0 2 4
Favours active Favours sham
(1) Oswestry Disability Index
(2) BPI - interference
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Analysis 3.17. Comparison 3 Transcranial direct current stimulation (tDCS), Outcome 17 Disability:
medium-term follow-up.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 3 Transcranial direct current stimulation (tDCS)
Outcome: 17 Disability: medium-term follow-up
Study or subgroup Active Sham
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Luedtke 2015 53 7 (6) 54 7 (5) 0.0 [ -0.38, 0.38 ]
Test for subgroup differences: Not applicable
-10 -5 0 5 10
Favours active Favours sham
Analysis 3.18. Comparison 3 Transcranial direct current stimulation (tDCS), Outcome 18 Quality of life:
short-term follow-up.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 3 Transcranial direct current stimulation (tDCS)
Outcome: 18 Quality of life: short-term follow-up
Study or subgroup Active stimulation Sham stimulation
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Jales Junior 2015 (1) 10 -35.43 (12.841) 10 -42.42 (28.241) 26.0 % 0.31 [ -0.58, 1.19 ]
Mori 2010 (2) 10 74.1 (19.5) 9 51.9 (15.2) 20.4 % 1.20 [ 0.21, 2.20 ]
Riberto 2011 (3) 11 49.8 (11.6) 12 37.9 (21.7) 28.5 % 0.65 [ -0.19, 1.49 ]
Volz 2016 (4) 10 127.6 (28.2) 10 111.1 (26.2) 25.1 % 0.58 [ -0.32, 1.48 ]
Total (95% CI) 41 41 100.0 % 0.66 [ 0.21, 1.11 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 1.79, df = 3 (P = 0.62); I2 =0.0%
Test for overall effect: Z = 2.85 (P = 0.0043)
Test for subgroup differences: Not applicable
-4 -2 0 2 4
Favours sham Favours active
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(1) FIQ (scales reversed)
(2) MS-QoL-54
(3) SF-36 total
(4) IBDQ QoL
Analysis 3.19. Comparison 3 Transcranial direct current stimulation (tDCS), Outcome 19 Quality of life:
medium-term follow-up.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 3 Transcranial direct current stimulation (tDCS)
Outcome: 19 Quality of life: medium-term follow-up
Study or subgroup Active stimulation Sham stimulation
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Fagerlund 2015 (1) 24 -41.93 (29.86) 24 -45.25 (20.12) 56.6 % 0.13 [ -0.44, 0.69 ]
Mori 2010 (2) 10 75 (23.3) 9 60 (17.7) 20.8 % 0.69 [ -0.25, 1.62 ]
Volz 2016 (3) 10 134.9 (38.1) 10 116.6 (26.5) 22.6 % 0.53 [ -0.36, 1.43 ]
Total (95% CI) 44 43 100.0 % 0.34 [ -0.09, 0.76 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 1.25, df = 2 (P = 0.54); I2 =0.0%
Test for overall effect: Z = 1.55 (P = 0.12)
Test for subgroup differences: Not applicable
-2 -1 0 1 2
Favours sham Favours active
(1) FIQ (scale reversed to correct directional diference with other scales in the meta-analysis)
(2) multiple sclerosis quality of life-54 scale (MSQoL-54)
(3) Inflammatory bowel disease QoL questionnaire
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Analysis 4.1. Comparison 4 Reduced impedance non-invasive cortical electrostimulation (RINCE),
Outcome 1 Pain: short-term follow-up.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 4 Reduced impedance non-invasive cortical electrostimulation (RINCE)
Outcome: 1 Pain: short-term follow-up
Study or subgroup Active Sham
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Hargrove 2012a (1) 39 4.6 (2.27) 38 6.01 (2.53) -1.41 [ -2.48, -0.34 ]
Test for subgroup differences: Not applicable
-10 -5 0 5 10
Favours RINCE Favours sham
(1) Per protocol analysis
Analysis 4.2. Comparison 4 Reduced impedance non-invasive cortical electrostimulation (RINCE),
Outcome 2 Sensitivity analysis - inclusion of high risk of bias studies. Pain: short-term follow-up.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 4 Reduced impedance non-invasive cortical electrostimulation (RINCE)
Outcome: 2 Sensitivity analysis - inclusion of high risk of bias studies. Pain: short-term follow-up
Study or subgroup Active Sham
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Deering 2017 (1) 16 46.69 (25.22) 3 56 (27.15) 10.5 % -0.35 [ -1.59, 0.89 ]
Deering 2017 (2) 15 35.8 (22.84) 4 56 (27.15) 12.4 % -0.82 [ -1.96, 0.33 ]
Hargrove 2012a (3) 39 4.6 (2.27) 38 6.01 (2.53) 77.2 % -0.58 [ -1.04, -0.12 ]
Total (95% CI) 70 45 100.0 % -0.59 [ -0.99, -0.18 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.30, df = 2 (P = 0.86); I2 =0.0%
Test for overall effect: Z = 2.86 (P = 0.0042)
Test for subgroup differences: Not applicable
-100 -50 0 50 100
Favours RINCE Favours sham
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(1) 8 week active intervention
(2) 12 week active intervetnion
(3) Per protocol analysis
Analysis 4.3. Comparison 4 Reduced impedance non-invasive cortical electrostimulation (RINCE),
Outcome 3 Quality of Life: short term follow-up.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 4 Reduced impedance non-invasive cortical electrostimulation (RINCE)
Outcome: 3 Quality of Life: short term follow-up
Study or subgroup Active Sham
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Hargrove 2012a 39 45.96 (20.42) 38 52.46 (18.53) -6.50 [ -15.21, 2.21 ]
Test for subgroup differences: Not applicable
-50 -25 0 25 50
Favours active Favours sham
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Analysis 4.4. Comparison 4 Reduced impedance non-invasive cortical electrostimulation (RINCE),
Outcome 4 Sensitivity analysis - inclusion of high risk of bias studies. Quality of life: short term follow-up.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 4 Reduced impedance non-invasive cortical electrostimulation (RINCE)
Outcome: 4 Sensitivity analysis - inclusion of high risk of bias studies. Quality of life: short term follow-up
Study or subgroup Active Sham
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Deering 2017 (1) 15 25.87 (15.53) 4 48.43 (22.72) 14.2 % -1.27 [ -2.46, -0.07 ]
Deering 2017 (2) 16 43.43 (24.81) 3 48.43 (22.72) 13.3 % -0.19 [ -1.43, 1.04 ]
Hargrove 2012a 39 45.96 (20.42) 38 52.46 (18.53) 72.4 % -0.33 [ -0.78, 0.12 ]
Total (95% CI) 70 45 100.0 % -0.45 [ -0.91, 0.02 ]
Heterogeneity: Tau2 = 0.02; Chi2 = 2.22, df = 2 (P = 0.33); I2 =10%
Test for overall effect: Z = 1.88 (P = 0.060)
Test for subgroup differences: Not applicable
-4 -2 0 2 4
Favours active Favours sham
(1) 12 week active intervention. Revised FIQ
(2) 8 week active intervention. Revised FIQ
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Analysis 5.1. Comparison 5 Transcranial random noise stimulation, Outcome 1 Pain.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 5 Transcranial random noise stimulation
Outcome: 1 Pain
Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Fixed,95% CI IV,Fixed,95% CI
Palm 2016 -0.189657 (0.230345) 100.0 % -0.19 [ -0.64, 0.26 ]
Total (95% CI) 100.0 % -0.19 [ -0.64, 0.26 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.82 (P = 0.41)
Test for subgroup differences: Not applicable
-1 -0.5 0 0.5 1
Favours active Favours sham
A D D I T I O N A L T A B L E S
Table 1. Repetitive transcranial magnetic stimulation (rTMS) studies - characteristics of stimulation
Study Location
of stimu-
lation
Coil ori-
entation
Frequency
(Hz)
Intensity
(% RMT)
Number
of trains
Duration
of trains
Inter-
train
intervals
(sec)
Number
of
pulses per
session
Treat-
ment ses-
sions per
group
Ahmed
2011
M1 stump
region
45° angle
from sagit-
tal line
20 80 10 10 sec 50 2000 5, x 1 daily
Attal 2016 M1 con-
tralateral
to painful
side
Antero-
posterior
induced
current
10 80 30 10 20 3000 3, x1 daily
André-
Obadia
2006
M1 con-
tralateral
to painful
side
Posteroan-
terior
20, 1 90 20 Hz: 20
1 Hz: 1
20 Hz: 4
sec
1 Hz: 26
min
20 Hz: 84 1600 1
André-
Obadia
2008
M1 con-
tralateral
to painful
side
Posteroan-
terior
Medial-
lateral
20 90 20 4 sec 84 1600 1
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Table 1. Repetitive transcranial magnetic stimulation (rTMS) studies - characteristics of stimulation (Continued)
André-
Obadia
2011
M1 hand
area, not
clearly re-
ported but
likely con-
tralateral
to painful
side
Not speci-
fied
20 90 20 4 sec 84 1600 1
Avery
2013
Left
DLPFC
Not speci-
fied
10 120 75 4 26 3000 15
Borckardt
2009
Left PFC Not speci-
fied
10 100 40 10 sec 20 4000 3 over a 5-
day period
Boyer
2014
Left M1 anteropos-
terior
10 90 20 10 50 2000 14, 10 ses-
sions in 2
weeks fol-
lowed
by mainte-
nance
phase of 1
session at
weeks 4, 6,
8, and 10
Carretero
2009
Right
DLPFC
Not speci-
fied
1 110 20 60 sec 45 1200 Up to 20
on consec-
u-
tive work-
ing days
Dall’Agnol
2014
Left M1 45° angle
from sagit-
tal line
10 80 16 10 26 1600 10,
timescale
not speci-
fied
Defrin
2007
M1
midline
Not speci-
fied
5 115 500 10 sec 30 ? 500* 10, x 1
daily
de Oliveira
2014
Left
DLPFC/
premotor
not speci-
fied
10 120 25 5 sec 25 1250 10,
x 1 daily
(working
days) for 2
weeks
Fregni
2005
Left and
right SII
Not speci-
fied
1 or 20 90 Not speci-
fied
Not speci-
fied
Not speci-
fied
1600 1
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Table 1. Repetitive transcranial magnetic stimulation (rTMS) studies - characteristics of stimulation (Continued)
Fregni
2011
Right SII Not speci-
fied
1 70% maxi-
mum stim-
ulator out-
put inten-
sity (not
RMT)
1 Not speci-
fied
Not speci-
fied
1600 10,
x 1 daily
(weekdays
only)
Hirayama
2006
M1,
S1, PMA,
SMA
Not speci-
fied
5 90 10 10 sec 50 500 1
Hosomi
2013
M1 corre-
sponding
to painful
region
Not speci-
fied
5 90 10 10 sec 50 500 10,
x 1 daily
(weekdays
only)
Irlbacher
2006
M1 con-
tralateral
to painful
side
Not speci-
fied
5, 1 95 Not speci-
fied
Not speci-
fied
Not speci-
fied
500 1
Jetté 2013 M1 hand
or leg area
with neuro
navigation
45º pos-
tero-lateral
10 90 40 5 25 2000 1, per stim-
ulation
condition
Kang 2009 Right M1 45º pos-
tero-lateral
10 80 20 5 sec 55 1000 5, x 1 daily
Khedr
2005
M1 con-
tralateral
to painful
side
Not speci-
fied
20 80 10 10 sec 50 2000 5, x 1 daily
Lee 2012 Right
DLPFC
(low-
frequency)
Left
M1 (high-
frequency)
Not speci-
fied
10, 1 10 Hz: 80
1 Hz: 110
10 Hz: 25
1 Hz: 2
10 Hz: 8
sec
1 Hz: 800
sec
10 Hz: 10
1 Hz: 60
10 Hz:
2000
1Hz: 1600
10,
x 1 daily
(weekdays
only)
Lefaucheur
2001a
M1 con-
tralateral
to painful
side
Not speci-
fied
10 80 20 5 sec 55 1000 1
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Table 1. Repetitive transcranial magnetic stimulation (rTMS) studies - characteristics of stimulation (Continued)
Lefaucheur
2001b
M1 con-
tralateral
to painful
side
Posteroan-
terior
10, 0.5 80 10 Hz: 20
0.5 Hz: 1
10 Hz: 5
sec
0.5 Hz: 20
min
10 Hz: 55 10 Hz:
1000
0.5 Hz:
600
1
Lefaucheur
2004
M1 con-
tralateral
to painful
side
Posteroan-
terior
10 80 20 5 sec 55 1000 1
Lefaucheur
2006
M1 con-
tralateral
to painful
side
Posteroan-
terior
10, 1 90 10 Hz: 20
1 Hz: 1
10 Hz: 6
sec
1 Hz: 20
min
10 Hz: 54 10 Hz:
1200
1Hz: 1200
1
Lefaucheur
2008
M1 con-
tralateral
to painful
side
Posteroan-
terior
10, 1 90 10 Hz: 20
1 Hz: 1
10 Hz: 6
sec
1 Hz: 20
min
10 Hz: 54 10 Hz:
1200
1Hz: 1200
1
Malavera
2013
M1 con-
tralateral
to painful
side
45° angle
from sagit-
tal line
10 90 20 6 54 1200 10,
x 1 daily
(weekdays
only)
Medeiros
2016
Left M1 45° angle
from sagit-
tal line
10 80 not
reported
not
reported
not
reported
1600 10, x 1
daily
Mhalla
2011
Left M1 Posteroan-
terior
10 80 15 10 sec 50 1500 14,
5 x 1 daily
(working
days), then
3
x 1 weekly,
then 3 x 1
fort-
nightly,
then 3 x 1
monthly
Nardone
2017
Left PFC Posteroan-
terior
10 120 25 5 sec 25 1250 10, x5 per
week for 2
weeks
Nurmikko
2016
M1
hotspot
contralat-
eral to pain
Posteroan-
terior
10 90 20 10 sec 60 2000 5, x 3-
5 times per
week
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Table 1. Repetitive transcranial magnetic stimulation (rTMS) studies - characteristics of stimulation (Continued)
M1
in reorgan-
ised area
contralat-
eral to pain
Onesti
2013
M1 deep
central sul-
cus
H-coil 20 100 30 2.5 sec 30 1500 5, x 1 daily
on consec-
utive days
Passard
2007
M1 con-
tralateral
to painful
side
Posteroan-
terior
10 80 25 8 sec 52 2000 10,
x 1 daily
(working
days)
Picarelli
2010
M1 con-
tralateral
to painful
side
Posteroan-
terior
10 100 25 10 sec 60 2500 10,
x 1 daily
(working
days)
Pleger
2004
M1 hand
area
Not speci-
fied
10 110 10 1.2 sec 10 120 1
Rollnik
2002
M1
midline
Not speci-
fied
20 80 20 2 sec Not speci-
fied
800 1
Saitoh
2007
M1 over
motor rep-
resentation
of painful
area
Not speci-
fied
10, 5, 1 90 10 Hz; 5
5 Hz: 10
1 Hz: 1
10 Hz: 10
sec
5 Hz: 10
sec
1 Hz: 500
sec
10 Hz: 50
5 Hz: 50
500 1
Short 2011 Left
DLPFC
Parasagit-
tal
10 120 80 5 sec 10 sec 4000 10,
x 1 daily
(working
days) for 2
weeks
Tekin
2014
M1
midline
45° angle
from sagit-
tal line
10 100 30 5 12 1500 10,
x 1 daily
(not clear if
only work
days)
Tzabazis
2013
Targeted
to ACC
4-coil con-
figuration
1 Hz (10
Hz data ex-
cluded
as not ran-
110 Not
reported
Not
reported
Not
reported
1800 20,
x 1 daily
(working
days)
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Table 1. Repetitive transcranial magnetic stimulation (rTMS) studies - characteristics of stimulation (Continued)
domised)
Umezaki
2016
Left
DLPFC
Not speci-
fied
10 100 10 5 10 3000 10, x1
daily
(working
days)
Yagci 2014 Left M1 Not speci-
fied
1 90 20 60 45 1200 10, x1
daily
(working
days)
Yilmaz
2014
M1
midline
Han-
dle point-
ing poste-
riorly
10 10 30 5 25 1500 10, x1
daily
(working
days)
ACC: anterior cingulate cortex; DLPFC: dorsolateral prefrontal cortex; M1: primary motor cortex; PFC: prefrontal cortex; PMA:
pre-motor area; RMT: resting motor threshold; dS1: primary somatosensory cortex; SII: secondary somatosensory cortex; SMA:
supplementary motor area
*Inconsistency between stimulation parameters and reported total number of pulses in study report. See Included studies section for
mored detail.
Table 2. Cranial electrotherapy stimulation (CES) studies - characteristics of stimulation
Study Electrode
placement
Frequency
(Hz)
Pulse width
(ms)
Waveform
shape
Intensity Duration
(min)
Treat-
ment sessions
per group
Capel 2003 Ear clip elec-
trodes
10 2 Not specified 12 µA 53 x 2 daily for 4
days
Cork 2004 Ear clip elec-
trodes
0.5 Not specified Modified
square-wave
biphasic
100 µA 60 ? daily for 3
weeks
Gabis 2003 Mas-
toid processes
and forehead
77 3.3 Biphasic
asymmetric
≤ 4 mA 30 x 1 daily for 8
days
Gabis 2009 Mas-
toid processes
and forehead
77 3.3 Biphasic
asymmetric
≤ 4 mA 30 x 1 daily for 8
days
Katsnelson
2004
Mas-
toid processes
and forehead
Not specified Not specified 2 conditions:
symmetric,
asymmetric
11 to 15 mA 40 x 1 daily for 5
days
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Table 2. Cranial electrotherapy stimulation (CES) studies - characteristics of stimulation (Continued)
Lichtbroun
2001
Ear clip elec-
trodes
0.5 Not specified Biphasic
square wave
100 µA 60 x 1 daily for 30
days
Rintala 2010 Ear clip elec-
trodes
Not specified Not specified Not specified 100 µA 40 x 1 daily for 6
weeks
Tan 2000 Ear clip elec-
trodes
0.5 Not specified Not specified 10 to 600 µA 20 12 (timing not
specified)
Tan 2006 Ear clip elec-
trodes
Not specified Not specified Not specified 100 to500µA 60 x 1 daily for 21
days
Tan 2011 Ear clip elec-
trodes
Not specified Not specified Not specified 100 µA 60 x 1 daily for 21
days
Taylor 2013 Ear clip elec-
trodes
0.5 Not specified Modified
square-wave
biphasic
100 µA 60 x 1 daily for 8
weeks
Table 3. Transcranial direct current stimulation (tDCS) studies - characteristics of stimulation
Study Lo-
cation of stimu-
lation (Anode)
Electrode pad
size
Intensity (mA) Anodal or
cathodal?
Stimulus dura-
tion (min)
Treatment ses-
sions per group
Ahn 2017 M1 contralateral
to painful side
35 cm2 2 mA Anodal 20 5, x 1 daily
Antal 2010 M1 left hand
area
35 cm2 1 mA Anodal 20 5, x 1 daily
Ayache 2016 Left DLPFC 25 cm2 2mA Anodal 20 3, x 1 daily
Bae 2014 M1 contralateral
to painful side
35 cm2 2 mA Anodal 20 x 3 per week for
3 weeks
Boggio 2009 M1 contralateral
to painful side
35 cm2 2 mA Anodal 30 1
Brietzke 2016 Left M1 25-35 cm2 2 mA Anodal 20 5, x 1 daily
Chang 2017 M1 contralateral
to painful side
35 cm2 1 mA Anodal 20 16, x 2weekly for
8 weeks
Donnell 2015 M1 contralateral
to painful side
HD-tDCS 2 mA Anodal 20 5, x 1 daily
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Table 3. Transcranial direct current stimulation (tDCS) studies - characteristics of stimulation (Continued)
Fagerlund 2015 M1, side not
specified
35 cm2 2mA Anodal 20 5, x 1 daily
Fenton 2009 M1 dominant
hemisphere
35 cm2 1 mA Anodal 20 2
Fregni 2006a M1 contralateral
to painful side or
dominant hand
35 cm2 2 mA Anodal 20 5, x 1 daily
Fregni 2006b M1 and DLPFC
contralateral to
painful side or
dominant hand
35 cm2 2 mA Anodal 20 5, x 1 daily
Hagenacker
2014
M1 contralateral
to painful side
40 cm2 1mA Anodal 20 Daily, self-ad-
ministered for 14
days
Harvey 2017 M1 contralateral
to painful side
35 cm2 2 mA Anodal 20 5, x 1 daily
Hazime 2017 M1 contralateral
to painful side
35 cm2 2 mA Anodal 20 12, x 3 per week
for 4 weeks
Jales Junior 2015 Left M1 15 cm2 1mA Anodal 20 x 1 weekly for 10
weeks
Jensen 2013 M1 left 35cm2 2 mA Anodal 20 1
Khedr 2017 M1 contralateral
to painful side
24 cm2 2 mA Anodal 20 10, x 1 daily, 5
days per week for
2 weeks
Kim 2013 M1, side not
specified
DLPFC
25 cm2 2mA Anodal 20 5, x 1 daily
Lagueux 2017 M1 contralateral
to painful side
35 cm2 2 mA Anodal 20 14, x 5 weekly
for 2 weeks, x
1 weekly for 4
weeks
Luedtke 2015 M1 left side not
specified
35 cm2 2 mA Anodal 20 5, x 1 daily
Mendonca 2011 Group 1: anodal
left M1
Group 2: catho-
35 cm2 2 mA Anodal or catho-
dal
20 1
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Table 3. Transcranial direct current stimulation (tDCS) studies - characteristics of stimulation (Continued)
dal left M1
Group 3: anodal
supraorbital
Group 4: catho-
dal supraorbital
Group 5: sham
Mendonca 2016 Left M1 35 cm2 2 mA Anodal 20 5, x 1 daily
Mori 2010 M1 contralateral
to painful side
35 cm2 2 mA Anodal 20 5, x 1 daily
Ngernyam 2015 M1 contralateral
to painful side
35 cm2 2 mA Anodal 20 1
Oliveira 2015 M1 contralateral
to painful side
35 cm2 2 mA Anodal 20 5, x 1 daily, then
x 2 weekly for 3
weeks, up to 10
sessions
Portilla 2013 M1 contralateral
to painful side
35 cm2 2 mA Anodal 20 x 1 per condition
Riberto 2011 M1 contralateral
to painful side or
dominant hand
35 cm2 2 mA Anodal 20 10, x 1 weekly
Sakrajai 2014 M1 contralateral
to painful side
35 cm2 1 mA Anodal 20 5, x 1 daily
Soler 2010 M1 contralateral
to painful side or
dominant hand
35 cm2 2 mA Anodal 20 10, x 1 daily
(weekdays only)
Souto 2014 Left M1 25 cm2 2 mA Anodal 20 5, x 1 daily
Thibaut 2017 M1 contralateral
to painful side
35 cm2 2 mA Anodal 20 5, x 1 daily
Valle 2009 M1 and DLPFC
contralateral to
painful side or
dominant hand
35 cm2 2 mA Anodal 20 5, x 1 daily
Villamar 2013 M1 left HD-tDCS 4 x 1-
ring montage
2 mA Anodal or catho-
dal
20 x 1 per condition
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Table 3. Transcranial direct current stimulation (tDCS) studies - characteristics of stimulation (Continued)
Wrigley 2014 M1 contralateral
to painful side or
dominant hand
35 cm2 2 mA Anodal 20 5, x 1 daily
Volz 2016 M1 contralateral
to painful side
35 cm2 2 mA Anodal 20 5, x 1 daily
DLPFC: dorsolateral prefrontal cortex; HD-tDCS: high definition tDCS;M1: primary motor cortex
A P P E N D I C E S
Appendix 1. Main database search strategies for current update
CENTRAL (CRSO)
#1 MESH DESCRIPTOR pain EXPLODE ALL TREES 32731
#2 (((chronic* or back or musculoskel* or intractabl* or neuropath* or phantom limb or fantom limb or neck or myofasc* or
“temporomandib* joint*” or “temperomandib* joint*” or “tempromandib* joint*” or central or post*stroke or complex or regional or
spinal cord) adj4 pain*)):TI,AB,KY 15073
#3 ((sciatica or back-ache or back*ache or lumbago or fibromyalg* or (trigemin* adj2 neuralg*) or (herp* adj2 neuralg*) or (diabet*
adj2 neuropath*) or (reflex adj4 dystroph*) or (sudeck* adj2 atroph*) or causalg* or whip-lash or whip*lash or polymyalg* or (failed
back adj4 surg*) or (failed back adj4 syndrome*))):TI,AB,KY 6757
#4 #1 OR #2 OR #3 45871
#5 MESH DESCRIPTOR Transcranial Magnetic Stimulation 974
#6 MESH DESCRIPTOR Electronarcosis 33
#7 (((brain* or cortex or cortical or transcranial* or cranial or magneti*) adj4 stimulat*)):TI,AB,KY 4072
#8 (((transcrani* or crani* or brain*) adj4 (electrostim* or electro-stim* or electrotherap* or electro-therap*))):TI,AB,KY 64
#9 (((non-invasive or non*invasive) adj4 stimulat*)):TI,AB,KY 337
#10 ((theta burst stimulat* or iTBS or cTBS)):TI,AB,KY 150
#11 ((transcranial magnetic stimulation or rTMS or transcranial direct current stimulation or tDCS or cranial electrostimulation or
cranial electrotherapy)):TI,AB,KY 2912
#12 ((electrosleep or electronarco*)):TI,AB,KY 47
#13 #5 OR #6 OR #7 OR #8 OR #9 OR #10 OR #11 OR #12 4355
#14 #4 AND #13 310
#15 31/07/2013 TO 30/09/2016:DL 264060
#16 #14 AND #15 176
MEDLINE (OVID)
1 exp Pain/ (283010)
2 ((chronic* or back or musculoskel* or intractabl* or neuropath* or phantom limb or fantom limb or neck or myofasc* or “temporo-
mandib* joint*” or “temperomandib* joint*” or “tempromandib* joint*” or central or post*stroke or complex or regional or spinal
cord) adj4 pain*).tw. (74023)
3 (sciatica or back-ache or back*ache or lumbago or fibromyalg* or (trigemin* adj2 neuralg*) or (herp* adj2 neuralg*) or (diabet* adj2
neuropath*) or (reflex adj4 dystroph*) or (sudeck* adj2 atroph*) or causalg* or whip-lash or whip*lash or polymyalg* or (failed back
adj4 surg*) or (failed back adj4 syndrome*)).tw. (28679)
4 or/1-3 (325946)
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5 Transcranial Magnetic Stimulation/ or Electronarcosis/ (6328)
6 ((brain* or cortex or cortical or transcranial* or cranial or magneti*) adj4 stimulat*).tw. (25872)
7 ((transcrani* or crani* or brain*) adj4 (electrostim* or electro-stim* or electrotherap* or electro-therap*)).tw. (147)
8 ((non-invasive or non*invasive) adj4 stimulat*).tw. (822)
9 (theta burst stimulat* or iTBS or cTBS).tw. (575)
10 (transcranial magnetic stimulation or rTMS or transcranial direct current stimulation or tDCS or cranial electrostimulation or
cranial electrotherapy).tw. (7423)
11 (electrosleep or electronarco*).tw. (357)
12 or/5-11 (28316)
13 randomized controlled trial.pt. (337806)
14 controlled clinical trial.pt. (84996)
15 randomized.ab. (241501)
16 placebo.ab. (134421)
17 drug therapy.fs. (1571905)
18 randomly.ab. (173459)
19 trial.ab. (248492)
20 groups.ab. (1134392)
21 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20 (2928552)
22 exp animals/ not humans.sh. (3751730)
23 21 not 22 (2487755)
24 4 and 12 and 23 (295)
25 (200911* or 200912* or 2010* or 2011* or 2012* or 2013*).ed. (2428299)
26 24 and 25 (112)
Embase (OVID)
1 exp Pain/ (1006798)
2 ((chronic* or back or musculoskel* or intractabl* or neuropath* or phantom limb or fantom limb or neck or myofasc* or “temporo-
mandib* joint*” or “temperomandib* joint*” or “tempromandib* joint*” or central or post*stroke or complex or regional or spinal
cord) adj4 pain*).tw. (158849)
3 (sciatica or back-ache or back*ache or lumbago or fibromyalg* or (trigemin* adj2 neuralg*) or (herp* adj2 neuralg*) or (diabet* adj2
neuropath*) or (reflex adj4 dystroph*) or (sudeck* adj2 atroph*) or causalg* or whip-lash or whip*lash or polymyalg* or (failed back
adj4 surg*) or (failed back adj4 syndrome*)).tw. (52041)
4 or/1-3 (1044575)
5 Transcranial Magnetic Stimulation/ or Electronarcosis/ (18453)
6 ((brain* or cortex or cortical or transcranial* or cranial or magneti*) adj4 stimulat*).tw. (50617)
7 ((transcrani* or crani* or brain*) adj4 (electrostim* or electro-stim* or electrotherap* or electro-therap*)).tw. (237)
8 ((non-invasive or non*invasive) adj4 stimulat*).tw. (2843)
9 (theta burst stimulat* or iTBS or cTBS).tw. (1549)
10 (transcranial magnetic stimulation or rTMS or transcranial direct current stimulation or tDCS or cranial electrostimulation or
cranial electrotherapy).tw. (17745)
11 (electrosleep or electronarco*).tw. (383)
12 or/5-11 (57298)
13 random$.tw. (1121981)
14 factorial$.tw. (28563)
15 crossover$.tw. (58949)
16 cross over$.tw. (26241)
17 cross-over$.tw. (26241)
18 placebo$.tw. (244121)
19 (doubl$ adj blind$).tw. (172110)
20 (singl$ adj blind$).tw. (18218)
21 assign$.tw. (295873)
22 allocat$.tw. (107828)
23 volunteer$.tw. (211373)
24 Crossover Procedure/ (48595)
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25 double-blind procedure.tw. (236)
26 Randomized Controlled Trial/ (419274)
27 Single Blind Procedure/ (23071)
28 or/13-27 (1749640)
29 (animal/ or nonhuman/) not human/ (5110486)
30 28 not 29 (1554658)
31 4 and 12 and 30 (1112)
32 (201307* or 201308* or 201309* or 201310* or 201311* or 201312* or 2014* or 2015* or 2016*).dd. (5443542)
33 31 and 32 (527)
34 limit 33 to embase (487)
PsycINFO (OVID)
1 exp Pain/ (48364)
2 ((chronic* or back or musculoskel* or intractabl* or neuropath* or phantom limb or fantom limb or neck or myofasc* or “temporo-
mandib* joint*” or “temperomandib* joint*” or “tempromandib* joint*” or central or post*stroke or complex or regional or spinal
cord) adj4 pain*).tw. (25922)
3 (sciatica or back-ache or back*ache or lumbago or fibromyalg* or (trigemin* adj2 neuralg*) or (herp* adj2 neuralg*) or (diabet* adj2
neuropath*) or (reflex adj4 dystroph*) or (sudeck* adj2 atroph*) or causalg* or whip-lash or whip*lash or polymyalg* or (failed back
adj4 surg*) or (failed back adj4 syndrome*)).tw. (4998)
4 or/1-3 (56650)
5 Transcranial Magnetic Stimulation/ or Electronarcosis/ (5956)
6 ((brain* or cortex or cortical or transcranial* or cranial or magneti*) adj4 stimulat*).tw. (17936)
7 ((transcrani* or crani* or brain*) adj4 (electrostim* or electro-stim* or electrotherap* or electro-therap*)).tw. (89)
8 ((non-invasive or non*invasive) adj4 stimulat*).tw. (983)
9 (theta burst stimulat* or iTBS or cTBS).tw. (791)
10 (transcranial magnetic stimulation or rTMS or transcranial direct current stimulation or tDCS or cranial electrostimulation or
cranial electrotherapy).tw. (7884)
11 (electrosleep or electronarco*).tw. (139)
12 or/5-11 (18853)
13 clinical trials/ (9724)
14 (randomis* or randomiz*).tw. (62274)
15 (random$ adj3 (allocat$ or assign$)).tw. (35100)
16 ((clinic$ or control$) adj trial$).tw. (52603)
17 ((singl$ or doubl$ or trebl$ or tripl$) adj3 (blind$ or mask$)).tw. (22429)
18 (crossover$ or “cross over$”).tw. (8346)
19 random sampling/ (699)
20 Experiment Controls/ (856)
21 Placebo/ (4606)
22 placebo$.tw. (35030)
23 exp program evaluation/ (18184)
24 treatment effectiveness evaluation/ (20144)
25 ((effectiveness or evaluat$) adj3 (stud$ or research$)).tw. (70971)
26 or/13-25 (221762)
27 4 and 12 and 26 (180)
28 limit 27 to yr=“2013 -Current” (82)
CINAHL (EBSCO)
S26 S25 Limiters - Published Date from: 20130701-20160914
S25 S15 AND S24
S24 S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23
S23 (allocat* random*)
S22 (MH “Quantitative Studies”)
S21 (MH “Placebos”)
S20 placebo*
S19 (random* allocat*)
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S18 (MH “Random Assignment”)
S17 (Randomi?ed control* trial*)
S16 (singl* blind* ) or (doubl* blind* ) or (tripl* blind* ) or (trebl* blind* ) or (trebl* mask* ) or (tripl* mask* ) or (doubl* mask* ) or
(singl* mask* )
S15 S4 AND S14
S14 S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13
S13 TI ( (electrosleep OR electronarco*) ) OR AB ( (electrosleep OR electronarco*) )
S12 TI ( (“transcranial magnetic stimulation” OR rTMS OR “transcranial direct current stimulation” OR tDCS OR “cranial electros-
timulation” OR “cranial electrotherapy”) ) OR AB ( (“transcranial magnetic stimulation” OR rTMS OR “transcranial direct current
stimulation” OR tDCS OR “cranial electrostimulation” OR “cranial electrotherapy”) )
S11 TI ( (“theta burst stimulat*” OR iTBS OR cTBS) ) OR AB ( (“theta burst stimulat*” OR iTBS OR cTBS) )
S10 TI ( ((“non-invasive brain” OR “non*invasive brain”) AND stimulat*) ) OR AB ( ((“non-invasive brain” OR “non*invasive brain”)
AND stimulat*) )
S9 TI ( ((transcrani* OR crani* OR brain*) AND (electrostim* OR electro-stim* OR electrotherap* OR electro-therap*)) ) OR AB (
((transcrani* OR crani* OR brain*) AND (electrostim* OR electro-stim* OR electrotherap* OR electro-therap*)) )
S8 TI ( ((transcrani* OR crani* OR brain*) AND (electrostim* OR electro-stim* OR electrotherap* OR electro-therap*)) ) OR AB (
((transcrani* OR crani* OR brain*) AND (electrostim* OR electro-stim* OR electrotherap* OR electro-therap*)) )
S7 TI ( ((brain* OR cortex OR cortical OR transcranial* OR cranial OR magneti*) AND stimulat*) ) OR AB ( ((brain* OR cortex
OR cortical OR transcranial* OR cranial OR magneti*) AND stimulat*) )
S6 (MH “Electric Stimulation”)
S5 (MH “Electronarcosis”)
S4 S1 OR S2 OR S3
S3 TI ( (sciatica OR back-ache OR back*ache OR lumbago OR fibromyalg* OR “trigemin* neuralg*” OR “herp* neuralg*” OR
“diabet* neuropath*” OR “reflex dystroph*” OR “sudeck* atroph*” OR causalg* OR whip-lash OR whip*lash OR polymyalg* OR
“failed back surg*” OR “failed back syndrome*”) ) OR AB ( (sciatica OR back-ache OR back*ache OR lumbago OR fibromyalg* OR
“trigemin* neuralg*” OR “herp* neuralg*” OR “diabet* neuropath*” OR “reflex dystroph*” OR “sudeck* atroph*” OR causalg* OR
whip-lash OR whip*lash OR polymyalg* OR “failed back surg*” OR “failed back syndrome*”) )
S2 TI ( ((chronic* OR back OR musculoskel* OR intractabl* OR neuropath* OR phantom limb OR fantom limb OR neck OR
myofasc* OR “temporomandib* joint*” OR “temperomandib* joint*” OR “tempromandib* joint*” OR central OR post*stroke
OR complex OR regional OR spinal cord) AND pain*). ) OR AB ( ((chronic* OR back OR musculoskel* OR intractabl* OR
neuropath* OR phantom limb OR fantom limb OR neck OR myofasc* OR “temporomandib* joint*” OR “temperomandib* joint*”
OR “tempromandib* joint*” OR central OR post*stroke OR complex OR regional OR spinal cord) AND pain*))
S1 (MH “Pain+”)
LILACS
1. Pain$ or dolor$ or intractabl$ or neuropath$ or phantom or fantom or myofasc$ or temp$romandibular or sciatic$ or back-ache or
backache or ache or lumbago or fibromyalg$ or neuralg$ or dystroph$ or atroph$ or causalgi$ or whip-lash or whiplash or polymyalg$
[Words]¬
2. ((Estimulaci$ or stimulat$) and (cerebra$ or brain$ or cortex or cortical or crania$ or transcranial$ or magneti$)) or electrostim$ or
electrotherapy$ or electro-therap$ or “theta burst stimul$” or iTBS or Ctbs or “transcrani$ magnet$ stimulat$” or rTMS or “transcrani$
direct current stimulat$” or tDCS or “cranial electrostimulat$” or “cranial electrotherapy$ or electrosleep or electronarco$ [Words]¬
3. ((Pt randomized controlled trial OR Pt controlled clinical trial OR Mh randomized controlled trials OR Mh random allocation
OR Mh double-blind method OR Mh single-blind method) AND NOT (Ct animal AND NOT (Ct human and Ct animal)) OR
(Pt clinical trial OR Ex E05.318.760.535$ OR (Tw clin$ AND (Tw trial$ OR Tw ensa$ OR Tw estud$ OR Tw experim$ OR Tw
investiga$)) OR ((Tw singl$ OR Tw simple$ OR Tw doubl$ OR Tw doble$ OR Tw duplo$ OR Tw trebl$ OR Tw trip$) AND (Tw
blind$ OR Tw cego$ OR Tw ciego$ OR Tw mask$ OR Tw mascar$)) OR Mh placebos OR Tw placebo$ OR (Tw random$ OR Tw
randon$ OR Tw casual$ OR Tw acaso$ OR Tw azar OR Tw aleator$) OR Mh research design) AND NOT (Ct animal AND NOT
(Ct human and Ct animal)) OR (Ct comparative study OR Ex E05.337$ OR Mh follow-up studies OR Mh prospective studies OR
Tw control$ OR Tw prospectiv$ OR Tw volunt$ OR Tw volunteer$) ANDNOT (Ct animal ANDNOT (Ct human and Ct animal)))
[Words]
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Appendix 2. Trials register search results for current update
Register Date of search Search terms Number of records
Clinical trials.gov 20 September 2016 Field - Interventional studies
CONDITION: chronic* OR back OR
musculoskel* OR intractabl* OR neu-
ropath*ORphantom limbOR fantom limb
ORneckORmyofasc*OR temp?romandib
joint OR central OR post*stroke OR com-
plex OR regional OR spinal cord OR sciat-
ica OR back-ache OR back*ache OR lum-
bago
INTERVENTION: brain* OR cortex OR
cortical OR transcranial* OR cranial OR
magneti* OR direct current OR DC OR
electric OR crani* OR electrostim* OR
electrotherap*OR electro-therap*ORnon-
invasive OR non*invasive OR theta burst
stimulat* OR iTBS OR Ctbs
OUTCOME: pain
91
Clinical trials.gov 20 September 2016 Field - Interventional studies
CONDITION: chronic* OR back OR
musculoskel* OR intractabl* OR neu-
ropath*ORphantom limbOR fantom limb
ORneckORmyofasc*OR temp?romandib
joint OR central OR post*stroke OR com-
plex OR regional OR spinal cord OR sciat-
ica OR back-ache OR back*ache OR lum-
bago
INTERVENTION: transcranial magnetic
stimulation OR rTMS OR transcranial
direct current stimulation OR tDCS
OR cranial electrostimulation OR cranial
electrotherapy OR electrosleep OR elec-
tronarco*
OUTCOME: pain
1
Clinical trials.gov 20 September 2016 Field - Interventional studies
CONDITION: fibromyalg* OR trigem*
neuralg* OR herp* neuralg* OR dia-
bet* neuropath* OR reflex dystroph* OR
sudeck* atroph* OR causalg* OR whip-
lash ORwhip*lash or polymyalg* OR failed
back surg* OR failed back syndrome
INTERVENTION: brain* OR cortex OR
cortical OR transcranial* OR cranial OR
magneti* OR direct current OR DC OR
electric OR crani* OR electrostim* OR
0
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(Continued)
electrotherap*OR electro-therap*ORnon-
invasive OR non*invasive OR theta burst
stimulat* OR iTBS OR Ctbs
OUTCOME: pain
Clinical trials.gov 20 September 2016 Field - Interventional studies
CONDITION: fibromyalg* OR trigem*
neuralg* OR herp* neuralg* OR dia-
bet* neuropath* OR reflex dystroph* OR
sudeck* atroph* OR causalg* OR whip-
lash ORwhip*lash or polymyalg* OR failed
back surg* OR failed back syndrome
INTERVENTION: transcranial magnetic
stimulation OR rTMS OR transcranial
direct current stimulation OR tDCS
OR cranial electrostimulation OR cranial
electrotherapy OR electrosleep OR elec-
tronarco*
OUTCOME: pain
0
WHO ICTRP 20 September 2016 Field - Interventional studies
CONDITION: chronic* OR back OR
musculoskel* OR intractabl* OR neu-
ropath*ORphantom limbOR fantom limb
ORneckORmyofasc*OR temp?romandib
joint OR central OR post*stroke OR com-
plex OR regional OR spinal cord OR sciat-
ica OR back-ache OR back*ache OR lum-
bago
INTERVENTION: brain* OR cortex OR
cortical OR transcranial* OR cranial OR
magneti* OR direct current OR DC OR
electric OR crani* OR electrostim* OR
electrotherap*OR electro-therap*ORnon-
invasive OR non*invasive OR theta burst
stimulat* OR iTBS OR Ctbs
OUTCOME: pain
01/01/2009 to 07/02/2013
adult
60
WHO ICTRP 20 September 2016 Field - Interventional studies
CONDITION: chronic* OR back OR
musculoskel* OR intractabl* OR neu-
ropath*ORphantom limbOR fantom limb
ORneckORmyofasc*OR temp?romandib
joint OR central OR post*stroke OR com-
plex OR regional OR spinal cord OR sciat-
ica OR back-ache OR back*ache OR lum-
bago
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(Continued)
INTERVENTION: transcranial magnetic
stimulation OR rTMS OR transcranial
direct current stimulation OR tDCS
OR cranial electrostimulation OR cranial
electrotherapy OR electrosleep OR elec-
tronarco*
OUTCOME: pain
WHO ICTRP 20/9/16 Field - Interventional studies
CONDITION: fibromyalg* OR trigem*
neuralg* OR herp* neuralg* OR dia-
bet* neuropath* OR reflex dystroph* OR
sudeck* atroph* OR causalg* OR whip-
lash ORwhip*lash or polymyalg* OR failed
back surg* OR failed back syndrome
INTERVENTION: brain* OR cortex OR
cortical OR transcranial* OR cranial OR
magneti* OR direct current OR DC OR
electric OR crani* OR electrostim* OR
electrotherap*OR electro-therap*ORnon-
invasive OR non*invasive OR theta burst
stimulat* OR iTBS OR Ctbs
OUTCOME: pain
2
WHO ICTRP 20 September 2016 Field - Interventional studies
CONDITION: fibromyalg* OR trigem*
neuralg* OR herp* neuralg* OR dia-
bet* neuropath* OR reflex dystroph* OR
sudeck* atroph* OR causalg* OR whip-
lash ORwhip*lash or polymyalg* OR failed
back surg* OR failed back syndrome
INTERVENTION: transcranial magnetic
stimulation OR rTMS OR transcranial
direct current stimulation OR tDCS
OR cranial electrostimulation OR cranial
electrotherapy OR electrosleep OR elec-
tronarco*
OUTCOME: pain
Register Date of search Search terms Number of records
Clinical trials.gov 18 Octoberr 2017 Field - Interventional studies
CONDITION: chronic*ORbackORmus-
culoskel* OR intractabl* OR neuropath*
OR phantom limb OR fantom limb OR
neck OR myofasc* OR temp*romandib
6
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(Continued)
joint OR central OR post*stroke OR com-
plexOR regionalOR spinal cordOR sciatica
OR back-ache OR back*ache OR lumbago
INTERVENTION: brain* OR cortex OR
cortical OR transcranial* OR cranial OR
magneti* OR direct current OR DC OR
electric OR crani* OR electrostim*OR elec-
trotherap* OR electro-therap* OR non-in-
vasiveORnon*invasiveOR theta burst stim-
ulat* OR iTBS OR Ctbs
OUTCOME: pain
Clinical trials.gov 18 Octoberr 2017 Field - Interventional studies
CONDITION: chronic*ORbackORmus-
culoskel* OR intractabl* OR neuropath*
OR phantom limb OR fantom limb OR
neck OR myofasc* OR temp*romandib
joint OR central OR post*stroke OR com-
plexOR regionalOR spinal cordOR sciatica
OR back-ache OR back*ache OR lumbago
INTERVENTION: transcranial magnetic
stimulation OR rTMS OR transcranial
direct current stimulation OR tDCS
OR cranial electrostimulation OR cranial
electrotherapy OR electrosleep OR elec-
tronarco*
OUTCOME: pain
3
Clinical trials.gov 18 Octoberr 2017 Field - Interventional studies
CONDITION: fibromyalg* OR trigem*
neuralg* OR herp* neuralg* OR diabet*
neuropath*ORreflexdystroph*ORsudeck*
atroph* OR causalg* OR whip-lash OR
whip*lash or polymyalg* OR failed back
surg* OR failed back syndrome
INTERVENTION: brain* OR cortex OR
cortical OR transcranial* OR cranial OR
magneti* OR direct current OR DC OR
electric OR crani* OR electrostim*OR elec-
trotherap* OR electro-therap* OR non-in-
vasiveORnon*invasiveOR theta burst stim-
ulat* OR iTBS OR Ctbs
OUTCOME: pain
3
Clinical trials.gov 18 Octoberr 2017 Field - Interventional studies
CONDITION: fibromyalg* OR trigem*
neuralg* OR herp* neuralg* OR diabet*
neuropath*ORreflexdystroph*ORsudeck*
atroph* OR causalg* OR whip-lash OR
0
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(Continued)
whip*lash or polymyalg* OR failed back
surg* OR failed back syndrome
INTERVENTION: transcranial magnetic
stimulation OR rTMS OR transcranial
direct current stimulation OR tDCS
OR cranial electrostimulation OR cranial
electrotherapy OR electrosleep OR elec-
tronarco*
OUTCOME: pain
WHO ICTRP 18 Octoberr 2017 Field - Interventional studies
CONDITION: chronic*ORbackORmus-
culoskel* OR intractabl* OR neuropath*
OR phantom limb OR fantom limb OR
neck OR myofasc* OR temp*romandib
joint OR central OR post*stroke OR com-
plexOR regionalOR spinal cordOR sciatica
OR back-ache OR back*ache OR lumbago
INTERVENTION: brain* OR cortex OR
cortical OR transcranial* OR cranial OR
magneti* OR direct current OR DC OR
electric OR crani* OR electrostim*OR elec-
trotherap* OR electro-therap* OR non-in-
vasiveORnon*invasiveOR theta burst stim-
ulat* OR iTBS OR Ctbs
OUTCOME: pain
01/01/2009 to 07/02/2013
adult
36
WHO ICTRP 18 Octoberr 2017 Field - Interventional studies
CONDITION: chronic*ORbackORmus-
culoskel* OR intractabl* OR neuropath*
OR phantom limb OR fantom limb OR
neck OR myofasc* OR temp*romandib
joint OR central OR post*stroke OR com-
plexOR regionalOR spinal cordOR sciatica
OR back-ache OR back*ache OR lumbago
INTERVENTION: transcranial magnetic
stimulation OR rTMS OR transcranial
direct current stimulation OR tDCS
OR cranial electrostimulation OR cranial
electrotherapy OR electrosleep OR elec-
tronarco*
OUTCOME: pain
8
WHO ICTRP 18 Octoberr 2017 Field - Interventional studies
CONDITION: fibromyalg* OR trigem*
neuralg* OR herp* neuralg* OR diabet*
neuropath*ORreflexdystroph*ORsudeck*
0
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(Continued)
atroph* OR causalg* OR whip-lash OR
whip*lash or polymyalg* OR failed back
surg* OR failed back syndrome
INTERVENTION: brain* OR cortex OR
cortical OR transcranial* OR cranial OR
magneti* OR direct current OR DC OR
electric OR crani* OR electrostim*OR elec-
trotherap* OR electro-therap* OR non-in-
vasiveORnon*invasiveOR theta burst stim-
ulat* OR iTBS OR Ctbs
OUTCOME: pain
WHO ICTRP 18 Octoberr 2017 Field - Interventional studies
CONDITION: fibromyalg* OR trigem*
neuralg* OR herp* neuralg* OR diabet*
neuropath*ORreflexdystroph*ORsudeck*
atroph* OR causalg* OR whip-lash OR
whip*lash or polymyalg* OR failed back
surg* OR failed back syndrome
INTERVENTION: transcranial magnetic
stimulation OR rTMS OR transcranial
direct current stimulation OR tDCS
OR cranial electrostimulation OR cranial
electrotherapy OR electrosleep OR elec-
tronarco*
OUTCOME: pain
0
Appendix 3. Search results summary table for current update
Database searched Date last searched Number of results
CENTRAL (CRSO) 31/07/2013 TO 30/
09/2016
11/10/17 243
MEDLINE (OVID) July 2013 to Aug
week 5 2016
11/10/17 217
Embase (OVID) July 2013 to 2016 week
37
11/10/17 595
PsycINFO (OVID) 2013 to July week 4
2016
11/10/17 117
CINAHL (EBSCO) July 2013 to Sept
2016
11/10/17 42
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(Continued)
LILACS (Birme) 2013 to Sept 2016 11/10/17 42
Total 1256
Appendix 4. Main database search strategies for 2014 update
CENTRAL (years 2009 to 2013 searched)
#1 MeSH descriptor: [Pain] explode all trees
#2 (chronic* or back or musculoskel* or intractabl* or neuropath* or phantom limb or fantom limb or neck or myofasc* or
“temporomandib* joint” or “temperomandib* joint” or “tempromandib* joint” or central or (post next stroke) or complex or regional
or “spinal cord”) near/4 pain*:ti,ab,kw (Word variations have been searched)
#3 (sciatica or back-ache or back*ache or lumbago or fibromyalg* or (trigemin* near/2 neuralg*) or (herp* near/2 neuralg*)
or (diabet* near/2 neuropath*) or (reflex near/4 dystroph*) or (sudeck* near/2 atroph*) or causalg* or whip-lash or whip*lash or
polymyalg* or (failed back near/4 surg*) or (failed back near/4 syndrome*)):ti,ab,kw (Word variations have been searched)
#4 #1 or #2 or #3
#5 MeSH descriptor: [Transcranial Magnetic Stimulation] this term only
#6 MeSH descriptor: [Electronarcosis] explode all trees
#7 (brain* or cortex or cortical or transcranial* or cranial or magneti*) near/4 stimulat*:ti,ab,kw (Word variations have been
searched)
#8 (transcrani* or crani* or brain*) near/4 (electrostim* or electro-stim* or electrotherap* or electro-therap*):ti,ab,kw (Word
variations have been searched)
#9 (non-invasive or non*invasive) near/4 stimulat*:ti,ab,kw (Word variations have been searched)
#10 “theta burst stimulat*” or iTBS or cTBS:ti,ab,kw (Word variations have been searched)
#11 “transcranial magnetic stimulation” or rTMS or “transcranial direct current stimulat*” or tDCS or “cranial electrostimulation”
or “cranial electrotherap*”:ti,ab,kw (Word variations have been searched)
#12 (electrosleep* or electronarco*):ti,ab,kw (Word variations have been searched)
#13 #5 or #6 or #7 or #8 or #9 or #10 or #11 or #12
#14 #4 and #13 from 2009 to 2013
MEDLINE and MEDLINE IN PROCESS (OVID)
1 exp Pain/ (283010)
2 ((chronic* or back or musculoskel* or intractabl* or neuropath* or phantom limb or fantom limb or neck or myofasc* or
“temporomandib* joint*” or “temperomandib* joint*” or “tempromandib* joint*” or central or post*stroke or complex or regional or
spinal cord) adj4 pain*).tw. (74023)
3 (sciatica or back-ache or back*ache or lumbago or fibromyalg* or (trigemin* adj2 neuralg*) or (herp* adj2 neuralg*) or (diabet*
adj2 neuropath*) or (reflex adj4 dystroph*) or (sudeck* adj2 atroph*) or causalg* or whip-lash or whip*lash or polymyalg* or (failed
back adj4 surg*) or (failed back adj4 syndrome*)).tw. (28679)
4 or/1-3 (325946)
5 Transcranial Magnetic Stimulation/ or Electronarcosis/ (6328)
6 ((brain* or cortex or cortical or transcranial* or cranial or magneti*) adj4 stimulat*).tw. (25872)
7 ((transcrani* or crani* or brain*) adj4 (electrostim* or electro-stim* or electrotherap* or electro-therap*)).tw. (147)
8 ((non-invasive or non*invasive) adj4 stimulat*).tw. (822)
9 (theta burst stimulat* or iTBS or cTBS).tw. (575)
10 (transcranial magnetic stimulation or rTMS or transcranial direct current stimulation or tDCS or cranial electrostimulation or
cranial electrotherapy).tw. (7423)
11 (electrosleep or electronarco*).tw. (357)
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12 or/5-11 (28316)
13 randomized controlled trial.pt. (337806)
14 controlled clinical trial.pt. (84996)
15 randomized.ab. (241501)
16 placebo.ab. (134421)
17 drug therapy.fs. (1571905)
18 randomly.ab. (173459)
19 trial.ab. (248492)
20 groups.ab. (1134392)
21 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20 (2928552)
22 exp animals/ not humans.sh. (3751730)
23 21 not 22 (2487755)
24 4 and 12 and 23 (295)
25 (200911* or 200912* or 2010* or 2011* or 2012* or 2013*).ed. (2428299)
26 24 and 25 (112)
Embase (OVID)
1 exp Pain/ (729490)
2 ((chronic* or back or musculoskel* or intractabl* or neuropath* or phantom limb or fantom limb or neck or myofasc* or
“temporomandib* joint*” or “temperomandib* joint*” or “tempromandib* joint*” or central or post*stroke or complex or regional or
spinal cord) adj4 pain*).tw. (112128)
3 (sciatica or back-ache or back*ache or lumbago or fibromyalg* or (trigemin* adj2 neuralg*) or (herp* adj2 neuralg*) or (diabet*
adj2 neuropath*) or (reflex adj4 dystroph*) or (sudeck* adj2 atroph*) or causalg* or whip-lash or whip*lash or polymyalg* or (failed
back adj4 surg*) or (failed back adj4 syndrome*)).tw. (41462)
4 or/1-3 (759765)
5 Transcranial Magnetic Stimulation/ or Electronarcosis/ (11875)
6 ((brain* or cortex or cortical or transcranial* or cranial or magneti*) adj4 stimulat*).tw. (35587)
7 ((transcrani* or crani* or brain*) adj4 (electrostim* or electro-stim* or electrotherap* or electro-therap*)).tw. (194)
8 ((non-invasive or non*invasive) adj4 stimulat*).tw. (1314)
9 (theta burst stimulat* or iTBS or cTBS).tw. (770)
10 (transcranial magnetic stimulation or rTMS or transcranial direct current stimulation or tDCS or cranial electrostimulation or
cranial electrotherapy).tw. (10413)
11 (electrosleep or electronarco*).tw. (375)
12 or/5-11 (39959)
13 4 and 12 (3078)
14 random$.tw. (793677)
15 factorial$.tw. (20700)
16 crossover$.tw. (46383)
17 cross over$.tw. (21096)
18 cross-over$.tw. (21096)
19 placebo$.tw. (189884)
20 (doubl$ adj blind$).tw. (140353)
21 (singl$ adj blind$).tw. (13272)
22 assign$.tw. (220119)
23 allocat$.tw. (74677)
24 volunteer$.tw. (170305)
25 Crossover Procedure/ (36109)
26 double-blind procedure.tw. (224)
27 Randomized Controlled Trial/ (338884)
28 Single Blind Procedure/ (16955)
29 or/14-28 (1300700)
30 (animal/ or nonhuman/) not human/ (4566449)
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31 29 not 30 (1146950)
32 13 and 31 (574)
33 (200911* or 200912* or 2010* or 2011* or 2012* or 2013*).dd. (4384183)
34 32 and 33 (303)
PsycINFO (OVID)
1 exp Pain/ (33859)
2 ((chronic* or back or musculoskel* or intractabl* or neuropath* or phantom limb or fantom limb or neck or myofasc* or
“temporomandib* joint*” or “temperomandib* joint*” or “tempromandib* joint*” or central or post*stroke or complex or regional or
spinal cord) adj4 pain*).tw. (17914)
3 (sciatica or back-ache or back*ache or lumbago or fibromyalg* or (trigemin* adj2 neuralg*) or (herp* adj2 neuralg*) or (diabet*
adj2 neuropath*) or (reflex adj4 dystroph*) or (sudeck* adj2 atroph*) or causalg* or whip-lash or whip*lash or polymyalg* or (failed
back adj4 surg*) or (failed back adj4 syndrome*)).tw. (3654)
4 or/1-3 (39372)
5 Transcranial Magnetic Stimulation/ or Electronarcosis/ (3412)
6 ((brain* or cortex or cortical or transcranial* or cranial or magneti*) adj4 stimulat*).tw. (9508)
7 ((transcrani* or crani* or brain*) adj4 (electrostim* or electro-stim* or electrotherap* or electro-therap*)).tw. (55)
8 ((non-invasive or non*invasive) adj4 stimulat*).tw. (401)
9 (theta burst stimulat* or iTBS or cTBS).tw. (441)
10 (transcranial magnetic stimulation or rTMS or transcranial direct current stimulation or tDCS or cranial electrostimulation or
cranial electrotherapy).tw. (4745)
11 (electrosleep or electronarco*).tw. (6)
12 or/5-11 (9914)
13 4 and 12 (481)
14 clinical trials/ (6486)
15 (randomis* or randomiz*).tw. (39676)
16 (random$ adj3 (allocat$ or assign$)).tw. (22629)
17 ((clinic$ or control$) adj trial$).tw. (33763)
18 ((singl$ or doubl$ or trebl$ or tripl$) adj3 (blind$ or mask$)).tw. (15332)
19 (crossover$ or “cross over$”).tw. (5478)
20 random sampling/ (445)
21 Experiment Controls/ (435)
22 Placebo/ (2892)
23 placebo$.tw. (23869)
24 exp program evaluation/ (12521)
25 treatment effectiveness evaluation/ (11860)
26 ((effectiveness or evaluat$) adj3 (stud$ or research$)).tw. (45199)
27 or/14-26 (142131)
28 13 and 27 (95)
29 limit 28 to yr=“2009 -Current” (60)
CINAHL (EBSCO)
S26 S25 Limiters - Published Date from: 20091101-20130231
S25 S15 AND S24
S24 S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23
S23 (allocat* random*)
S22 (MH “Quantitative Studies”)
S21 (MH “Placebos”)
S20 placebo*
S19 (random* allocat*)
S18 (MH “Random Assignment”)
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S17 (Randomi?ed control* trial*)
S16 (singl* blind* ) or (doubl* blind* ) or (tripl* blind* ) or (trebl* blind* ) or (trebl* mask* ) or (tripl* mask* ) or (doubl* mask*
) or (singl* mask* )
S15 S4 AND S14
S14 S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13
S13 TI ( (electrosleep OR electronarco*) ) OR AB ( (electrosleep OR electronarco*) )
S12 TI ( (“transcranial magnetic stimulation” OR rTMS OR “transcranial direct current stimulation” OR tDCS OR “cranial
electrostimulation” OR “cranial electrotherapy”) ) OR AB ( (“transcranial magnetic stimulation” OR rTMS OR “transcranial direct
current stimulation” OR tDCS OR “cranial electrostimulation” OR “cranial electrotherapy”) )
S11 TI ( (“theta burst stimulat*” OR iTBS OR cTBS) ) OR AB ( (“theta burst stimulat*” OR iTBS OR cTBS) )
S10 TI ( ((“non-invasive brain” OR “non*invasive brain”) AND stimulat*) ) OR AB ( ((“non-invasive brain” OR “non*invasive
brain”) AND stimulat*) )
S9 TI ( ((transcrani* OR crani* OR brain*) AND (electrostim* OR electro-stim* OR electrotherap* OR electro-therap*)) ) OR
AB ( ((transcrani* OR crani* OR brain*) AND (electrostim* OR electro-stim* OR electrotherap* OR electro-therap*)) )
S8 TI ( ((transcrani* OR crani* OR brain*) AND (electrostim* OR electro-stim* OR electrotherap* OR electro-therap*)) ) OR
AB ( ((transcrani* OR crani* OR brain*) AND (electrostim* OR electro-stim* OR electrotherap* OR electro-therap*)) )
S7 TI ( ((brain* OR cortex OR cortical OR transcranial* OR cranial OR magneti*) AND stimulat*) ) OR AB ( ((brain* OR
cortex OR cortical OR transcranial* OR cranial OR magneti*) AND stimulat*) )
S6 (MH “Electric Stimulation”)
S5 (MH “Electronarcosis”)
S4 S1 OR S2 OR S3
S3 TI ( (sciatica OR back-ache OR back*ache OR lumbago OR fibromyalg* OR “trigemin* neuralg*” OR “herp* neuralg*” OR
“diabet* neuropath*” OR “reflex dystroph*” OR “sudeck* atroph*” OR causalg* OR whip-lash OR whip*lash OR polymyalg* OR
“failed back surg*” OR “failed back syndrome*”) ) OR AB ( (sciatica OR back-ache OR back*ache OR lumbago OR fibromyalg* OR
“trigemin* neuralg*” OR “herp* neuralg*” OR “diabet* neuropath*” OR “reflex dystroph*” OR “sudeck* atroph*” OR causalg* OR
whip-lash OR whip*lash OR polymyalg* OR “failed back surg*” OR “failed back syndrome*”) )
S2 TI ( ((chronic* OR back OR musculoskel* OR intractabl* OR neuropath* OR phantom limb OR fantom limb OR neck
OR myofasc* OR “temporomandib* joint*” OR “temperomandib* joint*” OR “tempromandib* joint*” OR central OR post*stroke
OR complex OR regional OR spinal cord) AND pain*). ) OR AB ( ((chronic* OR back OR musculoskel* OR intractabl* OR
neuropath* OR phantom limb OR fantom limb OR neck OR myofasc* OR “temporomandib* joint*” OR “temperomandib* joint*”
OR “tempromandib* joint*” OR central OR post*stroke OR complex OR regional OR spinal cord) AND pain*))
S1 (MH “Pain+”)
LILACS (7 February 2013)
1. (chronic$ or back or musculoskel$ or intractabl$ or neuropath$ or phantom limb or fantom limb or neck or myofasc$ or
temporomandib$ or temperomandib$ or tempromandib$ or central or (post stroke) or complex or regional or spinal cord sciatica or
back-ache or back ache or lumbago or fibromyalg$ or trigemin$ neuralg$ or herp$ neuralg$ or diabet$ neuropath$ or reflex dystroph$
or sudeck$ atrophy$ or causalg$ or whip-lash or whip$lash or polymyalg$ or failed back) 69863
2. (brain$ or cortex or cortical or transcrani$ or cranial or magneti$ stimulat$ or electrostim$ or electro-stim$ or electrotherapy$ or
electro-therap$ or non-invasive or non invasive or stimul$ or theta burst stimulat$ or iTBS or cTBS or transcranial magnetic stimulat$
or rTMS or transcranial direct current stimulat$ or tDCS or cranial electrostimulation or cranial electrotherapy$ or electrosleep$ or
electronarco$) 24787
3. 1&2 5559
4. (randomized controlled trial or controlled clinical trial or placebo or sham or randomly or trial or groups) 31227
5. 3&4 545
6. REMOVE ANY PRE 2009 (removed 292) 253
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Appendix 5. Trials register search results for 2014 update
Register Date of search Search terms Number of records Number of relevant records
NRR archive 7 February 2013 (chronic* or back or mus-
culoskel* or intractabl*
or neuropath* or phan-
tom limb or fantom limb
or neck or myofasc* or
temp*romandib joint or
central or post*stroke or
complex or regional or
spinal cord or sciatica or
back-ache or back*ache or
lumbago or fibromyalg*
or trigem* neuralg* or
herp* neuralg* or diabet*
neuropath* or reflex dys-
troph* or sudeck* atroph*
or causalg* or whip-lash or
whip*lash or polymyalg*
or failed back surg*
or failed back syndrome)
AND (brain* or cortex or
cortical or transcranial* or
cranial or magneti* or di-
rect current or DC or elec-
tric or crani* or electros-
tim* or electrotherap* or
electro-therap* or non-in-
vasive or non*invasive or
theta burst stimulat* or
iTBS or Ctbs or transcra-
nial magnetic stimulation
or rTMSor transcranial di-
rect current stimulation or
tDCS or cranial electros-
timulation or cranial elec-
trotherapy or electrosleep
or electronarco*) al fields
AND (2009 OR 2010 OR
2011 OR 2012 OR 2013)
date started
2 0
Clinical trials.gov 7 February 2013 Field - Interventional
studies
CONDITION: chronic*
OR back OR muscu-
loskel* OR intractabl* OR
89 10
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(Continued)
neuropath* OR phantom
limb OR fantom limb OR
neck OR myofasc* OR
temp?romandib joint OR
central OR post*stroke
OR complex OR regional
OR spinal cord OR sci-
atica OR back-ache OR
back*ache OR lumbago
INTERVEN-
TION: brain* OR cortex
OR cortical OR transcra-
nial* OR cranial OR mag-
neti* OR direct current
OR DC OR electric OR
crani* OR electrostim*
OR electrotherap* OR
electro-therap* OR non-
invasive OR non*invasive
OR theta burst stimulat*
OR iTBS OR Ctbs
OUTCOME: pain
01/01/2009 to 07/02/
2013
adult
Clinical trials.gov 7 February 2013 Field - Interventional
studies
CONDITION: chronic*
OR back OR muscu-
loskel* OR intractabl* OR
neuropath* OR phantom
limb OR fantom limb OR
neck OR myofasc* OR
temp?romandib joint OR
central OR post*stroke
OR complex OR regional
OR spinal cord OR sci-
atica OR back-ache OR
back*ache OR lumbago
INTERVENTION: tran-
scranial magnetic stimu-
lation OR rTMS OR
transcranial direct current
20
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(Continued)
stimulation OR tDCS OR
cranial electrostimulation
OR cranial electrotherapy
OR electrosleep OR elec-
tronarco*
OUTCOME: pain
Clinical trials.gov 7 February 2013 Field - Interventional
studies
CONDITION:
fibromyalg* OR trigem*
neuralg* OR herp* neu-
ralg* OR diabet* neu-
ropath* OR reflex dys-
troph* OR sudeck* at-
roph* OR causalg* OR
whip-lash OR whip*lash
or polymyalg* OR failed
back surg* OR failed back
syndrome
INTERVEN-
TION: brain* OR cortex
OR cortical OR transcra-
nial* OR cranial OR mag-
neti* OR direct current
OR DC OR electric OR
crani* OR electrostim*
OR electrotherap* OR
electro-therap* OR non-
invasive OR non*invasive
OR theta burst stimulat*
OR iTBS OR Ctbs
OUTCOME: pain
2
Clinical trials.gov 7 February 2013
Field - Interventional
studies
CONDITION:
fibromyalg* OR trigem*
neuralg* OR herp* neu-
ralg* OR diabet* neu-
ropath* OR reflex dys-
0
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(Continued)
troph* OR sudeck* at-
roph* OR causalg* OR
whip-lash OR whip*lash
or polymyalg* OR failed
back surg* OR failed back
syndrome
INTERVENTION: tran-
scranial magnetic stimu-
lation OR rTMS OR
transcranial direct current
stimulation OR tDCS OR
cranial electrostimulation
OR cranial electrotherapy
OR electrosleep OR elec-
tronarco*
OUTCOME: pain
HSRProj 11 February 2013 ((chronic* or back or mus-
culoskel* or intractabl* or
neuropath* or phantom
limb or fantom limb or
neck or myofasc* or temp?
romandib joint or central
or post*stroke or complex
or regional or spinal cord
or sciatica or back-ache
or back*ache or lumbago
or fibromyalg* or trigem*
neuralg* or herp* neuralg*
or diabet* neuropath* or
reflex dystroph* or sudeck*
atroph* or causalg* or
whip-lash or whip*lash or
polymyalg* or failed back
surg* or failed back syn-
drome) AND (brain* or
cortex or cortical or tran-
scranial* or cranial or
magneti* or direct cur-
rent or DC or electric
or crani* or electrostim*
or electrotherap* or elec-
tro-therap* or non-inva-
sive or non*invasive or
theta burst stimulat* or
iTBS or Ctbs or transcra-
152 0
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(Continued)
nial magnetic stimulation
or rTMSor transcranial di-
rect current stimulation or
tDCS or cranial electros-
timulation or cranial elec-
trotherapy or electrosleep
or electronarco*))
Current controlled trials
(excl clinicatrials.gov)
11 February 2013 (sudeck* atroph*
OR causalg* OR whip-
lash OR whip*lash OR
polymyalg*OR failed back
surg* OR failed back syn-
drome) AND(cranial elec-
trotherapyORelectrosleep
OR electronarco*)
0 1
Current controlled trials
(excl clinicatrials.gov)
11 February 2013 (sudeck*
atroph* OR causalg* OR
whip-lash OR whip*lash
OR polymyalg* OR failed
back surg* OR failed back
syndrome) AND (Ctbs
OR transcranial magnetic
stimulationOR rTMSOR
transcranial direct current
stimulation OR tDCS OR
cranial electrostimulation)
0
Current controlled trials
(excl clinicatrials.gov)
25 February 2013 TRANSCRANIAL and
PAIN
1
Current controlled trials
(excl clinicatrials.gov)
25 February 2013 CRANIAL AND PAIN 4
Current controlled trials
(excl clinicatrials.gov)
25/2/13 STIMULATION AND
PAIN
75
Current controlled trials
(excl clinicatrials.gov)
25 February 2013 (Cortex or cortical) and
pain
8
Current controlled trials
(excl clinicatrials.gov)
25 February 2013 Brain and pain 33
Current controlled trials
(excl clinicatrials.gov)
25 February 2013 (Electro or electrical) and
pain
46
Total current controlled
trials
25 February 2013 167
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(Continued)
Total relevant trial records, all databases 11
Appendix 6. Search results summary table for 2014 update
Database searched Date searched Number of results
CENTRAL Issue 6 of 12, 2013 (The
Cochrane Library)
24 July 2013 2
MEDLINE (OVID) June 2013 to 19/7/
2013
MEDLINE In Process (OVID) - current
week
24 July 2013
24 July 2013
5
19
Embase (OVID) June 2013 to 2013 week
29
24 July 2013 8
PsycINFO (OVID) June 2013 to July week
3 2013
24 July 2013 1
CINAHL (EBSCO) June 2013 to July
2013
24 July 2013 4
Total 39
After de-duplication 35
After title abstract screening 0
After expert checking 2
Appendix 7. Full list of searches and results for 2009 version of review
1. Cochrane PaPaS Group Specialised Register, saved search: 177 results
“electric* stimulat* therap*” or “brain* stimulat*” or “cort* stimulat*” or “transcranial* stimulat*” or “cranial stimulat*” or “magneti*
stimulat*” or “direct current stimulat*” or “electric* stimulat*” or electrostim* or electrotherapy* or electro-therap* or “theta burst
stimulat*” or “transcran* magnet* stimulat*” or iTBS or cTBS or rTMS or “transcran* direct current stimulat*” or tDCS or electrosleep
or electronarco*
2. CENTRAL in The Cochrane Library
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#1 MeSH descriptor Pain explode all trees 25049
#2 (chronic* or back or musculoskel* or intractabl* or
neuropath* or phantom limb or fantom limb or neck or
myofasc* or “temporomandib* joint” or “temperomandib*
joint” or “tempromandib* joint” or central or (post NEXT
stroke) or complex or regional or “spinal cord”) near/4
pain*:ti,ab,kw
7785
#3 (sciatica or back-ache or back*ache or lumbago or
fibromyalg* or (trigemin* near/2 neuralg*) or (herp* near/2
neuralg*) or (diabet* near/2 neuropath*) or (reflex near/4
dystroph*) or (sudeck* near/2 atroph*) or causalg* or whip-
lash or whip*lash or polymyalg* or (failed back near/4
surg*) or (failed back near/4 syndrome*)):ti,ab,kw
3040
#4 (#1 OR #2 OR #3) 30353
#5 MeSH descriptor Transcranial Magnetic Stimulation
explode all trees
328
#6 MeSH descriptor Electronarcosis explode all trees 34
#7 (brain* or cortex or cortical or transcranial* or cranial or
magneti*) near/4 stimulat*:ti,ab,kw
1388
#8 (transcrani* or crani* or brain*) near/4 (electrostim* or
electro-stim* or electrotherap* or electro-therap*):ti,ab,kw
45
#9 (non-invasive or non*invasive) near/4 stimulat*:ti,ab,kw 55
#10 “theta burst stimulat*” or iTBS or cTBS:ti,ab,kw 9
#11 “transcranial magnetic stimulation” or rTMS or
“transcranial direct current stimulat*” or tDCS or “cranial
electrostimulation” or “cranial electrotherap*”:ti,ab,kw
747
#12 (electrosleep* or electronarco*):ti,ab,kw 45
#13 (#5 OR #6 OR #7 OR #8 OR #9 OR #10 OR #11 OR
#12)
1505
#14 (#4 AND #13) 106
3a. MEDLINE
Database: Ovid MEDLINE(R) <1950 to November Week 3 2009>
1 exp Pain/ (252061)
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2 ((chronic* or back or musculoskel* or intractabl* or neuropath* or phantom limb or fantom limb or neck or myofasc* or
“temporomandib* joint*” or “temperomandib* joint*” or “tempromandib* joint*” or central or post*stroke or complex or regional or
spinal cord) adj4 pain*).ab,ti. (61945)
3 (sciatica or back-ache or back*ache or lumbago or fibromyalg* or (trigemin* adj2 neuralg*) or (herp* adj2 neuralg*) or (diabet*
adj2 neuropath*) or (reflex adj4 dystroph*) or (sudeck* adj2 atroph*) or causalg* or whip-lash or whip*lash or polymyalg* or (failed
back adj4 surg*) or (failed back adj4 syndrome*)).ab,ti. (25802)
4 1 or 3 or 2 (288507)
5 Transcranial Magnetic Stimulation/ or Electronarcosis/ (4240)
6 ((brain* or cortex or cortical or transcranial* or cranial or magneti*) adj4 stimulat*).ab,ti. (21248)
7 ((transcrani* or crani* or brain*) adj4 (electrostim* or electro-stim* or electrotherap* or electro-therap*)).ab,ti. (116)
8 ((non-invasive or non*invasive) adj4 stimulat*).ab,ti. (526)
9 (theta burst stimulat* or iTBS or cTBS).ab,ti. (359)
10 (transcranial magnetic stimulation or rTMS or transcranial direct current stimulation or tDCS or cranial electrostimulation or
cranial electrotherapy).ab,ti. (5306)
11 (electrosleep or electronarco*).ab,ti. (357)
12 8 or 6 or 11 or 7 or 10 or 9 or 5 (23212)
13 4 and 12 (1069)
14 randomised controlled trial.pt. (291031)
15 controlled clinical trial.pt. (82962)
16 randomized.ab. (196258)
17 (placebo or sham).ab,ti. (164609)
18 drug therapy.fs. (1385685)
19 randomly.ab. (141449)
20 trial.ab. (203139)
21 groups.ab. (961704)
22 or/14-21 (2562312)
23 exp animals/ not humans.sh. (3518581)
24 22 not 23 (2157467)
25 24 and 13 (219)
3b. Database: Ovid MEDLINE(R) In-process & Other non-indexed citations
<25 November 2009>
1 exp Pain/ (6)
2 ((chronic* or back or musculoskel* or intractabl* or neuropath* or phantom limb or fantom limb or neck or myofasc* or
“temporomandib* joint*” or “temperomandib* joint*” or “tempromandib* joint*” or central or post*stroke or complex or regional or
spinal cord) adj4 pain*).ab,ti. (4772)
3 (sciatica or back-ache or back*ache or lumbago or fibromyalg* or (trigemin* adj2 neuralg*) or (herp* adj2 neuralg*) or (diabet*
adj2 neuropath*) or (reflex adj4 dystroph*) or (sudeck* adj2 atroph*) or causalg* or whip-lash or whip*lash or polymyalg* or (failed
back adj4 surg*) or (failed back adj4 syndrome*)).ab,ti. (1251)
4 1 or 3 or 2 (5661)
5 Transcranial Magnetic Stimulation/ or Electronarcosis/ (0)
6 ((brain* or cortex or cortical or transcranial* or cranial or magneti*) adj4 stimulat*).ab,ti. (1057)
7 ((transcrani* or crani* or brain*) adj4 (electrostim* or electro-stim* or electrotherap* or electro-therap*)).ab,ti. (5)
8 ((non-invasive or non*invasive) adj4 stimulat*).ab,ti. (42)
9 (theta burst stimulat* or iTBS or cTBS).ab,ti. (38)
10 (transcranial magnetic stimulation or rTMS or transcranial direct current stimulation or tDCS or cranial electrostimulation or
cranial electrotherapy).ab,ti. (375)
11 (electrosleep or electronarco*).ab,ti. (0)
12 8 or 6 or 11 or 7 or 10 or 9 or 5 (1113)
13 4 and 12 (39)
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4. Database: Embase
<1980 to 2009 Week 47>
1 exp Pain/ (394924)
2 ((chronic* or back or musculoskel* or intractabl* or neuropath* or phantom limb or fantom limb or neck or myofasc* or
“temporomandib* joint*” or “temperomandib* joint*” or “tempromandib* joint*” or central or post*stroke or complex or regional or
spinal cord) adj4 pain*).ab,ti. (57196)
3 (sciatica or back-ache or back*ache or lumbago or fibromyalg* or (trigemin* adj2 neuralg*) or (herp* adj2 neuralg*) or (diabet*
adj2 neuropath*) or (reflex adj4 dystroph*) or (sudeck* adj2 atroph*) or causalg* or whip-lash or whip*lash or polymyalg* or (failed
back adj4 surg*) or (failed back adj4 syndrome*)).ab,ti. (21356)
4 1 or 3 or 2 (410258)
5 Transcranial Magnetic Stimulation/ or Electronarcosis/ (5841)
6 ((brain* or cortex or cortical or transcranial* or cranial or magneti*) adj4 stimulat*).ab,ti. (18227)
7 ((transcrani* or crani* or brain*) adj4 (electrostim* or electro-stim* or electrotherap* or electro-therap*)).ab,ti. (74)
8 ((non-invasive or non*invasive) adj4 stimulat*).ab,ti. (498)
9 (theta burst stimulat* or iTBS or cTBS).ab,ti. (330)
10 (transcranial magnetic stimulation or rTMS or transcranial direct current stimulation or tDCS or cranial electrostimulation or
cranial electrotherapy).ab,ti. (5259)
11 (electrosleep or electronarco*).ab,ti. (20)
12 8 or 6 or 11 or 7 or 10 or 9 or 5 (19954)
13 4 and 12 (1331)
14 random*.ti,ab. (415216)
15 factorial*.ti,ab. (8708)
16 (crossover* or cross over* or cross-over*).ti,ab. (40788)
17 placebo*.ti,ab. (114266)
18 (doubl* adj blind*).ti,ab. (87525)
19 (singl* adj blind*).ti,ab. (7775)
20 assign*.ti,ab. (113729)
21 allocat*.ti,ab. (36179)
22 volunteer*.ti,ab. (102464)
23 CROSSOVER PROCEDURE.sh. (21985)
24 DOUBLE-BLIND PROCEDURE.sh. (74829)
25 RANDOMIZED CONTROLLED TRIAL.sh. (176320)
26 SINGLE BLIND PROCEDURE.sh. (8721)
27 or/14-26 (691134)
28 ANIMAL/ or NONHUMAN/ or ANIMAL EXPERIMENT/ (3551150)
29 HUMAN/ (6702208)
30 28 and 29 (569432)
31 28 not 30 (2981718)
32 27 not 31 (601828)
33 32 and 13 (234)
5. Database: PsycINFO
<1806 to November Week 4 2009>
1 exp Pain/ (26560)
2 ((chronic* or back or musculoskel* or intractabl* or neuropath* or phantom limb or fantom limb or neck or myofasc* or temp?
romandib* joint or central or post*stroke or complex or regional or spinal cord) adj4 pain*).ab,ti. (14094)
3 (sciatica or back-ache or back*ache or lumbago or fibromyalg* or (trigemin* adj2 neuralg*) or (herp* adj2 neuralg*) or (diabet*
adj2 neuropath*) or (reflex adj4 dystroph*) or (sudeck* adj2 atroph*) or causalg* or whip-lash or whip*lash or polymyalg* or (failed
back adj4 surg*) or (failed back adj4 syndrome*)).ab,ti. (2649)
4 1 or 3 or 2 (30822)
5 Transcranial Magnetic Stimulation/ or Electrosleep treatment/ (1830)
6 ((brain* or cortex or cortical or transcranial* or cranial or magneti*) adj4 stimulat*).ab,ti. (7832)
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7 ((transcrani* or crani* or brain*) adj4 (electrostim* or electro-stim* or electrotherap* or electro-therap*)).ab,ti. (47)
8 ((non-invasive or non*invasive) adj4 stimulat*).ab,ti. (144)
9 (theta burst stimulat* or iTBS or cTBS).ab,ti. (259)
10 (transcranial magnetic stimulation or rTMS or transcranial direct current stimulation or tDCS or cranial electrostimulation or
cranial electrotherapy).ab,ti. (2652)
11 (electrosleep or electronarco*).ab,ti. (140)
12 8 or 6 or 11 or 7 or 10 or 9 or 5 (8307)
13 4 and 12 (277)
14 (random* or placebo* or sham or trial or groups).ti,ab. (391590)
15 13 and 14 (64)
6. CINAHL
<Search run 11 January 2010>
1 exp PAIN/ 64959
2 ((chronic* OR back OR musculoskel* OR intractabl* OR
neuropath* OR phantom limb OR fantom limb OR neck
OR myofasc* OR ”temporomandib* joint*“ OR ”tempero-
mandib* joint*“ OR ”tempromandib* joint*“ OR central OR
post*stroke OR complex OR regional OR spinal cord) AND
pain*).ti,ab
25127
3 (sciatica OR back-ache OR back*ache OR lumbago OR fi-
bromyalg* OR ”trigemin* neuralg*“ OR ”herp* neuralg*“ OR
”diabet* neuropath*“ OR ”reflex dystroph*“ OR ”sudeck*
atroph*“ OR causalg* OR whip-lash OR whip*lash OR
polymyalg* OR ”failed back surg*“ OR ”failed back syn-
drome*“).ti,ab
4111
4 1 OR 2 OR 3 75018
5 ELECTRONARCOSIS/ 1
6 ELECTRIC STIMULATION/ 3829
7 ((brain* OR cortex OR cortical OR transcranial* OR cranial
OR ”magneti*) AND stimulat*).ti,ab
545
8 ((transcrani* OR crani* OR brain*) AND (electrostim* OR
electro-stim* OR electrotherap* OR electro-therap*)).ti,ab
26
9 ((“non-invasive brain” OR “non*invasive brain”) AND stimu-
lat*).ti,ab
12
10 (“theta burst stimulat*” OR iTBS OR cTBS).ti,ab 16
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(Continued)
11 (“transcranial magnetic stimulation” OR rTMS OR “transcra-
nial direct current stimulation” OR tDCS OR “cranial elec-
trostimulation” OR “cranial electrotherapy”).ti,ab
437
12 (electrosleep OR electronarco*).ti,ab 1
13 5 OR 6 OR 7 OR 8 OR 9 OR 10 OR 11 OR 12 4387
14 4 AND 13 836
15 exp CLINICAL TRIALS/ 79642
16 (clinical AND trial*).af 148411
17 ((singl* OR doubl* OR trebl* OR tripl*) AND (blind* OR
mask*)).ti,ab
11736
18 (Randomi?ed AND control* AND trial*).af 65515
19 RANDOM ASSIGNMENT/ 22506
20 (Random* AND allocat*).ti,ab 3666
21 placebo*.af 34556
22 PLACEBOS/ 5386
23 QUANTITATIVE STUDIES/ 5131
24 15 OR 16 OR17 OR 18 OR 19 OR 20 OR 21 OR 22 OR 23 176918
25 14 AND 24 226
7. SCOPUS
We did not search this database as it includes all of MEDLINE, all of Embase and some of CINAHL, which have been searched
separately.
8. Search strategy for LILACS
http://bases.bireme.br/cgi-bin/wxislind.exe/iah/online/
1. Pain$ or dolor$ or intractabl$ or neuropath$ or phantom or fantom or myofasc$ or temp$romandibular or sciatic$ or back-ache or
backache or ache or lumbago or fibromyalg$ or neuralg$ or dystroph$ or atroph$ or causalgi$ or whip-lash or whiplash or polymyalg$
[Words]
2. ((Estimulaci$ or stimulat$) and (cerebra$ or brain$ or cortex or cortical or crania$ or transcranial$ or magneti$)) or electrostim$ or
electrotherapy$ or electro-therap$ or “theta burst stimul$” or iTBS or Ctbs or “transcrani$ magnet$ stimulat$” or rTMS or “transcrani$
direct current stimulat$” or tDCS or “cranial electrostimulat$” or “cranial electrotherapy$ or electrosleep or electronarco$ [Words]
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3. ((Pt randomized controlled trial OR Pt controlled clinical trial OR Mh randomized controlled trials OR Mh random allocation
OR Mh double-blind method OR Mh single-blind method) AND NOT (Ct animal AND NOT (Ct human and Ct animal)) OR
(Pt clinical trial OR Ex E05.318.760.535$ OR (Tw clin$ AND (Tw trial$ OR Tw ensa$ OR Tw estud$ OR Tw experim$ OR Tw
investiga$)) OR ((Tw singl$ OR Tw simple$ OR Tw doubl$ OR Tw doble$ OR Tw duplo$ OR Tw trebl$ OR Tw trip$) AND (Tw
blind$ OR Tw cego$ OR Tw ciego$ OR Tw mask$ OR Tw mascar$)) OR Mh placebos OR Tw placebo$ OR (Tw random$ OR Tw
randon$ OR Tw casual$ OR Tw acaso$ OR Tw azar OR Tw aleator$) OR Mh research design) AND NOT (Ct animal AND NOT
(Ct human and Ct animal)) OR (Ct comparative study OR Ex E05.337$ OR Mh follow-up studies OR Mh prospective studies OR
Tw control$ OR Tw prospectiv$ OR Tw volunt$ OR Tw volunteer$) ANDNOT (Ct animal ANDNOT (Ct human and Ct animal)))
[Words]
4. 1 and 2 and 3 (68)
Appendix 8. Trials register search results for 2009 version of review
Database Date of search Search strategy No. hits Agreed potential stud-
ies
National Research Reg-
ister (NRR) Archive
(NIHR)
23 October 2009 (chronic* or back
or musculoskel* or in-
tractabl* or neuropath*
or phantom limb or fan-
tom limb or neck or
myofasc* or temp?ro-
mandib joint or central
or post*stroke or com-
plex or regional or spinal
cord or sciatica or back-
ache or back*ache or
lumbago or fibromyalg*
or trigem* neuralg* or
herp* neuralg* or dia-
bet* neuropath* or re-
flex dystroph* or sudeck*
atroph* or causalg* or
whip-lash or whip*lash
or polymyalg* or failed
back surg* or failed back
syndrome) AND (brain*
or cortex or cortical or
transcranial* or cranial
or
magneti* or direct cur-
rent or DC or electric or
crani* or electrostim* or
electrotherap* or electro-
therap* or non-invasive
or non*invasive or theta
burst stimulat* or iTBS
or Ctbs or transcranial
magnetic stimulation or
366 2
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(Continued)
rTMS or transcranial di-
rect current stimulation
or tDCS or cranial elec-
trostimulation or cranial
electrotherapy
or electrosleep or elec-
tronarco*) IN “TITLE”
Field
Clinicaltrials.gov 23 October 2009
Search 1
Field - Interventional
studies
CONDITION:
chronic* OR back OR
musculoskel* OR in-
tractabl*ORneuropath*
OR phantom limb OR
fantom limb OR neck
OR myofasc* OR temp?
romandib joint OR cen-
tral OR post*stroke OR
complex OR regional
OR spinal cord OR sci-
atica OR back-ache OR
back*ache OR lumbago
INTER-
VENTION: brain* OR
cortex OR cortical OR
transcranial* OR cranial
OR magneti* OR di-
rect current ORDCOR
electric OR crani* OR
electrostim* OR elec-
trotherap* OR electro-
therap* OR non-inva-
sive OR non*invasive
OR theta burst stimulat*
OR iTBS OR Ctbs
OUTCOME: pain
62
Clinicaltrials.gov 23 October 2009
Search 2
Field - Interventional
studies
CONDITION:
chronic* OR back OR
musculoskel* OR in-
tractabl*ORneuropath*
OR phantom limb OR
fantom limb OR neck
OR myofasc* OR temp?
romandib joint OR cen-
8 (all also picked up in
search 1)
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(Continued)
tral OR post*stroke OR
complex OR regional
OR spinal cord OR sci-
atica OR back-ache OR
back*ache OR lumbago
INTERVENTION:
transcranial magnetic
stimulation OR rTMS
OR transcranial direct
current stimulation OR
tDCS OR cranial elec-
trostimulation OR cra-
nial electrotherapy OR
electrosleep OR elec-
tronarco*
OUTCOME: pain
Clinicaltrials.gov 23 October 2009
Search 3
Field - Interventional
studies
CONDITION:
fibromyalg* OR trigem*
neuralg* OR herp* neu-
ralg* OR diabet* neu-
ropath* OR reflex dys-
troph* OR sudeck* at-
roph* OR causalg* OR
whip-lash OR whip*lash
or polymyalg* OR failed
back surg* OR failed
back syndrome
INTER-
VENTION: brain* OR
cortex OR cortical OR
transcranial* OR cranial
OR magneti* OR di-
rect current ORDCOR
electric OR crani* OR
electrostim* OR elec-
trotherap* OR electro-
therap* OR non-inva-
sive OR non*invasive
OR theta burst stimulat*
OR iTBS OR Ctbs
OUTCOME: pain
0
Clinicaltrials.gov 23 October 2009
Search 4
Field - Interventional
studies
CONDITION:
fibromyalg* OR trigem*
0
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(Continued)
neuralg* OR herp* neu-
ralg* OR diabet* neu-
ropath* OR reflex dys-
troph* OR sudeck* at-
roph* OR causalg* OR
whip-lash OR whip*lash
or polymyalg* OR failed
back surg* OR failed
back syndrome
INTERVENTION:
transcranial magnetic
stimulation OR rTMS
OR transcranial direct
current stimulation OR
tDCS OR cranial elec-
trostimulation OR cra-
nial electrotherapy OR
electrosleep OR elec-
tronarco*
OUTCOME: pain
TOTAL UNIQUE RE-
SULTS FOR CLINI-
CAL TRIALS.GOV
62 7
HSRProj (Health Ser-
vices Research Projects
in Progress)
23 October 2009 (chronic* or back
or musculoskel* or in-
tractabl* or neuropath*
or phantom limb or fan-
tom limb or neck or
myofasc* or temp?ro-
mandib joint or central
or post*stroke or com-
plex or regional or spinal
cord or sciatica or back-
ache or back*ache or
lumbago or fibromyalg*
or trigem* neuralg* or
herp* neuralg* or dia-
bet* neuropath* or re-
flex dystroph* or sudeck*
atroph* or causalg* or
whip-lash or whip*lash
or polymyalg* or failed
back surg* or failed back
syndrome) AND (brain*
or cortex or cortical or
transcranial* or cranial
or
77 0
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(Continued)
magneti* or direct cur-
rent or DC or electric or
crani* or electrostim* or
electrotherap* or electro-
therap* or non-invasive
or non*invasive or theta
burst stimulat* or iTBS
or Ctbs or transcranial
magnetic stimulation or
rTMS or transcranial di-
rect current stimulation
or tDCS or cranial elec-
trostimulation or cranial
electrotherapy
or electrosleep or elec-
tronarco*)
Current Controlled Tri-
als
23 October 2009
Search 1
(sudeck* atroph*
OR causalg* OR whip-
lash OR whip*lash OR
polymyalg* OR failed
back surg* OR failed
back syndrome) AND
(cranial electrother-
apy OR electrosleep OR
electronarco*)
0
Current Controlled Tri-
als
23 October 2009
Search 2
(sudeck* atroph*
OR causalg* OR whip-
lash OR whip*lash OR
polymyalg* OR failed
back surg* OR failed
back syndrome) AND
(Ctbs OR transcranial
magnetic stimulation
OR rTMS OR transcra-
nial direct current stimu-
lationOR tDCSORcra-
nial electrostimulation)
0
Current Controlled Tri-
als
23 October 2009
Search 3
(sudeck* atroph*
OR causalg* OR whip-
lash OR whip*lash OR
polymyalg* OR failed
back surg* OR failed
back syndrome) AND
(crani* OR electrostim*
OR
electrotherap* OR elec-
4
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(Continued)
tro-therap* OR non-in-
vasive OR non*invasive
OR theta burst stimulat*
OR iTBS)
Current Controlled Tri-
als
23 October 2009
Search 4
(sudeck* atroph*
OR causalg* OR whip-
lash OR whip*lash OR
polymyalg* OR failed
back surg* OR failed
back syndrome) AND
(brain* OR cortex OR
corticalOR transcranial*
OR cranialORmagneti*
OR direct current OR
DC)
13
Current Controlled Tri-
als
23 October 2009
Search 5
(back-ache
OR back*ache OR lum-
bago OR fibromyalg*
OR trigem* neuralg*
OR herp* neuralg* OR
diabet* neuropath* OR
reflex dystroph*) AND
(cranial electrostimula-
tion
OR cranial electrother-
apy OR electrosleep OR
electronarco*)
0
Current Controlled Tri-
als
23 October 2009
Search 6
(back-ache
OR back*ache OR lum-
bago OR fibromyalg*
OR trigem* neuralg*
OR herp* neuralg* OR
diabet* neuropath* OR
reflex dystroph*) AND
(Ctbs OR transcranial
magnetic stimulation
OR rTMS OR transcra-
nial direct current stim-
ulation OR tDCS )
9
Current Controlled Tri-
als
3 November 2009
Search 7
(back-ache
OR back*ache OR lum-
bago OR fibromyalg*
OR trigem* neuralg*
OR herp* neuralg* OR
diabet* neuropath* OR
36
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(Continued)
reflex dystroph*) AND
(crani* OR electrostim*
OR electrotherap* OR
electro-therap*)
Current Controlled Tri-
als
23 October 2009
Search 8
(back-
ache OR back*ache OR
lumbago OR
fibromyalg* OR trigem*
neuralg* OR herp* neu-
ralg* OR diabet* neu-
ropath* OR reflex dys-
troph*) AND (non-in-
vasive OR non*invasive
OR theta burst stimulat*
OR iTBS)
53
Current Controlled Tri-
als
3 November 2009
Search 9
(back-ache
OR back*ache OR lum-
bago OR fibromyalg*
OR trigem* neuralg*
OR herp* neuralg* OR
diabet* neuropath* OR
reflex dystroph*) AND
(cranial OR magneti*
OR direct current OR
DC)
52
Current Controlled Tri-
als
3 November 2009
Search 10
(back-ache
OR back*ache OR lum-
bago OR fibromyalg*
OR trigem* neuralg*
OR herp* neuralg* OR
diabet* neuropath* OR
reflex dystroph*) AND
(brain* OR cortex OR
cortical OR transcra-
nial*)
63
Current Controlled Tri-
als
3 November 2009
Search 11
(temp?
romandib joint OR cen-
tral OR post*stroke OR
complex OR regional
OR spinal cord OR sci-
atica) AND(cranial elec-
trostimulation OR cra-
nial electrotherapy OR
electrosleep OR elec-
tronarco*)
0
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(Continued)
Current Controlled Tri-
als
3 November 2009
Search 12
(temp?
romandib joint OR cen-
tral OR post*stroke OR
complex OR regional
OR spinal cord OR sci-
atica) AND (transcranial
direct current stimula-
tion OR tDCS)
11
Current Controlled Tri-
als
3 November 2009
Search 13
(central OR post*stroke
OR com-
plex OR regional OR
spinal cord OR sciatica)
AND (iTBS OR cTBS
OR transcranial mag-
netic stimulation OR
rTMS)
48
Current Controlled Tri-
als
3 November 2009
Search 14
(central OR post*stroke
OR complex OR re-
gional OR spinal cord
OR sciatica) AND (elec-
trotherap* OR electro-
therap* OR non-inva-
sive OR non*invasive
OR theta burst stimu-
lat*)
199
Current Controlled Tri-
als
3 November 2009
Search 15
(central OR
post*stroke OR complex
OR regional OR spinal
cord OR sciatica) AND
(brain* OR cortex OR
corticalOR transcranial*
OR cranialORmagneti*
OR direct current OR
DC OR crani* OR elec-
trostim*)
1905
Current Controlled Tri-
als
3 November 2009
Search 16
(temp?romandib joint)
AND (brain* OR cor-
texOR cortical OR tran-
scranial* OR cranial OR
magneti* OR direct cur-
rent ORDCOR electric
OR crani* OR electros-
tim* OR electrotherap*
OR electro-therap*)
0
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(Continued)
Current Controlled Tri-
als
3 November 2009
Search 17
(temp?romandib joint)
AND (iTBS OR cTBS
OR transcranial mag-
netic stimulation OR
rTMS)
0
Current Controlled Tri-
als
3 November 2009
Search 18
(temp?romandib joint)
AND (non-invasive OR
non*invasive OR theta
burst stimulat*)
0
Current Controlled Tri-
als
3 November 2009
Search 19
(chronic* OR back OR
musculoskel* OR in-
tractabl*ORneuropath*
OR phantom limb OR
fantom limb OR neck)
AND (transcranial di-
rect current stimulation
OR tDCS OR cranial
electrostimulation
OR cranial electrother-
apy OR electrosleep OR
electronarco*)
16
Current Controlled Tri-
als
3 November 2009
Search 20
(chronic* OR back OR
musculoskel* OR in-
tractabl*ORneuropath*
OR phantom limb OR
fantom limb OR neck)
AND (Ctbs OR tran-
scranial magnetic stimu-
lation OR Rtms)
55
Current Controlled Tri-
als
3 November 2009
Search 21
(chronic* OR back OR
musculoskel* OR in-
tractabl*ORneuropath*
OR phantom limb OR
fantom limb OR neck)
AND (crani* OR elec-
trostim* OR
electrotherap* OR elec-
tro-therap* OR non-in-
vasive OR non*invasive
OR theta burst stimulat*
OR iTBS)
557
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(Continued)
Current Controlled Tri-
als
3 November 2009
Search 22
(chronic* OR back OR
musculoskel* OR in-
tractabl*ORneuropath*
OR phantom limb OR
fantom limb OR neck)
AND (brain* OR cor-
texOR cortical OR tran-
scranial* OR cranial OR
magneti* OR direct cur-
rent OR DC)
2385
Current Controlled Tri-
als
3 November 2009
Search 23
(temp*romandibular
joint) AND (brain* OR
cortex OR cortical OR
transcranial* OR cranial
OR magneti* OR di-
rect current ORDCOR
electric OR crani* OR
electrostim* OR elec-
trotherap*)
8
Current Controlled Tri-
als
3 November 2009
Search 24
(temp*romandibular
joint) AND (elec-
tro-therap* OR non-in-
vasive OR non*invasive
OR theta burst stimu-
lat* OR iTBS OR Ctbs
OR transcranial mag-
netic stimulation)
1
Current Controlled Tri-
als
3 November 2009
Search 25
(temp*romandibular
joint) AND (rTMS OR
transcranial direct
current stimulation OR
tDCS OR cranial elec-
trostimulation OR cra-
nial electrotherapy OR
electrosleep OR elec-
tronarco*)
0
TOTAL
RESULTS FOR CUR-
RENT CON-
TROLLED TRIALS
5415 14
TOTAL
RESULTS FROM ALL
DATABASES
23
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(Continued)
DUPLICATES BE-
TWEEN DATABASES
7
FINAL TOTAL FROM
TRIALS REGISTERS
SEARCHES
16
F E E D B A C K
Feedback received, 7 August 2018
Summary
Name: Caroline Struthers
Email Address: caroline.struthers@csm.ox.ac.uk
Affiliation: UK EQUATOR Centre
Role: Education and Training Manager
Congratulations on this important update. I would like to challenge the authors to go a step further from the detailed “implications for
research” section, design the perfect trial to answer the review question and publish an open-access Cochrane-branded trial protocol.
With the knowledge about the strengths and weaknesses of previous research gained through writing and updating the review, a
structured protocol for a future trial written using the SPIRIT reporting guidelines would be possible to draft in a relatively short space
of time. This would be a constructive way to encourage the production of reliable evidence in this area. There would be huge added
value in the protocol being explicitly linked to the long-standing uncertainty revealed by a Cochrane review. Cochrane could also take
this opportunity to prove its commitment to patient and public involvement in research by involving patients in the design of the
trial including selecting patient-relevant outcomes, and methods to encourage participation. I accept that it’s useful to point out the
flaws in previous research which limit confidence in existing evidence. All Cochrane reviews do this. It would be more constructive
for Cochrane to use the considerable methodological expertise of its authors, and its commitment to patient and public involvement
to help future researchers do better quality primary research. This would distinguish Cochrane from all other producers of systematic
reviews. It would also be of interest to funders who all need assurance that the funds they award go to well-designed research studies of
relevance to patients and carers and will not be wasted. Assuming the protocols were adhered to and reported following the CONSORT
reporting guidelines (and GRIPP2 for patient involvement), the risk of bias would be low across the board, and facilitate inclusion in
future review updates.
Reply
Many thanks for this feedback and your interesting suggestion. While we are not familiar with the concept of a “Cochrane branded
trial protocol” we agree that the development of a full trial protocol would be an important step towards better evaluating a number
of forms of NIBS. As you will appreciate, such a process is a major and complex piece of work that would require funding and goes
beyond the normal scope of undertaking a Cochrane review. It is further complicated by the scope of our review which potentially
might lead to multiple protocols of different NIBS interventions for different patient groups. We feel that we have been quite specific
in our overall recommendations for the design of better future trials, and hope these are useful to the international research community.
However we do not currently have plans to develop a detailed trial protocol.
Reply submitted by Neil E O’Connell
Contributors
Cochrane Pain, Palliative and Supportive Care Review Group Co-ordinating Editor Professor Christopher Eccleston, Feedback Editor
Hayley Barnes, and Managing Editor Anna Erskine.
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WH A T ’ S N E W
Last assessed as up-to-date: 11 October 2017.
Date Event Description
23 August 2018 Feedback has been incorporated See Feedback.
H I S T O R Y
Protocol first published: Issue 1, 2010
Review first published: Issue 9, 2010
Date Event Description
12 April 2018 Amended Review to be published with Gold Open Access.
12 April 2018 New citation required but conclusions have not
changed
Review to be published with Gold Open Access.
7 November 2017 New citation required but conclusions have not
changed
We have updated all analyses and GRADE quality as-
sessments for all core comparisons. The addition of
data has not substantially altered our conclusions that
there remains substantial uncertainty regarding the
effectiveness of non invasive brain stimulation tech-
niques for chronic pain
11 October 2017 New search has been performed We have performed a full update of the searches (Oc-
tober 2017). This involved the inclusion of 38 new
trials with an additional 1225 participants
11 February 2013 New search has been performed For this update we have altered the ’Risk of bias’ assess-
ment to reflect new evidence regarding the adequacy
of blinding of studies of tDCS and we have included
the following new ’Risk of bias’ criteria: sample size
and study duration. Details of this can be found in the
sections: Assessment of risk of bias in included studies
and Description of the intervention. We have also ap-
plied the GRADE approach to assessing the quality of
evidence
13 September 2010 Amended We amended the ’Risk of bias’ tables so that the crite-
rion “allocation concealment” is not assessed for stud-
ies with cross-over designs and the criterion “free from
carry-over effects?” is not assessed for studies with par-
allel designs. These changes are now reflected in Figure
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(Continued)
2, where those criteria now appear as empty boxes for
the appropriate studies. This is in line with the origi-
nal review protocol and the changes are necessary due
to a copy-editing error rather than any change to the
review methods
C O N T R I B U T I O N S O F A U T H O R S
For this update
NOC: co-implemented the search strategy alongside the Cochrane PaPaS Group Information Specialist, applied eligibility criteria,
assessed studies, extracted and analysed data, and led the write-up of the review.
BW: acted as the second review author, applied eligibility criteria, assessed studies, extracted data and assisted with the write-up of the
review.
LM: provided statistical advice and support throughout the review.
LDS: acted as a third review author for conflicts in applying eligibility criteria and assessing included studies.
SS: aupported the implementation and reporting of the review throughout.
All review authors read and commented upon the systematic review and commented on and approved the final manuscript.
For previous versions of this review
NOC: conceived and designed the review protocol, co-implemented the search strategy alongside the Cochrane PaPaS Group Infor-
mation Specialist, applied eligibility criteria, assessed studies, extracted and analysed data, and led the write-up of the review.
BW: closely informed the protocol design and acted as the second review author, applied eligibility criteria, assessed studies, extracted
data and assisted with the write-up of the review.
LM: provided statistical advice and support throughout the review and contributed to the design of the protocol.
LDS: was involved in the conception and design of the review and acted as a third review author for conflicts in applying eligibility
criteria and assessing included studies.
SS: informed the design of the protocol and has supported the implementation and reporting of the review throughout.
All review authors read and commented upon the systematic review and commented on and approved the final manuscript.
D E C L A R A T I O N S O F I N T E R E S T
NOC: none known
LM: none known
SS: none known
LHD: none known
BW: none known
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Internal sources
• Brunel University London, UK.
Salary for authors NOC, LDS
• Edge Hill University, UK.
Salary for author SS
• University College London, UK.
Salary for author LM
• University of Notre Dame Australia, Australia.
Salary for author BMW
External sources
• No sources of support supplied
D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
For this update
For this update we searched ClinialTrials.gov and the World Health Organization International Clinical Trials Registry Platform, as
these searches offer superior coverage to those outlined in our original protocol, and because the meta-register of controlled trials is no
longer operational. We assessed the quality of the body of evidence using GRADE and added three ’Summary of findings’ tables.
For the 2014 update
We did not search the database Scopus in the 2014 update or this update as the other searches had covered the full scope of this database.
In compliance with new author guidelines from Cochrane Pain, Palliative and Supportive Care and the recommendations of Moore
2010 we added two criteria, ’study size’ and ’study duration’, to our ’Risk of bias’ assessment using the thresholds for judgement
suggested by Moore 2010:
• size (we rated studies with fewer than 50 participants per arm as being at high risk of bias, those with between 50 and 199
participants per arm at unclear risk of bias, and 200 or more participants per arm at low risk of bias);
• duration (we rated studies with follow-up of less than two weeks as being at high risk of bias, two to seven weeks at unclear risk
of bias and eight weeks or longer at low risk of bias).
For the 2010 update
As described in detail in Unit of analysis issues, on advice from a Cochrane statistician we meta-analysed parallel and cross-over studies
using the generic inverse variance method rather than combining them without this statistical adjustment as was specified in the
protocol. Subsequently the planned sensitivity analysis investigating the influence of study design was not deemed necessary. However
on advice from a Cochrane statistician we performed a sensitivity analysis to assess the impact of our approach to imputation of standard
errors for cross-over studies.
In order to meet our second objective of considering the influence of varying stimulation parameters, we included studies regardless of
the number of stimulation sessions delivered, including single-dose studies.
The following decision was taken on encountering multiple outcomes within the same time period: for short-term outcomes where
more than one data point was available, we used the first post-stimulation measure; where multiple treatments were given, we took the
first outcome at the end of the treatment period. For medium-term outcomes where more than one data point was available we used
the measure that was closest to the mid-point of this time period. We decided to pool data from studies with a low or unclear risk of
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bias as we felt that the analysis specified in the protocol (including only those studies with an overall low risk of bias) was too stringent
and would not allow any statistical assessment of the data.
We did not use overall risk of bias in sensitivity analyses as we found that it lacked sensitivity. Instead we considered individual criteria
in the ’Risk of bias’ assessment for sensitivity analyses. However, we excluded studies with a ’high’ risk of bias for any criterion from
the meta-analysis except study size and study duration.
For this update we have altered the ’Risk of bias’ assessment to reflect new evidence regarding the adequacy of blinding of studies of
tDCS. Details of this can be found in Assessment of risk of bias in included studies and Description of the intervention.
I N D E X T E R M S
Medical Subject Headings (MeSH)
Brain [∗physiology]; Chronic Pain [∗therapy]; Electric Stimulation Therapy [adverse effects; ∗methods]; PainManagement [∗methods];
Randomized Controlled Trials as Topic; Transcranial Magnetic Stimulation [adverse effects; ∗methods]
MeSH check words
Humans
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